GeneName,gid,AOP_ID,KeyEventName,kid,IsMIE
GABA receptors,"[NCBIGene:2569, 200959]",10,"Generation, Amplified excitatory postsynaptic potential (EPSP)",682,false
GABA receptors,"[NCBIGene:2569, 200959]",10,"Reduction, Neuronal synaptic inhibition",669,false
GABA receptors,"[NCBIGene:2569, 200959]",10,"Binding at picrotoxin site, iGABAR chloride channel",667,true
GABA receptors,"[NCBIGene:2569, 200959]",10,"Occurrence, Epileptic seizure",613,false
GABA receptors,"[NCBIGene:2569, 200959]",10,"Occurrence, A paroxysmal depolarizing shift",616,false
GABA receptors,"[NCBIGene:2569, 200959]",10,"Reduction, Ionotropic GABA receptor chloride channel conductance",64,false
GABAA receptor,[NCBIGene:2550],10,"Generation, Amplified excitatory postsynaptic potential (EPSP)",682,false
GABAA receptor,[NCBIGene:2550],10,"Reduction, Neuronal synaptic inhibition",669,false
GABAA receptor,[NCBIGene:2550],10,"Binding at picrotoxin site, iGABAR chloride channel",667,true
GABAA receptor,[NCBIGene:2550],10,"Occurrence, Epileptic seizure",613,false
GABAA receptor,[NCBIGene:2550],10,"Occurrence, A paroxysmal depolarizing shift",616,false
GABAA receptor,[NCBIGene:2550],10,"Reduction, Ionotropic GABA receptor chloride channel conductance",64,false
GABAB receptors,[NCBIGene:165829],10,"Generation, Amplified excitatory postsynaptic potential (EPSP)",682,false
GABAB receptors,[NCBIGene:165829],10,"Reduction, Neuronal synaptic inhibition",669,false
GABAB receptors,[NCBIGene:165829],10,"Binding at picrotoxin site, iGABAR chloride channel",667,true
GABAB receptors,[NCBIGene:165829],10,"Occurrence, Epileptic seizure",613,false
GABAB receptors,[NCBIGene:165829],10,"Occurrence, A paroxysmal depolarizing shift",616,false
GABAB receptors,[NCBIGene:165829],10,"Reduction, Ionotropic GABA receptor chloride channel conductance",64,false
GABAC receptor,[NCBIGene:200959],10,"Generation, Amplified excitatory postsynaptic potential (EPSP)",682,false
GABAC receptor,[NCBIGene:200959],10,"Reduction, Neuronal synaptic inhibition",669,false
GABAC receptor,[NCBIGene:200959],10,"Binding at picrotoxin site, iGABAR chloride channel",667,true
GABAC receptor,[NCBIGene:200959],10,"Occurrence, Epileptic seizure",613,false
GABAC receptor,[NCBIGene:200959],10,"Occurrence, A paroxysmal depolarizing shift",616,false
GABAC receptor,[NCBIGene:200959],10,"Reduction, Ionotropic GABA receptor chloride channel conductance",64,false
iGABA receptor,[NCBIGene:973],10,"Generation, Amplified excitatory postsynaptic potential (EPSP)",682,false
iGABA receptor,[NCBIGene:973],10,"Reduction, Neuronal synaptic inhibition",669,false
iGABA receptor,[NCBIGene:973],10,"Binding at picrotoxin site, iGABAR chloride channel",667,true
iGABA receptor,[NCBIGene:973],10,"Occurrence, Epileptic seizure",613,false
iGABA receptor,[NCBIGene:973],10,"Occurrence, A paroxysmal depolarizing shift",616,false
iGABA receptor,[NCBIGene:973],10,"Reduction, Ionotropic GABA receptor chloride channel conductance",64,false
iGABAR,[NCBIGene:6418],10,"Generation, Amplified excitatory postsynaptic potential (EPSP)",682,false
iGABAR,[NCBIGene:6418],10,"Reduction, Neuronal synaptic inhibition",669,false
iGABAR,[NCBIGene:6418],10,"Binding at picrotoxin site, iGABAR chloride channel",667,true
iGABAR,[NCBIGene:6418],10,"Occurrence, Epileptic seizure",613,false
iGABAR,[NCBIGene:6418],10,"Occurrence, A paroxysmal depolarizing shift",616,false
iGABAR,[NCBIGene:6418],10,"Reduction, Ionotropic GABA receptor chloride channel conductance",64,false
iGABARs,[NCBIGene:50945],10,"Generation, Amplified excitatory postsynaptic potential (EPSP)",682,false
iGABARs,[NCBIGene:50945],10,"Reduction, Neuronal synaptic inhibition",669,false
iGABARs,[NCBIGene:50945],10,"Binding at picrotoxin site, iGABAR chloride channel",667,true
iGABARs,[NCBIGene:50945],10,"Occurrence, Epileptic seizure",613,false
iGABARs,[NCBIGene:50945],10,"Occurrence, A paroxysmal depolarizing shift",616,false
iGABARs,[NCBIGene:50945],10,"Reduction, Ionotropic GABA receptor chloride channel conductance",64,false
insect iGABARs,[NCBIGene:11188],10,"Generation, Amplified excitatory postsynaptic potential (EPSP)",682,false
insect iGABARs,[NCBIGene:11188],10,"Reduction, Neuronal synaptic inhibition",669,false
insect iGABARs,[NCBIGene:11188],10,"Binding at picrotoxin site, iGABAR chloride channel",667,true
insect iGABARs,[NCBIGene:11188],10,"Occurrence, Epileptic seizure",613,false
insect iGABARs,[NCBIGene:11188],10,"Occurrence, A paroxysmal depolarizing shift",616,false
insect iGABARs,[NCBIGene:11188],10,"Reduction, Ionotropic GABA receptor chloride channel conductance",64,false
mGABAR,[NCBIGene:706],10,"Generation, Amplified excitatory postsynaptic potential (EPSP)",682,false
mGABAR,[NCBIGene:706],10,"Reduction, Neuronal synaptic inhibition",669,false
mGABAR,[NCBIGene:706],10,"Binding at picrotoxin site, iGABAR chloride channel",667,true
mGABAR,[NCBIGene:706],10,"Occurrence, Epileptic seizure",613,false
mGABAR,[NCBIGene:706],10,"Occurrence, A paroxysmal depolarizing shift",616,false
mGABAR,[NCBIGene:706],10,"Reduction, Ionotropic GABA receptor chloride channel conductance",64,false
metabotropic G-protein-coupled receptors,[NCBIGene:2911],10,"Generation, Amplified excitatory postsynaptic potential (EPSP)",682,false
metabotropic G-protein-coupled receptors,[NCBIGene:2911],10,"Reduction, Neuronal synaptic inhibition",669,false
metabotropic G-protein-coupled receptors,[NCBIGene:2911],10,"Binding at picrotoxin site, iGABAR chloride channel",667,true
metabotropic G-protein-coupled receptors,[NCBIGene:2911],10,"Occurrence, Epileptic seizure",613,false
metabotropic G-protein-coupled receptors,[NCBIGene:2911],10,"Occurrence, A paroxysmal depolarizing shift",616,false
metabotropic G-protein-coupled receptors,[NCBIGene:2911],10,"Reduction, Ionotropic GABA receptor chloride channel conductance",64,false
picrotoxin site,[NCBIGene:27445],10,"Generation, Amplified excitatory postsynaptic potential (EPSP)",682,false
picrotoxin site,[NCBIGene:27445],10,"Reduction, Neuronal synaptic inhibition",669,false
picrotoxin site,[NCBIGene:27445],10,"Binding at picrotoxin site, iGABAR chloride channel",667,true
picrotoxin site,[NCBIGene:27445],10,"Occurrence, Epileptic seizure",613,false
picrotoxin site,[NCBIGene:27445],10,"Occurrence, A paroxysmal depolarizing shift",616,false
picrotoxin site,[NCBIGene:27445],10,"Reduction, Ionotropic GABA receptor chloride channel conductance",64,false
Cyclooxygenase,[NCBIGene:5742],100,"Reduced, Reproductive Success",675,false
Cyclooxygenase,[NCBIGene:5742],100,"Reduced, Prostaglandin F2alpha concentration, plasma",671,false
Cyclooxygenase,[NCBIGene:5742],100,"Reduced, Prostaglandin F2alpha synthesis, ovary",672,false
Cyclooxygenase,[NCBIGene:5742],100,"Reduced, Spawning behavior",673,false
Cyclooxygenase,[NCBIGene:5742],100,"Reduced, Ability to attract spawning mates",674,false
Cyclooxygenase,[NCBIGene:5742],100,"Inhibition, Cyclooxygenase activity",79,true
Cyclooxygenase,[NCBIGene:5742],100,"Decrease, Population growth rate",360,false
Cyclooxygenase,[NCBIGene:5742],101,"Reduced, Reproductive Success",675,false
Cyclooxygenase,[NCBIGene:5742],101,"Reduced, Prostaglandin F2alpha concentration, plasma",671,false
Cyclooxygenase,[NCBIGene:5742],101,"Reduced, Ability to attract spawning mates",674,false
Cyclooxygenase,[NCBIGene:5742],101,"Reduced, Pheromone release",678,false
Cyclooxygenase,[NCBIGene:5742],101,"Decreased, Prostaglandin F2alpha synthesis, ovary",681,false
Cyclooxygenase,[NCBIGene:5742],101,"Inhibition, Cyclooxygenase activity",79,true
Cyclooxygenase,[NCBIGene:5742],101,"Decrease, Population growth rate",360,false
Cyclooxygenase,[NCBIGene:5742],102,"Reduced, Reproductive Success",675,false
Cyclooxygenase,[NCBIGene:5742],102,"Reduced, Maturation inducing steroid, plasma",691,false
Cyclooxygenase,[NCBIGene:5742],102,"Reduced, Maturation inducing steroid receptor signalling, oocyte",692,false
Cyclooxygenase,[NCBIGene:5742],102,"Reduced, Meiotic prophase I/metaphase I transition, oocyte",694,false
Cyclooxygenase,[NCBIGene:5742],102,"Increased, cyclic adenosine monophosphate",693,false
Cyclooxygenase,[NCBIGene:5742],102,"Inhibition, Cyclooxygenase activity",79,true
Cyclooxygenase,[NCBIGene:5742],102,"Decrease, Population growth rate",360,false
Cyclooxygenase,[NCBIGene:5742],102,"Reduced, Prostaglandin E2 concentration, hypothalamus",687,false
Cyclooxygenase,[NCBIGene:5742],102,"Reduced, Gonadotropin releasing hormone, hypothalamus",689,false
Cyclooxygenase,[NCBIGene:5742],102,"Reduced, Luteinizing hormone (LH), plasma",690,false
Cyclooxygenase,[NCBIGene:5742],103,"Reduced, Reproductive Success",675,false
Cyclooxygenase,[NCBIGene:5742],103,"Increased, Chromosome misseggregation",696,false
Cyclooxygenase,[NCBIGene:5742],103,"Reduced, Maturation inducing steroid, plasma",691,false
Cyclooxygenase,[NCBIGene:5742],103,"Reduced, Maturation inducing steroid receptor signalling, oocyte",692,false
Cyclooxygenase,[NCBIGene:5742],103,"Upregulated, Spindle assembly checkpoint protein Mad2-oocyte",695,false
Cyclooxygenase,[NCBIGene:5742],103,"Inhibition, Cyclooxygenase activity",79,true
Cyclooxygenase,[NCBIGene:5742],103,"Decrease, Population growth rate",360,false
Cyclooxygenase,[NCBIGene:5742],103,"Reduced, Prostaglandin E2 concentration, hypothalamus",687,false
Cyclooxygenase,[NCBIGene:5742],103,"Reduced, Gonadotropin releasing hormone, hypothalamus",689,false
Cyclooxygenase,[NCBIGene:5742],103,"Reduced, Luteinizing hormone (LH), plasma",690,false
2u-globulin,[NCBIGene:6066],105,"Increase, Cytotoxicity (renal tubular cell)",709,false
2u-globulin,[NCBIGene:6066],105,"Increase, Regenerative cell proliferation (tubular epithelial cells)",710,false
2u-globulin,[NCBIGene:6066],105,"Increase, Adenomas/carcinomas (renal tubular)",713,false
2u-globulin,[NCBIGene:6066],105,"Increase, Hyperplasia (renal tubular cells)",767,false
2u-globulin,[NCBIGene:6066],105,"Increased, Binding of chemicals to 2u (serum)",714,true
2u-globulin,[NCBIGene:6066],105,"Increased, Accumulation of alpha2u microglobulin (proximal tubular epithelium)",708,false
Alpha2u-microglobulin,[NCBIGene:567],105,"Increase, Cytotoxicity (renal tubular cell)",709,false
Alpha2u-microglobulin,[NCBIGene:567],105,"Increase, Regenerative cell proliferation (tubular epithelial cells)",710,false
Alpha2u-microglobulin,[NCBIGene:567],105,"Increase, Adenomas/carcinomas (renal tubular)",713,false
Alpha2u-microglobulin,[NCBIGene:567],105,"Increase, Hyperplasia (renal tubular cells)",767,false
Alpha2u-microglobulin,[NCBIGene:567],105,"Increased, Binding of chemicals to 2u (serum)",714,true
Alpha2u-microglobulin,[NCBIGene:567],105,"Increased, Accumulation of alpha2u microglobulin (proximal tubular epithelium)",708,false
PDK,[NCBIGene:5170],108,"Increase, Cytotoxicity",768,false
PDK,[NCBIGene:5170],108,"Increased, Induction of pyruvate dehydrogenase (PDH)",726,false
PDK,[NCBIGene:5170],108,"Inhibition, Pyruvate dehydrogenase kinase (PDK) enzyme",724,true
PDK,[NCBIGene:5170],108,"Increase, Oxidative metabolism",769,false
PDK,[NCBIGene:5170],108,Peptide Oxidation,209,false
PDK,[NCBIGene:5170],108,"Increase, hepatocellular adenomas and carcinomas",719,false
pyruvate dehydrogenase kinase,[NCBIGene:5163],108,"Increase, Cytotoxicity",768,false
pyruvate dehydrogenase kinase,[NCBIGene:5163],108,"Increased, Induction of pyruvate dehydrogenase (PDH)",726,false
pyruvate dehydrogenase kinase,[NCBIGene:5163],108,"Inhibition, Pyruvate dehydrogenase kinase (PDK) enzyme",724,true
pyruvate dehydrogenase kinase,[NCBIGene:5163],108,"Increase, Oxidative metabolism",769,false
pyruvate dehydrogenase kinase,[NCBIGene:5163],108,Peptide Oxidation,209,false
pyruvate dehydrogenase kinase,[NCBIGene:5163],108,"Increase, hepatocellular adenomas and carcinomas",719,false
Cyp2a4,[NCBIGene:1591],11,"Activation, PXR/SXR",245,true
Fos,[NCBIGene:2353],11,"Activation, PXR/SXR",245,true
ISG,[NCBIGene:340061],11,"Activation, PXR/SXR",245,true
Junb,[NCBIGene:3726],11,"Activation, PXR/SXR",245,true
Nrf2,[NCBIGene:4780],11,"Activation, PXR/SXR",245,true
PCP,[NCBIGene:5547],11,"Activation, PXR/SXR",245,true
PXR,[NCBIGene:8856],11,"Activation, PXR/SXR",245,true
Toll like receptors,[NCBIGene:7096],11,"Activation, PXR/SXR",245,true
interferon alpha,[NCBIGene:3439],11,"Activation, PXR/SXR",245,true
interferon receptor,[NCBIGene:3455],11,"Activation, PXR/SXR",245,true
interferon regulatory factors,[NCBIGene:3659],11,"Activation, PXR/SXR",245,true
interferon signalling network genes,[NCBIGene:3438],11,"Activation, PXR/SXR",245,true
Iodide pump,[NCBIGene:160728],110,"Thyroid hormone synthesis, Decreased",277,false
Iodide pump,[NCBIGene:160728],110,"Increase, Hypertrophy and proliferation (follicular cell)",739,false
Iodide pump,[NCBIGene:160728],110,"Inhibition, Na+/I- symporter (NIS)",424,true
Iodide pump,[NCBIGene:160728],110,"Increase, Hyperplasia (follicular cells)",740,false
Iodide pump,[NCBIGene:160728],110,"Increase, Adenomas/carcinomas (follicular cell)",741,false
Iodide pump,[NCBIGene:160728],110,"Increased, Thyroid-stimulating hormone (TSH)",1023,false
Iodide pump,[NCBIGene:160728],110,"Thyroxine (T4) in serum, Decreased",281,false
AR,"[NCBIGene:367, 231, 2232]",111,"Decreased, Testosterone binding to androgen receptor (hypothalamus)",743,false
AR,"[NCBIGene:367, 231, 2232]",111,"Increase, Hyperplasia (Leydig cells)",744,false
AR,"[NCBIGene:367, 231, 2232]",111,"Increase, Leydig cell tumors",745,false
AR,"[NCBIGene:367, 231, 2232]",111,"Increased, Luteinizing hormone (LH)",754,false
AR,"[NCBIGene:367, 231, 2232]",111,"Decrease, androgen receptor activation",1614,true
Cys-loop ligand-gated ion channel superfamily,[NCBIGene:353174],113,"Decreased, population 1",765,false
Cys-loop ligand-gated ion channel superfamily,[NCBIGene:353174],113,"Activation, Glutamate-gated chloride channel",760,true
Cys-loop ligand-gated ion channel superfamily,[NCBIGene:353174],113,"Increased, Chloride conductance",761,false
Cys-loop ligand-gated ion channel superfamily,[NCBIGene:353174],113,"hyperpolarisation, neuron",763,false
Cys-loop ligand-gated ion channel superfamily,[NCBIGene:353174],113,"N/A, Ataxia, paralysis, or hyperactivity",764,false
Cys-loop ligand-gated ion channel superfamily,[NCBIGene:353174],113,Increased Mortality,351,false
GluCl,"[NCBIGene:2629, 57733, 2630]",113,"Decreased, population 1",765,false
GluCl,"[NCBIGene:2629, 57733, 2630]",113,"Activation, Glutamate-gated chloride channel",760,true
GluCl,"[NCBIGene:2629, 57733, 2630]",113,"Increased, Chloride conductance",761,false
GluCl,"[NCBIGene:2629, 57733, 2630]",113,"hyperpolarisation, neuron",763,false
GluCl,"[NCBIGene:2629, 57733, 2630]",113,"N/A, Ataxia, paralysis, or hyperactivity",764,false
GluCl,"[NCBIGene:2629, 57733, 2630]",113,Increased Mortality,351,false
GluCl channel,[NCBIGene:414328],113,"Decreased, population 1",765,false
GluCl channel,[NCBIGene:414328],113,"Activation, Glutamate-gated chloride channel",760,true
GluCl channel,[NCBIGene:414328],113,"Increased, Chloride conductance",761,false
GluCl channel,[NCBIGene:414328],113,"hyperpolarisation, neuron",763,false
GluCl channel,[NCBIGene:414328],113,"N/A, Ataxia, paralysis, or hyperactivity",764,false
GluCl channel,[NCBIGene:414328],113,Increased Mortality,351,false
HPPD,[NCBIGene:100682260],114,"Inhibition, 4-hydroxyphenyl-pyruvate dioxygenase (HPPD) enzyme",766,true
HPPD,[NCBIGene:100682260],114,"Increased, Plasma tyrosine",775,false
HPPD,[NCBIGene:100682260],114,"Increase, Cytotoxicity (corneal cells)",776,false
HPPD,[NCBIGene:100682260],114,"Increase, Inflammation (corneal cells)",777,false
HPPD,[NCBIGene:100682260],114,"Increase, Regenerative cell proliferation (corneal cells)",778,false
HPPD,[NCBIGene:100682260],114,"Increase, Papillomas/carcinomas (squamous cells)",779,false
AR,"[NCBIGene:367, 231, 2232]",117,"Increase, Preneoplastic foci (hepatocytes)",774,false
AR,"[NCBIGene:367, 231, 2232]",117,"Increase, cell proliferation (hepatocytes)",716,false
AR,"[NCBIGene:367, 231, 2232]",117,"Increase, hepatocellular adenomas and carcinomas",719,false
AR,"[NCBIGene:367, 231, 2232]",117,"Agonism, Androgen receptor",25,true
Thyroperoxidase,[NCBIGene:7173],119,"Thyroperoxidase, Inhibition",279,true
Thyroperoxidase,[NCBIGene:7173],119,"Thyroid hormone synthesis, Decreased",277,false
Thyroperoxidase,[NCBIGene:7173],119,"Increase, Hypertrophy and proliferation (follicular cell)",739,false
Thyroperoxidase,[NCBIGene:7173],119,"Increase, Hyperplasia (follicular cells)",740,false
Thyroperoxidase,[NCBIGene:7173],119,"Increase, Adenomas/carcinomas (follicular cell)",741,false
Thyroperoxidase,[NCBIGene:7173],119,"Increased, Thyroid-stimulating hormone (TSH)",1023,false
Thyroperoxidase,[NCBIGene:7173],119,"Thyroxine (T4) in serum, Decreased",281,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],12,Neuroinflammation,188,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],12,"Impairment, Learning and memory",341,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],12,"Increase, Cell injury/death",55,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],12,Reduced levels of BDNF,381,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],12,"Binding of antagonist, NMDA receptors",201,true
N-methyl-D-aspartate receptors,[NCBIGene:2902],12,"Decreased, Calcium influx",52,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],12,"N/A, Neurodegeneration",352,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],12,"Inhibition, NMDARs",195,false
tau,[NCBIGene:4137],12,Neuroinflammation,188,false
tau,[NCBIGene:4137],12,"Impairment, Learning and memory",341,false
tau,[NCBIGene:4137],12,"Increase, Cell injury/death",55,false
tau,[NCBIGene:4137],12,Reduced levels of BDNF,381,false
tau,[NCBIGene:4137],12,"Binding of antagonist, NMDA receptors",201,true
tau,[NCBIGene:4137],12,"Decreased, Calcium influx",52,false
tau,[NCBIGene:4137],12,"N/A, Neurodegeneration",352,false
tau,[NCBIGene:4137],12,"Inhibition, NMDARs",195,false
5-reductase,[NCBIGene:6715],120,"Increase, Hyperplasia (Leydig cells)",744,false
5-reductase,[NCBIGene:6715],120,"Increase, Leydig cell tumors",745,false
5-reductase,[NCBIGene:6715],120,"Increased, Leutinizing hormone (LH)",791,false
5-reductase,[NCBIGene:6715],120,"Inhibition, 5α-reductase",1617,true
5-reductase,[NCBIGene:6715],120,"Decrease, circulating testosterone levels",1690,false
HIF1 heterodimer,[NCBIGene:29072],122,"Inhibition, Prolyl hydroxylases",798,true
HIF1 heterodimer,[NCBIGene:29072],122,"Increased, HIF-1 heterodimer",799,false
HIF1 heterodimer,[NCBIGene:29072],122,"Decreased, Aromatase (Cyp19a1) mRNA",800,false
HIF1 heterodimer,[NCBIGene:29072],122,"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development",309,false
HIF1 heterodimer,[NCBIGene:29072],122,"Reduction, Plasma vitellogenin concentrations",221,false
HIF1 heterodimer,[NCBIGene:29072],122,"Reduction, Cumulative fecundity and spawning",78,false
HIF1 heterodimer,[NCBIGene:29072],122,"Reduction, Vitellogenin synthesis in liver",285,false
HIF1 heterodimer,[NCBIGene:29072],122,"Decrease, Population growth rate",360,false
HIF1 heterodimer,[NCBIGene:29072],122,"Reduction, Plasma 17beta-estradiol concentrations",219,false
HIF1 heterodimer,[NCBIGene:29072],122,"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells",3,false
Prolyl hydroxylase,"[NCBIGene:112398, 100529264]",122,"Inhibition, Prolyl hydroxylases",798,true
Prolyl hydroxylase,"[NCBIGene:112398, 100529264]",122,"Increased, HIF-1 heterodimer",799,false
Prolyl hydroxylase,"[NCBIGene:112398, 100529264]",122,"Decreased, Aromatase (Cyp19a1) mRNA",800,false
Prolyl hydroxylase,"[NCBIGene:112398, 100529264]",122,"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development",309,false
Prolyl hydroxylase,"[NCBIGene:112398, 100529264]",122,"Reduction, Plasma vitellogenin concentrations",221,false
Prolyl hydroxylase,"[NCBIGene:112398, 100529264]",122,"Reduction, Cumulative fecundity and spawning",78,false
Prolyl hydroxylase,"[NCBIGene:112398, 100529264]",122,"Reduction, Vitellogenin synthesis in liver",285,false
Prolyl hydroxylase,"[NCBIGene:112398, 100529264]",122,"Decrease, Population growth rate",360,false
Prolyl hydroxylase,"[NCBIGene:112398, 100529264]",122,"Reduction, Plasma 17beta-estradiol concentrations",219,false
Prolyl hydroxylase,"[NCBIGene:112398, 100529264]",122,"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells",3,false
HIF-1alpha,[NCBIGene:3091],123,"Increased, HIF-1 alpha transcription",802,false
HIF-1alpha,[NCBIGene:3091],123,"Increased, HIF-1 heterodimer",799,false
HIF-1alpha,[NCBIGene:3091],123,"Decreased, Aromatase (Cyp19a1) mRNA",800,false
HIF-1alpha,[NCBIGene:3091],123,"modulation, Unknown",801,true
HIF-1alpha,[NCBIGene:3091],123,"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development",309,false
HIF-1alpha,[NCBIGene:3091],123,"Reduction, Plasma vitellogenin concentrations",221,false
HIF-1alpha,[NCBIGene:3091],123,"Reduction, Cumulative fecundity and spawning",78,false
HIF-1alpha,[NCBIGene:3091],123,"Reduction, Vitellogenin synthesis in liver",285,false
HIF-1alpha,[NCBIGene:3091],123,"Decrease, Population growth rate",360,false
HIF-1alpha,[NCBIGene:3091],123,"Reduction, Plasma 17beta-estradiol concentrations",219,false
HIF-1alpha,[NCBIGene:3091],123,"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells",3,false
HMG-CoA reductase,[NCBIGene:3156],124,"Inhibition, HMG-CoA reductase",804,true
HMG-CoA reductase,[NCBIGene:3156],124,"Decreased, mevalonate",805,false
HMG-CoA reductase,[NCBIGene:3156],124,"Decreased, cholesterol",807,false
HMG-CoA reductase,[NCBIGene:3156],124,"malformed, Male reproductive tract",809,false
HMG-CoA reductase,[NCBIGene:3156],124,"Decrease, Fertility",330,false
HMG-CoA reductase,[NCBIGene:3156],124,"Decrease, circulating testosterone levels",1690,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],13,"Reduced, Presynaptic release of glutamate",383,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],13,Decrease of neuronal network function,386,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],13,Decrease of synaptogenesis,385,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],13,"Aberrant, Dendritic morphology",382,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],13,"Impairment, Learning and memory",341,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],13,"Increase, Cell injury/death",55,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],13,Reduced levels of BDNF,381,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],13,"Binding of antagonist, NMDA receptors",201,true
N-methyl-D-aspartate receptors,[NCBIGene:2902],13,"Decreased, Calcium influx",52,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],13,"Inhibition, NMDARs",195,false
NMDAR 2A and 2B subunits,[NCBIGene:2903],13,"Reduced, Presynaptic release of glutamate",383,false
NMDAR 2A and 2B subunits,[NCBIGene:2903],13,Decrease of neuronal network function,386,false
NMDAR 2A and 2B subunits,[NCBIGene:2903],13,Decrease of synaptogenesis,385,false
NMDAR 2A and 2B subunits,[NCBIGene:2903],13,"Aberrant, Dendritic morphology",382,false
NMDAR 2A and 2B subunits,[NCBIGene:2903],13,"Impairment, Learning and memory",341,false
NMDAR 2A and 2B subunits,[NCBIGene:2903],13,"Increase, Cell injury/death",55,false
NMDAR 2A and 2B subunits,[NCBIGene:2903],13,Reduced levels of BDNF,381,false
NMDAR 2A and 2B subunits,[NCBIGene:2903],13,"Binding of antagonist, NMDA receptors",201,true
NMDAR 2A and 2B subunits,[NCBIGene:2903],13,"Decreased, Calcium influx",52,false
NMDAR 2A and 2B subunits,[NCBIGene:2903],13,"Inhibition, NMDARs",195,false
brain derived neurotrophic factor,[NCBIGene:627],13,"Reduced, Presynaptic release of glutamate",383,false
brain derived neurotrophic factor,[NCBIGene:627],13,Decrease of neuronal network function,386,false
brain derived neurotrophic factor,[NCBIGene:627],13,Decrease of synaptogenesis,385,false
brain derived neurotrophic factor,[NCBIGene:627],13,"Aberrant, Dendritic morphology",382,false
brain derived neurotrophic factor,[NCBIGene:627],13,"Impairment, Learning and memory",341,false
brain derived neurotrophic factor,[NCBIGene:627],13,"Increase, Cell injury/death",55,false
brain derived neurotrophic factor,[NCBIGene:627],13,Reduced levels of BDNF,381,false
brain derived neurotrophic factor,[NCBIGene:627],13,"Binding of antagonist, NMDA receptors",201,true
brain derived neurotrophic factor,[NCBIGene:627],13,"Decreased, Calcium influx",52,false
brain derived neurotrophic factor,[NCBIGene:627],13,"Inhibition, NMDARs",195,false
LPLA2,[NCBIGene:23659],130,"Inhibition, Phospholipase A",828,true
LPLA2,[NCBIGene:23659],130,"Damage, Lipid bilayer",829,false
LPLA2,[NCBIGene:23659],130,"Disturbance, Lysosomal function",831,false
LPLA2,[NCBIGene:23659],130,"Occurrence, Cytoplasmic vacuolization (hepatocyte)",833,false
LPLA2,[NCBIGene:23659],130,"Occurrence, Ballooning degeneration (hepatocyte)",835,false
LPLA2,[NCBIGene:23659],130,"Induction, Microvesicular fat",838,false
LPLA2,[NCBIGene:23659],130,"Occurrence, Cytoplasmic vacuolization (Bile duct cell)",836,false
LPLA2,[NCBIGene:23659],130,Mitochondrial dysfunction,177,false
LPLA2,[NCBIGene:23659],130,"Occurrence, Cytoplasmic vacuolization (kupffer cell)",837,false
LPLA2,[NCBIGene:23659],130,"Formation, Mallory body",839,false
LPLA2,[NCBIGene:23659],130,"Formation, Liver fibrosis",840,false
Phospholipase A2,[NCBIGene:151056],130,"Inhibition, Phospholipase A",828,true
Phospholipase A2,[NCBIGene:151056],130,"Damage, Lipid bilayer",829,false
Phospholipase A2,[NCBIGene:151056],130,"Disturbance, Lysosomal function",831,false
Phospholipase A2,[NCBIGene:151056],130,"Occurrence, Cytoplasmic vacuolization (hepatocyte)",833,false
Phospholipase A2,[NCBIGene:151056],130,"Occurrence, Ballooning degeneration (hepatocyte)",835,false
Phospholipase A2,[NCBIGene:151056],130,"Induction, Microvesicular fat",838,false
Phospholipase A2,[NCBIGene:151056],130,"Occurrence, Cytoplasmic vacuolization (Bile duct cell)",836,false
Phospholipase A2,[NCBIGene:151056],130,Mitochondrial dysfunction,177,false
Phospholipase A2,[NCBIGene:151056],130,"Occurrence, Cytoplasmic vacuolization (kupffer cell)",837,false
Phospholipase A2,[NCBIGene:151056],130,"Formation, Mallory body",839,false
Phospholipase A2,[NCBIGene:151056],130,"Formation, Liver fibrosis",840,false
AhR,[NCBIGene:196],131,"Oxidation, Uroporphyrinogen",844,false
AhR,[NCBIGene:196],131,"Inhibition, UROD",845,false
AhR,[NCBIGene:196],131,"Accumulation, Highly carboxylated porphyrins",846,false
AhR,[NCBIGene:196],131,Uroporphyria,369,false
AhR,[NCBIGene:196],131,"Induction, CYP1A2/CYP1A5",850,false
AhR,[NCBIGene:196],131,"Activation, AhR",18,true
catalases,[NCBIGene:847],131,"Oxidation, Uroporphyrinogen",844,false
catalases,[NCBIGene:847],131,"Inhibition, UROD",845,false
catalases,[NCBIGene:847],131,"Accumulation, Highly carboxylated porphyrins",846,false
catalases,[NCBIGene:847],131,Uroporphyria,369,false
catalases,[NCBIGene:847],131,"Induction, CYP1A2/CYP1A5",850,false
catalases,[NCBIGene:847],131,"Activation, AhR",18,true
cytochrome P450 1A2,[NCBIGene:1544],131,"Oxidation, Uroporphyrinogen",844,false
cytochrome P450 1A2,[NCBIGene:1544],131,"Inhibition, UROD",845,false
cytochrome P450 1A2,[NCBIGene:1544],131,"Accumulation, Highly carboxylated porphyrins",846,false
cytochrome P450 1A2,[NCBIGene:1544],131,Uroporphyria,369,false
cytochrome P450 1A2,[NCBIGene:1544],131,"Induction, CYP1A2/CYP1A5",850,false
cytochrome P450 1A2,[NCBIGene:1544],131,"Activation, AhR",18,true
cytochromes,[NCBIGene:5447],131,"Oxidation, Uroporphyrinogen",844,false
cytochromes,[NCBIGene:5447],131,"Inhibition, UROD",845,false
cytochromes,[NCBIGene:5447],131,"Accumulation, Highly carboxylated porphyrins",846,false
cytochromes,[NCBIGene:5447],131,Uroporphyria,369,false
cytochromes,[NCBIGene:5447],131,"Induction, CYP1A2/CYP1A5",850,false
cytochromes,[NCBIGene:5447],131,"Activation, AhR",18,true
ferroprotein,[NCBIGene:2235],131,"Oxidation, Uroporphyrinogen",844,false
ferroprotein,[NCBIGene:2235],131,"Inhibition, UROD",845,false
ferroprotein,[NCBIGene:2235],131,"Accumulation, Highly carboxylated porphyrins",846,false
ferroprotein,[NCBIGene:2235],131,Uroporphyria,369,false
ferroprotein,[NCBIGene:2235],131,"Induction, CYP1A2/CYP1A5",850,false
ferroprotein,[NCBIGene:2235],131,"Activation, AhR",18,true
hemoglobin,[NCBIGene:114757],131,"Oxidation, Uroporphyrinogen",844,false
hemoglobin,[NCBIGene:114757],131,"Inhibition, UROD",845,false
hemoglobin,[NCBIGene:114757],131,"Accumulation, Highly carboxylated porphyrins",846,false
hemoglobin,[NCBIGene:114757],131,Uroporphyria,369,false
hemoglobin,[NCBIGene:114757],131,"Induction, CYP1A2/CYP1A5",850,false
hemoglobin,[NCBIGene:114757],131,"Activation, AhR",18,true
hemoproteins,[NCBIGene:55363],131,"Oxidation, Uroporphyrinogen",844,false
hemoproteins,[NCBIGene:55363],131,"Inhibition, UROD",845,false
hemoproteins,[NCBIGene:55363],131,"Accumulation, Highly carboxylated porphyrins",846,false
hemoproteins,[NCBIGene:55363],131,Uroporphyria,369,false
hemoproteins,[NCBIGene:55363],131,"Induction, CYP1A2/CYP1A5",850,false
hemoproteins,[NCBIGene:55363],131,"Activation, AhR",18,true
uroporphyrinogen decarboxylase,[NCBIGene:7389],131,"Oxidation, Uroporphyrinogen",844,false
uroporphyrinogen decarboxylase,[NCBIGene:7389],131,"Inhibition, UROD",845,false
uroporphyrinogen decarboxylase,[NCBIGene:7389],131,"Accumulation, Highly carboxylated porphyrins",846,false
uroporphyrinogen decarboxylase,[NCBIGene:7389],131,Uroporphyria,369,false
uroporphyrinogen decarboxylase,[NCBIGene:7389],131,"Induction, CYP1A2/CYP1A5",850,false
uroporphyrinogen decarboxylase,[NCBIGene:7389],131,"Activation, AhR",18,true
Na+/I- symporter,[NCBIGene:6528],134,"Thyroid hormone synthesis, Decreased",277,false
Na+/I- symporter,[NCBIGene:6528],134,"Cognitive function, decreased",402,false
Na+/I- symporter,[NCBIGene:6528],134,Decrease of Thyroidal iodide,425,false
Na+/I- symporter,[NCBIGene:6528],134,"Inhibition, Na+/I- symporter (NIS)",424,true
Na+/I- symporter,[NCBIGene:6528],134,"Hippocampal gene expression, Altered",756,false
Na+/I- symporter,[NCBIGene:6528],134,"Thyroxine (T4) in neuronal tissue, Decreased",280,false
Na+/I- symporter,[NCBIGene:6528],134,"Thyroxine (T4) in serum, Decreased",281,false
Na+/I- symporter,[NCBIGene:6528],134,"Hippocampal anatomy, Altered",757,false
Na+/I- symporter,[NCBIGene:6528],134,"Hippocampal Physiology, Altered",758,false
THs,[NCBIGene:7057],134,"Thyroid hormone synthesis, Decreased",277,false
THs,[NCBIGene:7057],134,"Cognitive function, decreased",402,false
THs,[NCBIGene:7057],134,Decrease of Thyroidal iodide,425,false
THs,[NCBIGene:7057],134,"Inhibition, Na+/I- symporter (NIS)",424,true
THs,[NCBIGene:7057],134,"Hippocampal gene expression, Altered",756,false
THs,[NCBIGene:7057],134,"Thyroxine (T4) in neuronal tissue, Decreased",280,false
THs,[NCBIGene:7057],134,"Thyroxine (T4) in serum, Decreased",281,false
THs,[NCBIGene:7057],134,"Hippocampal anatomy, Altered",757,false
THs,[NCBIGene:7057],134,"Hippocampal Physiology, Altered",758,false
Organic anion transporter,[NCBIGene:9356],138,"Increased, blood uric acid concentration",1096,false
Organic anion transporter,[NCBIGene:9356],138,"Occurrence, renal proximal tubular necrosis",1097,false
Organic anion transporter,[NCBIGene:9356],138,"Increased, blood potassium concentration",1098,false
Organic anion transporter,[NCBIGene:9356],138,"Occurrence, tophi (urate) deposition",1102,false
Organic anion transporter,[NCBIGene:9356],138,"Occurrence, cardiac arrhythmia",1106,false
Organic anion transporter,[NCBIGene:9356],138,"Inhibition, organic anion transporter 1 (OAT1)",877,true
Organic anion transporter,[NCBIGene:9356],138,Oxidative Stress,1392,false
Organic anion transporter,[NCBIGene:9356],138,"Decrease, Population growth rate",360,false
Organic anion transporter,[NCBIGene:9356],138,Increased Mortality,351,false
Glucocorticoid Receptor,[NCBIGene:2908],14,"Suppression, Immune system",403,false
Glucocorticoid Receptor,[NCBIGene:2908],14,"Increased, Disease susceptibility",323,false
Glucocorticoid Receptor,[NCBIGene:2908],14,"Induction, IKB inhibitory protein",145,false
Glucocorticoid Receptor,[NCBIGene:2908],14,"Decreased, Lymphocytes",168,false
Glucocorticoid Receptor,[NCBIGene:2908],14,"Suppression, Inflammatory cytokines",152,false
Glucocorticoid Receptor,[NCBIGene:2908],14,"Inhibition, Nuclear factor kappa B (NF-kB)",202,false
Glucocorticoid Receptor,[NCBIGene:2908],14,"Activation, Glucocorticoid Receptor",122,true
EGFR,[NCBIGene:1956],148,"Activation, EGFR",941,true
EGFR,[NCBIGene:1956],148,"Decrease, Lung function",1250,false
EGFR,[NCBIGene:1956],148,"Increase, Mucin production",962,false
EGFR,[NCBIGene:1956],148,"Increase, goblet cell number",2117,false
mucin,[NCBIGene:100508689],148,"Activation, EGFR",941,true
mucin,[NCBIGene:100508689],148,"Decrease, Lung function",1250,false
mucin,[NCBIGene:100508689],148,"Increase, Mucin production",962,false
mucin,[NCBIGene:100508689],148,"Increase, goblet cell number",2117,false
mucins,[NCBIGene:4586],148,"Activation, EGFR",941,true
mucins,[NCBIGene:4586],148,"Decrease, Lung function",1250,false
mucins,[NCBIGene:4586],148,"Increase, Mucin production",962,false
mucins,[NCBIGene:4586],148,"Increase, goblet cell number",2117,false
AKT,[NCBIGene:207],149,"KE6 : Depletion, Nitric Oxide",933,false
AKT,[NCBIGene:207],149,"KE7 : Impaired, Vasodilation",937,false
AKT,[NCBIGene:207],149,"KE2 : Decrease, GTPCH-1",935,false
AKT,[NCBIGene:207],149,"KE3 : Decrease, Tetrahydrobiopterin",934,false
AKT,[NCBIGene:207],149,"KE4 : Uncoupling, eNOS",932,false
AKT,[NCBIGene:207],149,"KE8 : Increase, Vascular Resistance",951,false
AKT,[NCBIGene:207],149,Hypertension,952,false
AKT,[NCBIGene:207],149,"KE5 : Decrease, AKT/eNOS activity",973,false
AKT,[NCBIGene:207],149,Peptide Oxidation,209,true
AKT,[NCBIGene:207],149,"KE1 : S-Glutathionylation, eNOS",927,false
GTPCH-1,[NCBIGene:2643],149,"KE6 : Depletion, Nitric Oxide",933,false
GTPCH-1,[NCBIGene:2643],149,"KE7 : Impaired, Vasodilation",937,false
GTPCH-1,[NCBIGene:2643],149,"KE2 : Decrease, GTPCH-1",935,false
GTPCH-1,[NCBIGene:2643],149,"KE3 : Decrease, Tetrahydrobiopterin",934,false
GTPCH-1,[NCBIGene:2643],149,"KE4 : Uncoupling, eNOS",932,false
GTPCH-1,[NCBIGene:2643],149,"KE8 : Increase, Vascular Resistance",951,false
GTPCH-1,[NCBIGene:2643],149,Hypertension,952,false
GTPCH-1,[NCBIGene:2643],149,"KE5 : Decrease, AKT/eNOS activity",973,false
GTPCH-1,[NCBIGene:2643],149,Peptide Oxidation,209,true
GTPCH-1,[NCBIGene:2643],149,"KE1 : S-Glutathionylation, eNOS",927,false
endothelial nitric oxide synthase,[NCBIGene:4846],149,"KE6 : Depletion, Nitric Oxide",933,false
endothelial nitric oxide synthase,[NCBIGene:4846],149,"KE7 : Impaired, Vasodilation",937,false
endothelial nitric oxide synthase,[NCBIGene:4846],149,"KE2 : Decrease, GTPCH-1",935,false
endothelial nitric oxide synthase,[NCBIGene:4846],149,"KE3 : Decrease, Tetrahydrobiopterin",934,false
endothelial nitric oxide synthase,[NCBIGene:4846],149,"KE4 : Uncoupling, eNOS",932,false
endothelial nitric oxide synthase,[NCBIGene:4846],149,"KE8 : Increase, Vascular Resistance",951,false
endothelial nitric oxide synthase,[NCBIGene:4846],149,Hypertension,952,false
endothelial nitric oxide synthase,[NCBIGene:4846],149,"KE5 : Decrease, AKT/eNOS activity",973,false
endothelial nitric oxide synthase,[NCBIGene:4846],149,Peptide Oxidation,209,true
endothelial nitric oxide synthase,[NCBIGene:4846],149,"KE1 : S-Glutathionylation, eNOS",927,false
protein kinase B,[NCBIGene:2185],149,"KE6 : Depletion, Nitric Oxide",933,false
protein kinase B,[NCBIGene:2185],149,"KE7 : Impaired, Vasodilation",937,false
protein kinase B,[NCBIGene:2185],149,"KE2 : Decrease, GTPCH-1",935,false
protein kinase B,[NCBIGene:2185],149,"KE3 : Decrease, Tetrahydrobiopterin",934,false
protein kinase B,[NCBIGene:2185],149,"KE4 : Uncoupling, eNOS",932,false
protein kinase B,[NCBIGene:2185],149,"KE8 : Increase, Vascular Resistance",951,false
protein kinase B,[NCBIGene:2185],149,Hypertension,952,false
protein kinase B,[NCBIGene:2185],149,"KE5 : Decrease, AKT/eNOS activity",973,false
protein kinase B,[NCBIGene:2185],149,Peptide Oxidation,209,true
protein kinase B,[NCBIGene:2185],149,"KE1 : S-Glutathionylation, eNOS",927,false
AhR,[NCBIGene:196],151,"reduced production, VEGF",948,false
AhR,[NCBIGene:196],151,"reduced dimerization, ARNT/HIF1-alpha",945,false
AhR,[NCBIGene:196],151,"abnormal, placental vasculature morphology",1891,false
AhR,[NCBIGene:196],151,"increase, Preeclampsia",1893,false
AhR,[NCBIGene:196],151,"increase, placental insufficiency",1892,false
AhR,[NCBIGene:196],151,"dimerization, AHR/ARNT",944,false
AhR,[NCBIGene:196],151,"Activation, AhR",18,true
TH,[NCBIGene:7054],152,"Cognitive function, decreased",402,false
TH,[NCBIGene:7054],152,"Displacement, Serum thyroxine (T4) from transthyretin",958,false
TH,[NCBIGene:7054],152,"Binding, Transthyretin in serum",957,true
TH,[NCBIGene:7054],152,"Hippocampal gene expression, Altered",756,false
TH,[NCBIGene:7054],152,"Increased, Free serum thyroxine (T4)",959,false
TH,[NCBIGene:7054],152,"Increased, Uptake of thyroxine into tissue",960,false
TH,[NCBIGene:7054],152,"Thyroxine (T4) in neuronal tissue, Decreased",280,false
TH,[NCBIGene:7054],152,"Thyroxine (T4) in serum, Decreased",281,false
TH,[NCBIGene:7054],152,"Hippocampal anatomy, Altered",757,false
TH,[NCBIGene:7054],152,"Hippocampal Physiology, Altered",758,false
TH,[NCBIGene:7054],152,"Increased, Clearance of thyroxine from serum",961,false
albumin,[NCBIGene:213],152,"Cognitive function, decreased",402,false
albumin,[NCBIGene:213],152,"Displacement, Serum thyroxine (T4) from transthyretin",958,false
albumin,[NCBIGene:213],152,"Binding, Transthyretin in serum",957,true
albumin,[NCBIGene:213],152,"Hippocampal gene expression, Altered",756,false
albumin,[NCBIGene:213],152,"Increased, Free serum thyroxine (T4)",959,false
albumin,[NCBIGene:213],152,"Increased, Uptake of thyroxine into tissue",960,false
albumin,[NCBIGene:213],152,"Thyroxine (T4) in neuronal tissue, Decreased",280,false
albumin,[NCBIGene:213],152,"Thyroxine (T4) in serum, Decreased",281,false
albumin,[NCBIGene:213],152,"Hippocampal anatomy, Altered",757,false
albumin,[NCBIGene:213],152,"Hippocampal Physiology, Altered",758,false
albumin,[NCBIGene:213],152,"Increased, Clearance of thyroxine from serum",961,false
serum binding proteinsthat,[NCBIGene:2690],152,"Cognitive function, decreased",402,false
serum binding proteinsthat,[NCBIGene:2690],152,"Displacement, Serum thyroxine (T4) from transthyretin",958,false
serum binding proteinsthat,[NCBIGene:2690],152,"Binding, Transthyretin in serum",957,true
serum binding proteinsthat,[NCBIGene:2690],152,"Hippocampal gene expression, Altered",756,false
serum binding proteinsthat,[NCBIGene:2690],152,"Increased, Free serum thyroxine (T4)",959,false
serum binding proteinsthat,[NCBIGene:2690],152,"Increased, Uptake of thyroxine into tissue",960,false
serum binding proteinsthat,[NCBIGene:2690],152,"Thyroxine (T4) in neuronal tissue, Decreased",280,false
serum binding proteinsthat,[NCBIGene:2690],152,"Thyroxine (T4) in serum, Decreased",281,false
serum binding proteinsthat,[NCBIGene:2690],152,"Hippocampal anatomy, Altered",757,false
serum binding proteinsthat,[NCBIGene:2690],152,"Hippocampal Physiology, Altered",758,false
serum binding proteinsthat,[NCBIGene:2690],152,"Increased, Clearance of thyroxine from serum",961,false
thyroid serum binding protein transthyretin,[NCBIGene:7276],152,"Cognitive function, decreased",402,false
thyroid serum binding protein transthyretin,[NCBIGene:7276],152,"Displacement, Serum thyroxine (T4) from transthyretin",958,false
thyroid serum binding protein transthyretin,[NCBIGene:7276],152,"Binding, Transthyretin in serum",957,true
thyroid serum binding protein transthyretin,[NCBIGene:7276],152,"Hippocampal gene expression, Altered",756,false
thyroid serum binding protein transthyretin,[NCBIGene:7276],152,"Increased, Free serum thyroxine (T4)",959,false
thyroid serum binding protein transthyretin,[NCBIGene:7276],152,"Increased, Uptake of thyroxine into tissue",960,false
thyroid serum binding protein transthyretin,[NCBIGene:7276],152,"Thyroxine (T4) in neuronal tissue, Decreased",280,false
thyroid serum binding protein transthyretin,[NCBIGene:7276],152,"Thyroxine (T4) in serum, Decreased",281,false
thyroid serum binding protein transthyretin,[NCBIGene:7276],152,"Hippocampal anatomy, Altered",757,false
thyroid serum binding protein transthyretin,[NCBIGene:7276],152,"Hippocampal Physiology, Altered",758,false
thyroid serum binding protein transthyretin,[NCBIGene:7276],152,"Increased, Clearance of thyroxine from serum",961,false
thyroxine-binding globulin,[NCBIGene:6906],152,"Cognitive function, decreased",402,false
thyroxine-binding globulin,[NCBIGene:6906],152,"Displacement, Serum thyroxine (T4) from transthyretin",958,false
thyroxine-binding globulin,[NCBIGene:6906],152,"Binding, Transthyretin in serum",957,true
thyroxine-binding globulin,[NCBIGene:6906],152,"Hippocampal gene expression, Altered",756,false
thyroxine-binding globulin,[NCBIGene:6906],152,"Increased, Free serum thyroxine (T4)",959,false
thyroxine-binding globulin,[NCBIGene:6906],152,"Increased, Uptake of thyroxine into tissue",960,false
thyroxine-binding globulin,[NCBIGene:6906],152,"Thyroxine (T4) in neuronal tissue, Decreased",280,false
thyroxine-binding globulin,[NCBIGene:6906],152,"Thyroxine (T4) in serum, Decreased",281,false
thyroxine-binding globulin,[NCBIGene:6906],152,"Hippocampal anatomy, Altered",757,false
thyroxine-binding globulin,[NCBIGene:6906],152,"Hippocampal Physiology, Altered",758,false
thyroxine-binding globulin,[NCBIGene:6906],152,"Increased, Clearance of thyroxine from serum",961,false
Aromatase,[NCBIGene:1588],153,"Inhibition of Aromatase Enzyme, Chemical exposure during critical window of estrous cycle between diestrus 2 and proestrus inhibits aromatase conversion of testosterone to estradiol",964,true
Aromatase,[NCBIGene:1588],153,"reduction in ovarian granulosa cells synthesis of estradiol, Reduced steroidogenic production of estradiol in granulosa cells",965,false
Aromatase,[NCBIGene:1588],153,"Reduced Estradiol in Circulation, Reduced steroidogenic production of estradiol in granulosa cells leading to decreased estradiol in circulation",966,false
Aromatase,[NCBIGene:1588],153,"Decreased positive estrogenic feedback on hypothalamus, Reduced estradiol in circulation decreases estrogen concentration at hypothalamus",967,false
Aromatase,[NCBIGene:1588],153,"Decreased Kisspeptin release from neurons in AVPV, Decreased hypothalamic estrogen reduces kisspeptinergic neuron response",968,false
Aromatase,[NCBIGene:1588],153,"Ovulation of oocytes Reduced, Delayed, or Blocked, Decrease or delay in LH surge required for ovulation",971,false
Aromatase,[NCBIGene:1588],153,"Decreased fertility, Reduced number of oocytes ovulated",972,false
Aromatase,[NCBIGene:1588],153,"Decreased GnRH Release, Decreased Kisspeptin stimulation of GnRH neurons",969,false
Aromatase,[NCBIGene:1588],153,"Decreased LH release from Anterior Pituitary, Decreased GnRH stimulation of Anterior Pituitary Gonadotrophs",970,false
CN,[NCBIGene:4934],154,"Interference, nuclear localization of NFAT",979,false
CN,[NCBIGene:4934],154,"Reduction, NFAT/AP-1 complex formation",981,false
CN,[NCBIGene:4934],154,"Impairment, T-cell dependent antibody response",984,false
CN,[NCBIGene:4934],154,"Suppression, IL-2 and IL-4 production",1202,false
CN,[NCBIGene:4934],154,"Inhibition, Calcineurin Activity",980,true
CN phosphatase,[NCBIGene:1267],154,"Interference, nuclear localization of NFAT",979,false
CN phosphatase,[NCBIGene:1267],154,"Reduction, NFAT/AP-1 complex formation",981,false
CN phosphatase,[NCBIGene:1267],154,"Impairment, T-cell dependent antibody response",984,false
CN phosphatase,[NCBIGene:1267],154,"Suppression, IL-2 and IL-4 production",1202,false
CN phosphatase,[NCBIGene:1267],154,"Inhibition, Calcineurin Activity",980,true
Calcineurin,[NCBIGene:5534],154,"Interference, nuclear localization of NFAT",979,false
Calcineurin,[NCBIGene:5534],154,"Reduction, NFAT/AP-1 complex formation",981,false
Calcineurin,[NCBIGene:5534],154,"Impairment, T-cell dependent antibody response",984,false
Calcineurin,[NCBIGene:5534],154,"Suppression, IL-2 and IL-4 production",1202,false
Calcineurin,[NCBIGene:5534],154,"Inhibition, Calcineurin Activity",980,true
FKBP12,[NCBIGene:2282],154,"Interference, nuclear localization of NFAT",979,false
FKBP12,[NCBIGene:2282],154,"Reduction, NFAT/AP-1 complex formation",981,false
FKBP12,[NCBIGene:2282],154,"Impairment, T-cell dependent antibody response",984,false
FKBP12,[NCBIGene:2282],154,"Suppression, IL-2 and IL-4 production",1202,false
FKBP12,[NCBIGene:2282],154,"Inhibition, Calcineurin Activity",980,true
IL-2,[NCBIGene:3558],154,"Interference, nuclear localization of NFAT",979,false
IL-2,[NCBIGene:3558],154,"Reduction, NFAT/AP-1 complex formation",981,false
IL-2,[NCBIGene:3558],154,"Impairment, T-cell dependent antibody response",984,false
IL-2,[NCBIGene:3558],154,"Suppression, IL-2 and IL-4 production",1202,false
IL-2,[NCBIGene:3558],154,"Inhibition, Calcineurin Activity",980,true
IL-4,[NCBIGene:3565],154,"Interference, nuclear localization of NFAT",979,false
IL-4,[NCBIGene:3565],154,"Reduction, NFAT/AP-1 complex formation",981,false
IL-4,[NCBIGene:3565],154,"Impairment, T-cell dependent antibody response",984,false
IL-4,[NCBIGene:3565],154,"Suppression, IL-2 and IL-4 production",1202,false
IL-4,[NCBIGene:3565],154,"Inhibition, Calcineurin Activity",980,true
NFAT,[NCBIGene:4773],154,"Interference, nuclear localization of NFAT",979,false
NFAT,[NCBIGene:4773],154,"Reduction, NFAT/AP-1 complex formation",981,false
NFAT,[NCBIGene:4773],154,"Impairment, T-cell dependent antibody response",984,false
NFAT,[NCBIGene:4773],154,"Suppression, IL-2 and IL-4 production",1202,false
NFAT,[NCBIGene:4773],154,"Inhibition, Calcineurin Activity",980,true
NFAT complexes,[NCBIGene:4772],154,"Interference, nuclear localization of NFAT",979,false
NFAT complexes,[NCBIGene:4772],154,"Reduction, NFAT/AP-1 complex formation",981,false
NFAT complexes,[NCBIGene:4772],154,"Impairment, T-cell dependent antibody response",984,false
NFAT complexes,[NCBIGene:4772],154,"Suppression, IL-2 and IL-4 production",1202,false
NFAT complexes,[NCBIGene:4772],154,"Inhibition, Calcineurin Activity",980,true
TDAR,[NCBIGene:10656],154,"Interference, nuclear localization of NFAT",979,false
TDAR,[NCBIGene:10656],154,"Reduction, NFAT/AP-1 complex formation",981,false
TDAR,[NCBIGene:10656],154,"Impairment, T-cell dependent antibody response",984,false
TDAR,[NCBIGene:10656],154,"Suppression, IL-2 and IL-4 production",1202,false
TDAR,[NCBIGene:10656],154,"Inhibition, Calcineurin Activity",980,true
activator protein-1,[NCBIGene:2354],154,"Interference, nuclear localization of NFAT",979,false
activator protein-1,[NCBIGene:2354],154,"Reduction, NFAT/AP-1 complex formation",981,false
activator protein-1,[NCBIGene:2354],154,"Impairment, T-cell dependent antibody response",984,false
activator protein-1,[NCBIGene:2354],154,"Suppression, IL-2 and IL-4 production",1202,false
activator protein-1,[NCBIGene:2354],154,"Inhibition, Calcineurin Activity",980,true
cyclophilin,[NCBIGene:85313],154,"Interference, nuclear localization of NFAT",979,false
cyclophilin,[NCBIGene:85313],154,"Reduction, NFAT/AP-1 complex formation",981,false
cyclophilin,[NCBIGene:85313],154,"Impairment, T-cell dependent antibody response",984,false
cyclophilin,[NCBIGene:85313],154,"Suppression, IL-2 and IL-4 production",1202,false
cyclophilin,[NCBIGene:85313],154,"Inhibition, Calcineurin Activity",980,true
immunophilins,[NCBIGene:2288],154,"Interference, nuclear localization of NFAT",979,false
immunophilins,[NCBIGene:2288],154,"Reduction, NFAT/AP-1 complex formation",981,false
immunophilins,[NCBIGene:2288],154,"Impairment, T-cell dependent antibody response",984,false
immunophilins,[NCBIGene:2288],154,"Suppression, IL-2 and IL-4 production",1202,false
immunophilins,[NCBIGene:2288],154,"Inhibition, Calcineurin Activity",980,true
phosphatase,[NCBIGene:5504],154,"Interference, nuclear localization of NFAT",979,false
phosphatase,[NCBIGene:5504],154,"Reduction, NFAT/AP-1 complex formation",981,false
phosphatase,[NCBIGene:5504],154,"Impairment, T-cell dependent antibody response",984,false
phosphatase,[NCBIGene:5504],154,"Suppression, IL-2 and IL-4 production",1202,false
phosphatase,[NCBIGene:5504],154,"Inhibition, Calcineurin Activity",980,true
DIO1,[NCBIGene:1733],159,"Thyroperoxidase, Inhibition",279,true
DIO1,[NCBIGene:1733],159,"Thyroid hormone synthesis, Decreased",277,false
DIO1,[NCBIGene:1733],159,"Decreased, Triiodothyronine (T3)",1003,false
DIO1,[NCBIGene:1733],159,"Reduced, Swimming performance",1005,false
DIO1,[NCBIGene:1733],159,"Reduced, Anterior swim bladder inflation",1007,false
DIO1,[NCBIGene:1733],159,"Decrease, Population growth rate",360,false
DIO1,[NCBIGene:1733],159,Increased Mortality,351,false
DIO1,[NCBIGene:1733],159,"Thyroxine (T4) in serum, Decreased",281,false
DIO2,[NCBIGene:1734],159,"Thyroperoxidase, Inhibition",279,true
DIO2,[NCBIGene:1734],159,"Thyroid hormone synthesis, Decreased",277,false
DIO2,[NCBIGene:1734],159,"Decreased, Triiodothyronine (T3)",1003,false
DIO2,[NCBIGene:1734],159,"Reduced, Swimming performance",1005,false
DIO2,[NCBIGene:1734],159,"Reduced, Anterior swim bladder inflation",1007,false
DIO2,[NCBIGene:1734],159,"Decrease, Population growth rate",360,false
DIO2,[NCBIGene:1734],159,Increased Mortality,351,false
DIO2,[NCBIGene:1734],159,"Thyroxine (T4) in serum, Decreased",281,false
THs,[NCBIGene:7057],159,"Thyroperoxidase, Inhibition",279,true
THs,[NCBIGene:7057],159,"Thyroid hormone synthesis, Decreased",277,false
THs,[NCBIGene:7057],159,"Decreased, Triiodothyronine (T3)",1003,false
THs,[NCBIGene:7057],159,"Reduced, Swimming performance",1005,false
THs,[NCBIGene:7057],159,"Reduced, Anterior swim bladder inflation",1007,false
THs,[NCBIGene:7057],159,"Decrease, Population growth rate",360,false
THs,[NCBIGene:7057],159,Increased Mortality,351,false
THs,[NCBIGene:7057],159,"Thyroxine (T4) in serum, Decreased",281,false
Thyroperoxidase,[NCBIGene:7173],159,"Thyroperoxidase, Inhibition",279,true
Thyroperoxidase,[NCBIGene:7173],159,"Thyroid hormone synthesis, Decreased",277,false
Thyroperoxidase,[NCBIGene:7173],159,"Decreased, Triiodothyronine (T3)",1003,false
Thyroperoxidase,[NCBIGene:7173],159,"Reduced, Swimming performance",1005,false
Thyroperoxidase,[NCBIGene:7173],159,"Reduced, Anterior swim bladder inflation",1007,false
Thyroperoxidase,[NCBIGene:7173],159,"Decrease, Population growth rate",360,false
Thyroperoxidase,[NCBIGene:7173],159,Increased Mortality,351,false
Thyroperoxidase,[NCBIGene:7173],159,"Thyroxine (T4) in serum, Decreased",281,false
Acetylcholinesterase,[NCBIGene:43],16,"Decrease, Population growth rate",360,false
Acetylcholinesterase,[NCBIGene:43],16,Dysregulation of heart rate and vascular tone,1703,false
Acetylcholinesterase,[NCBIGene:43],16,Increased Cholinergic Signaling,39,false
Acetylcholinesterase,[NCBIGene:43],16,Respiratory distress/arrest,445,false
Acetylcholinesterase,[NCBIGene:43],16,Acetylcholine accumulation in synapses,10,false
Acetylcholinesterase,[NCBIGene:43],16,Acetylcholinesterase (AchE) Inhibition,12,true
Acetylcholinesterase,[NCBIGene:43],16,Increased Mortality,351,false
GABAA receptor,[NCBIGene:2550],160,"Increased, Chloride conductance",761,false
GABAA receptor,[NCBIGene:2550],160,"Activation, ionotropic GABA Receptor chloride channel",762,true
GABAA receptor,[NCBIGene:2550],160,"Increased, Inhibitory postsynaptic potential",1012,false
GABAA receptor,[NCBIGene:2550],160,"Induction, Somatic muscle paralysis",1014,false
GABAA receptor,[NCBIGene:2550],160,"Increased, Neuronal synaptic inhibition",1015,false
GABAA receptor,[NCBIGene:2550],160,"Inhibition, Feeding",1016,false
GABAA receptor,[NCBIGene:2550],160,Increased Mortality,351,false
iGABAR,[NCBIGene:6418],160,"Increased, Chloride conductance",761,false
iGABAR,[NCBIGene:6418],160,"Activation, ionotropic GABA Receptor chloride channel",762,true
iGABAR,[NCBIGene:6418],160,"Increased, Inhibitory postsynaptic potential",1012,false
iGABAR,[NCBIGene:6418],160,"Induction, Somatic muscle paralysis",1014,false
iGABAR,[NCBIGene:6418],160,"Increased, Neuronal synaptic inhibition",1015,false
iGABAR,[NCBIGene:6418],160,"Inhibition, Feeding",1016,false
iGABAR,[NCBIGene:6418],160,Increased Mortality,351,false
GluCl,"[NCBIGene:2629, 57733, 2630]",161,"Increased, Chloride conductance",761,false
GluCl,"[NCBIGene:2629, 57733, 2630]",161,"Increased, Inhibitory postsynaptic potential",1012,false
GluCl,"[NCBIGene:2629, 57733, 2630]",161,"Increased, Neuronal synaptic inhibition",1015,false
GluCl,"[NCBIGene:2629, 57733, 2630]",161,"Inhibition, Feeding",1016,false
GluCl,"[NCBIGene:2629, 57733, 2630]",161,"Activation, Glutamate-gated chloride channels",1018,true
GluCl,"[NCBIGene:2629, 57733, 2630]",161,"Induction, pharyngeal muscle paralysis",1019,false
GluCl,"[NCBIGene:2629, 57733, 2630]",161,Increased Mortality,351,false
PPAR gamma,[NCBIGene:5468],163,"Activation of specific nuclear receptors, PPAR-gamma activation",1028,true
PPAR gamma,[NCBIGene:5468],163,"Increased, adipogenesis",1029,false
PPAR gamma,[NCBIGene:5468],163,"Increased, secretion of local growth factors",1032,false
PPAR gamma,[NCBIGene:5468],163,"Increased, proliferation of mesenchymal cells",1033,false
PPAR gamma,[NCBIGene:5468],163,"Increased, IGF-1 (mouse)",1034,false
PPAR gamma,[NCBIGene:5468],163,"Increased, Firbrosarcoma",1035,false
PPAR gamma,[NCBIGene:5468],163,"Increased, liposarcoma",1036,false
PPAR gamma,[NCBIGene:5468],163,"Increased, hemagiosarcoma",1037,false
Beta-,[NCBIGene:1748],164,"Activation, beta-2 adrenergic receptor",1038,true
Beta-,[NCBIGene:1748],164,"Increased activity, beta-2 adrenergic receptor",1039,false
Beta-,[NCBIGene:1748],164,"relaxation, smooth muscle",1040,false
Beta-,[NCBIGene:1748],164,"Proliferation/Clonal Expansion, smooth muscle",1042,false
Beta-,[NCBIGene:1748],164,"Hypertrophy/hyperplasia, smooth muscle",1043,false
Beta-,[NCBIGene:1748],164,"Promotion, mesovarian leiomyomas",1044,false
Beta-2,[NCBIGene:10242],164,"Activation, beta-2 adrenergic receptor",1038,true
Beta-2,[NCBIGene:10242],164,"Increased activity, beta-2 adrenergic receptor",1039,false
Beta-2,[NCBIGene:10242],164,"relaxation, smooth muscle",1040,false
Beta-2,[NCBIGene:10242],164,"Proliferation/Clonal Expansion, smooth muscle",1042,false
Beta-2,[NCBIGene:10242],164,"Hypertrophy/hyperplasia, smooth muscle",1043,false
Beta-2,[NCBIGene:10242],164,"Promotion, mesovarian leiomyomas",1044,false
PPAR,[NCBIGene:5465],166,"Increased, PPAR-alpha activation",1057,false
PPAR,[NCBIGene:5465],166,"Decreased, bile flow",1058,false
PPAR,[NCBIGene:5465],166,"Increased, cholestasis",1059,false
PPAR,[NCBIGene:5465],166,"Alteration, lipid metabolism",1060,false
PPAR,[NCBIGene:5465],166,"prolonged, elevation of serun CCK",1061,false
PPAR,[NCBIGene:5465],166,"Increased, Cellular proliferation / hyperplasia of acinar cells",1062,false
PPAR,[NCBIGene:5465],166,"Increased, Pancreatic acinar tumors",1063,false
ER,"[NCBIGene:2099, 2069]",167,"Activation, estrogen receptor alpha",1065,true
ER,"[NCBIGene:2099, 2069]",167,"Promotion, SIX-1 postive basal-type progenitor cells",1066,false
ER,"[NCBIGene:2099, 2069]",167,"Proliferation/Clonal Expansion, aberrant basal cells",1067,false
ER,"[NCBIGene:2099, 2069]",167,"squamous metaplasia, aberrant basal cells",1068,false
ER,"[NCBIGene:2099, 2069]",167,"Increased, Hyperplasia (glandular epithelial cells of endometrium)",1069,false
ER,"[NCBIGene:2099, 2069]",167,"Increased, adenosquamous carcinomas of endometrium",1070,false
GnRH,[NCBIGene:2796],168,"prolonged, estrus",1075,false
GnRH,[NCBIGene:2796],168,"Increased, circulating estrogen levels",1076,false
GnRH,[NCBIGene:2796],168,"Increased, prolactin exposure",1077,false
GnRH,[NCBIGene:2796],168,"Hyperplasia, Mammary gland",1078,false
GnRH,[NCBIGene:2796],168,"Increased, Adenomas/carcinomas (mammary)",1079,false
GnRH,[NCBIGene:2796],168,"Increased, latency period",1080,false
GnRH,[NCBIGene:2796],168,"Decreased, GnRH pulsatility/release in hypothalamus",1071,false
GnRH,[NCBIGene:2796],168,"Decreased, LH Surge from anterior pituitary",1072,false
GnRH,[NCBIGene:2796],168,"interruption, Ovulation",1074,false
GnRH,[NCBIGene:2796],169,"prolonged, estrus",1075,false
GnRH,[NCBIGene:2796],169,"Increased, circulating estrogen levels",1076,false
GnRH,[NCBIGene:2796],169,"Increased, lactotroph hyperplasia and hypertrophy",1081,false
GnRH,[NCBIGene:2796],169,"Increased, adenomas (pituitary)",1082,false
GnRH,[NCBIGene:2796],169,"Decreased, GnRH pulsatility/release in hypothalamus",1071,false
GnRH,[NCBIGene:2796],169,"Decreased, LH Surge from anterior pituitary",1072,false
GnRH,[NCBIGene:2796],169,"interruption, Ovulation",1074,false
SH-/ seleno-proteins,[NCBIGene:55829],17,Neuroinflammation,188,false
SH-/ seleno-proteins,[NCBIGene:55829],17,Decreased protection against oxidative stress,1538,false
SH-/ seleno-proteins,[NCBIGene:55829],17,Increased Pro-inflammatory mediators,1493,false
SH-/ seleno-proteins,[NCBIGene:55829],17,Tissue resident cell activation,1492,false
SH-/ seleno-proteins,[NCBIGene:55829],17,Glutamate dyshomeostasis,1488,false
SH-/ seleno-proteins,[NCBIGene:55829],17,Oxidative Stress,1392,false
SH-/ seleno-proteins,[NCBIGene:55829],17,"Binding, Thiol/seleno-proteins involved in protection against oxidative stress",1487,true
SH-/ seleno-proteins,[NCBIGene:55829],17,Decrease of neuronal network function,386,false
SH-/ seleno-proteins,[NCBIGene:55829],17,"Impairment, Learning and memory",341,false
SH-/ seleno-proteins,[NCBIGene:55829],17,"Increase, Cell injury/death",55,false
DIO2,[NCBIGene:1734],175,"Thyroperoxidase, Inhibition",279,true
DIO2,[NCBIGene:1734],175,"Thyroid hormone synthesis, Decreased",277,false
DIO2,[NCBIGene:1734],175,"Altered, Amphibian metamorphosis",1101,false
DIO2,[NCBIGene:1734],175,"Thyroxine (T4) in serum, Decreased",281,false
DIO2 AOP,[NCBIGene:84734],175,"Thyroperoxidase, Inhibition",279,true
DIO2 AOP,[NCBIGene:84734],175,"Thyroid hormone synthesis, Decreased",277,false
DIO2 AOP,[NCBIGene:84734],175,"Altered, Amphibian metamorphosis",1101,false
DIO2 AOP,[NCBIGene:84734],175,"Thyroxine (T4) in serum, Decreased",281,false
THR,[NCBIGene:7069],175,"Thyroperoxidase, Inhibition",279,true
THR,[NCBIGene:7069],175,"Thyroid hormone synthesis, Decreased",277,false
THR,[NCBIGene:7069],175,"Altered, Amphibian metamorphosis",1101,false
THR,[NCBIGene:7069],175,"Thyroxine (T4) in serum, Decreased",281,false
Thyroperoxidase,[NCBIGene:7173],175,"Thyroperoxidase, Inhibition",279,true
Thyroperoxidase,[NCBIGene:7173],175,"Thyroid hormone synthesis, Decreased",277,false
Thyroperoxidase,[NCBIGene:7173],175,"Altered, Amphibian metamorphosis",1101,false
Thyroperoxidase,[NCBIGene:7173],175,"Thyroxine (T4) in serum, Decreased",281,false
thyroglobulin,[NCBIGene:7038],175,"Thyroperoxidase, Inhibition",279,true
thyroglobulin,[NCBIGene:7038],175,"Thyroid hormone synthesis, Decreased",277,false
thyroglobulin,[NCBIGene:7038],175,"Altered, Amphibian metamorphosis",1101,false
thyroglobulin,[NCBIGene:7038],175,"Thyroxine (T4) in serum, Decreased",281,false
thyroid stimulating hormone,[NCBIGene:7253],175,"Thyroperoxidase, Inhibition",279,true
thyroid stimulating hormone,[NCBIGene:7253],175,"Thyroid hormone synthesis, Decreased",277,false
thyroid stimulating hormone,[NCBIGene:7253],175,"Altered, Amphibian metamorphosis",1101,false
thyroid stimulating hormone,[NCBIGene:7253],175,"Thyroxine (T4) in serum, Decreased",281,false
DIO1,[NCBIGene:1733],176,"Thyroid hormone synthesis, Decreased",277,false
DIO1,[NCBIGene:1733],176,Decrease of Thyroidal iodide,425,false
DIO1,[NCBIGene:1733],176,"Inhibition, Na+/I- symporter (NIS)",424,true
DIO1,[NCBIGene:1733],176,"Altered, Amphibian metamorphosis",1101,false
DIO1,[NCBIGene:1733],176,"Thyroxine (T4) in serum, Decreased",281,false
DIO2 pAOPs,[NCBIGene:1136],176,"Thyroid hormone synthesis, Decreased",277,false
DIO2 pAOPs,[NCBIGene:1136],176,Decrease of Thyroidal iodide,425,false
DIO2 pAOPs,[NCBIGene:1136],176,"Inhibition, Na+/I- symporter (NIS)",424,true
DIO2 pAOPs,[NCBIGene:1136],176,"Altered, Amphibian metamorphosis",1101,false
DIO2 pAOPs,[NCBIGene:1136],176,"Thyroxine (T4) in serum, Decreased",281,false
Na+/I- symporter,[NCBIGene:6528],176,"Thyroid hormone synthesis, Decreased",277,false
Na+/I- symporter,[NCBIGene:6528],176,Decrease of Thyroidal iodide,425,false
Na+/I- symporter,[NCBIGene:6528],176,"Inhibition, Na+/I- symporter (NIS)",424,true
Na+/I- symporter,[NCBIGene:6528],176,"Altered, Amphibian metamorphosis",1101,false
Na+/I- symporter,[NCBIGene:6528],176,"Thyroxine (T4) in serum, Decreased",281,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",176,"Thyroid hormone synthesis, Decreased",277,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",176,Decrease of Thyroidal iodide,425,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",176,"Inhibition, Na+/I- symporter (NIS)",424,true
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",176,"Altered, Amphibian metamorphosis",1101,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",176,"Thyroxine (T4) in serum, Decreased",281,false
Thyroperoxidase,[NCBIGene:7173],176,"Thyroid hormone synthesis, Decreased",277,false
Thyroperoxidase,[NCBIGene:7173],176,Decrease of Thyroidal iodide,425,false
Thyroperoxidase,[NCBIGene:7173],176,"Inhibition, Na+/I- symporter (NIS)",424,true
Thyroperoxidase,[NCBIGene:7173],176,"Altered, Amphibian metamorphosis",1101,false
Thyroperoxidase,[NCBIGene:7173],176,"Thyroxine (T4) in serum, Decreased",281,false
thyroglobulin,[NCBIGene:7038],176,"Thyroid hormone synthesis, Decreased",277,false
thyroglobulin,[NCBIGene:7038],176,Decrease of Thyroidal iodide,425,false
thyroglobulin,[NCBIGene:7038],176,"Inhibition, Na+/I- symporter (NIS)",424,true
thyroglobulin,[NCBIGene:7038],176,"Altered, Amphibian metamorphosis",1101,false
thyroglobulin,[NCBIGene:7038],176,"Thyroxine (T4) in serum, Decreased",281,false
thyroid stimulating hormone,[NCBIGene:7253],176,"Thyroid hormone synthesis, Decreased",277,false
thyroid stimulating hormone,[NCBIGene:7253],176,Decrease of Thyroidal iodide,425,false
thyroid stimulating hormone,[NCBIGene:7253],176,"Inhibition, Na+/I- symporter (NIS)",424,true
thyroid stimulating hormone,[NCBIGene:7253],176,"Altered, Amphibian metamorphosis",1101,false
thyroid stimulating hormone,[NCBIGene:7253],176,"Thyroxine (T4) in serum, Decreased",281,false
COX1,[NCBIGene:4512],177,"Increased, blood uric acid concentration",1096,false
COX1,[NCBIGene:4512],177,"Occurrence, renal proximal tubular necrosis",1097,false
COX1,[NCBIGene:4512],177,"Increased, blood potassium concentration",1098,false
COX1,[NCBIGene:4512],177,"Occurrence, tophi (urate) deposition",1102,false
COX1,[NCBIGene:4512],177,"Occurrence, cardiac arrhythmia",1106,false
COX1,[NCBIGene:4512],177,"Decreased, Prostaglandin F2alpha concentration, plasma",1104,false
COX1,[NCBIGene:4512],177,"Occurrence, renal ischemia",1105,false
COX1,[NCBIGene:4512],177,"Inhibition, Cyclooxygenase 1 activity",1103,true
COX1,[NCBIGene:4512],177,Oxidative Stress,1392,false
COX1,[NCBIGene:4512],177,"Decrease, Population growth rate",360,false
COX1,[NCBIGene:4512],177,Increased Mortality,351,false
Cyclooxygenase,[NCBIGene:5742],177,"Increased, blood uric acid concentration",1096,false
Cyclooxygenase,[NCBIGene:5742],177,"Occurrence, renal proximal tubular necrosis",1097,false
Cyclooxygenase,[NCBIGene:5742],177,"Increased, blood potassium concentration",1098,false
Cyclooxygenase,[NCBIGene:5742],177,"Occurrence, tophi (urate) deposition",1102,false
Cyclooxygenase,[NCBIGene:5742],177,"Occurrence, cardiac arrhythmia",1106,false
Cyclooxygenase,[NCBIGene:5742],177,"Decreased, Prostaglandin F2alpha concentration, plasma",1104,false
Cyclooxygenase,[NCBIGene:5742],177,"Occurrence, renal ischemia",1105,false
Cyclooxygenase,[NCBIGene:5742],177,"Inhibition, Cyclooxygenase 1 activity",1103,true
Cyclooxygenase,[NCBIGene:5742],177,Oxidative Stress,1392,false
Cyclooxygenase,[NCBIGene:5742],177,"Decrease, Population growth rate",360,false
Cyclooxygenase,[NCBIGene:5742],177,Increased Mortality,351,false
Nicotinic acetylcholine receptor,[NCBIGene:1134],178,"Weakened, Colony",1107,false
Nicotinic acetylcholine receptor,[NCBIGene:1134],178,"Activation, Nicotinic acetylcholine receptor",559,true
Nicotinic acetylcholine receptor,[NCBIGene:1134],178,"Death/Failure, Colony",563,false
Nicotinic acetylcholine receptor,[NCBIGene:1134],178,Mitochondrial dysfunction,177,false
nAChR,[NCBIGene:1137],178,"Weakened, Colony",1107,false
nAChR,[NCBIGene:1137],178,"Activation, Nicotinic acetylcholine receptor",559,true
nAChR,[NCBIGene:1137],178,"Death/Failure, Colony",563,false
nAChR,[NCBIGene:1137],178,Mitochondrial dysfunction,177,false
AR,"[NCBIGene:367, 231, 2232]",18,"Decrease, circulating testosterone levels",1690,false
AR,"[NCBIGene:367, 231, 2232]",18,"Malformation, Male reproductive tract",348,false
AR,"[NCBIGene:367, 231, 2232]",18,"Decrease, Translocator protein (TSPO)",289,false
AR,"[NCBIGene:367, 231, 2232]",18,"Reduction, Testosterone synthesis in Leydig cells",413,false
AR,"[NCBIGene:367, 231, 2232]",18,"Reduction, Cholesterol transport in mitochondria",447,false
AR,"[NCBIGene:367, 231, 2232]",18,"Decrease, Steroidogenic acute regulatory protein (STAR)",266,false
AR,"[NCBIGene:367, 231, 2232]",18,"Activation, PPARα",227,true
AR,"[NCBIGene:367, 231, 2232]",18,"decreased, Fertility",406,false
PPAR,[NCBIGene:5465],18,"Decrease, circulating testosterone levels",1690,false
PPAR,[NCBIGene:5465],18,"Malformation, Male reproductive tract",348,false
PPAR,[NCBIGene:5465],18,"Decrease, Translocator protein (TSPO)",289,false
PPAR,[NCBIGene:5465],18,"Reduction, Testosterone synthesis in Leydig cells",413,false
PPAR,[NCBIGene:5465],18,"Reduction, Cholesterol transport in mitochondria",447,false
PPAR,[NCBIGene:5465],18,"Decrease, Steroidogenic acute regulatory protein (STAR)",266,false
PPAR,[NCBIGene:5465],18,"Activation, PPARα",227,true
PPAR,[NCBIGene:5465],18,"decreased, Fertility",406,false
steroid and thyroid hormone receptors,[NCBIGene:3164],18,"Decrease, circulating testosterone levels",1690,false
steroid and thyroid hormone receptors,[NCBIGene:3164],18,"Malformation, Male reproductive tract",348,false
steroid and thyroid hormone receptors,[NCBIGene:3164],18,"Decrease, Translocator protein (TSPO)",289,false
steroid and thyroid hormone receptors,[NCBIGene:3164],18,"Reduction, Testosterone synthesis in Leydig cells",413,false
steroid and thyroid hormone receptors,[NCBIGene:3164],18,"Reduction, Cholesterol transport in mitochondria",447,false
steroid and thyroid hormone receptors,[NCBIGene:3164],18,"Decrease, Steroidogenic acute regulatory protein (STAR)",266,false
steroid and thyroid hormone receptors,[NCBIGene:3164],18,"Activation, PPARα",227,true
steroid and thyroid hormone receptors,[NCBIGene:3164],18,"decreased, Fertility",406,false
vitamin K epoxide reductase,[NCBIGene:79001],187,"Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failure of secondary hemostasis",1122,false
vitamin K epoxide reductase,[NCBIGene:79001],187,"Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)",1130,false
vitamin K epoxide reductase,[NCBIGene:79001],187,"Failure in gamma-glutamyl carboxylation of  clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin)",1131,false
vitamin K epoxide reductase,[NCBIGene:79001],187,"Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal",1132,false
vitamin K epoxide reductase,[NCBIGene:79001],187,"Hemostasis, Depletion from blood of fully functional carboxylated clotting factors",1133,false
vitamin K epoxide reductase,[NCBIGene:79001],187,"Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone",1134,true
vitamin K epoxide reductase,[NCBIGene:79001],187,"Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction",1135,false
vitamin K epoxide reductase,[NCBIGene:79001],187,"Impaired recruitment , Population trajectory",1136,false
vitamin K epoxide reductase,[NCBIGene:79001],187,"Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP",1138,true
vitamin K epoxide reductase,[NCBIGene:79001],187,"Osteoporosis and vascular calcification, Bone deterioration",1151,false
vitamin K epoxide reductase,[NCBIGene:79001],187,"Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone, Impairment of post-translational modification (carboxylation) of osteocalcin",1169,true
Glucose oxidase,[NCBIGene:9563],188,"Thyroid hormone synthesis, Decreased",277,false
Glucose oxidase,[NCBIGene:9563],188,Decrease of Thyroidal iodide,425,false
Glucose oxidase,[NCBIGene:9563],188,"Altered, Amphibian metamorphosis",1101,false
Glucose oxidase,[NCBIGene:9563],188,"Inhibition, Iodotyrosine deiodinase (IYD)",1152,true
Glucose oxidase,[NCBIGene:9563],188,"Thyroxine (T4) in serum, Decreased",281,false
Iodotyrosine deiodinase,[NCBIGene:389434],188,"Thyroid hormone synthesis, Decreased",277,false
Iodotyrosine deiodinase,[NCBIGene:389434],188,Decrease of Thyroidal iodide,425,false
Iodotyrosine deiodinase,[NCBIGene:389434],188,"Altered, Amphibian metamorphosis",1101,false
Iodotyrosine deiodinase,[NCBIGene:389434],188,"Inhibition, Iodotyrosine deiodinase (IYD)",1152,true
Iodotyrosine deiodinase,[NCBIGene:389434],188,"Thyroxine (T4) in serum, Decreased",281,false
TSH,"[NCBIGene:10194, 79896]",188,"Thyroid hormone synthesis, Decreased",277,false
TSH,"[NCBIGene:10194, 79896]",188,Decrease of Thyroidal iodide,425,false
TSH,"[NCBIGene:10194, 79896]",188,"Altered, Amphibian metamorphosis",1101,false
TSH,"[NCBIGene:10194, 79896]",188,"Inhibition, Iodotyrosine deiodinase (IYD)",1152,true
TSH,"[NCBIGene:10194, 79896]",188,"Thyroxine (T4) in serum, Decreased",281,false
DIO1,[NCBIGene:1733],189,"Decreased, Triiodothyronine (T3)",1003,false
DIO1,[NCBIGene:1733],189,"Inhibition, Deiodinase 1",1009,true
DIO1,[NCBIGene:1733],189,"Altered, Amphibian metamorphosis",1101,false
DIO1,[NCBIGene:1733],189,"Decreased, Triiodothyronine (T3) in tissues",1116,false
DIO2,[NCBIGene:1734],189,"Decreased, Triiodothyronine (T3)",1003,false
DIO2,[NCBIGene:1734],189,"Inhibition, Deiodinase 1",1009,true
DIO2,[NCBIGene:1734],189,"Altered, Amphibian metamorphosis",1101,false
DIO2,[NCBIGene:1734],189,"Decreased, Triiodothyronine (T3) in tissues",1116,false
Iodotyrosine deiodinase,[NCBIGene:389434],189,"Decreased, Triiodothyronine (T3)",1003,false
Iodotyrosine deiodinase,[NCBIGene:389434],189,"Inhibition, Deiodinase 1",1009,true
Iodotyrosine deiodinase,[NCBIGene:389434],189,"Altered, Amphibian metamorphosis",1101,false
Iodotyrosine deiodinase,[NCBIGene:389434],189,"Decreased, Triiodothyronine (T3) in tissues",1116,false
AR,"[NCBIGene:367, 231, 2232]",19,"Feminisation or incomplete development, Primary and accessory male sex organs",240,false
AR,"[NCBIGene:367, 231, 2232]",19,"Antagonism, Androgen receptor",26,true
AR,"[NCBIGene:367, 231, 2232]",19,"N/A, Impairment of reproductive capacity",337,false
AR,"[NCBIGene:367, 231, 2232]",19,"Altered, Transcription of genes by the androgen receptor",286,false
AR,"[NCBIGene:367, 231, 2232]",19,"Alteration, Wnt pathway",310,false
DIO1,[NCBIGene:1733],190,"Increased, Thyroid-stimulating hormone (TSH)",1023,false
DIO1,[NCBIGene:1733],190,"Inhibition, Deiodinase 2",1002,true
DIO1,[NCBIGene:1733],190,"Altered, Amphibian metamorphosis",1101,false
DIO1,[NCBIGene:1733],190,"Decreased, Triiodothyronine (T3) in tissues",1116,false
DIO1,[NCBIGene:1733],190,"Increased, Thyroxine (T4) in serum",1828,false
DIO1,[NCBIGene:1733],190,"Altered, Thyroid hormone-dependent gene expression",1829,false
DIO2,[NCBIGene:1734],190,"Increased, Thyroid-stimulating hormone (TSH)",1023,false
DIO2,[NCBIGene:1734],190,"Inhibition, Deiodinase 2",1002,true
DIO2,[NCBIGene:1734],190,"Altered, Amphibian metamorphosis",1101,false
DIO2,[NCBIGene:1734],190,"Decreased, Triiodothyronine (T3) in tissues",1116,false
DIO2,[NCBIGene:1734],190,"Increased, Thyroxine (T4) in serum",1828,false
DIO2,[NCBIGene:1734],190,"Altered, Thyroid hormone-dependent gene expression",1829,false
Iodotyrosine deiodinase,[NCBIGene:389434],190,"Increased, Thyroid-stimulating hormone (TSH)",1023,false
Iodotyrosine deiodinase,[NCBIGene:389434],190,"Inhibition, Deiodinase 2",1002,true
Iodotyrosine deiodinase,[NCBIGene:389434],190,"Altered, Amphibian metamorphosis",1101,false
Iodotyrosine deiodinase,[NCBIGene:389434],190,"Decreased, Triiodothyronine (T3) in tissues",1116,false
Iodotyrosine deiodinase,[NCBIGene:389434],190,"Increased, Thyroxine (T4) in serum",1828,false
Iodotyrosine deiodinase,[NCBIGene:389434],190,"Altered, Thyroid hormone-dependent gene expression",1829,false
DIO1,[NCBIGene:1733],191,"Altered, Amphibian metamorphosis",1101,false
DIO1,[NCBIGene:1733],191,"Altered, Thyroid hormone-dependent gene expression",1829,false
DIO1,[NCBIGene:1733],191,"Inhibition, Deiodinase 3",1153,true
DIO1,[NCBIGene:1733],191,"Increased, Triiodothyronine (T3) in tissues",1154,false
Iodotyrosine deiodinase,[NCBIGene:389434],191,"Altered, Amphibian metamorphosis",1101,false
Iodotyrosine deiodinase,[NCBIGene:389434],191,"Altered, Thyroid hormone-dependent gene expression",1829,false
Iodotyrosine deiodinase,[NCBIGene:389434],191,"Inhibition, Deiodinase 3",1153,true
Iodotyrosine deiodinase,[NCBIGene:389434],191,"Increased, Triiodothyronine (T3) in tissues",1154,false
Type III iodotyrosine deiodinase,[NCBIGene:1735],191,"Altered, Amphibian metamorphosis",1101,false
Type III iodotyrosine deiodinase,[NCBIGene:1735],191,"Altered, Thyroid hormone-dependent gene expression",1829,false
Type III iodotyrosine deiodinase,[NCBIGene:1735],191,"Inhibition, Deiodinase 3",1153,true
Type III iodotyrosine deiodinase,[NCBIGene:1735],191,"Increased, Triiodothyronine (T3) in tissues",1154,false
Pendrin,[NCBIGene:5172],192,"Thyroid hormone synthesis, Decreased",277,false
Pendrin,[NCBIGene:5172],192,"Altered, Amphibian metamorphosis",1101,false
Pendrin,[NCBIGene:5172],192,"Inhibition, Pendrin",1155,true
Pendrin,[NCBIGene:5172],192,"Thyroxine (T4) in serum, Decreased",281,false
Dual oxidase,[NCBIGene:53905],193,"Thyroid hormone synthesis, Decreased",277,false
Dual oxidase,[NCBIGene:53905],193,"Altered, Amphibian metamorphosis",1101,false
Dual oxidase,[NCBIGene:53905],193,"Inhibition, Dual oxidase",1156,true
Dual oxidase,[NCBIGene:53905],193,"Thyroxine (T4) in serum, Decreased",281,false
iNOS,[NCBIGene:4843],194,"Altered, Amphibian metamorphosis",1101,false
iNOS,[NCBIGene:4843],194,"Activation, Hepatic nuclear receptor(s)",1157,true
iNOS,[NCBIGene:4843],194,"Increased, Hepatic thyroid hormone uptake/transport",1158,false
iNOS,[NCBIGene:4843],194,"Thyroxine (T4) in serum, Decreased",281,false
iNOS,[NCBIGene:4843],194,"Induction, Upregulation of glucuronyltransferase activity",295,false
iNOS,[NCBIGene:4843],194,"Increased, Clearance of thyroxine from serum",961,false
5-hydroxytryptamine transporter,[NCBIGene:6532],195,"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)",619,true
5-hydroxytryptamine transporter,[NCBIGene:6532],195,"Increased, valve movement",1142,false
5-hydroxytryptamine transporter,[NCBIGene:6532],195,"Increased, serotonin (5-HT)",626,false
5-hydroxytryptamine transporter,[NCBIGene:6532],195,"Increased, oocyte maturation",1161,false
5-hydroxytryptamine transporter,[NCBIGene:6532],195,"Increased, Population",1164,false
5-hydroxytryptamine transporter,[NCBIGene:6532],195,induced spawning,1255,false
5-hydroxytryptamine transporter,[NCBIGene:6532],195,"Increased, Reproductive Success",1163,false
5-hydroxytryptamine transporter,[NCBIGene:6532],195,"Increase, cilia movement",621,false
TRP receptors,[NCBIGene:7220],196,"TRPA1 activation, TRPA1 Receptor",1215,true
TRP receptors,[NCBIGene:7220],196,"Opening of calcium channel, Calcium influx",1218,false
TRP receptors,[NCBIGene:7220],196,Trigeminal nerve activation,1220,false
TRP receptors,[NCBIGene:7220],196,"SP (Substance P) release, Local increase of SP",1222,false
TRP receptors,[NCBIGene:7220],196,"Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea",1223,false
TRP receptors,[NCBIGene:7220],196,"Increased Respiratory irritability and Chronic Cough,",1226,false
TRP receptors,[NCBIGene:7220],196,"Increased CGRP, neuronal release of CGRP",1433,false
TRP receptors,[NCBIGene:7220],196,Irritation of nasal mucosa inducing sneeze reflex,1434,false
TRP receptors,[NCBIGene:7220],196,Increased neurokinin A (NKA) by neuronal cells,1435,false
TRPA1 Receptor,[NCBIGene:8989],196,"TRPA1 activation, TRPA1 Receptor",1215,true
TRPA1 Receptor,[NCBIGene:8989],196,"Opening of calcium channel, Calcium influx",1218,false
TRPA1 Receptor,[NCBIGene:8989],196,Trigeminal nerve activation,1220,false
TRPA1 Receptor,[NCBIGene:8989],196,"SP (Substance P) release, Local increase of SP",1222,false
TRPA1 Receptor,[NCBIGene:8989],196,"Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea",1223,false
TRPA1 Receptor,[NCBIGene:8989],196,"Increased Respiratory irritability and Chronic Cough,",1226,false
TRPA1 Receptor,[NCBIGene:8989],196,"Increased CGRP, neuronal release of CGRP",1433,false
TRPA1 Receptor,[NCBIGene:8989],196,Irritation of nasal mucosa inducing sneeze reflex,1434,false
TRPA1 Receptor,[NCBIGene:8989],196,Increased neurokinin A (NKA) by neuronal cells,1435,false
NaV1,[NCBIGene:89796],197,"Inhibition, sodium channel",584,true
NaV1,[NCBIGene:89796],197,"Decreased, sodium conductance 2",1176,false
NaV1,[NCBIGene:89796],197,"Decreased, GABA release",1179,false
Sodium channel,[NCBIGene:6335],197,"Inhibition, sodium channel",584,true
Sodium channel,[NCBIGene:6335],197,"Decreased, sodium conductance 2",1176,false
Sodium channel,[NCBIGene:6335],197,"Decreased, GABA release",1179,false
ER,"[NCBIGene:2099, 2069]",200,"Increase, Cell Proliferation (Epithelial Cells)",1182,false
ER,"[NCBIGene:2099, 2069]",200,Mitochondrial dysfunction,177,false
ER,"[NCBIGene:2099, 2069]",200,"Increased, ER binding to T.F. to DNA (non-classical pathway)",1188,false
ER,"[NCBIGene:2099, 2069]",200,"Increased, Proliferation (Endothelial cells)",1189,false
ER,"[NCBIGene:2099, 2069]",200,"Increased, Migration (Endothelial Cells)",1190,false
ER,"[NCBIGene:2099, 2069]",200,"Increased, Non-genomic signaling",1191,false
ER,"[NCBIGene:2099, 2069]",200,"Increased, Ductal Hyperplasia",1192,false
ER,"[NCBIGene:2099, 2069]",200,"N/A, Breast Cancer",1193,false
ER,"[NCBIGene:2099, 2069]",200,"Increase, DNA damage",1194,false
ER,"[NCBIGene:2099, 2069]",200,"modulation, Extracellular Matrix Composition",1195,false
ER,"[NCBIGene:2099, 2069]",200,"Increased, Invasion",1196,false
ER,"[NCBIGene:2099, 2069]",200,"Activation, Fibroblasts",1197,false
ER,"[NCBIGene:2099, 2069]",200,"Activation, Macrophages",1198,false
ER,"[NCBIGene:2099, 2069]",200,"Increased, Angiogenesis",1213,false
ER,"[NCBIGene:2099, 2069]",200,"Altered, Gene Expression",1239,false
ER,"[NCBIGene:2099, 2069]",200,"Altered, Protein Production",1240,false
ER,"[NCBIGene:2099, 2069]",200,"Increased, Motility",1241,false
ER,"[NCBIGene:2099, 2069]",200,"Increased, Second Messenger Production",1242,false
ER,"[NCBIGene:2099, 2069]",200,"Agonism, Estrogen receptor",111,true
ER,"[NCBIGene:2099, 2069]",200,Oxidative Stress,1392,false
ER,"[NCBIGene:2099, 2069]",200,"Decreased, Apoptosis (Epithelial Cells)",1183,false
ER,"[NCBIGene:2099, 2069]",200,"Increased, ER binding to DNA (classical pathway)",1187,false
JHR,[NCBIGene:148738],201,"Alteration, Food-web structures",1210,false
JHR,[NCBIGene:148738],201,"Activation, Juvenile hormone receptor",1205,true
JHR,[NCBIGene:148738],201,"Induction, Doublesex1 gene",1206,false
JHR,[NCBIGene:148738],201,"Increased, Male offspring",1208,false
JHR,[NCBIGene:148738],201,"Induction, Male reproductive tract",1209,false
JHR,[NCBIGene:148738],201,"Decline, Population",361,false
Met,"[NCBIGene:4233, 8731]",201,"Alteration, Food-web structures",1210,false
Met,"[NCBIGene:4233, 8731]",201,"Activation, Juvenile hormone receptor",1205,true
Met,"[NCBIGene:4233, 8731]",201,"Induction, Doublesex1 gene",1206,false
Met,"[NCBIGene:4233, 8731]",201,"Increased, Male offspring",1208,false
Met,"[NCBIGene:4233, 8731]",201,"Induction, Male reproductive tract",1209,false
Met,"[NCBIGene:4233, 8731]",201,"Decline, Population",361,false
doublesex genes,[NCBIGene:10655],201,"Alteration, Food-web structures",1210,false
doublesex genes,[NCBIGene:10655],201,"Activation, Juvenile hormone receptor",1205,true
doublesex genes,[NCBIGene:10655],201,"Induction, Doublesex1 gene",1206,false
doublesex genes,[NCBIGene:10655],201,"Increased, Male offspring",1208,false
doublesex genes,[NCBIGene:10655],201,"Induction, Male reproductive tract",1209,false
doublesex genes,[NCBIGene:10655],201,"Decline, Population",361,false
serum binding proteinsthat,[NCBIGene:2690],201,"Alteration, Food-web structures",1210,false
serum binding proteinsthat,[NCBIGene:2690],201,"Activation, Juvenile hormone receptor",1205,true
serum binding proteinsthat,[NCBIGene:2690],201,"Induction, Doublesex1 gene",1206,false
serum binding proteinsthat,[NCBIGene:2690],201,"Increased, Male offspring",1208,false
serum binding proteinsthat,[NCBIGene:2690],201,"Induction, Male reproductive tract",1209,false
serum binding proteinsthat,[NCBIGene:2690],201,"Decline, Population",361,false
5-hydroxytryptamine transporter,[NCBIGene:6532],203,"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)",619,true
5-hydroxytryptamine transporter,[NCBIGene:6532],203,"Increased, valve movement",1142,false
5-hydroxytryptamine transporter,[NCBIGene:6532],203,increased mantel display,1256,false
5-hydroxytryptamine transporter,[NCBIGene:6532],203,Induced parturition,1257,false
5-hydroxytryptamine transporter,[NCBIGene:6532],203,"Decreased, Reproductive Success",1141,false
5-hydroxytryptamine transporter,[NCBIGene:6532],203,"Increased, serotonin (5-HT)",626,false
5-hydroxytryptamine transporter,[NCBIGene:6532],203,"Decrease, Population growth rate",360,false
5-hydroxytryptamine transporter,[NCBIGene:6532],203,"Increase, cilia movement",621,false
5-hydroxytryptamine transporter,[NCBIGene:6532],204,"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)",619,true
5-hydroxytryptamine transporter,[NCBIGene:6532],204,"Increased, valve movement",1142,false
5-hydroxytryptamine transporter,[NCBIGene:6532],204,increased mantel display,1256,false
5-hydroxytryptamine transporter,[NCBIGene:6532],204,Induced parturition,1257,false
5-hydroxytryptamine transporter,[NCBIGene:6532],204,"Increased, serotonin (5-HT)",626,false
5-hydroxytryptamine transporter,[NCBIGene:6532],204,"Increased, Population",1164,false
5-hydroxytryptamine transporter,[NCBIGene:6532],204,"Increased, Reproductive Success",1163,false
5-hydroxytryptamine transporter,[NCBIGene:6532],204,"Increase, cilia movement",621,false
PPAR,[NCBIGene:5465],206,"Increase, Inflammation",149,false
PPAR,[NCBIGene:5465],206,Inactivation of PPARγ,1270,true
PPAR,[NCBIGene:5465],206,Activation of TGF-β signaling,1271,false
PPAR,[NCBIGene:5465],206,Collagen Deposition,1275,false
PPAR,[NCBIGene:5465],206,Lung fibrosis,1276,false
PPAR,[NCBIGene:5465],206,Epithelial Mesenchymal Transition,1457,false
ROCK,[NCBIGene:6093],206,"Increase, Inflammation",149,false
ROCK,[NCBIGene:6093],206,Inactivation of PPARγ,1270,true
ROCK,[NCBIGene:6093],206,Activation of TGF-β signaling,1271,false
ROCK,[NCBIGene:6093],206,Collagen Deposition,1275,false
ROCK,[NCBIGene:6093],206,Lung fibrosis,1276,false
ROCK,[NCBIGene:6093],206,Epithelial Mesenchymal Transition,1457,false
Smad3,[NCBIGene:4088],206,"Increase, Inflammation",149,false
Smad3,[NCBIGene:4088],206,Inactivation of PPARγ,1270,true
Smad3,[NCBIGene:4088],206,Activation of TGF-β signaling,1271,false
Smad3,[NCBIGene:4088],206,Collagen Deposition,1275,false
Smad3,[NCBIGene:4088],206,Lung fibrosis,1276,false
Smad3,[NCBIGene:4088],206,Epithelial Mesenchymal Transition,1457,false
actin,"[NCBIGene:148709, 402221]",206,"Increase, Inflammation",149,false
actin,"[NCBIGene:148709, 402221]",206,Inactivation of PPARγ,1270,true
actin,"[NCBIGene:148709, 402221]",206,Activation of TGF-β signaling,1271,false
actin,"[NCBIGene:148709, 402221]",206,Collagen Deposition,1275,false
actin,"[NCBIGene:148709, 402221]",206,Lung fibrosis,1276,false
actin,"[NCBIGene:148709, 402221]",206,Epithelial Mesenchymal Transition,1457,false
collagen,[NCBIGene:1280],206,"Increase, Inflammation",149,false
collagen,[NCBIGene:1280],206,Inactivation of PPARγ,1270,true
collagen,[NCBIGene:1280],206,Activation of TGF-β signaling,1271,false
collagen,[NCBIGene:1280],206,Collagen Deposition,1275,false
collagen,[NCBIGene:1280],206,Lung fibrosis,1276,false
collagen,[NCBIGene:1280],206,Epithelial Mesenchymal Transition,1457,false
fibrillar and non-fibrillar collagens,[NCBIGene:2091],206,"Increase, Inflammation",149,false
fibrillar and non-fibrillar collagens,[NCBIGene:2091],206,Inactivation of PPARγ,1270,true
fibrillar and non-fibrillar collagens,[NCBIGene:2091],206,Activation of TGF-β signaling,1271,false
fibrillar and non-fibrillar collagens,[NCBIGene:2091],206,Collagen Deposition,1275,false
fibrillar and non-fibrillar collagens,[NCBIGene:2091],206,Lung fibrosis,1276,false
fibrillar and non-fibrillar collagens,[NCBIGene:2091],206,Epithelial Mesenchymal Transition,1457,false
rho,[NCBIGene:6010],206,"Increase, Inflammation",149,false
rho,[NCBIGene:6010],206,Inactivation of PPARγ,1270,true
rho,[NCBIGene:6010],206,Activation of TGF-β signaling,1271,false
rho,[NCBIGene:6010],206,Collagen Deposition,1275,false
rho,[NCBIGene:6010],206,Lung fibrosis,1276,false
rho,[NCBIGene:6010],206,Epithelial Mesenchymal Transition,1457,false
transforming growth factor,[NCBIGene:7039],206,"Increase, Inflammation",149,false
transforming growth factor,[NCBIGene:7039],206,Inactivation of PPARγ,1270,true
transforming growth factor,[NCBIGene:7039],206,Activation of TGF-β signaling,1271,false
transforming growth factor,[NCBIGene:7039],206,Collagen Deposition,1275,false
transforming growth factor,[NCBIGene:7039],206,Lung fibrosis,1276,false
transforming growth factor,[NCBIGene:7039],206,Epithelial Mesenchymal Transition,1457,false
HIF-1alpha,[NCBIGene:3091],207,Mitochondrial dysfunction,177,false
HIF-1alpha,[NCBIGene:3091],207,"Increase, Reactive oxygen species",1115,false
HIF-1alpha,[NCBIGene:3091],207,Apoptosis,1262,false
HIF-1alpha,[NCBIGene:3091],207,"Activation, NADPH Oxidase",1174,true
HIF-1alpha,[NCBIGene:3091],207,Reproductive failure,1277,false
HIF-1alpha,[NCBIGene:3091],207,"Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK",1279,false
HIF-1alpha,[NCBIGene:3091],207,"Activation, HIF-1",1280,false
HIF-1alpha,[NCBIGene:3091],207,"Increased, DNA Damage-Repair",1281,false
NADPH oxidase,[NCBIGene:27035],207,Mitochondrial dysfunction,177,false
NADPH oxidase,[NCBIGene:27035],207,"Increase, Reactive oxygen species",1115,false
NADPH oxidase,[NCBIGene:27035],207,Apoptosis,1262,false
NADPH oxidase,[NCBIGene:27035],207,"Activation, NADPH Oxidase",1174,true
NADPH oxidase,[NCBIGene:27035],207,Reproductive failure,1277,false
NADPH oxidase,[NCBIGene:27035],207,"Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK",1279,false
NADPH oxidase,[NCBIGene:27035],207,"Activation, HIF-1",1280,false
NADPH oxidase,[NCBIGene:27035],207,"Increased, DNA Damage-Repair",1281,false
P38 MAPK,[NCBIGene:1432],207,Mitochondrial dysfunction,177,false
P38 MAPK,[NCBIGene:1432],207,"Increase, Reactive oxygen species",1115,false
P38 MAPK,[NCBIGene:1432],207,Apoptosis,1262,false
P38 MAPK,[NCBIGene:1432],207,"Activation, NADPH Oxidase",1174,true
P38 MAPK,[NCBIGene:1432],207,Reproductive failure,1277,false
P38 MAPK,[NCBIGene:1432],207,"Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK",1279,false
P38 MAPK,[NCBIGene:1432],207,"Activation, HIF-1",1280,false
P38 MAPK,[NCBIGene:1432],207,"Increased, DNA Damage-Repair",1281,false
bli-3,[NCBIGene:3486],207,Mitochondrial dysfunction,177,false
bli-3,[NCBIGene:3486],207,"Increase, Reactive oxygen species",1115,false
bli-3,[NCBIGene:3486],207,Apoptosis,1262,false
bli-3,[NCBIGene:3486],207,"Activation, NADPH Oxidase",1174,true
bli-3,[NCBIGene:3486],207,Reproductive failure,1277,false
bli-3,[NCBIGene:3486],207,"Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK",1279,false
bli-3,[NCBIGene:3486],207,"Activation, HIF-1",1280,false
bli-3,[NCBIGene:3486],207,"Increased, DNA Damage-Repair",1281,false
cyp35a2,[NCBIGene:100128781],207,Mitochondrial dysfunction,177,false
cyp35a2,[NCBIGene:100128781],207,"Increase, Reactive oxygen species",1115,false
cyp35a2,[NCBIGene:100128781],207,Apoptosis,1262,false
cyp35a2,[NCBIGene:100128781],207,"Activation, NADPH Oxidase",1174,true
cyp35a2,[NCBIGene:100128781],207,Reproductive failure,1277,false
cyp35a2,[NCBIGene:100128781],207,"Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK",1279,false
cyp35a2,[NCBIGene:100128781],207,"Activation, HIF-1",1280,false
cyp35a2,[NCBIGene:100128781],207,"Increased, DNA Damage-Repair",1281,false
fmo-2,[NCBIGene:2327],207,Mitochondrial dysfunction,177,false
fmo-2,[NCBIGene:2327],207,"Increase, Reactive oxygen species",1115,false
fmo-2,[NCBIGene:2327],207,Apoptosis,1262,false
fmo-2,[NCBIGene:2327],207,"Activation, NADPH Oxidase",1174,true
fmo-2,[NCBIGene:2327],207,Reproductive failure,1277,false
fmo-2,[NCBIGene:2327],207,"Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK",1279,false
fmo-2,[NCBIGene:2327],207,"Activation, HIF-1",1280,false
fmo-2,[NCBIGene:2327],207,"Increased, DNA Damage-Repair",1281,false
nth-,[NCBIGene:4913],207,Mitochondrial dysfunction,177,false
nth-,[NCBIGene:4913],207,"Increase, Reactive oxygen species",1115,false
nth-,[NCBIGene:4913],207,Apoptosis,1262,false
nth-,[NCBIGene:4913],207,"Activation, NADPH Oxidase",1174,true
nth-,[NCBIGene:4913],207,Reproductive failure,1277,false
nth-,[NCBIGene:4913],207,"Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK",1279,false
nth-,[NCBIGene:4913],207,"Activation, HIF-1",1280,false
nth-,[NCBIGene:4913],207,"Increased, DNA Damage-Repair",1281,false
pmk-1,[NCBIGene:10654],207,Mitochondrial dysfunction,177,false
pmk-1,[NCBIGene:10654],207,"Increase, Reactive oxygen species",1115,false
pmk-1,[NCBIGene:10654],207,Apoptosis,1262,false
pmk-1,[NCBIGene:10654],207,"Activation, NADPH Oxidase",1174,true
pmk-1,[NCBIGene:10654],207,Reproductive failure,1277,false
pmk-1,[NCBIGene:10654],207,"Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK",1279,false
pmk-1,[NCBIGene:10654],207,"Activation, HIF-1",1280,false
pmk-1,[NCBIGene:10654],207,"Increased, DNA Damage-Repair",1281,false
sod-3,[NCBIGene:6649],207,Mitochondrial dysfunction,177,false
sod-3,[NCBIGene:6649],207,"Increase, Reactive oxygen species",1115,false
sod-3,[NCBIGene:6649],207,Apoptosis,1262,false
sod-3,[NCBIGene:6649],207,"Activation, NADPH Oxidase",1174,true
sod-3,[NCBIGene:6649],207,Reproductive failure,1277,false
sod-3,[NCBIGene:6649],207,"Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK",1279,false
sod-3,[NCBIGene:6649],207,"Activation, HIF-1",1280,false
sod-3,[NCBIGene:6649],207,"Increased, DNA Damage-Repair",1281,false
Janus kinase,[NCBIGene:3716],208,Reproductive failure,1277,false
Janus kinase,[NCBIGene:3716],208,"Activation, JAK/STAT pathway",1282,false
Janus kinase,[NCBIGene:3716],208,"Activation, TGF-beta pathway",1283,false
STAT,[NCBIGene:6646],208,Reproductive failure,1277,false
STAT,[NCBIGene:6646],208,"Activation, JAK/STAT pathway",1282,false
STAT,[NCBIGene:6646],208,"Activation, TGF-beta pathway",1283,false
Signal transducer and activator of transcription,[NCBIGene:6772],208,Reproductive failure,1277,false
Signal transducer and activator of transcription,[NCBIGene:6772],208,"Activation, JAK/STAT pathway",1282,false
Signal transducer and activator of transcription,[NCBIGene:6772],208,"Activation, TGF-beta pathway",1283,false
TGF-1,[NCBIGene:7040],208,Reproductive failure,1277,false
TGF-1,[NCBIGene:7040],208,"Activation, JAK/STAT pathway",1282,false
TGF-1,[NCBIGene:7040],208,"Activation, TGF-beta pathway",1283,false
transforming growth factor,[NCBIGene:7039],208,Reproductive failure,1277,false
transforming growth factor,[NCBIGene:7039],208,"Activation, JAK/STAT pathway",1282,false
transforming growth factor,[NCBIGene:7039],208,"Activation, TGF-beta pathway",1283,false
GSTA1,[NCBIGene:2938],209,"Up Regulation, SREBF2",1284,false
GSTA1,[NCBIGene:2938],209,"Up Regulation, Unsaturated fatty acid",1285,false
GSTA1,[NCBIGene:2938],209,"Down Regulation, GSS and GSTs gene",1286,false
GSTA1,[NCBIGene:2938],209,Glutathione synthesis,1287,false
GSTA1,[NCBIGene:2938],209,"Activation, 3-hydroxy-3-methylglutaryl-CoA reductase gene",1288,false
GSTA1,[NCBIGene:2938],209,Perturbation of cholesterol,1289,false
GSTA1,[NCBIGene:2938],209,Glutathione homeostasis,1290,false
GSTA1,[NCBIGene:2938],209,Hepatotoxicity,1291,false
GSTA2,[NCBIGene:2939],209,"Up Regulation, SREBF2",1284,false
GSTA2,[NCBIGene:2939],209,"Up Regulation, Unsaturated fatty acid",1285,false
GSTA2,[NCBIGene:2939],209,"Down Regulation, GSS and GSTs gene",1286,false
GSTA2,[NCBIGene:2939],209,Glutathione synthesis,1287,false
GSTA2,[NCBIGene:2939],209,"Activation, 3-hydroxy-3-methylglutaryl-CoA reductase gene",1288,false
GSTA2,[NCBIGene:2939],209,Perturbation of cholesterol,1289,false
GSTA2,[NCBIGene:2939],209,Glutathione homeostasis,1290,false
GSTA2,[NCBIGene:2939],209,Hepatotoxicity,1291,false
GSTA3,[NCBIGene:2940],209,"Up Regulation, SREBF2",1284,false
GSTA3,[NCBIGene:2940],209,"Up Regulation, Unsaturated fatty acid",1285,false
GSTA3,[NCBIGene:2940],209,"Down Regulation, GSS and GSTs gene",1286,false
GSTA3,[NCBIGene:2940],209,Glutathione synthesis,1287,false
GSTA3,[NCBIGene:2940],209,"Activation, 3-hydroxy-3-methylglutaryl-CoA reductase gene",1288,false
GSTA3,[NCBIGene:2940],209,Perturbation of cholesterol,1289,false
GSTA3,[NCBIGene:2940],209,Glutathione homeostasis,1290,false
GSTA3,[NCBIGene:2940],209,Hepatotoxicity,1291,false
GSTA5,[NCBIGene:221357],209,"Up Regulation, SREBF2",1284,false
GSTA5,[NCBIGene:221357],209,"Up Regulation, Unsaturated fatty acid",1285,false
GSTA5,[NCBIGene:221357],209,"Down Regulation, GSS and GSTs gene",1286,false
GSTA5,[NCBIGene:221357],209,Glutathione synthesis,1287,false
GSTA5,[NCBIGene:221357],209,"Activation, 3-hydroxy-3-methylglutaryl-CoA reductase gene",1288,false
GSTA5,[NCBIGene:221357],209,Perturbation of cholesterol,1289,false
GSTA5,[NCBIGene:221357],209,Glutathione homeostasis,1290,false
GSTA5,[NCBIGene:221357],209,Hepatotoxicity,1291,false
glutathione synthetase,[NCBIGene:2937],209,"Up Regulation, SREBF2",1284,false
glutathione synthetase,[NCBIGene:2937],209,"Up Regulation, Unsaturated fatty acid",1285,false
glutathione synthetase,[NCBIGene:2937],209,"Down Regulation, GSS and GSTs gene",1286,false
glutathione synthetase,[NCBIGene:2937],209,Glutathione synthesis,1287,false
glutathione synthetase,[NCBIGene:2937],209,"Activation, 3-hydroxy-3-methylglutaryl-CoA reductase gene",1288,false
glutathione synthetase,[NCBIGene:2937],209,Perturbation of cholesterol,1289,false
glutathione synthetase,[NCBIGene:2937],209,Glutathione homeostasis,1290,false
glutathione synthetase,[NCBIGene:2937],209,Hepatotoxicity,1291,false
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],209,"Up Regulation, SREBF2",1284,false
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],209,"Up Regulation, Unsaturated fatty acid",1285,false
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],209,"Down Regulation, GSS and GSTs gene",1286,false
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],209,Glutathione synthesis,1287,false
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],209,"Activation, 3-hydroxy-3-methylglutaryl-CoA reductase gene",1288,false
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],209,Perturbation of cholesterol,1289,false
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],209,Glutathione homeostasis,1290,false
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],209,Hepatotoxicity,1291,false
-16,[NCBIGene:537],210,Peptide Oxidation,209,false
-16,[NCBIGene:537],210,Reproductive failure,1277,false
-16,[NCBIGene:537],210,"Activation, JNK",1292,false
-16,[NCBIGene:537],210,"Activation, FOXO",1293,false
-16,[NCBIGene:537],210,"Inhibition, Wnt pathway",1294,false
-16,[NCBIGene:537],210,Defect of Embryogenesis,1295,false
DAF,[NCBIGene:1604],210,Peptide Oxidation,209,false
DAF,[NCBIGene:1604],210,Reproductive failure,1277,false
DAF,[NCBIGene:1604],210,"Activation, JNK",1292,false
DAF,[NCBIGene:1604],210,"Activation, FOXO",1293,false
DAF,[NCBIGene:1604],210,"Inhibition, Wnt pathway",1294,false
DAF,[NCBIGene:1604],210,Defect of Embryogenesis,1295,false
FOXO,[NCBIGene:2309],210,Peptide Oxidation,209,false
FOXO,[NCBIGene:2309],210,Reproductive failure,1277,false
FOXO,[NCBIGene:2309],210,"Activation, JNK",1292,false
FOXO,[NCBIGene:2309],210,"Activation, FOXO",1293,false
FOXO,[NCBIGene:2309],210,"Inhibition, Wnt pathway",1294,false
FOXO,[NCBIGene:2309],210,Defect of Embryogenesis,1295,false
Forkhead box O,[NCBIGene:2308],210,Peptide Oxidation,209,false
Forkhead box O,[NCBIGene:2308],210,Reproductive failure,1277,false
Forkhead box O,[NCBIGene:2308],210,"Activation, JNK",1292,false
Forkhead box O,[NCBIGene:2308],210,"Activation, FOXO",1293,false
Forkhead box O,[NCBIGene:2308],210,"Inhibition, Wnt pathway",1294,false
Forkhead box O,[NCBIGene:2308],210,Defect of Embryogenesis,1295,false
WNT,[NCBIGene:7471],210,Peptide Oxidation,209,false
WNT,[NCBIGene:7471],210,Reproductive failure,1277,false
WNT,[NCBIGene:7471],210,"Activation, JNK",1292,false
WNT,[NCBIGene:7471],210,"Activation, FOXO",1293,false
WNT,[NCBIGene:7471],210,"Inhibition, Wnt pathway",1294,false
WNT,[NCBIGene:7471],210,Defect of Embryogenesis,1295,false
c-Jun N-terminal kinase,[NCBIGene:5599],210,Peptide Oxidation,209,false
c-Jun N-terminal kinase,[NCBIGene:5599],210,Reproductive failure,1277,false
c-Jun N-terminal kinase,[NCBIGene:5599],210,"Activation, JNK",1292,false
c-Jun N-terminal kinase,[NCBIGene:5599],210,"Activation, FOXO",1293,false
c-Jun N-terminal kinase,[NCBIGene:5599],210,"Inhibition, Wnt pathway",1294,false
c-Jun N-terminal kinase,[NCBIGene:5599],210,Defect of Embryogenesis,1295,false
HDAC,[NCBIGene:9734],212,Apoptosis,1262,false
HDAC,[NCBIGene:9734],212,Histone deacetylase inhibition,1502,true
HDAC,[NCBIGene:9734],212,"Histone acetylation, increase",1503,false
HDAC,[NCBIGene:9734],212,"Cell cycle, disrupted",1505,false
HDAC,[NCBIGene:9734],212,Testicular atrophy,1506,false
HDAC,[NCBIGene:9734],212,Spermatocyte depletion,1515,false
Histone deacetylase,[NCBIGene:3065],212,Apoptosis,1262,false
Histone deacetylase,[NCBIGene:3065],212,Histone deacetylase inhibition,1502,true
Histone deacetylase,[NCBIGene:3065],212,"Histone acetylation, increase",1503,false
Histone deacetylase,[NCBIGene:3065],212,"Cell cycle, disrupted",1505,false
Histone deacetylase,[NCBIGene:3065],212,Testicular atrophy,1506,false
Histone deacetylase,[NCBIGene:3065],212,Spermatocyte depletion,1515,false
histone,[NCBIGene:54145],212,Apoptosis,1262,false
histone,[NCBIGene:54145],212,Histone deacetylase inhibition,1502,true
histone,[NCBIGene:54145],212,"Histone acetylation, increase",1503,false
histone,[NCBIGene:54145],212,"Cell cycle, disrupted",1505,false
histone,[NCBIGene:54145],212,Testicular atrophy,1506,false
histone,[NCBIGene:54145],212,Spermatocyte depletion,1515,false
CYP7B,[NCBIGene:9420],218,"Decreased, Reproductive Success",1141,false
CYP7B,[NCBIGene:9420],218,"CYP7B activity, inhibition",1386,true
CYP7B,[NCBIGene:9420],218,"7α-hydroxypregnenolone synthesis in the brain, decreased",1387,false
CYP7B,[NCBIGene:9420],218,"Dopamine release in the brain, decreased",1388,false
CYP7B,[NCBIGene:9420],218,"Locomotor activity, decreased",1389,false
CYP7B,[NCBIGene:9420],218,"Decrease, Population growth rate",360,false
D2 receptorwhich,[NCBIGene:1813],218,"Decreased, Reproductive Success",1141,false
D2 receptorwhich,[NCBIGene:1813],218,"CYP7B activity, inhibition",1386,true
D2 receptorwhich,[NCBIGene:1813],218,"7α-hydroxypregnenolone synthesis in the brain, decreased",1387,false
D2 receptorwhich,[NCBIGene:1813],218,"Dopamine release in the brain, decreased",1388,false
D2 receptorwhich,[NCBIGene:1813],218,"Locomotor activity, decreased",1389,false
D2 receptorwhich,[NCBIGene:1813],218,"Decrease, Population growth rate",360,false
cytochrome P450 enzymes,[NCBIGene:4051],218,"Decreased, Reproductive Success",1141,false
cytochrome P450 enzymes,[NCBIGene:4051],218,"CYP7B activity, inhibition",1386,true
cytochrome P450 enzymes,[NCBIGene:4051],218,"7α-hydroxypregnenolone synthesis in the brain, decreased",1387,false
cytochrome P450 enzymes,[NCBIGene:4051],218,"Dopamine release in the brain, decreased",1388,false
cytochrome P450 enzymes,[NCBIGene:4051],218,"Locomotor activity, decreased",1389,false
cytochrome P450 enzymes,[NCBIGene:4051],218,"Decrease, Population growth rate",360,false
cytochromeP450s,[NCBIGene:29785],218,"Decreased, Reproductive Success",1141,false
cytochromeP450s,[NCBIGene:29785],218,"CYP7B activity, inhibition",1386,true
cytochromeP450s,[NCBIGene:29785],218,"7α-hydroxypregnenolone synthesis in the brain, decreased",1387,false
cytochromeP450s,[NCBIGene:29785],218,"Dopamine release in the brain, decreased",1388,false
cytochromeP450s,[NCBIGene:29785],218,"Locomotor activity, decreased",1389,false
cytochromeP450s,[NCBIGene:29785],218,"Decrease, Population growth rate",360,false
CYP7B,[NCBIGene:9420],219,"Decreased, Reproductive Success",1141,false
CYP7B,[NCBIGene:9420],219,"CYP7B activity, inhibition",1386,true
CYP7B,[NCBIGene:9420],219,"7α-hydroxypregnenolone synthesis in the brain, decreased",1387,false
CYP7B,[NCBIGene:9420],219,"Dopamine release in the brain, decreased",1388,false
CYP7B,[NCBIGene:9420],219,"Sexual behavior, decreased",1390,false
CYP7B,[NCBIGene:9420],219,"Decrease, Population growth rate",360,false
D2 receptorwhich,[NCBIGene:1813],219,"Decreased, Reproductive Success",1141,false
D2 receptorwhich,[NCBIGene:1813],219,"CYP7B activity, inhibition",1386,true
D2 receptorwhich,[NCBIGene:1813],219,"7α-hydroxypregnenolone synthesis in the brain, decreased",1387,false
D2 receptorwhich,[NCBIGene:1813],219,"Dopamine release in the brain, decreased",1388,false
D2 receptorwhich,[NCBIGene:1813],219,"Sexual behavior, decreased",1390,false
D2 receptorwhich,[NCBIGene:1813],219,"Decrease, Population growth rate",360,false
P450s,[NCBIGene:1555],219,"Decreased, Reproductive Success",1141,false
P450s,[NCBIGene:1555],219,"CYP7B activity, inhibition",1386,true
P450s,[NCBIGene:1555],219,"7α-hydroxypregnenolone synthesis in the brain, decreased",1387,false
P450s,[NCBIGene:1555],219,"Dopamine release in the brain, decreased",1388,false
P450s,[NCBIGene:1555],219,"Sexual behavior, decreased",1390,false
P450s,[NCBIGene:1555],219,"Decrease, Population growth rate",360,false
cytochrome,[NCBIGene:54205],219,"Decreased, Reproductive Success",1141,false
cytochrome,[NCBIGene:54205],219,"CYP7B activity, inhibition",1386,true
cytochrome,[NCBIGene:54205],219,"7α-hydroxypregnenolone synthesis in the brain, decreased",1387,false
cytochrome,[NCBIGene:54205],219,"Dopamine release in the brain, decreased",1388,false
cytochrome,[NCBIGene:54205],219,"Sexual behavior, decreased",1390,false
cytochrome,[NCBIGene:54205],219,"Decrease, Population growth rate",360,false
5-hydroxytryptamine transporter,[NCBIGene:6532],223,"Increased, extracellular serotonin",1320,false
5-hydroxytryptamine transporter,[NCBIGene:6532],223,"Increased, seizure",1344,false
5-hydroxytryptamine transporter,[NCBIGene:6532],223,"Decreased, extracellular serotonin",1347,false
5-hydroxytryptamine transporter,[NCBIGene:6532],223,"Increased, serotonin transporter activity",1397,true
5-hydroxytryptamine transporter,[NCBIGene:6532],223,"Increased, intracellular serotonin",1398,false
5-hydroxytryptamine transporter,[NCBIGene:6532],223,"Increased, packaged serotonin",1399,false
5-hydroxytryptamine transporter,[NCBIGene:6532],223,"Increased, synaptic release",1400,false
5-hydroxytryptamine transporter,[NCBIGene:6532],223,"Decreased, 5-HT3",1401,false
5-hydroxytryptamine transporter,[NCBIGene:6532],224,"Increased, extracellular serotonin",1320,false
5-hydroxytryptamine transporter,[NCBIGene:6532],224,"Inactivated, 5-HTR (serotonin receptors)",1328,false
5-hydroxytryptamine transporter,[NCBIGene:6532],224,"Reduce expression, BDNF (Brain-derived neurotrophic factor)",1329,false
5-hydroxytryptamine transporter,[NCBIGene:6532],224,"Decreased, neuroplasticity",1330,false
5-hydroxytryptamine transporter,[NCBIGene:6532],224,"Increased, depression",1346,false
5-hydroxytryptamine transporter,[NCBIGene:6532],224,"Decreased, extracellular serotonin",1347,false
5-hydroxytryptamine transporter,[NCBIGene:6532],224,"Increased, serotonin transporter activity",1397,true
5-hydroxytryptamine transporter,[NCBIGene:6532],224,"Increased, intracellular serotonin",1398,false
5-hydroxytryptamine transporter,[NCBIGene:6532],224,"Increased, packaged serotonin",1399,false
5-hydroxytryptamine transporter,[NCBIGene:6532],224,"Increased, synaptic release",1400,false
5-hydroxytryptamine transporter,[NCBIGene:6532],225,"Increased, extracellular serotonin",1320,false
5-hydroxytryptamine transporter,[NCBIGene:6532],225,"Inactivated, 5-HTR (serotonin receptors)",1328,false
5-hydroxytryptamine transporter,[NCBIGene:6532],225,"Reduce expression, BDNF (Brain-derived neurotrophic factor)",1329,false
5-hydroxytryptamine transporter,[NCBIGene:6532],225,"Decreased, neuroplasticity",1330,false
5-hydroxytryptamine transporter,[NCBIGene:6532],225,"Increased, agitation",1345,false
5-hydroxytryptamine transporter,[NCBIGene:6532],225,"Decreased, extracellular serotonin",1347,false
5-hydroxytryptamine transporter,[NCBIGene:6532],225,"Increased, serotonin transporter activity",1397,false
5-hydroxytryptamine transporter,[NCBIGene:6532],225,"Increased, intracellular serotonin",1398,false
5-hydroxytryptamine transporter,[NCBIGene:6532],225,"Increased, packaged serotonin",1399,false
5-hydroxytryptamine transporter,[NCBIGene:6532],225,"Increased, synaptic release",1400,false
5-hydroxytryptamine transporter,[NCBIGene:6532],226,"Decreased, serotonin transporter activity",1317,true
5-hydroxytryptamine transporter,[NCBIGene:6532],226,"Increased, extracellular serotonin",1320,false
5-hydroxytryptamine transporter,[NCBIGene:6532],226,"Decreased, intracellular serotonin",1323,false
5-hydroxytryptamine transporter,[NCBIGene:6532],226,"Decreased, packaged serotonin",1324,false
5-hydroxytryptamine transporter,[NCBIGene:6532],226,"Decreased, synaptic release",1325,false
5-hydroxytryptamine transporter,[NCBIGene:6532],226,"Activation, 5-HT2A (Serotonin 2A)",1336,false
5-hydroxytryptamine transporter,[NCBIGene:6532],226,"Activate, PLC (Phospholipase C)",1337,false
5-hydroxytryptamine transporter,[NCBIGene:6532],226,"Increase, inositol triphosphate",1338,false
5-hydroxytryptamine transporter,[NCBIGene:6532],226,"Increase, intracellular calcium",1339,false
5-hydroxytryptamine transporter,[NCBIGene:6532],226,"Activate, calmodulin",1340,false
5-hydroxytryptamine transporter,[NCBIGene:6532],226,"Increase, myosin light chain phosphorylation",1341,false
5-hydroxytryptamine transporter,[NCBIGene:6532],226,"Increase, vascular smooth muscle contraction",1342,false
5-hydroxytryptamine transporter,[NCBIGene:6532],226,"Increase, hypertension",1343,false
5-hydroxytryptamine transporter,[NCBIGene:6532],226,"Decreased, extracellular serotonin",1347,false
Cyclooxygenase,[NCBIGene:5742],227,"Decreased, bicarbonate",1407,false
Cyclooxygenase,[NCBIGene:5742],227,"Activated, gastric ulcer formation",1385,false
Cyclooxygenase,[NCBIGene:5742],227,"Reduced, PTGS1 function",1402,true
Cyclooxygenase,[NCBIGene:5742],227,"Reduced, platelet aggregation",1403,false
Cyclooxygenase,[NCBIGene:5742],227,"Decreased, mucosal blood flow",1404,false
Cyclooxygenase,[NCBIGene:5742],227,"Reduced, mucosal defense",1405,false
Cyclooxygenase,[NCBIGene:5742],227,"Decreased, mucous",1406,false
PTGS2,[NCBIGene:5743],228,"Activated, gastric ulcer formation",1385,false
PTGS2,[NCBIGene:5743],228,"Reduced, PTGS2 function",1408,true
PTGS2,[NCBIGene:5743],228,"Decreased, angiogenesis",1409,false
PTGS2,[NCBIGene:5743],228,"Increased, leukocyte adherence",1410,false
PTGS2,[NCBIGene:5743],228,"Increased, leukocyte activation",1411,false
AR,"[NCBIGene:367, 231, 2232]",23,"Reduction, Gonadotropins, circulating concentrations",129,false
AR,"[NCBIGene:367, 231, 2232]",23,"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development",309,false
AR,"[NCBIGene:367, 231, 2232]",23,"Reduction, Plasma vitellogenin concentrations",221,false
AR,"[NCBIGene:367, 231, 2232]",23,"Reduction, Cumulative fecundity and spawning",78,false
AR,"[NCBIGene:367, 231, 2232]",23,"Reduction, Vitellogenin synthesis in liver",285,false
AR,"[NCBIGene:367, 231, 2232]",23,"Reduction, Testosterone synthesis by ovarian theca cells",274,false
AR,"[NCBIGene:367, 231, 2232]",23,"Agonism, Androgen receptor",25,true
AR,"[NCBIGene:367, 231, 2232]",23,"Decrease, Population growth rate",360,false
AR,"[NCBIGene:367, 231, 2232]",23,"Reduction, Plasma 17beta-estradiol concentrations",219,false
AR,"[NCBIGene:367, 231, 2232]",23,"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells",3,false
NFE2,[NCBIGene:4778],232,"Increased, Liver Steatosis",459,false
NFE2,[NCBIGene:4778],232,NFE2/Nrf2 repression,1417,true
NFE2,[NCBIGene:4778],232,"Reduced, FXR activity",1419,false
NFE2,[NCBIGene:4778],232,"Reduced, SHP activity",1420,false
NFE2,[NCBIGene:4778],232,"Activated, LXR",1421,false
NFE2,[NCBIGene:4778],232,"Reduced, PPARalpha",1422,false
NFE2,[NCBIGene:4778],232,"Reduced, HSD17B4 activity",1423,false
NFE2,[NCBIGene:4778],232,"Reduced, fatty acid beta oxidation",1424,false
Nrf2,[NCBIGene:4780],232,"Increased, Liver Steatosis",459,false
Nrf2,[NCBIGene:4780],232,NFE2/Nrf2 repression,1417,true
Nrf2,[NCBIGene:4780],232,"Reduced, FXR activity",1419,false
Nrf2,[NCBIGene:4780],232,"Reduced, SHP activity",1420,false
Nrf2,[NCBIGene:4780],232,"Activated, LXR",1421,false
Nrf2,[NCBIGene:4780],232,"Reduced, PPARalpha",1422,false
Nrf2,[NCBIGene:4780],232,"Reduced, HSD17B4 activity",1423,false
Nrf2,[NCBIGene:4780],232,"Reduced, fatty acid beta oxidation",1424,false
G proteins,[NCBIGene:9567],233,"hyperpolarisation, neuron",763,false
G proteins,[NCBIGene:9567],233,Mu Opioid Receptor Agonism,1425,true
G proteins,[NCBIGene:9567],233,Release of G Proteins,1426,false
G proteins,[NCBIGene:9567],233,Opening of G protein gated inward rectifying K channels,1427,false
G proteins,[NCBIGene:9567],233,Analgesia,1428,false
Mu Opioid Receptor,[NCBIGene:4988],233,"hyperpolarisation, neuron",763,false
Mu Opioid Receptor,[NCBIGene:4988],233,Mu Opioid Receptor Agonism,1425,true
Mu Opioid Receptor,[NCBIGene:4988],233,Release of G Proteins,1426,false
Mu Opioid Receptor,[NCBIGene:4988],233,Opening of G protein gated inward rectifying K channels,1427,false
Mu Opioid Receptor,[NCBIGene:4988],233,Analgesia,1428,false
endorphins,[NCBIGene:5443],233,"hyperpolarisation, neuron",763,false
endorphins,[NCBIGene:5443],233,Mu Opioid Receptor Agonism,1425,true
endorphins,[NCBIGene:5443],233,Release of G Proteins,1426,false
endorphins,[NCBIGene:5443],233,Opening of G protein gated inward rectifying K channels,1427,false
endorphins,[NCBIGene:5443],233,Analgesia,1428,false
opioid receptors,[NCBIGene:11054],233,"hyperpolarisation, neuron",763,false
opioid receptors,[NCBIGene:11054],233,Mu Opioid Receptor Agonism,1425,true
opioid receptors,[NCBIGene:11054],233,Release of G Proteins,1426,false
opioid receptors,[NCBIGene:11054],233,Opening of G protein gated inward rectifying K channels,1427,false
opioid receptors,[NCBIGene:11054],233,Analgesia,1428,false
G proteins,[NCBIGene:9567],234,Mu Opioid Receptor Agonism,1425,true
G proteins,[NCBIGene:9567],234,Release of G Proteins,1426,false
G proteins,[NCBIGene:9567],234,Analgesia,1428,false
G proteins,[NCBIGene:9567],234,Inhibition of N-type Ca ion channels,1429,false
G proteins,[NCBIGene:9567],234,Inhibition of neurotransmitter vesicle release,1430,false
Mu Opioid Receptor,[NCBIGene:4988],234,Mu Opioid Receptor Agonism,1425,true
Mu Opioid Receptor,[NCBIGene:4988],234,Release of G Proteins,1426,false
Mu Opioid Receptor,[NCBIGene:4988],234,Analgesia,1428,false
Mu Opioid Receptor,[NCBIGene:4988],234,Inhibition of N-type Ca ion channels,1429,false
Mu Opioid Receptor,[NCBIGene:4988],234,Inhibition of neurotransmitter vesicle release,1430,false
endorphins,[NCBIGene:5443],234,Mu Opioid Receptor Agonism,1425,true
endorphins,[NCBIGene:5443],234,Release of G Proteins,1426,false
endorphins,[NCBIGene:5443],234,Analgesia,1428,false
endorphins,[NCBIGene:5443],234,Inhibition of N-type Ca ion channels,1429,false
endorphins,[NCBIGene:5443],234,Inhibition of neurotransmitter vesicle release,1430,false
opioid receptors,[NCBIGene:11054],234,Mu Opioid Receptor Agonism,1425,true
opioid receptors,[NCBIGene:11054],234,Release of G Proteins,1426,false
opioid receptors,[NCBIGene:11054],234,Analgesia,1428,false
opioid receptors,[NCBIGene:11054],234,Inhibition of N-type Ca ion channels,1429,false
opioid receptors,[NCBIGene:11054],234,Inhibition of neurotransmitter vesicle release,1430,false
G proteins,[NCBIGene:9567],235,"hyperpolarisation, neuron",763,false
G proteins,[NCBIGene:9567],235,Release of G Proteins,1426,false
G proteins,[NCBIGene:9567],235,Opening of G protein gated inward rectifying K channels,1427,false
G proteins,[NCBIGene:9567],235,Serotonin 1A Receptor Agonism,1431,true
G proteins,[NCBIGene:9567],235,Anti-depressant Activity,1432,false
GPCRs,"[NCBIGene:8322, 23566, 222545, 165140, 59352, 259249, 134391, 117196, 117195, 441931, 442206]",235,"hyperpolarisation, neuron",763,false
GPCRs,"[NCBIGene:8322, 23566, 222545, 165140, 59352, 259249, 134391, 117196, 117195, 441931, 442206]",235,Release of G Proteins,1426,false
GPCRs,"[NCBIGene:8322, 23566, 222545, 165140, 59352, 259249, 134391, 117196, 117195, 441931, 442206]",235,Opening of G protein gated inward rectifying K channels,1427,false
GPCRs,"[NCBIGene:8322, 23566, 222545, 165140, 59352, 259249, 134391, 117196, 117195, 441931, 442206]",235,Serotonin 1A Receptor Agonism,1431,true
GPCRs,"[NCBIGene:8322, 23566, 222545, 165140, 59352, 259249, 134391, 117196, 117195, 441931, 442206]",235,Anti-depressant Activity,1432,false
Serotonin 1A Receptor,[NCBIGene:3350],235,"hyperpolarisation, neuron",763,false
Serotonin 1A Receptor,[NCBIGene:3350],235,Release of G Proteins,1426,false
Serotonin 1A Receptor,[NCBIGene:3350],235,Opening of G protein gated inward rectifying K channels,1427,false
Serotonin 1A Receptor,[NCBIGene:3350],235,Serotonin 1A Receptor Agonism,1431,true
Serotonin 1A Receptor,[NCBIGene:3350],235,Anti-depressant Activity,1432,false
Serotonin receptors,[NCBIGene:3359],235,"hyperpolarisation, neuron",763,false
Serotonin receptors,[NCBIGene:3359],235,Release of G Proteins,1426,false
Serotonin receptors,[NCBIGene:3359],235,Opening of G protein gated inward rectifying K channels,1427,false
Serotonin receptors,[NCBIGene:3359],235,Serotonin 1A Receptor Agonism,1431,true
Serotonin receptors,[NCBIGene:3359],235,Anti-depressant Activity,1432,false
G proteins,[NCBIGene:9567],236,Release of G Proteins,1426,false
G proteins,[NCBIGene:9567],236,Inhibition of N-type Ca ion channels,1429,false
G proteins,[NCBIGene:9567],236,Inhibition of neurotransmitter vesicle release,1430,false
G proteins,[NCBIGene:9567],236,Serotonin 1A Receptor Agonism,1431,true
G proteins,[NCBIGene:9567],236,Anti-depressant Activity,1432,false
GPCRs,"[NCBIGene:8322, 23566, 222545, 165140, 59352, 259249, 134391, 117196, 117195, 441931, 442206]",236,Release of G Proteins,1426,false
GPCRs,"[NCBIGene:8322, 23566, 222545, 165140, 59352, 259249, 134391, 117196, 117195, 441931, 442206]",236,Inhibition of N-type Ca ion channels,1429,false
GPCRs,"[NCBIGene:8322, 23566, 222545, 165140, 59352, 259249, 134391, 117196, 117195, 441931, 442206]",236,Inhibition of neurotransmitter vesicle release,1430,false
GPCRs,"[NCBIGene:8322, 23566, 222545, 165140, 59352, 259249, 134391, 117196, 117195, 441931, 442206]",236,Serotonin 1A Receptor Agonism,1431,true
GPCRs,"[NCBIGene:8322, 23566, 222545, 165140, 59352, 259249, 134391, 117196, 117195, 441931, 442206]",236,Anti-depressant Activity,1432,false
Serotonin 1A Receptor,[NCBIGene:3350],236,Release of G Proteins,1426,false
Serotonin 1A Receptor,[NCBIGene:3350],236,Inhibition of N-type Ca ion channels,1429,false
Serotonin 1A Receptor,[NCBIGene:3350],236,Inhibition of neurotransmitter vesicle release,1430,false
Serotonin 1A Receptor,[NCBIGene:3350],236,Serotonin 1A Receptor Agonism,1431,true
Serotonin 1A Receptor,[NCBIGene:3350],236,Anti-depressant Activity,1432,false
Serotonin receptors,[NCBIGene:3359],236,Release of G Proteins,1426,false
Serotonin receptors,[NCBIGene:3359],236,Inhibition of N-type Ca ion channels,1429,false
Serotonin receptors,[NCBIGene:3359],236,Inhibition of neurotransmitter vesicle release,1430,false
Serotonin receptors,[NCBIGene:3359],236,Serotonin 1A Receptor Agonism,1431,true
Serotonin receptors,[NCBIGene:3359],236,Anti-depressant Activity,1432,false
TGF-1,[NCBIGene:7040],241,Epithelial Mesenchymal Transition,1457,false
TGF-1,[NCBIGene:7040],241,Pulmonary fibrosis,1458,false
TGF-1,[NCBIGene:7040],241,"Accumulation, Collagen",68,false
TGF-1,[NCBIGene:7040],241,"Increase, Differentiation of fibroblasts",1456,false
TGF-1,[NCBIGene:7040],241,"Activation, Latent Transforming Growth Factor Beta 1",1468,true
TGF-1,[NCBIGene:7040],241,"Activation, Transforming Growth Factor beta pathway",1469,false
lysyl oxidase,[NCBIGene:4015],242,"Decreased, survival",636,false
lysyl oxidase,[NCBIGene:4015],242,"Reduced, Swimming performance",1005,false
lysyl oxidase,[NCBIGene:4015],242,Thiol group of chemicals interact with sulfuhydryl groups of proteins to form thiol adducts,1462,true
lysyl oxidase,[NCBIGene:4015],242,Inhibition of lysyl oxidase,1463,false
lysyl oxidase,[NCBIGene:4015],242,Reduction of collagen crosslinking,1464,false
lysyl oxidase,[NCBIGene:4015],242,Weak collagen matrix,1465,false
lysyl oxidase,[NCBIGene:4015],242,Notochord distortion or malformations,1466,false
lysyl oxidase,[NCBIGene:4015],242,"Growth, reduction",1467,false
Aromatase,[NCBIGene:1588],25,"Inhibition, Aromatase",36,true
Aromatase,[NCBIGene:1588],25,"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development",309,false
Aromatase,[NCBIGene:1588],25,"Reduction, Plasma vitellogenin concentrations",221,false
Aromatase,[NCBIGene:1588],25,"Reduction, Cumulative fecundity and spawning",78,false
Aromatase,[NCBIGene:1588],25,"Reduction, Vitellogenin synthesis in liver",285,false
Aromatase,[NCBIGene:1588],25,"Decrease, Population growth rate",360,false
Aromatase,[NCBIGene:1588],25,"Reduction, Plasma 17beta-estradiol concentrations",219,false
Aromatase,[NCBIGene:1588],25,"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells",3,false
OAT1,[NCBIGene:3777],256,"Increase, Cytotoxicity (renal tubular cell)",709,false
OAT1,[NCBIGene:3777],256,"Occurrence, Kidney toxicity",814,false
OAT1,[NCBIGene:3777],256,Mitochondrial dysfunction,177,false
OAT1,[NCBIGene:3777],256,Inhibition of mitochondrial DNA polymerase gamma (Pol gamma),1481,true
OAT1,[NCBIGene:3777],256,"Depletion, mtDNA",1482,false
OAT3,[NCBIGene:9376],256,"Increase, Cytotoxicity (renal tubular cell)",709,false
OAT3,[NCBIGene:9376],256,"Occurrence, Kidney toxicity",814,false
OAT3,[NCBIGene:9376],256,Mitochondrial dysfunction,177,false
OAT3,[NCBIGene:9376],256,Inhibition of mitochondrial DNA polymerase gamma (Pol gamma),1481,true
OAT3,[NCBIGene:9376],256,"Depletion, mtDNA",1482,false
mitochondrial DNA polymerase gamma,[NCBIGene:5428],256,"Increase, Cytotoxicity (renal tubular cell)",709,false
mitochondrial DNA polymerase gamma,[NCBIGene:5428],256,"Occurrence, Kidney toxicity",814,false
mitochondrial DNA polymerase gamma,[NCBIGene:5428],256,Mitochondrial dysfunction,177,false
mitochondrial DNA polymerase gamma,[NCBIGene:5428],256,Inhibition of mitochondrial DNA polymerase gamma (Pol gamma),1481,true
mitochondrial DNA polymerase gamma,[NCBIGene:5428],256,"Depletion, mtDNA",1482,false
reverse transcriptase,[NCBIGene:100616496],256,"Increase, Cytotoxicity (renal tubular cell)",709,false
reverse transcriptase,[NCBIGene:100616496],256,"Occurrence, Kidney toxicity",814,false
reverse transcriptase,[NCBIGene:100616496],256,Mitochondrial dysfunction,177,false
reverse transcriptase,[NCBIGene:100616496],256,Inhibition of mitochondrial DNA polymerase gamma (Pol gamma),1481,true
reverse transcriptase,[NCBIGene:100616496],256,"Depletion, mtDNA",1482,false
viral DNA polymerases,"[NCBIGene:105376906, 100862688, 100616102]",256,"Increase, Cytotoxicity (renal tubular cell)",709,false
viral DNA polymerases,"[NCBIGene:105376906, 100862688, 100616102]",256,"Occurrence, Kidney toxicity",814,false
viral DNA polymerases,"[NCBIGene:105376906, 100862688, 100616102]",256,Mitochondrial dysfunction,177,false
viral DNA polymerases,"[NCBIGene:105376906, 100862688, 100616102]",256,Inhibition of mitochondrial DNA polymerase gamma (Pol gamma),1481,true
viral DNA polymerases,"[NCBIGene:105376906, 100862688, 100616102]",256,"Depletion, mtDNA",1482,false
lysosomal enzymes,[NCBIGene:3988],257,"Increase, Cytotoxicity (renal tubular cell)",709,false
lysosomal enzymes,[NCBIGene:3988],257,"Occurrence, Kidney toxicity",814,false
lysosomal enzymes,[NCBIGene:3988],257,"Disturbance, Lysosomal function",831,false
lysosomal enzymes,[NCBIGene:3988],257,"Disruption, Lysosome",898,false
lysosomal enzymes,[NCBIGene:3988],257,"Binding of substrate, endocytic receptor",1486,true
calcium ATPase,"[NCBIGene:491, 492]",26,"Disruption, Mitochondrial electron transport chain",178,false
calcium ATPase,"[NCBIGene:491, 492]",26,"Decrease, Mitochondrial ATP production",40,false
calcium ATPase,"[NCBIGene:491, 492]",26,"Decreased, Nitric Oxide",193,false
calcium ATPase,"[NCBIGene:491, 492]",26,"Decreased, Long-term potentiation (LTP)",166,false
calcium ATPase,"[NCBIGene:491, 492]",26,"Increase, Reactive oxygen species",1115,false
calcium ATPase,"[NCBIGene:491, 492]",26,"Increase, Ca++ (intracellular)",50,false
calcium ATPase,"[NCBIGene:491, 492]",26,"Inhibition, Ca++ ATPase",51,true
calcium ATPase,"[NCBIGene:491, 492]",26,Oxidative Stress,1392,false
CYP2E1,[NCBIGene:1571],260,CYP2E1 Activation,1508,true
CYP2E1,[NCBIGene:1571],260,Protein Adduct Formation,1509,true
CYP2E1,[NCBIGene:1571],260,Lipid Peroxidation,1511,false
CYP2E1,[NCBIGene:1571],260,Unfolded Protein Response,1512,false
CYP2E1,[NCBIGene:1571],260,General Apoptosis,1513,false
CYP2E1,[NCBIGene:1571],260,Neurodegeneration,1514,false
CYP2E1,[NCBIGene:1571],260,Oxidative Stress,1392,false
L-type calcium channels,[NCBIGene:54499],261,"Blockade, L-Type Calcium Channels",1529,true
L-type calcium channels,[NCBIGene:54499],261,"Decrease, Calcium currents",1530,false
L-type calcium channels,[NCBIGene:54499],261,"Decrease, Calcium binding to Troponin C",1531,false
L-type calcium channels,[NCBIGene:54499],261,"Decrease, Cardiac contractility",1532,false
L-type calcium channels,[NCBIGene:54499],261,"Decrease, Cardiac ejection fraction",1533,false
L-type calcium channels,[NCBIGene:54499],261,Heart failure,1535,false
L-type calcium channels,[NCBIGene:54499],261,"Disruption, Intracellular calcium mobilization",1536,false
L-type calcium channels,[NCBIGene:54499],261,"Disruption, Sarcomere assembly",1537,false
LTCCs,[NCBIGene:123096],261,"Blockade, L-Type Calcium Channels",1529,true
LTCCs,[NCBIGene:123096],261,"Decrease, Calcium currents",1530,false
LTCCs,[NCBIGene:123096],261,"Decrease, Calcium binding to Troponin C",1531,false
LTCCs,[NCBIGene:123096],261,"Decrease, Cardiac contractility",1532,false
LTCCs,[NCBIGene:123096],261,"Decrease, Cardiac ejection fraction",1533,false
LTCCs,[NCBIGene:123096],261,Heart failure,1535,false
LTCCs,[NCBIGene:123096],261,"Disruption, Intracellular calcium mobilization",1536,false
LTCCs,[NCBIGene:123096],261,"Disruption, Sarcomere assembly",1537,false
hERG,[NCBIGene:3757],261,"Blockade, L-Type Calcium Channels",1529,true
hERG,[NCBIGene:3757],261,"Decrease, Calcium currents",1530,false
hERG,[NCBIGene:3757],261,"Decrease, Calcium binding to Troponin C",1531,false
hERG,[NCBIGene:3757],261,"Decrease, Cardiac contractility",1532,false
hERG,[NCBIGene:3757],261,"Decrease, Cardiac ejection fraction",1533,false
hERG,[NCBIGene:3757],261,Heart failure,1535,false
hERG,[NCBIGene:3757],261,"Disruption, Intracellular calcium mobilization",1536,false
hERG,[NCBIGene:3757],261,"Disruption, Sarcomere assembly",1537,false
Na-K ATPase,[NCBIGene:476],266,"Decrease, Adenosine triphosphate pool",1771,false
Na-K ATPase,[NCBIGene:476],266,"Decrease, Coupling of oxidative phosphorylation",1446,true
Na-K ATPase,[NCBIGene:476],266,Decreased Na/K ATPase activity,1562,false
Na-K ATPase,[NCBIGene:476],266,"Increase, Cell membrane depolarization",1527,false
Na-K ATPase,[NCBIGene:476],266,"Increase, Cell injury/death",55,false
Na-K ATPase,[NCBIGene:476],266,"Decrease, Growth",1521,false
ABCB11,[NCBIGene:8647],27,"Increase, Reactive oxygen species",1115,false
ABCB11,[NCBIGene:8647],27,"Inhibition, Bile Salt Export Pump (ABCB11)",41,true
ABCB11,[NCBIGene:8647],27,"Activation of specific nuclear receptors, Transcriptional change",288,false
ABCB11,[NCBIGene:8647],27,"Bile accumulation, Pathological condition",214,false
ABCB11,[NCBIGene:8647],27,"Release, Cytokine",87,false
ABCB11,[NCBIGene:8647],27,"Increase, Inflammation",149,false
ABCB11,[NCBIGene:8647],27,Peptide Oxidation,209,false
ABCB11,[NCBIGene:8647],27,"Cholestasis, Pathology",357,false
Thyroperoxidase,[NCBIGene:7173],271,"Thyroperoxidase, Inhibition",279,true
Thyroperoxidase,[NCBIGene:7173],271,"Thyroid hormone synthesis, Decreased",277,false
Thyroperoxidase,[NCBIGene:7173],271,"Reduction, Plasma vitellogenin concentrations",221,false
Thyroperoxidase,[NCBIGene:7173],271,"Reduction, Cumulative fecundity and spawning",78,false
Thyroperoxidase,[NCBIGene:7173],271,"Reduction, Plasma 17beta-estradiol concentrations",219,false
"I,II,III,IV","[NCBIGene:27090, 8114]",273,"Impaired, Proteostasis",889,false
"I,II,III,IV","[NCBIGene:27090, 8114]",273,"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)",888,true
"I,II,III,IV","[NCBIGene:27090, 8114]",273,"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)",887,true
"I,II,III,IV","[NCBIGene:27090, 8114]",273,Mitochondrial dysfunction,177,false
"I,II,III,IV","[NCBIGene:27090, 8114]",273,"Increase, Reactive oxygen species",1115,false
"I,II,III,IV","[NCBIGene:27090, 8114]",273,"Increase, Mitochondrial complex III antagonism",1542,true
"I,II,III,IV","[NCBIGene:27090, 8114]",273,Mitochondrial Complex IV inhibition,1543,true
"I,II,III,IV","[NCBIGene:27090, 8114]",273,Mitochondrial Complex V inhibition,1544,true
"I,II,III,IV","[NCBIGene:27090, 8114]",273,Decrease in mitochondrial oxidative phosphorylation,1545,false
"I,II,III,IV","[NCBIGene:27090, 8114]",273,Mitochondrial Injury,1547,false
"I,II,III,IV","[NCBIGene:27090, 8114]",273,Necrotic Tissue,1548,false
"I,II,III,IV","[NCBIGene:27090, 8114]",273,Liver Injury,1549,false
"I,II,III,IV","[NCBIGene:27090, 8114]",273,Binding of inhibitor to mitochondrial complex III,1653,true
"I,II,III,IV","[NCBIGene:27090, 8114]",273,Binding of inhibitor to mitochondrial complex IV,1654,true
"I,II,III,IV","[NCBIGene:27090, 8114]",273,Binding of inhibitor to mitochondrial complex V,1655,true
"I,II,III,IV","[NCBIGene:27090, 8114]",273,"Increase, Cell injury/death",55,false
mitochondrial complexes,[NCBIGene:55972],273,"Impaired, Proteostasis",889,false
mitochondrial complexes,[NCBIGene:55972],273,"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)",888,true
mitochondrial complexes,[NCBIGene:55972],273,"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)",887,true
mitochondrial complexes,[NCBIGene:55972],273,Mitochondrial dysfunction,177,false
mitochondrial complexes,[NCBIGene:55972],273,"Increase, Reactive oxygen species",1115,false
mitochondrial complexes,[NCBIGene:55972],273,"Increase, Mitochondrial complex III antagonism",1542,true
mitochondrial complexes,[NCBIGene:55972],273,Mitochondrial Complex IV inhibition,1543,true
mitochondrial complexes,[NCBIGene:55972],273,Mitochondrial Complex V inhibition,1544,true
mitochondrial complexes,[NCBIGene:55972],273,Decrease in mitochondrial oxidative phosphorylation,1545,false
mitochondrial complexes,[NCBIGene:55972],273,Mitochondrial Injury,1547,false
mitochondrial complexes,[NCBIGene:55972],273,Necrotic Tissue,1548,false
mitochondrial complexes,[NCBIGene:55972],273,Liver Injury,1549,false
mitochondrial complexes,[NCBIGene:55972],273,Binding of inhibitor to mitochondrial complex III,1653,true
mitochondrial complexes,[NCBIGene:55972],273,Binding of inhibitor to mitochondrial complex IV,1654,true
mitochondrial complexes,[NCBIGene:55972],273,Binding of inhibitor to mitochondrial complex V,1655,true
mitochondrial complexes,[NCBIGene:55972],273,"Increase, Cell injury/death",55,false
HDAC,[NCBIGene:9734],274,"Neural crest cell migration, reduced",1557,false
HDAC,[NCBIGene:9734],274,"Collagen production, reduced",1558,false
HDAC,[NCBIGene:9734],274,Facial cartilage structures are reduced in size and morphologically distorted,1559,false
HDAC,[NCBIGene:9734],274,Histone deacetylase inhibition,1502,true
Histone deacetylase,[NCBIGene:3065],274,"Neural crest cell migration, reduced",1557,false
Histone deacetylase,[NCBIGene:3065],274,"Collagen production, reduced",1558,false
Histone deacetylase,[NCBIGene:3065],274,Facial cartilage structures are reduced in size and morphologically distorted,1559,false
Histone deacetylase,[NCBIGene:3065],274,Histone deacetylase inhibition,1502,true
Histone deacetylases,[NCBIGene:9759],274,"Neural crest cell migration, reduced",1557,false
Histone deacetylases,[NCBIGene:9759],274,"Collagen production, reduced",1558,false
Histone deacetylases,[NCBIGene:9759],274,Facial cartilage structures are reduced in size and morphologically distorted,1559,false
Histone deacetylases,[NCBIGene:9759],274,Histone deacetylase inhibition,1502,true
collagen,[NCBIGene:1280],274,"Neural crest cell migration, reduced",1557,false
collagen,[NCBIGene:1280],274,"Collagen production, reduced",1558,false
collagen,[NCBIGene:1280],274,Facial cartilage structures are reduced in size and morphologically distorted,1559,false
collagen,[NCBIGene:1280],274,Histone deacetylase inhibition,1502,true
HDAC,[NCBIGene:9734],275,"Altered, Gene Expression",1239,false
HDAC,[NCBIGene:9734],275,Altered differentiation,1560,false
HDAC,[NCBIGene:9734],275,Neural tube defects,1561,false
HDAC,[NCBIGene:9734],275,Histone deacetylase inhibition,1502,true
HDAC,[NCBIGene:9734],275,"Histone acetylation, increase",1503,false
Histone deacetylase,[NCBIGene:3065],275,"Altered, Gene Expression",1239,false
Histone deacetylase,[NCBIGene:3065],275,Altered differentiation,1560,false
Histone deacetylase,[NCBIGene:3065],275,Neural tube defects,1561,false
Histone deacetylase,[NCBIGene:3065],275,Histone deacetylase inhibition,1502,true
Histone deacetylase,[NCBIGene:3065],275,"Histone acetylation, increase",1503,false
Histone deacetylases,[NCBIGene:9759],275,"Altered, Gene Expression",1239,false
Histone deacetylases,[NCBIGene:9759],275,Altered differentiation,1560,false
Histone deacetylases,[NCBIGene:9759],275,Neural tube defects,1561,false
Histone deacetylases,[NCBIGene:9759],275,Histone deacetylase inhibition,1502,true
Histone deacetylases,[NCBIGene:9759],275,"Histone acetylation, increase",1503,false
histone,[NCBIGene:54145],275,"Altered, Gene Expression",1239,false
histone,[NCBIGene:54145],275,Altered differentiation,1560,false
histone,[NCBIGene:54145],275,Neural tube defects,1561,false
histone,[NCBIGene:54145],275,Histone deacetylase inhibition,1502,true
histone,[NCBIGene:54145],275,"Histone acetylation, increase",1503,false
Na-K ATPase,[NCBIGene:476],276,"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)",888,true
Na-K ATPase,[NCBIGene:476],276,"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)",887,false
Na-K ATPase,[NCBIGene:476],276,Decreased Na/K ATPase activity,1562,false
Na-K ATPase,[NCBIGene:476],276,Decreased proximal tubular vectorial transport,1563,false
Na-K ATPase,[NCBIGene:476],276,Chemical induced Fanconi syndrome,1564,false
Na-K ATPase,[NCBIGene:476],276,"Decrease, Oxidative phosphorylation",1477,false
mitochondrial complex I,[NCBIGene:4723],276,"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)",888,true
mitochondrial complex I,[NCBIGene:4723],276,"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)",887,false
mitochondrial complex I,[NCBIGene:4723],276,Decreased Na/K ATPase activity,1562,false
mitochondrial complex I,[NCBIGene:4723],276,Decreased proximal tubular vectorial transport,1563,false
mitochondrial complex I,[NCBIGene:4723],276,Chemical induced Fanconi syndrome,1564,false
mitochondrial complex I,[NCBIGene:4723],276,"Decrease, Oxidative phosphorylation",1477,false
Caspase 8,[NCBIGene:841],278,Necrotic Tissue,1548,false
Caspase 8,[NCBIGene:841],278,Liver Injury,1549,false
Caspase 8,[NCBIGene:841],278,"Inhibition, IKK complex",1574,true
Caspase 8,[NCBIGene:841],278,"Activation, Caspase 8 pathway",1575,false
Caspase 8,[NCBIGene:841],278,"Activation, Tissue resident cells (Kuppfer cells)",1576,false
Caspase 8,[NCBIGene:841],278,"Increase, proinflammatory mediators (TNFalpha)",1579,false
Caspase 8,[NCBIGene:841],278,"Inhibition, Nuclear factor kappa B (NF-kB)",202,false
Caspase 8,[NCBIGene:841],278,"Increase, Cell injury/death",55,false
IKK complex,[NCBIGene:9641],278,Necrotic Tissue,1548,false
IKK complex,[NCBIGene:9641],278,Liver Injury,1549,false
IKK complex,[NCBIGene:9641],278,"Inhibition, IKK complex",1574,true
IKK complex,[NCBIGene:9641],278,"Activation, Caspase 8 pathway",1575,false
IKK complex,[NCBIGene:9641],278,"Activation, Tissue resident cells (Kuppfer cells)",1576,false
IKK complex,[NCBIGene:9641],278,"Increase, proinflammatory mediators (TNFalpha)",1579,false
IKK complex,[NCBIGene:9641],278,"Inhibition, Nuclear factor kappa B (NF-kB)",202,false
IKK complex,[NCBIGene:9641],278,"Increase, Cell injury/death",55,false
NF-kB,[NCBIGene:4790],278,Necrotic Tissue,1548,false
NF-kB,[NCBIGene:4790],278,Liver Injury,1549,false
NF-kB,[NCBIGene:4790],278,"Inhibition, IKK complex",1574,true
NF-kB,[NCBIGene:4790],278,"Activation, Caspase 8 pathway",1575,false
NF-kB,[NCBIGene:4790],278,"Activation, Tissue resident cells (Kuppfer cells)",1576,false
NF-kB,[NCBIGene:4790],278,"Increase, proinflammatory mediators (TNFalpha)",1579,false
NF-kB,[NCBIGene:4790],278,"Inhibition, Nuclear factor kappa B (NF-kB)",202,false
NF-kB,[NCBIGene:4790],278,"Increase, Cell injury/death",55,false
TNF-receptor,[NCBIGene:7132],278,Necrotic Tissue,1548,false
TNF-receptor,[NCBIGene:7132],278,Liver Injury,1549,false
TNF-receptor,[NCBIGene:7132],278,"Inhibition, IKK complex",1574,true
TNF-receptor,[NCBIGene:7132],278,"Activation, Caspase 8 pathway",1575,false
TNF-receptor,[NCBIGene:7132],278,"Activation, Tissue resident cells (Kuppfer cells)",1576,false
TNF-receptor,[NCBIGene:7132],278,"Increase, proinflammatory mediators (TNFalpha)",1579,false
TNF-receptor,[NCBIGene:7132],278,"Inhibition, Nuclear factor kappa B (NF-kB)",202,false
TNF-receptor,[NCBIGene:7132],278,"Increase, Cell injury/death",55,false
TNFalpha,[NCBIGene:7124],278,Necrotic Tissue,1548,false
TNFalpha,[NCBIGene:7124],278,Liver Injury,1549,false
TNFalpha,[NCBIGene:7124],278,"Inhibition, IKK complex",1574,true
TNFalpha,[NCBIGene:7124],278,"Activation, Caspase 8 pathway",1575,false
TNFalpha,[NCBIGene:7124],278,"Activation, Tissue resident cells (Kuppfer cells)",1576,false
TNFalpha,[NCBIGene:7124],278,"Increase, proinflammatory mediators (TNFalpha)",1579,false
TNFalpha,[NCBIGene:7124],278,"Inhibition, Nuclear factor kappa B (NF-kB)",202,false
TNFalpha,[NCBIGene:7124],278,"Increase, Cell injury/death",55,false
caspase 3,[NCBIGene:836],278,Necrotic Tissue,1548,false
caspase 3,[NCBIGene:836],278,Liver Injury,1549,false
caspase 3,[NCBIGene:836],278,"Inhibition, IKK complex",1574,true
caspase 3,[NCBIGene:836],278,"Activation, Caspase 8 pathway",1575,false
caspase 3,[NCBIGene:836],278,"Activation, Tissue resident cells (Kuppfer cells)",1576,false
caspase 3,[NCBIGene:836],278,"Increase, proinflammatory mediators (TNFalpha)",1579,false
caspase 3,[NCBIGene:836],278,"Inhibition, Nuclear factor kappa B (NF-kB)",202,false
caspase 3,[NCBIGene:836],278,"Increase, Cell injury/death",55,false
Cyclooxygenase,[NCBIGene:5742],28,"Inhibition, Cyclooxygenase activity",79,true
Cyclooxygenase,[NCBIGene:5742],28,"Reduction, Prostaglandin E2 concentration",243,false
Cyclooxygenase,[NCBIGene:5742],28,"Reduction, Ca and HCO3 transport to shell gland",49,false
Cyclooxygenase,[NCBIGene:5742],28,"Reduction, Eggshell thickness",106,false
Cyclooxygenase,[NCBIGene:5742],28,"N/A, Gap",119,false
Cyclooxygenase,[NCBIGene:5742],28,"N/A, Reproductive failure",253,false
Acetylcholinesterase,[NCBIGene:43],281,"Overactivation, NMDARs",388,false
Acetylcholinesterase,[NCBIGene:43],281,"Increased, Intracellular Calcium overload",389,false
Acetylcholinesterase,[NCBIGene:43],281,"Increased, glutamate",1350,false
Acetylcholinesterase,[NCBIGene:43],281,Increased Muscarinic Acetylcholine Receptors,1602,false
Acetylcholinesterase,[NCBIGene:43],281,"Occurrence, Focal Seizure",1623,false
Acetylcholinesterase,[NCBIGene:43],281,Status epilepticus,1788,false
Acetylcholinesterase,[NCBIGene:43],281,Acetylcholine accumulation in synapses,10,false
Acetylcholinesterase,[NCBIGene:43],281,Acetylcholinesterase (AchE) Inhibition,12,true
Acetylcholinesterase,[NCBIGene:43],281,"Increase, Cell injury/death",55,false
Acetylcholinesterase,[NCBIGene:43],281,"N/A, Neurodegeneration",352,false
Cholinesterase,[NCBIGene:590],281,"Overactivation, NMDARs",388,false
Cholinesterase,[NCBIGene:590],281,"Increased, Intracellular Calcium overload",389,false
Cholinesterase,[NCBIGene:590],281,"Increased, glutamate",1350,false
Cholinesterase,[NCBIGene:590],281,Increased Muscarinic Acetylcholine Receptors,1602,false
Cholinesterase,[NCBIGene:590],281,"Occurrence, Focal Seizure",1623,false
Cholinesterase,[NCBIGene:590],281,Status epilepticus,1788,false
Cholinesterase,[NCBIGene:590],281,Acetylcholine accumulation in synapses,10,false
Cholinesterase,[NCBIGene:590],281,Acetylcholinesterase (AchE) Inhibition,12,true
Cholinesterase,[NCBIGene:590],281,"Increase, Cell injury/death",55,false
Cholinesterase,[NCBIGene:590],281,"N/A, Neurodegeneration",352,false
Nicotinic acetylcholine receptor,[NCBIGene:1134],281,"Overactivation, NMDARs",388,false
Nicotinic acetylcholine receptor,[NCBIGene:1134],281,"Increased, Intracellular Calcium overload",389,false
Nicotinic acetylcholine receptor,[NCBIGene:1134],281,"Increased, glutamate",1350,false
Nicotinic acetylcholine receptor,[NCBIGene:1134],281,Increased Muscarinic Acetylcholine Receptors,1602,false
Nicotinic acetylcholine receptor,[NCBIGene:1134],281,"Occurrence, Focal Seizure",1623,false
Nicotinic acetylcholine receptor,[NCBIGene:1134],281,Status epilepticus,1788,false
Nicotinic acetylcholine receptor,[NCBIGene:1134],281,Acetylcholine accumulation in synapses,10,false
Nicotinic acetylcholine receptor,[NCBIGene:1134],281,Acetylcholinesterase (AchE) Inhibition,12,true
Nicotinic acetylcholine receptor,[NCBIGene:1134],281,"Increase, Cell injury/death",55,false
Nicotinic acetylcholine receptor,[NCBIGene:1134],281,"N/A, Neurodegeneration",352,false
CHOP,[NCBIGene:1649],285,Unfolded Protein Response,1512,false
CHOP,[NCBIGene:1649],285,Apoptosis,1262,false
CHOP,[NCBIGene:1649],285,Liver Injury,1549,false
CHOP,[NCBIGene:1649],285,"Increased, Liver Steatosis",459,false
CHOP,[NCBIGene:1649],285,Inhibition of N-linked glycosylation,1604,true
CHOP,[NCBIGene:1649],285,Accumulation of misfolded proteins,1605,false
CHOP,[NCBIGene:1649],285,Activation of hepatic stellate cells,1606,false
UPR,[NCBIGene:139596],285,Unfolded Protein Response,1512,false
UPR,[NCBIGene:139596],285,Apoptosis,1262,false
UPR,[NCBIGene:139596],285,Liver Injury,1549,false
UPR,[NCBIGene:139596],285,"Increased, Liver Steatosis",459,false
UPR,[NCBIGene:139596],285,Inhibition of N-linked glycosylation,1604,true
UPR,[NCBIGene:139596],285,Accumulation of misfolded proteins,1605,false
UPR,[NCBIGene:139596],285,Activation of hepatic stellate cells,1606,false
Mitochondrial complex III,[NCBIGene:4537],286,"Decrease, Adenosine triphosphate pool",1771,false
Mitochondrial complex III,[NCBIGene:4537],286,"Decrease, Cell proliferation",1821,false
Mitochondrial complex III,[NCBIGene:4537],286,"Increase, Mitochondrial complex III antagonism",1542,true
Mitochondrial complex III,[NCBIGene:4537],286,"Decrease, Growth",1521,false
Mitochondrial complex III,[NCBIGene:4537],287,"Decrease, Adenosine triphosphate pool",1771,false
Mitochondrial complex III,[NCBIGene:4537],287,"Increase, Mitochondrial complex III antagonism",1542,true
Mitochondrial complex III,[NCBIGene:4537],287,"Increase, Cell death",1825,false
Mitochondrial complex III,[NCBIGene:4537],287,"Decrease, Growth",1521,false
17-hydrolase,[NCBIGene:94274],288,"Decrease, androgen receptor activation",1614,false
17-hydrolase,[NCBIGene:94274],288,"Decrease, circulating testosterone levels",1690,false
17-hydrolase,[NCBIGene:94274],288,"Inhibition, Cytochrome P450 enzyme (CYP17A1) activity",1609,true
17-hydrolase,[NCBIGene:94274],288,"Reduction, dehydroepiandrosterone",1610,false
17-hydrolase,[NCBIGene:94274],288,"Reduction, androstenedione",1611,false
17-hydrolase,[NCBIGene:94274],288,"Decrease, dihydrotestosterone (DHT) level",1613,false
17-hydrolase,[NCBIGene:94274],288,Impaired inguinoscrotal testicular descent phase,1615,false
17-hydrolase,[NCBIGene:94274],288,"Malformation, cryptorchidism - maldescended testis",1616,false
"17-hydrolase/C 10,20-lyase",[NCBIGene:1586],288,"Decrease, androgen receptor activation",1614,false
"17-hydrolase/C 10,20-lyase",[NCBIGene:1586],288,"Decrease, circulating testosterone levels",1690,false
"17-hydrolase/C 10,20-lyase",[NCBIGene:1586],288,"Inhibition, Cytochrome P450 enzyme (CYP17A1) activity",1609,true
"17-hydrolase/C 10,20-lyase",[NCBIGene:1586],288,"Reduction, dehydroepiandrosterone",1610,false
"17-hydrolase/C 10,20-lyase",[NCBIGene:1586],288,"Reduction, androstenedione",1611,false
"17-hydrolase/C 10,20-lyase",[NCBIGene:1586],288,"Decrease, dihydrotestosterone (DHT) level",1613,false
"17-hydrolase/C 10,20-lyase",[NCBIGene:1586],288,Impaired inguinoscrotal testicular descent phase,1615,false
"17-hydrolase/C 10,20-lyase",[NCBIGene:1586],288,"Malformation, cryptorchidism - maldescended testis",1616,false
7-hydroxylase,[NCBIGene:1581],288,"Decrease, androgen receptor activation",1614,false
7-hydroxylase,[NCBIGene:1581],288,"Decrease, circulating testosterone levels",1690,false
7-hydroxylase,[NCBIGene:1581],288,"Inhibition, Cytochrome P450 enzyme (CYP17A1) activity",1609,true
7-hydroxylase,[NCBIGene:1581],288,"Reduction, dehydroepiandrosterone",1610,false
7-hydroxylase,[NCBIGene:1581],288,"Reduction, androstenedione",1611,false
7-hydroxylase,[NCBIGene:1581],288,"Decrease, dihydrotestosterone (DHT) level",1613,false
7-hydroxylase,[NCBIGene:1581],288,Impaired inguinoscrotal testicular descent phase,1615,false
7-hydroxylase,[NCBIGene:1581],288,"Malformation, cryptorchidism - maldescended testis",1616,false
AR,"[NCBIGene:367, 231, 2232]",288,"Decrease, androgen receptor activation",1614,false
AR,"[NCBIGene:367, 231, 2232]",288,"Decrease, circulating testosterone levels",1690,false
AR,"[NCBIGene:367, 231, 2232]",288,"Inhibition, Cytochrome P450 enzyme (CYP17A1) activity",1609,true
AR,"[NCBIGene:367, 231, 2232]",288,"Reduction, dehydroepiandrosterone",1610,false
AR,"[NCBIGene:367, 231, 2232]",288,"Reduction, androstenedione",1611,false
AR,"[NCBIGene:367, 231, 2232]",288,"Decrease, dihydrotestosterone (DHT) level",1613,false
AR,"[NCBIGene:367, 231, 2232]",288,Impaired inguinoscrotal testicular descent phase,1615,false
AR,"[NCBIGene:367, 231, 2232]",288,"Malformation, cryptorchidism - maldescended testis",1616,false
"C 10,20-lyase",[NCBIGene:1583],288,"Decrease, androgen receptor activation",1614,false
"C 10,20-lyase",[NCBIGene:1583],288,"Decrease, circulating testosterone levels",1690,false
"C 10,20-lyase",[NCBIGene:1583],288,"Inhibition, Cytochrome P450 enzyme (CYP17A1) activity",1609,true
"C 10,20-lyase",[NCBIGene:1583],288,"Reduction, dehydroepiandrosterone",1610,false
"C 10,20-lyase",[NCBIGene:1583],288,"Reduction, androstenedione",1611,false
"C 10,20-lyase",[NCBIGene:1583],288,"Decrease, dihydrotestosterone (DHT) level",1613,false
"C 10,20-lyase",[NCBIGene:1583],288,Impaired inguinoscrotal testicular descent phase,1615,false
"C 10,20-lyase",[NCBIGene:1583],288,"Malformation, cryptorchidism - maldescended testis",1616,false
CYP51,[NCBIGene:1595],288,"Decrease, androgen receptor activation",1614,false
CYP51,[NCBIGene:1595],288,"Decrease, circulating testosterone levels",1690,false
CYP51,[NCBIGene:1595],288,"Inhibition, Cytochrome P450 enzyme (CYP17A1) activity",1609,true
CYP51,[NCBIGene:1595],288,"Reduction, dehydroepiandrosterone",1610,false
CYP51,[NCBIGene:1595],288,"Reduction, androstenedione",1611,false
CYP51,[NCBIGene:1595],288,"Decrease, dihydrotestosterone (DHT) level",1613,false
CYP51,[NCBIGene:1595],288,Impaired inguinoscrotal testicular descent phase,1615,false
CYP51,[NCBIGene:1595],288,"Malformation, cryptorchidism - maldescended testis",1616,false
5-reductase,[NCBIGene:6715],289,"Inhibition, 5α-reductase",1617,true
5-reductase,[NCBIGene:6715],289,"Reduction, Plasma vitellogenin concentrations",221,false
5-reductase,[NCBIGene:6715],289,"Reduction, Cumulative fecundity and spawning",78,false
5-reductase,[NCBIGene:6715],289,"Decrease, dihydrotestosterone (DHT) level",1613,false
5-reductase,[NCBIGene:6715],289,"Decrease, Population growth rate",360,false
5-reductase,[NCBIGene:6715],289,"Reduction, Plasma 17beta-estradiol concentrations",219,false
AR,"[NCBIGene:367, 231, 2232]",289,"Inhibition, 5α-reductase",1617,true
AR,"[NCBIGene:367, 231, 2232]",289,"Reduction, Plasma vitellogenin concentrations",221,false
AR,"[NCBIGene:367, 231, 2232]",289,"Reduction, Cumulative fecundity and spawning",78,false
AR,"[NCBIGene:367, 231, 2232]",289,"Decrease, dihydrotestosterone (DHT) level",1613,false
AR,"[NCBIGene:367, 231, 2232]",289,"Decrease, Population growth rate",360,false
AR,"[NCBIGene:367, 231, 2232]",289,"Reduction, Plasma 17beta-estradiol concentrations",219,false
ER,"[NCBIGene:2099, 2069]",289,"Inhibition, 5α-reductase",1617,true
ER,"[NCBIGene:2099, 2069]",289,"Reduction, Plasma vitellogenin concentrations",221,false
ER,"[NCBIGene:2099, 2069]",289,"Reduction, Cumulative fecundity and spawning",78,false
ER,"[NCBIGene:2099, 2069]",289,"Decrease, dihydrotestosterone (DHT) level",1613,false
ER,"[NCBIGene:2099, 2069]",289,"Decrease, Population growth rate",360,false
ER,"[NCBIGene:2099, 2069]",289,"Reduction, Plasma 17beta-estradiol concentrations",219,false
ER,"[NCBIGene:2099, 2069]",29,"Agonism, Estrogen receptor",111,true
ER,"[NCBIGene:2099, 2069]",29,"Increase, Plasma vitellogenin concentrations",220,false
ER,"[NCBIGene:2099, 2069]",29,"Increase, Vitellogenin synthesis in liver",307,false
ER,"[NCBIGene:2099, 2069]",29,"Increase, Renal pathology due to VTG deposition",252,false
ER,"[NCBIGene:2099, 2069]",29,"Altered, Reproductive behaviour",363,false
ER,"[NCBIGene:2099, 2069]",29,"Altered, Larval development",339,false
ER,"[NCBIGene:2099, 2069]",29,"Impaired development of, Reproductive organs",364,false
ER,"[NCBIGene:2099, 2069]",29,"Reduction, Cumulative fecundity and spawning",78,false
ER,"[NCBIGene:2099, 2069]",29,"Decrease, Population growth rate",360,false
VTG,[NCBIGene:246319],29,"Agonism, Estrogen receptor",111,true
VTG,[NCBIGene:246319],29,"Increase, Plasma vitellogenin concentrations",220,false
VTG,[NCBIGene:246319],29,"Increase, Vitellogenin synthesis in liver",307,false
VTG,[NCBIGene:246319],29,"Increase, Renal pathology due to VTG deposition",252,false
VTG,[NCBIGene:246319],29,"Altered, Reproductive behaviour",363,false
VTG,[NCBIGene:246319],29,"Altered, Larval development",339,false
VTG,[NCBIGene:246319],29,"Impaired development of, Reproductive organs",364,false
VTG,[NCBIGene:246319],29,"Reduction, Cumulative fecundity and spawning",78,false
VTG,[NCBIGene:246319],29,"Decrease, Population growth rate",360,false
vitellogenin,[NCBIGene:7350],29,"Agonism, Estrogen receptor",111,true
vitellogenin,[NCBIGene:7350],29,"Increase, Plasma vitellogenin concentrations",220,false
vitellogenin,[NCBIGene:7350],29,"Increase, Vitellogenin synthesis in liver",307,false
vitellogenin,[NCBIGene:7350],29,"Increase, Renal pathology due to VTG deposition",252,false
vitellogenin,[NCBIGene:7350],29,"Altered, Reproductive behaviour",363,false
vitellogenin,[NCBIGene:7350],29,"Altered, Larval development",339,false
vitellogenin,[NCBIGene:7350],29,"Impaired development of, Reproductive organs",364,false
vitellogenin,[NCBIGene:7350],29,"Reduction, Cumulative fecundity and spawning",78,false
vitellogenin,[NCBIGene:7350],29,"Decrease, Population growth rate",360,false
Mitochondrial ATP synthase,[NCBIGene:27109],290,"Decrease, Adenosine triphosphate pool",1771,false
Mitochondrial ATP synthase,[NCBIGene:27109],290,"Decrease, Cell proliferation",1821,false
Mitochondrial ATP synthase,[NCBIGene:27109],290,"Increase, Mitochondrial ATP synthase antagonism",1785,true
Mitochondrial ATP synthase,[NCBIGene:27109],290,"Decrease, Growth",1521,false
Mitochondrial ATP synthase,[NCBIGene:27109],291,"Decrease, Adenosine triphosphate pool",1771,false
Mitochondrial ATP synthase,[NCBIGene:27109],291,"Increase, Cell death",1825,false
Mitochondrial ATP synthase,[NCBIGene:27109],291,"Increase, Mitochondrial ATP synthase antagonism",1785,true
Mitochondrial ATP synthase,[NCBIGene:27109],291,"Decrease, Growth",1521,false
tyrosinase,[NCBIGene:7299],292,Inhibition of tyrosinase,1627,true
tyrosinase,[NCBIGene:7299],292,Reduction of L-Dopaquinone,1628,false
tyrosinase,[NCBIGene:7299],292,Reduction in melanin level,1629,false
tyrosinase,[NCBIGene:7299],292,Reduction of melanosome level,1630,false
tyrosinase,[NCBIGene:7299],292,Reduction fo Pigmentation pattern,1631,false
tyrosinase,[NCBIGene:7299],292,"Decrease, Population growth rate",360,false
RA-binding protein,[NCBIGene:1381],297,Retinaldehyde dehydrogenase inhibition,1637,true
RA-binding protein,[NCBIGene:1381],297,"Altered, Photoreceptor patterning",1640,false
RA-binding protein,[NCBIGene:1381],297,Decreased retinoic acid (RA) synthesis,1641,false
RA-binding protein,[NCBIGene:1381],297,Decreased plasma RA level,1642,false
RA-binding protein,[NCBIGene:1381],297,"Altered, Visual function",1643,false
RA-binding protein,[NCBIGene:1381],297,"Decrease, Population growth rate",360,false
RARs,[NCBIGene:5917],297,Retinaldehyde dehydrogenase inhibition,1637,true
RARs,[NCBIGene:5917],297,"Altered, Photoreceptor patterning",1640,false
RARs,[NCBIGene:5917],297,Decreased retinoic acid (RA) synthesis,1641,false
RARs,[NCBIGene:5917],297,Decreased plasma RA level,1642,false
RARs,[NCBIGene:5917],297,"Altered, Visual function",1643,false
RARs,[NCBIGene:5917],297,"Decrease, Population growth rate",360,false
cellular,[NCBIGene:1057],297,Retinaldehyde dehydrogenase inhibition,1637,true
cellular,[NCBIGene:1057],297,"Altered, Photoreceptor patterning",1640,false
cellular,[NCBIGene:1057],297,Decreased retinoic acid (RA) synthesis,1641,false
cellular,[NCBIGene:1057],297,Decreased plasma RA level,1642,false
cellular,[NCBIGene:1057],297,"Altered, Visual function",1643,false
cellular,[NCBIGene:1057],297,"Decrease, Population growth rate",360,false
retinaldehyde dehydrogenase,[NCBIGene:216],297,Retinaldehyde dehydrogenase inhibition,1637,true
retinaldehyde dehydrogenase,[NCBIGene:216],297,"Altered, Photoreceptor patterning",1640,false
retinaldehyde dehydrogenase,[NCBIGene:216],297,Decreased retinoic acid (RA) synthesis,1641,false
retinaldehyde dehydrogenase,[NCBIGene:216],297,Decreased plasma RA level,1642,false
retinaldehyde dehydrogenase,[NCBIGene:216],297,"Altered, Visual function",1643,false
retinaldehyde dehydrogenase,[NCBIGene:216],297,"Decrease, Population growth rate",360,false
retinoic acid receptors,[NCBIGene:10966],297,Retinaldehyde dehydrogenase inhibition,1637,true
retinoic acid receptors,[NCBIGene:10966],297,"Altered, Photoreceptor patterning",1640,false
retinoic acid receptors,[NCBIGene:10966],297,Decreased retinoic acid (RA) synthesis,1641,false
retinoic acid receptors,[NCBIGene:10966],297,Decreased plasma RA level,1642,false
retinoic acid receptors,[NCBIGene:10966],297,"Altered, Visual function",1643,false
retinoic acid receptors,[NCBIGene:10966],297,"Decrease, Population growth rate",360,false
retinoid X receptor,[NCBIGene:6256],297,Retinaldehyde dehydrogenase inhibition,1637,true
retinoid X receptor,[NCBIGene:6256],297,"Altered, Photoreceptor patterning",1640,false
retinoid X receptor,[NCBIGene:6256],297,Decreased retinoic acid (RA) synthesis,1641,false
retinoid X receptor,[NCBIGene:6256],297,Decreased plasma RA level,1642,false
retinoid X receptor,[NCBIGene:6256],297,"Altered, Visual function",1643,false
retinoid X receptor,[NCBIGene:6256],297,"Decrease, Population growth rate",360,false
WNT,[NCBIGene:7471],298,"Increase, Reactive oxygen species",1115,true
WNT,[NCBIGene:7471],298,Epithelial Mesenchymal Transition,1457,false
WNT,[NCBIGene:7471],298,Treatment-resistant gastric cancer,1651,false
WNT,[NCBIGene:7471],298,Chronic reactive oxygen species,1753,true
WNT,[NCBIGene:7471],298,"Increase, porcupine-induced Wnt secretion and Wnt signaling activation",1754,false
WNT,[NCBIGene:7471],298,beta-catenin activation,1755,false
beta-catenin,[NCBIGene:1499],298,"Increase, Reactive oxygen species",1115,true
beta-catenin,[NCBIGene:1499],298,Epithelial Mesenchymal Transition,1457,false
beta-catenin,[NCBIGene:1499],298,Treatment-resistant gastric cancer,1651,false
beta-catenin,[NCBIGene:1499],298,Chronic reactive oxygen species,1753,true
beta-catenin,[NCBIGene:1499],298,"Increase, porcupine-induced Wnt secretion and Wnt signaling activation",1754,false
beta-catenin,[NCBIGene:1499],298,beta-catenin activation,1755,false
porcupine,[NCBIGene:64840],298,"Increase, Reactive oxygen species",1115,true
porcupine,[NCBIGene:64840],298,Epithelial Mesenchymal Transition,1457,false
porcupine,[NCBIGene:64840],298,Treatment-resistant gastric cancer,1651,false
porcupine,[NCBIGene:64840],298,Chronic reactive oxygen species,1753,true
porcupine,[NCBIGene:64840],298,"Increase, porcupine-induced Wnt secretion and Wnt signaling activation",1754,false
porcupine,[NCBIGene:64840],298,beta-catenin activation,1755,false
mitochondrial complex I,[NCBIGene:4723],3,Degeneration of dopaminergic neurons of the nigrostriatal pathway,890,false
mitochondrial complex I,[NCBIGene:4723],3,"Impaired, Proteostasis",889,false
mitochondrial complex I,[NCBIGene:4723],3,"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)",888,true
mitochondrial complex I,[NCBIGene:4723],3,"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)",887,false
mitochondrial complex I,[NCBIGene:4723],3,Parkinsonian motor deficits,896,false
mitochondrial complex I,[NCBIGene:4723],3,Neuroinflammation,188,false
mitochondrial complex I,[NCBIGene:4723],3,Mitochondrial dysfunction,177,false
viral-mutated -synuclein,[NCBIGene:9639],3,Degeneration of dopaminergic neurons of the nigrostriatal pathway,890,false
viral-mutated -synuclein,[NCBIGene:9639],3,"Impaired, Proteostasis",889,false
viral-mutated -synuclein,[NCBIGene:9639],3,"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)",888,true
viral-mutated -synuclein,[NCBIGene:9639],3,"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)",887,false
viral-mutated -synuclein,[NCBIGene:9639],3,Parkinsonian motor deficits,896,false
viral-mutated -synuclein,[NCBIGene:9639],3,Neuroinflammation,188,false
viral-mutated -synuclein,[NCBIGene:9639],3,Mitochondrial dysfunction,177,false
ER,"[NCBIGene:2099, 2069]",30,"Antagonism, Estrogen receptor",112,true
ER,"[NCBIGene:2099, 2069]",30,"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development",309,false
ER,"[NCBIGene:2099, 2069]",30,"Reduction, Plasma vitellogenin concentrations",221,false
ER,"[NCBIGene:2099, 2069]",30,"Reduction, Cumulative fecundity and spawning",78,false
ER,"[NCBIGene:2099, 2069]",30,"Reduction, Vitellogenin synthesis in liver",285,false
ER,"[NCBIGene:2099, 2069]",30,"Decrease, Population growth rate",360,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",300,"Cognitive function, decreased",402,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",300,"Hippocampal gene expression, Altered",756,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",300,"Antagonism, Thyroid Receptor",1656,true
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",300,"Hippocampal anatomy, Altered",757,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",300,"Hippocampal Physiology, Altered",758,false
thyroid stimulating hormone,[NCBIGene:7253],300,"Cognitive function, decreased",402,false
thyroid stimulating hormone,[NCBIGene:7253],300,"Hippocampal gene expression, Altered",756,false
thyroid stimulating hormone,[NCBIGene:7253],300,"Antagonism, Thyroid Receptor",1656,true
thyroid stimulating hormone,[NCBIGene:7253],300,"Hippocampal anatomy, Altered",757,false
thyroid stimulating hormone,[NCBIGene:7253],300,"Hippocampal Physiology, Altered",758,false
C-reactive protein,[NCBIGene:1401],301,Inhibition of cystathionine beta-synthase,1657,true
C-reactive protein,[NCBIGene:1401],301,Increased Homocysteine level,1661,false
C-reactive protein,[NCBIGene:1401],301,"Increased, Plasma HCY level",1665,false
C-reactive protein,[NCBIGene:1401],301,"Induced, dysfunction of microcirculation",1666,false
C-reactive protein,[NCBIGene:1401],301,"Impaired,anterior-posterior axis development",1667,false
Cystathionine Beta synthase,[NCBIGene:875],301,Inhibition of cystathionine beta-synthase,1657,true
Cystathionine Beta synthase,[NCBIGene:875],301,Increased Homocysteine level,1661,false
Cystathionine Beta synthase,[NCBIGene:875],301,"Increased, Plasma HCY level",1665,false
Cystathionine Beta synthase,[NCBIGene:875],301,"Induced, dysfunction of microcirculation",1666,false
Cystathionine Beta synthase,[NCBIGene:875],301,"Impaired,anterior-posterior axis development",1667,false
P38 MAPK,[NCBIGene:1432],301,Inhibition of cystathionine beta-synthase,1657,true
P38 MAPK,[NCBIGene:1432],301,Increased Homocysteine level,1661,false
P38 MAPK,[NCBIGene:1432],301,"Increased, Plasma HCY level",1665,false
P38 MAPK,[NCBIGene:1432],301,"Induced, dysfunction of microcirculation",1666,false
P38 MAPK,[NCBIGene:1432],301,"Impaired,anterior-posterior axis development",1667,false
SBS,[NCBIGene:1540],301,Inhibition of cystathionine beta-synthase,1657,true
SBS,[NCBIGene:1540],301,Increased Homocysteine level,1661,false
SBS,[NCBIGene:1540],301,"Increased, Plasma HCY level",1665,false
SBS,[NCBIGene:1540],301,"Induced, dysfunction of microcirculation",1666,false
SBS,[NCBIGene:1540],301,"Impaired,anterior-posterior axis development",1667,false
betaine homocysteine methyltransferase,[NCBIGene:635],301,Inhibition of cystathionine beta-synthase,1657,true
betaine homocysteine methyltransferase,[NCBIGene:635],301,Increased Homocysteine level,1661,false
betaine homocysteine methyltransferase,[NCBIGene:635],301,"Increased, Plasma HCY level",1665,false
betaine homocysteine methyltransferase,[NCBIGene:635],301,"Induced, dysfunction of microcirculation",1666,false
betaine homocysteine methyltransferase,[NCBIGene:635],301,"Impaired,anterior-posterior axis development",1667,false
ionotropic glutamate receptors,[NCBIGene:2890],301,Inhibition of cystathionine beta-synthase,1657,true
ionotropic glutamate receptors,[NCBIGene:2890],301,Increased Homocysteine level,1661,false
ionotropic glutamate receptors,[NCBIGene:2890],301,"Increased, Plasma HCY level",1665,false
ionotropic glutamate receptors,[NCBIGene:2890],301,"Induced, dysfunction of microcirculation",1666,false
ionotropic glutamate receptors,[NCBIGene:2890],301,"Impaired,anterior-posterior axis development",1667,false
metabotropic G-protein-coupled receptors,[NCBIGene:2911],301,Inhibition of cystathionine beta-synthase,1657,true
metabotropic G-protein-coupled receptors,[NCBIGene:2911],301,Increased Homocysteine level,1661,false
metabotropic G-protein-coupled receptors,[NCBIGene:2911],301,"Increased, Plasma HCY level",1665,false
metabotropic G-protein-coupled receptors,[NCBIGene:2911],301,"Induced, dysfunction of microcirculation",1666,false
metabotropic G-protein-coupled receptors,[NCBIGene:2911],301,"Impaired,anterior-posterior axis development",1667,false
methionine synthase,[NCBIGene:4548],301,Inhibition of cystathionine beta-synthase,1657,true
methionine synthase,[NCBIGene:4548],301,Increased Homocysteine level,1661,false
methionine synthase,[NCBIGene:4548],301,"Increased, Plasma HCY level",1665,false
methionine synthase,[NCBIGene:4548],301,"Induced, dysfunction of microcirculation",1666,false
methionine synthase,[NCBIGene:4548],301,"Impaired,anterior-posterior axis development",1667,false
peroxidase,[NCBIGene:137902],301,Inhibition of cystathionine beta-synthase,1657,true
peroxidase,[NCBIGene:137902],301,Increased Homocysteine level,1661,false
peroxidase,[NCBIGene:137902],301,"Increased, Plasma HCY level",1665,false
peroxidase,[NCBIGene:137902],301,"Induced, dysfunction of microcirculation",1666,false
peroxidase,[NCBIGene:137902],301,"Impaired,anterior-posterior axis development",1667,false
superoxide dismutase,[NCBIGene:6647],301,Inhibition of cystathionine beta-synthase,1657,true
superoxide dismutase,[NCBIGene:6647],301,Increased Homocysteine level,1661,false
superoxide dismutase,[NCBIGene:6647],301,"Increased, Plasma HCY level",1665,false
superoxide dismutase,[NCBIGene:6647],301,"Induced, dysfunction of microcirculation",1666,false
superoxide dismutase,[NCBIGene:6647],301,"Impaired,anterior-posterior axis development",1667,false
TBX1,[NCBIGene:6899],304,"Inhibition, TBX1",1680,true
TBX1,[NCBIGene:6899],304,"Disruption, Neural crest cell migration",1681,false
TBX1,[NCBIGene:6899],304,"Disruption, Progenitor cells of second heart field",1682,false
TBX1,[NCBIGene:6899],304,"Impairment, Fourth pharyngeal arch development",1683,false
TBX1,[NCBIGene:6899],304,"Abnormalities, Cardiac outflow tract formation",1684,false
TBX1,[NCBIGene:6899],304,"Anomalies, Congenital cardiac conotruncal",1685,false
5-reductase,[NCBIGene:6715],305,"Decrease, androgen receptor activation",1614,false
5-reductase,[NCBIGene:6715],305,"Inhibition, 5α-reductase",1617,true
5-reductase,[NCBIGene:6715],305,"Decrease, dihydrotestosterone (DHT) level",1613,false
5-reductase,[NCBIGene:6715],305,"Altered, Transcription of genes by the androgen receptor",286,false
5-reductase,[NCBIGene:6715],305,"anogenital distance (AGD), decreased",1688,false
AR,"[NCBIGene:367, 231, 2232]",305,"Decrease, androgen receptor activation",1614,false
AR,"[NCBIGene:367, 231, 2232]",305,"Inhibition, 5α-reductase",1617,true
AR,"[NCBIGene:367, 231, 2232]",305,"Decrease, dihydrotestosterone (DHT) level",1613,false
AR,"[NCBIGene:367, 231, 2232]",305,"Altered, Transcription of genes by the androgen receptor",286,false
AR,"[NCBIGene:367, 231, 2232]",305,"anogenital distance (AGD), decreased",1688,false
LABC complex,[NCBIGene:100506885],305,"Decrease, androgen receptor activation",1614,false
LABC complex,[NCBIGene:100506885],305,"Inhibition, 5α-reductase",1617,true
LABC complex,[NCBIGene:100506885],305,"Decrease, dihydrotestosterone (DHT) level",1613,false
LABC complex,[NCBIGene:100506885],305,"Altered, Transcription of genes by the androgen receptor",286,false
LABC complex,[NCBIGene:100506885],305,"anogenital distance (AGD), decreased",1688,false
enzyme 5-reductase,[NCBIGene:6716],305,"Decrease, androgen receptor activation",1614,false
enzyme 5-reductase,[NCBIGene:6716],305,"Inhibition, 5α-reductase",1617,true
enzyme 5-reductase,[NCBIGene:6716],305,"Decrease, dihydrotestosterone (DHT) level",1613,false
enzyme 5-reductase,[NCBIGene:6716],305,"Altered, Transcription of genes by the androgen receptor",286,false
enzyme 5-reductase,[NCBIGene:6716],305,"anogenital distance (AGD), decreased",1688,false
5-reductase,[NCBIGene:6715],306,"Decrease, androgen receptor activation",1614,false
5-reductase,[NCBIGene:6715],306,"Antagonism, Androgen receptor",26,true
5-reductase,[NCBIGene:6715],306,"Altered, Transcription of genes by the androgen receptor",286,false
5-reductase,[NCBIGene:6715],306,"anogenital distance (AGD), decreased",1688,false
AR,"[NCBIGene:367, 231, 2232]",306,"Decrease, androgen receptor activation",1614,false
AR,"[NCBIGene:367, 231, 2232]",306,"Antagonism, Androgen receptor",26,true
AR,"[NCBIGene:367, 231, 2232]",306,"Altered, Transcription of genes by the androgen receptor",286,false
AR,"[NCBIGene:367, 231, 2232]",306,"anogenital distance (AGD), decreased",1688,false
LABC,[NCBIGene:7462],306,"Decrease, androgen receptor activation",1614,false
LABC,[NCBIGene:7462],306,"Antagonism, Androgen receptor",26,true
LABC,[NCBIGene:7462],306,"Altered, Transcription of genes by the androgen receptor",286,false
LABC,[NCBIGene:7462],306,"anogenital distance (AGD), decreased",1688,false
LABC complex,[NCBIGene:100506885],306,"Decrease, androgen receptor activation",1614,false
LABC complex,[NCBIGene:100506885],306,"Antagonism, Androgen receptor",26,true
LABC complex,[NCBIGene:100506885],306,"Altered, Transcription of genes by the androgen receptor",286,false
LABC complex,[NCBIGene:100506885],306,"anogenital distance (AGD), decreased",1688,false
"17-hydrolase/C 10,20-lyase",[NCBIGene:1586],307,"Decrease, androgen receptor activation",1614,false
"17-hydrolase/C 10,20-lyase",[NCBIGene:1586],307,"Decrease, circulating testosterone levels",1690,false
"17-hydrolase/C 10,20-lyase",[NCBIGene:1586],307,"Altered, Transcription of genes by the androgen receptor",286,false
"17-hydrolase/C 10,20-lyase",[NCBIGene:1586],307,"anogenital distance (AGD), decreased",1688,false
"17-hydrolase/C 10,20-lyase",[NCBIGene:1586],307,"Decrease, intratesticular testosterone levels",2298,false
5-reductase,[NCBIGene:6715],307,"Decrease, androgen receptor activation",1614,false
5-reductase,[NCBIGene:6715],307,"Decrease, circulating testosterone levels",1690,false
5-reductase,[NCBIGene:6715],307,"Altered, Transcription of genes by the androgen receptor",286,false
5-reductase,[NCBIGene:6715],307,"anogenital distance (AGD), decreased",1688,false
5-reductase,[NCBIGene:6715],307,"Decrease, intratesticular testosterone levels",2298,false
AR,"[NCBIGene:367, 231, 2232]",307,"Decrease, androgen receptor activation",1614,false
AR,"[NCBIGene:367, 231, 2232]",307,"Decrease, circulating testosterone levels",1690,false
AR,"[NCBIGene:367, 231, 2232]",307,"Altered, Transcription of genes by the androgen receptor",286,false
AR,"[NCBIGene:367, 231, 2232]",307,"anogenital distance (AGD), decreased",1688,false
AR,"[NCBIGene:367, 231, 2232]",307,"Decrease, intratesticular testosterone levels",2298,false
"C 10,20-lyase",[NCBIGene:1583],307,"Decrease, androgen receptor activation",1614,false
"C 10,20-lyase",[NCBIGene:1583],307,"Decrease, circulating testosterone levels",1690,false
"C 10,20-lyase",[NCBIGene:1583],307,"Altered, Transcription of genes by the androgen receptor",286,false
"C 10,20-lyase",[NCBIGene:1583],307,"anogenital distance (AGD), decreased",1688,false
"C 10,20-lyase",[NCBIGene:1583],307,"Decrease, intratesticular testosterone levels",2298,false
CYP enzymes,[NCBIGene:9360],307,"Decrease, androgen receptor activation",1614,false
CYP enzymes,[NCBIGene:9360],307,"Decrease, circulating testosterone levels",1690,false
CYP enzymes,[NCBIGene:9360],307,"Altered, Transcription of genes by the androgen receptor",286,false
CYP enzymes,[NCBIGene:9360],307,"anogenital distance (AGD), decreased",1688,false
CYP enzymes,[NCBIGene:9360],307,"Decrease, intratesticular testosterone levels",2298,false
LABC complex,[NCBIGene:100506885],307,"Decrease, androgen receptor activation",1614,false
LABC complex,[NCBIGene:100506885],307,"Decrease, circulating testosterone levels",1690,false
LABC complex,[NCBIGene:100506885],307,"Altered, Transcription of genes by the androgen receptor",286,false
LABC complex,[NCBIGene:100506885],307,"anogenital distance (AGD), decreased",1688,false
LABC complex,[NCBIGene:100506885],307,"Decrease, intratesticular testosterone levels",2298,false
"C 10,20-lyase",[NCBIGene:1583],309,"Antagonism,LH receptor",1691,true
"C 10,20-lyase",[NCBIGene:1583],309,"Reduction, Progesterone synthesis",1692,false
"C 10,20-lyase",[NCBIGene:1583],309,"Decreased, Progesterone levels",1693,false
"C 10,20-lyase",[NCBIGene:1583],309,"Reduction, progesterone uptake, decresed maturation",1694,false
"C 10,20-lyase",[NCBIGene:1583],309,Impaired ovulation,1695,false
"C 10,20-lyase",[NCBIGene:1583],309,Decrease of egg production and cummulative fecundity,1696,false
"C 10,20-lyase",[NCBIGene:1583],309,"Decline, Population trajectory",679,false
Hepatic Nuclear Receptors,[NCBIGene:190],309,"Antagonism,LH receptor",1691,true
Hepatic Nuclear Receptors,[NCBIGene:190],309,"Reduction, Progesterone synthesis",1692,false
Hepatic Nuclear Receptors,[NCBIGene:190],309,"Decreased, Progesterone levels",1693,false
Hepatic Nuclear Receptors,[NCBIGene:190],309,"Reduction, progesterone uptake, decresed maturation",1694,false
Hepatic Nuclear Receptors,[NCBIGene:190],309,Impaired ovulation,1695,false
Hepatic Nuclear Receptors,[NCBIGene:190],309,Decrease of egg production and cummulative fecundity,1696,false
Hepatic Nuclear Receptors,[NCBIGene:190],309,"Decline, Population trajectory",679,false
LHR,[NCBIGene:3973],309,"Antagonism,LH receptor",1691,true
LHR,[NCBIGene:3973],309,"Reduction, Progesterone synthesis",1692,false
LHR,[NCBIGene:3973],309,"Decreased, Progesterone levels",1693,false
LHR,[NCBIGene:3973],309,"Reduction, progesterone uptake, decresed maturation",1694,false
LHR,[NCBIGene:3973],309,Impaired ovulation,1695,false
LHR,[NCBIGene:3973],309,Decrease of egg production and cummulative fecundity,1696,false
LHR,[NCBIGene:3973],309,"Decline, Population trajectory",679,false
Luteinizing,[NCBIGene:5351],309,"Antagonism,LH receptor",1691,true
Luteinizing,[NCBIGene:5351],309,"Reduction, Progesterone synthesis",1692,false
Luteinizing,[NCBIGene:5351],309,"Decreased, Progesterone levels",1693,false
Luteinizing,[NCBIGene:5351],309,"Reduction, progesterone uptake, decresed maturation",1694,false
Luteinizing,[NCBIGene:5351],309,Impaired ovulation,1695,false
Luteinizing,[NCBIGene:5351],309,Decrease of egg production and cummulative fecundity,1696,false
Luteinizing,[NCBIGene:5351],309,"Decline, Population trajectory",679,false
Luteinizing hormone receptor,"[NCBIGene:960, 3973]",309,"Antagonism,LH receptor",1691,true
Luteinizing hormone receptor,"[NCBIGene:960, 3973]",309,"Reduction, Progesterone synthesis",1692,false
Luteinizing hormone receptor,"[NCBIGene:960, 3973]",309,"Decreased, Progesterone levels",1693,false
Luteinizing hormone receptor,"[NCBIGene:960, 3973]",309,"Reduction, progesterone uptake, decresed maturation",1694,false
Luteinizing hormone receptor,"[NCBIGene:960, 3973]",309,Impaired ovulation,1695,false
Luteinizing hormone receptor,"[NCBIGene:960, 3973]",309,Decrease of egg production and cummulative fecundity,1696,false
Luteinizing hormone receptor,"[NCBIGene:960, 3973]",309,"Decline, Population trajectory",679,false
gonadotropins,[NCBIGene:59352],309,"Antagonism,LH receptor",1691,true
gonadotropins,[NCBIGene:59352],309,"Reduction, Progesterone synthesis",1692,false
gonadotropins,[NCBIGene:59352],309,"Decreased, Progesterone levels",1693,false
gonadotropins,[NCBIGene:59352],309,"Reduction, progesterone uptake, decresed maturation",1694,false
gonadotropins,[NCBIGene:59352],309,Impaired ovulation,1695,false
gonadotropins,[NCBIGene:59352],309,Decrease of egg production and cummulative fecundity,1696,false
gonadotropins,[NCBIGene:59352],309,"Decline, Population trajectory",679,false
progesterone receptor,[NCBIGene:5241],309,"Antagonism,LH receptor",1691,true
progesterone receptor,[NCBIGene:5241],309,"Reduction, Progesterone synthesis",1692,false
progesterone receptor,[NCBIGene:5241],309,"Decreased, Progesterone levels",1693,false
progesterone receptor,[NCBIGene:5241],309,"Reduction, progesterone uptake, decresed maturation",1694,false
progesterone receptor,[NCBIGene:5241],309,Impaired ovulation,1695,false
progesterone receptor,[NCBIGene:5241],309,Decrease of egg production and cummulative fecundity,1696,false
progesterone receptor,[NCBIGene:5241],309,"Decline, Population trajectory",679,false
Glucose-6-phosphate dehydrogenase,[NCBIGene:2539],31,"Altered regulation, Alpha hemoglobin",21,false
Glucose-6-phosphate dehydrogenase,[NCBIGene:2539],31,"Damaging, Red blood cells; hemolysis",250,false
Glucose-6-phosphate dehydrogenase,[NCBIGene:2539],31,"Formation, Formation of hemoglobin adducts",118,false
Glucose-6-phosphate dehydrogenase,[NCBIGene:2539],31,"Down Regulation, Gulcose-6-phosphate dehydrogenase",131,false
Glucose-6-phosphate dehydrogenase,[NCBIGene:2539],31,"Increase, RBC congestion in liver",246,false
Glucose-6-phosphate dehydrogenase,[NCBIGene:2539],31,"Increase, Liver and splenic hemosiderosis",161,false
Glucose-6-phosphate dehydrogenase,[NCBIGene:2539],31,"N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number",173,false
Glucose-6-phosphate dehydrogenase,[NCBIGene:2539],31,"N/A, Cyanosis occurs",321,false
Glucose-6-phosphate dehydrogenase,[NCBIGene:2539],31,"N/A, Parent compound is converted to the reactive metabolite and forms free radicals leading to oxidation of heme iron(II) in hemoglobin to iron(III)",213,true
Glucose-6-phosphate dehydrogenase,[NCBIGene:2539],31,Oxidative Stress,1392,false
Nrf2,[NCBIGene:4780],31,"Altered regulation, Alpha hemoglobin",21,false
Nrf2,[NCBIGene:4780],31,"Damaging, Red blood cells; hemolysis",250,false
Nrf2,[NCBIGene:4780],31,"Formation, Formation of hemoglobin adducts",118,false
Nrf2,[NCBIGene:4780],31,"Down Regulation, Gulcose-6-phosphate dehydrogenase",131,false
Nrf2,[NCBIGene:4780],31,"Increase, RBC congestion in liver",246,false
Nrf2,[NCBIGene:4780],31,"Increase, Liver and splenic hemosiderosis",161,false
Nrf2,[NCBIGene:4780],31,"N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number",173,false
Nrf2,[NCBIGene:4780],31,"N/A, Cyanosis occurs",321,false
Nrf2,[NCBIGene:4780],31,"N/A, Parent compound is converted to the reactive metabolite and forms free radicals leading to oxidation of heme iron(II) in hemoglobin to iron(III)",213,true
Nrf2,[NCBIGene:4780],31,Oxidative Stress,1392,false
hemoglobin,[NCBIGene:114757],31,"Altered regulation, Alpha hemoglobin",21,false
hemoglobin,[NCBIGene:114757],31,"Damaging, Red blood cells; hemolysis",250,false
hemoglobin,[NCBIGene:114757],31,"Formation, Formation of hemoglobin adducts",118,false
hemoglobin,[NCBIGene:114757],31,"Down Regulation, Gulcose-6-phosphate dehydrogenase",131,false
hemoglobin,[NCBIGene:114757],31,"Increase, RBC congestion in liver",246,false
hemoglobin,[NCBIGene:114757],31,"Increase, Liver and splenic hemosiderosis",161,false
hemoglobin,[NCBIGene:114757],31,"N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number",173,false
hemoglobin,[NCBIGene:114757],31,"N/A, Cyanosis occurs",321,false
hemoglobin,[NCBIGene:114757],31,"N/A, Parent compound is converted to the reactive metabolite and forms free radicals leading to oxidation of heme iron(II) in hemoglobin to iron(III)",213,true
hemoglobin,[NCBIGene:114757],31,Oxidative Stress,1392,false
methemoglobin,[NCBIGene:3048],31,"Altered regulation, Alpha hemoglobin",21,false
methemoglobin,[NCBIGene:3048],31,"Damaging, Red blood cells; hemolysis",250,false
methemoglobin,[NCBIGene:3048],31,"Formation, Formation of hemoglobin adducts",118,false
methemoglobin,[NCBIGene:3048],31,"Down Regulation, Gulcose-6-phosphate dehydrogenase",131,false
methemoglobin,[NCBIGene:3048],31,"Increase, RBC congestion in liver",246,false
methemoglobin,[NCBIGene:3048],31,"Increase, Liver and splenic hemosiderosis",161,false
methemoglobin,[NCBIGene:3048],31,"N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number",173,false
methemoglobin,[NCBIGene:3048],31,"N/A, Cyanosis occurs",321,false
methemoglobin,[NCBIGene:3048],31,"N/A, Parent compound is converted to the reactive metabolite and forms free radicals leading to oxidation of heme iron(II) in hemoglobin to iron(III)",213,true
methemoglobin,[NCBIGene:3048],31,Oxidative Stress,1392,false
AhR,[NCBIGene:196],310,"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development",309,false
AhR,[NCBIGene:196],310,"Reduction, Plasma vitellogenin concentrations",221,false
AhR,[NCBIGene:196],310,"Reduction, Cumulative fecundity and spawning",78,false
AhR,[NCBIGene:196],310,"Reduction, Vitellogenin synthesis in liver",285,false
AhR,[NCBIGene:196],310,"dimerization, AHR/ARNT",944,false
AhR,[NCBIGene:196],310,"Activation, AhR",18,true
AhR,[NCBIGene:196],310,"Decrease, Population growth rate",360,false
AhR,[NCBIGene:196],310,"Reduction, Plasma 17beta-estradiol concentrations",219,false
AhR,[NCBIGene:196],310,"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells",3,false
AhR,[NCBIGene:196],310,"Increase, DNA methyltransferase expression",1697,false
AhR,[NCBIGene:196],310,"Increase, hypermethylation of the promotor region of gonadotropin releasing hormone receptor",1698,false
AhR,[NCBIGene:196],310,"Decrease, expression of gonadotropin releasing hormone receptor",1699,false
GnRHR,[NCBIGene:2798],310,"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development",309,false
GnRHR,[NCBIGene:2798],310,"Reduction, Plasma vitellogenin concentrations",221,false
GnRHR,[NCBIGene:2798],310,"Reduction, Cumulative fecundity and spawning",78,false
GnRHR,[NCBIGene:2798],310,"Reduction, Vitellogenin synthesis in liver",285,false
GnRHR,[NCBIGene:2798],310,"dimerization, AHR/ARNT",944,false
GnRHR,[NCBIGene:2798],310,"Activation, AhR",18,true
GnRHR,[NCBIGene:2798],310,"Decrease, Population growth rate",360,false
GnRHR,[NCBIGene:2798],310,"Reduction, Plasma 17beta-estradiol concentrations",219,false
GnRHR,[NCBIGene:2798],310,"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells",3,false
GnRHR,[NCBIGene:2798],310,"Increase, DNA methyltransferase expression",1697,false
GnRHR,[NCBIGene:2798],310,"Increase, hypermethylation of the promotor region of gonadotropin releasing hormone receptor",1698,false
GnRHR,[NCBIGene:2798],310,"Decrease, expression of gonadotropin releasing hormone receptor",1699,false
Acetylcholinesterase,[NCBIGene:43],312,"Decrease, Population growth rate",360,false
Acetylcholinesterase,[NCBIGene:43],312,Increased Cholinergic Signaling,39,false
Acetylcholinesterase,[NCBIGene:43],312,Acetylcholine accumulation in synapses,10,false
Acetylcholinesterase,[NCBIGene:43],312,Acetylcholinesterase (AchE) Inhibition,12,true
Acetylcholinesterase,[NCBIGene:43],312,Increased Mortality,351,false
Acetylcholinesterase,[NCBIGene:43],312,Impaired coordination and movement,1705,false
IL-13,[NCBIGene:3596],315,Inhibition of JAK3,1715,true
IL-13,[NCBIGene:3596],315,Blockade of STAT5 phosphorylation,1716,false
IL-13,[NCBIGene:3596],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
IL-13,[NCBIGene:3596],315,Suppression of IL-4 production,1718,false
IL-13,[NCBIGene:3596],315,Impairment of T-cell dependent antibody response,1719,false
IL-15,[NCBIGene:3600],315,Inhibition of JAK3,1715,true
IL-15,[NCBIGene:3600],315,Blockade of STAT5 phosphorylation,1716,false
IL-15,[NCBIGene:3600],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
IL-15,[NCBIGene:3600],315,Suppression of IL-4 production,1718,false
IL-15,[NCBIGene:3600],315,Impairment of T-cell dependent antibody response,1719,false
IL-2,[NCBIGene:3558],315,Inhibition of JAK3,1715,true
IL-2,[NCBIGene:3558],315,Blockade of STAT5 phosphorylation,1716,false
IL-2,[NCBIGene:3558],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
IL-2,[NCBIGene:3558],315,Suppression of IL-4 production,1718,false
IL-2,[NCBIGene:3558],315,Impairment of T-cell dependent antibody response,1719,false
IL-21,[NCBIGene:59067],315,Inhibition of JAK3,1715,true
IL-21,[NCBIGene:59067],315,Blockade of STAT5 phosphorylation,1716,false
IL-21,[NCBIGene:59067],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
IL-21,[NCBIGene:59067],315,Suppression of IL-4 production,1718,false
IL-21,[NCBIGene:59067],315,Impairment of T-cell dependent antibody response,1719,false
IL-23,[NCBIGene:51561],315,Inhibition of JAK3,1715,true
IL-23,[NCBIGene:51561],315,Blockade of STAT5 phosphorylation,1716,false
IL-23,[NCBIGene:51561],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
IL-23,[NCBIGene:51561],315,Suppression of IL-4 production,1718,false
IL-23,[NCBIGene:51561],315,Impairment of T-cell dependent antibody response,1719,false
IL-31,[NCBIGene:386653],315,Inhibition of JAK3,1715,true
IL-31,[NCBIGene:386653],315,Blockade of STAT5 phosphorylation,1716,false
IL-31,[NCBIGene:386653],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
IL-31,[NCBIGene:386653],315,Suppression of IL-4 production,1718,false
IL-31,[NCBIGene:386653],315,Impairment of T-cell dependent antibody response,1719,false
IL-4,[NCBIGene:3565],315,Inhibition of JAK3,1715,true
IL-4,[NCBIGene:3565],315,Blockade of STAT5 phosphorylation,1716,false
IL-4,[NCBIGene:3565],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
IL-4,[NCBIGene:3565],315,Suppression of IL-4 production,1718,false
IL-4,[NCBIGene:3565],315,Impairment of T-cell dependent antibody response,1719,false
IL-7,[NCBIGene:3574],315,Inhibition of JAK3,1715,true
IL-7,[NCBIGene:3574],315,Blockade of STAT5 phosphorylation,1716,false
IL-7,[NCBIGene:3574],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
IL-7,[NCBIGene:3574],315,Suppression of IL-4 production,1718,false
IL-7,[NCBIGene:3574],315,Impairment of T-cell dependent antibody response,1719,false
IL-9,[NCBIGene:3578],315,Inhibition of JAK3,1715,true
IL-9,[NCBIGene:3578],315,Blockade of STAT5 phosphorylation,1716,false
IL-9,[NCBIGene:3578],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
IL-9,[NCBIGene:3578],315,Suppression of IL-4 production,1718,false
IL-9,[NCBIGene:3578],315,Impairment of T-cell dependent antibody response,1719,false
JAK2,[NCBIGene:3717],315,Inhibition of JAK3,1715,true
JAK2,[NCBIGene:3717],315,Blockade of STAT5 phosphorylation,1716,false
JAK2,[NCBIGene:3717],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
JAK2,[NCBIGene:3717],315,Suppression of IL-4 production,1718,false
JAK2,[NCBIGene:3717],315,Impairment of T-cell dependent antibody response,1719,false
JAK3,[NCBIGene:3718],315,Inhibition of JAK3,1715,true
JAK3,[NCBIGene:3718],315,Blockade of STAT5 phosphorylation,1716,false
JAK3,[NCBIGene:3718],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
JAK3,[NCBIGene:3718],315,Suppression of IL-4 production,1718,false
JAK3,[NCBIGene:3718],315,Impairment of T-cell dependent antibody response,1719,false
Janus kinase,[NCBIGene:3716],315,Inhibition of JAK3,1715,true
Janus kinase,[NCBIGene:3716],315,Blockade of STAT5 phosphorylation,1716,false
Janus kinase,[NCBIGene:3716],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
Janus kinase,[NCBIGene:3716],315,Suppression of IL-4 production,1718,false
Janus kinase,[NCBIGene:3716],315,Impairment of T-cell dependent antibody response,1719,false
STAT,[NCBIGene:6646],315,Inhibition of JAK3,1715,true
STAT,[NCBIGene:6646],315,Blockade of STAT5 phosphorylation,1716,false
STAT,[NCBIGene:6646],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
STAT,[NCBIGene:6646],315,Suppression of IL-4 production,1718,false
STAT,[NCBIGene:6646],315,Impairment of T-cell dependent antibody response,1719,false
STAT2,[NCBIGene:6773],315,Inhibition of JAK3,1715,true
STAT2,[NCBIGene:6773],315,Blockade of STAT5 phosphorylation,1716,false
STAT2,[NCBIGene:6773],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
STAT2,[NCBIGene:6773],315,Suppression of IL-4 production,1718,false
STAT2,[NCBIGene:6773],315,Impairment of T-cell dependent antibody response,1719,false
STAT3,[NCBIGene:6774],315,Inhibition of JAK3,1715,true
STAT3,[NCBIGene:6774],315,Blockade of STAT5 phosphorylation,1716,false
STAT3,[NCBIGene:6774],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
STAT3,[NCBIGene:6774],315,Suppression of IL-4 production,1718,false
STAT3,[NCBIGene:6774],315,Impairment of T-cell dependent antibody response,1719,false
STAT4,[NCBIGene:6775],315,Inhibition of JAK3,1715,true
STAT4,[NCBIGene:6775],315,Blockade of STAT5 phosphorylation,1716,false
STAT4,[NCBIGene:6775],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
STAT4,[NCBIGene:6775],315,Suppression of IL-4 production,1718,false
STAT4,[NCBIGene:6775],315,Impairment of T-cell dependent antibody response,1719,false
STAT5a,[NCBIGene:6776],315,Inhibition of JAK3,1715,true
STAT5a,[NCBIGene:6776],315,Blockade of STAT5 phosphorylation,1716,false
STAT5a,[NCBIGene:6776],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
STAT5a,[NCBIGene:6776],315,Suppression of IL-4 production,1718,false
STAT5a,[NCBIGene:6776],315,Impairment of T-cell dependent antibody response,1719,false
STAT5b,[NCBIGene:6777],315,Inhibition of JAK3,1715,true
STAT5b,[NCBIGene:6777],315,Blockade of STAT5 phosphorylation,1716,false
STAT5b,[NCBIGene:6777],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
STAT5b,[NCBIGene:6777],315,Suppression of IL-4 production,1718,false
STAT5b,[NCBIGene:6777],315,Impairment of T-cell dependent antibody response,1719,false
STAT6,[NCBIGene:6778],315,Inhibition of JAK3,1715,true
STAT6,[NCBIGene:6778],315,Blockade of STAT5 phosphorylation,1716,false
STAT6,[NCBIGene:6778],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
STAT6,[NCBIGene:6778],315,Suppression of IL-4 production,1718,false
STAT6,[NCBIGene:6778],315,Impairment of T-cell dependent antibody response,1719,false
Signal transducer and activator of transcription,[NCBIGene:6772],315,Inhibition of JAK3,1715,true
Signal transducer and activator of transcription,[NCBIGene:6772],315,Blockade of STAT5 phosphorylation,1716,false
Signal transducer and activator of transcription,[NCBIGene:6772],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
Signal transducer and activator of transcription,[NCBIGene:6772],315,Suppression of IL-4 production,1718,false
Signal transducer and activator of transcription,[NCBIGene:6772],315,Impairment of T-cell dependent antibody response,1719,false
TDAR,[NCBIGene:10656],315,Inhibition of JAK3,1715,true
TDAR,[NCBIGene:10656],315,Blockade of STAT5 phosphorylation,1716,false
TDAR,[NCBIGene:10656],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
TDAR,[NCBIGene:10656],315,Suppression of IL-4 production,1718,false
TDAR,[NCBIGene:10656],315,Impairment of T-cell dependent antibody response,1719,false
TYK2,[NCBIGene:7297],315,Inhibition of JAK3,1715,true
TYK2,[NCBIGene:7297],315,Blockade of STAT5 phosphorylation,1716,false
TYK2,[NCBIGene:7297],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
TYK2,[NCBIGene:7297],315,Suppression of IL-4 production,1718,false
TYK2,[NCBIGene:7297],315,Impairment of T-cell dependent antibody response,1719,false
activator of transcription,[NCBIGene:1385],315,Inhibition of JAK3,1715,true
activator of transcription,[NCBIGene:1385],315,Blockade of STAT5 phosphorylation,1716,false
activator of transcription,[NCBIGene:1385],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
activator of transcription,[NCBIGene:1385],315,Suppression of IL-4 production,1718,false
activator of transcription,[NCBIGene:1385],315,Impairment of T-cell dependent antibody response,1719,false
cytokine,[NCBIGene:943],315,Inhibition of JAK3,1715,true
cytokine,[NCBIGene:943],315,Blockade of STAT5 phosphorylation,1716,false
cytokine,[NCBIGene:943],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
cytokine,[NCBIGene:943],315,Suppression of IL-4 production,1718,false
cytokine,[NCBIGene:943],315,Impairment of T-cell dependent antibody response,1719,false
cytokine genes,[NCBIGene:5307],315,Inhibition of JAK3,1715,true
cytokine genes,[NCBIGene:5307],315,Blockade of STAT5 phosphorylation,1716,false
cytokine genes,[NCBIGene:5307],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
cytokine genes,[NCBIGene:5307],315,Suppression of IL-4 production,1718,false
cytokine genes,[NCBIGene:5307],315,Impairment of T-cell dependent antibody response,1719,false
interferon alpha,[NCBIGene:3439],315,Inhibition of JAK3,1715,true
interferon alpha,[NCBIGene:3439],315,Blockade of STAT5 phosphorylation,1716,false
interferon alpha,[NCBIGene:3439],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
interferon alpha,[NCBIGene:3439],315,Suppression of IL-4 production,1718,false
interferon alpha,[NCBIGene:3439],315,Impairment of T-cell dependent antibody response,1719,false
signal transducer,[NCBIGene:5650],315,Inhibition of JAK3,1715,true
signal transducer,[NCBIGene:5650],315,Blockade of STAT5 phosphorylation,1716,false
signal transducer,[NCBIGene:5650],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
signal transducer,[NCBIGene:5650],315,Suppression of IL-4 production,1718,false
signal transducer,[NCBIGene:5650],315,Impairment of T-cell dependent antibody response,1719,false
thymic stromal lymphopoietin,[NCBIGene:85480],315,Inhibition of JAK3,1715,true
thymic stromal lymphopoietin,[NCBIGene:85480],315,Blockade of STAT5 phosphorylation,1716,false
thymic stromal lymphopoietin,[NCBIGene:85480],315,Suppression of STAT5 binding to cytokine gene promoters,1717,false
thymic stromal lymphopoietin,[NCBIGene:85480],315,Suppression of IL-4 production,1718,false
thymic stromal lymphopoietin,[NCBIGene:85480],315,Impairment of T-cell dependent antibody response,1719,false
Glucocorticoid Receptor,[NCBIGene:2908],318,"Accumulation, Triglyceride",291,false
Glucocorticoid Receptor,[NCBIGene:2908],318,"Decreased, Mitochondrial Fatty Acid Beta Oxidation",860,false
Glucocorticoid Receptor,[NCBIGene:2908],318,"Decrease, Acyl-CoA dehydrogenases",1834,false
Glucocorticoid Receptor,[NCBIGene:2908],318,"Increased, Liver Steatosis",459,false
Glucocorticoid Receptor,[NCBIGene:2908],318,"Activation, Glucocorticoid Receptor",122,true
ACE2,[NCBIGene:59272],319,"Increased, secretion of proinflammatory mediators",1496,false
ACE2,[NCBIGene:59272],319,"Increase, Reactive oxygen species",1115,false
ACE2,[NCBIGene:59272],319,Increased Angiotensin II,1752,false
ACE2,[NCBIGene:59272],319,Induced dysregulation of ACE2,1740,true
ACE2,[NCBIGene:59272],319,"Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)",1851,false
ACE2,[NCBIGene:59272],319,"Increased activation, Nuclear factor kappa B (NF-kB)",1172,false
ACE2,[NCBIGene:59272],319,"Dysregulation, ACE2 expression and activity",1854,false
ACE2,[NCBIGene:59272],319,Lung fibrosis,1276,false
ACE2,[NCBIGene:59272],319,"Accumulation, Collagen",68,false
Ang II,[NCBIGene:285],319,"Increased, secretion of proinflammatory mediators",1496,false
Ang II,[NCBIGene:285],319,"Increase, Reactive oxygen species",1115,false
Ang II,[NCBIGene:285],319,Increased Angiotensin II,1752,false
Ang II,[NCBIGene:285],319,Induced dysregulation of ACE2,1740,true
Ang II,[NCBIGene:285],319,"Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)",1851,false
Ang II,[NCBIGene:285],319,"Increased activation, Nuclear factor kappa B (NF-kB)",1172,false
Ang II,[NCBIGene:285],319,"Dysregulation, ACE2 expression and activity",1854,false
Ang II,[NCBIGene:285],319,Lung fibrosis,1276,false
Ang II,[NCBIGene:285],319,"Accumulation, Collagen",68,false
Ang-(1-7),[NCBIGene:284],319,"Increased, secretion of proinflammatory mediators",1496,false
Ang-(1-7),[NCBIGene:284],319,"Increase, Reactive oxygen species",1115,false
Ang-(1-7),[NCBIGene:284],319,Increased Angiotensin II,1752,false
Ang-(1-7),[NCBIGene:284],319,Induced dysregulation of ACE2,1740,true
Ang-(1-7),[NCBIGene:284],319,"Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)",1851,false
Ang-(1-7),[NCBIGene:284],319,"Increased activation, Nuclear factor kappa B (NF-kB)",1172,false
Ang-(1-7),[NCBIGene:284],319,"Dysregulation, ACE2 expression and activity",1854,false
Ang-(1-7),[NCBIGene:284],319,Lung fibrosis,1276,false
Ang-(1-7),[NCBIGene:284],319,"Accumulation, Collagen",68,false
Angiotensin-converting enzyme,[NCBIGene:1636],319,"Increased, secretion of proinflammatory mediators",1496,false
Angiotensin-converting enzyme,[NCBIGene:1636],319,"Increase, Reactive oxygen species",1115,false
Angiotensin-converting enzyme,[NCBIGene:1636],319,Increased Angiotensin II,1752,false
Angiotensin-converting enzyme,[NCBIGene:1636],319,Induced dysregulation of ACE2,1740,true
Angiotensin-converting enzyme,[NCBIGene:1636],319,"Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)",1851,false
Angiotensin-converting enzyme,[NCBIGene:1636],319,"Increased activation, Nuclear factor kappa B (NF-kB)",1172,false
Angiotensin-converting enzyme,[NCBIGene:1636],319,"Dysregulation, ACE2 expression and activity",1854,false
Angiotensin-converting enzyme,[NCBIGene:1636],319,Lung fibrosis,1276,false
Angiotensin-converting enzyme,[NCBIGene:1636],319,"Accumulation, Collagen",68,false
angiotensin,[NCBIGene:183],319,"Increased, secretion of proinflammatory mediators",1496,false
angiotensin,[NCBIGene:183],319,"Increase, Reactive oxygen species",1115,false
angiotensin,[NCBIGene:183],319,Increased Angiotensin II,1752,false
angiotensin,[NCBIGene:183],319,Induced dysregulation of ACE2,1740,true
angiotensin,[NCBIGene:183],319,"Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)",1851,false
angiotensin,[NCBIGene:183],319,"Increased activation, Nuclear factor kappa B (NF-kB)",1172,false
angiotensin,[NCBIGene:183],319,"Dysregulation, ACE2 expression and activity",1854,false
angiotensin,[NCBIGene:183],319,Lung fibrosis,1276,false
angiotensin,[NCBIGene:183],319,"Accumulation, Collagen",68,false
collagen,[NCBIGene:1280],319,"Increased, secretion of proinflammatory mediators",1496,false
collagen,[NCBIGene:1280],319,"Increase, Reactive oxygen species",1115,false
collagen,[NCBIGene:1280],319,Increased Angiotensin II,1752,false
collagen,[NCBIGene:1280],319,Induced dysregulation of ACE2,1740,true
collagen,[NCBIGene:1280],319,"Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)",1851,false
collagen,[NCBIGene:1280],319,"Increased activation, Nuclear factor kappa B (NF-kB)",1172,false
collagen,[NCBIGene:1280],319,"Dysregulation, ACE2 expression and activity",1854,false
collagen,[NCBIGene:1280],319,Lung fibrosis,1276,false
collagen,[NCBIGene:1280],319,"Accumulation, Collagen",68,false
renin,[NCBIGene:5972],319,"Increased, secretion of proinflammatory mediators",1496,false
renin,[NCBIGene:5972],319,"Increase, Reactive oxygen species",1115,false
renin,[NCBIGene:5972],319,Increased Angiotensin II,1752,false
renin,[NCBIGene:5972],319,Induced dysregulation of ACE2,1740,true
renin,[NCBIGene:5972],319,"Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)",1851,false
renin,[NCBIGene:5972],319,"Increased activation, Nuclear factor kappa B (NF-kB)",1172,false
renin,[NCBIGene:5972],319,"Dysregulation, ACE2 expression and activity",1854,false
renin,[NCBIGene:5972],319,Lung fibrosis,1276,false
renin,[NCBIGene:5972],319,"Accumulation, Collagen",68,false
type 1 angiotensin receptor,[NCBIGene:185],319,"Increased, secretion of proinflammatory mediators",1496,false
type 1 angiotensin receptor,[NCBIGene:185],319,"Increase, Reactive oxygen species",1115,false
type 1 angiotensin receptor,[NCBIGene:185],319,Increased Angiotensin II,1752,false
type 1 angiotensin receptor,[NCBIGene:185],319,Induced dysregulation of ACE2,1740,true
type 1 angiotensin receptor,[NCBIGene:185],319,"Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)",1851,false
type 1 angiotensin receptor,[NCBIGene:185],319,"Increased activation, Nuclear factor kappa B (NF-kB)",1172,false
type 1 angiotensin receptor,[NCBIGene:185],319,"Dysregulation, ACE2 expression and activity",1854,false
type 1 angiotensin receptor,[NCBIGene:185],319,Lung fibrosis,1276,false
type 1 angiotensin receptor,[NCBIGene:185],319,"Accumulation, Collagen",68,false
MAGf,[NCBIGene:84803],32,"Production, Critical Metabolites (CGA 330050 and CGA 265307)",77,false
MAGf,[NCBIGene:84803],32,"Inhibition, Inducible Nitric Oxide Synthase by Metabolite CGA 265307",147,false
MAGf,[NCBIGene:84803],32,"Induction, Sustained Hepatotoxicity",270,false
MAGf,[NCBIGene:84803],32,"Induction, Liver “Dysfunctional” Changes by CGA 330050",164,false
MAGf,[NCBIGene:84803],32,"Induction, Sustained Cell Proliferation",269,false
MAGf,[NCBIGene:84803],32,"Formation, Liver tumor",347,false
Tif,[NCBIGene:7301],32,"Production, Critical Metabolites (CGA 330050 and CGA 265307)",77,false
Tif,[NCBIGene:7301],32,"Inhibition, Inducible Nitric Oxide Synthase by Metabolite CGA 265307",147,false
Tif,[NCBIGene:7301],32,"Induction, Sustained Hepatotoxicity",270,false
Tif,[NCBIGene:7301],32,"Induction, Liver “Dysfunctional” Changes by CGA 330050",164,false
Tif,[NCBIGene:7301],32,"Induction, Sustained Cell Proliferation",269,false
Tif,[NCBIGene:7301],32,"Formation, Liver tumor",347,false
iNOS,[NCBIGene:4843],32,"Production, Critical Metabolites (CGA 330050 and CGA 265307)",77,false
iNOS,[NCBIGene:4843],32,"Inhibition, Inducible Nitric Oxide Synthase by Metabolite CGA 265307",147,false
iNOS,[NCBIGene:4843],32,"Induction, Sustained Hepatotoxicity",270,false
iNOS,[NCBIGene:4843],32,"Induction, Liver “Dysfunctional” Changes by CGA 330050",164,false
iNOS,[NCBIGene:4843],32,"Induction, Sustained Cell Proliferation",269,false
iNOS,[NCBIGene:4843],32,"Formation, Liver tumor",347,false
nitric oxide synthases,[NCBIGene:4842],32,"Production, Critical Metabolites (CGA 330050 and CGA 265307)",77,false
nitric oxide synthases,[NCBIGene:4842],32,"Inhibition, Inducible Nitric Oxide Synthase by Metabolite CGA 265307",147,false
nitric oxide synthases,[NCBIGene:4842],32,"Induction, Sustained Hepatotoxicity",270,false
nitric oxide synthases,[NCBIGene:4842],32,"Induction, Liver “Dysfunctional” Changes by CGA 330050",164,false
nitric oxide synthases,[NCBIGene:4842],32,"Induction, Sustained Cell Proliferation",269,false
nitric oxide synthases,[NCBIGene:4842],32,"Formation, Liver tumor",347,false
ACE2,[NCBIGene:59272],320,"Increased, secretion of proinflammatory mediators",1496,false
ACE2,[NCBIGene:59272],320,SARS-CoV-2 cell entry,1738,false
ACE2,[NCBIGene:59272],320,Binding to ACE2,1739,true
ACE2,[NCBIGene:59272],320,"Increase, the risk of acute respiratory failure",1748,false
ACE2,[NCBIGene:59272],320,Increased inflammatory immune responses,1750,false
ACE2,[NCBIGene:59272],320,Toll Like Receptor (TLR) Dysregulation,1848,false
ACE2,[NCBIGene:59272],320,Increased SARS-CoV-2 production,1847,false
ACE2,[NCBIGene:59272],320,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
ACE2,[NCBIGene:59272],320,Increased Mortality,351,false
ACE2 receptor,[NCBIGene:340485],320,"Increased, secretion of proinflammatory mediators",1496,false
ACE2 receptor,[NCBIGene:340485],320,SARS-CoV-2 cell entry,1738,false
ACE2 receptor,[NCBIGene:340485],320,Binding to ACE2,1739,true
ACE2 receptor,[NCBIGene:340485],320,"Increase, the risk of acute respiratory failure",1748,false
ACE2 receptor,[NCBIGene:340485],320,Increased inflammatory immune responses,1750,false
ACE2 receptor,[NCBIGene:340485],320,Toll Like Receptor (TLR) Dysregulation,1848,false
ACE2 receptor,[NCBIGene:340485],320,Increased SARS-CoV-2 production,1847,false
ACE2 receptor,[NCBIGene:340485],320,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
ACE2 receptor,[NCBIGene:340485],320,Increased Mortality,351,false
Ang II,[NCBIGene:285],320,"Increased, secretion of proinflammatory mediators",1496,false
Ang II,[NCBIGene:285],320,SARS-CoV-2 cell entry,1738,false
Ang II,[NCBIGene:285],320,Binding to ACE2,1739,true
Ang II,[NCBIGene:285],320,"Increase, the risk of acute respiratory failure",1748,false
Ang II,[NCBIGene:285],320,Increased inflammatory immune responses,1750,false
Ang II,[NCBIGene:285],320,Toll Like Receptor (TLR) Dysregulation,1848,false
Ang II,[NCBIGene:285],320,Increased SARS-CoV-2 production,1847,false
Ang II,[NCBIGene:285],320,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
Ang II,[NCBIGene:285],320,Increased Mortality,351,false
Ang-(1-7),[NCBIGene:284],320,"Increased, secretion of proinflammatory mediators",1496,false
Ang-(1-7),[NCBIGene:284],320,SARS-CoV-2 cell entry,1738,false
Ang-(1-7),[NCBIGene:284],320,Binding to ACE2,1739,true
Ang-(1-7),[NCBIGene:284],320,"Increase, the risk of acute respiratory failure",1748,false
Ang-(1-7),[NCBIGene:284],320,Increased inflammatory immune responses,1750,false
Ang-(1-7),[NCBIGene:284],320,Toll Like Receptor (TLR) Dysregulation,1848,false
Ang-(1-7),[NCBIGene:284],320,Increased SARS-CoV-2 production,1847,false
Ang-(1-7),[NCBIGene:284],320,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
Ang-(1-7),[NCBIGene:284],320,Increased Mortality,351,false
AngI,[NCBIGene:10563],320,"Increased, secretion of proinflammatory mediators",1496,false
AngI,[NCBIGene:10563],320,SARS-CoV-2 cell entry,1738,false
AngI,[NCBIGene:10563],320,Binding to ACE2,1739,true
AngI,[NCBIGene:10563],320,"Increase, the risk of acute respiratory failure",1748,false
AngI,[NCBIGene:10563],320,Increased inflammatory immune responses,1750,false
AngI,[NCBIGene:10563],320,Toll Like Receptor (TLR) Dysregulation,1848,false
AngI,[NCBIGene:10563],320,Increased SARS-CoV-2 production,1847,false
AngI,[NCBIGene:10563],320,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
AngI,[NCBIGene:10563],320,Increased Mortality,351,false
Angiotensin-converting enzyme,[NCBIGene:1636],320,"Increased, secretion of proinflammatory mediators",1496,false
Angiotensin-converting enzyme,[NCBIGene:1636],320,SARS-CoV-2 cell entry,1738,false
Angiotensin-converting enzyme,[NCBIGene:1636],320,Binding to ACE2,1739,true
Angiotensin-converting enzyme,[NCBIGene:1636],320,"Increase, the risk of acute respiratory failure",1748,false
Angiotensin-converting enzyme,[NCBIGene:1636],320,Increased inflammatory immune responses,1750,false
Angiotensin-converting enzyme,[NCBIGene:1636],320,Toll Like Receptor (TLR) Dysregulation,1848,false
Angiotensin-converting enzyme,[NCBIGene:1636],320,Increased SARS-CoV-2 production,1847,false
Angiotensin-converting enzyme,[NCBIGene:1636],320,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
Angiotensin-converting enzyme,[NCBIGene:1636],320,Increased Mortality,351,false
Furin,[NCBIGene:5045],320,"Increased, secretion of proinflammatory mediators",1496,false
Furin,[NCBIGene:5045],320,SARS-CoV-2 cell entry,1738,false
Furin,[NCBIGene:5045],320,Binding to ACE2,1739,true
Furin,[NCBIGene:5045],320,"Increase, the risk of acute respiratory failure",1748,false
Furin,[NCBIGene:5045],320,Increased inflammatory immune responses,1750,false
Furin,[NCBIGene:5045],320,Toll Like Receptor (TLR) Dysregulation,1848,false
Furin,[NCBIGene:5045],320,Increased SARS-CoV-2 production,1847,false
Furin,[NCBIGene:5045],320,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
Furin,[NCBIGene:5045],320,Increased Mortality,351,false
S-glycoprotein,[NCBIGene:6295],320,"Increased, secretion of proinflammatory mediators",1496,false
S-glycoprotein,[NCBIGene:6295],320,SARS-CoV-2 cell entry,1738,false
S-glycoprotein,[NCBIGene:6295],320,Binding to ACE2,1739,true
S-glycoprotein,[NCBIGene:6295],320,"Increase, the risk of acute respiratory failure",1748,false
S-glycoprotein,[NCBIGene:6295],320,Increased inflammatory immune responses,1750,false
S-glycoprotein,[NCBIGene:6295],320,Toll Like Receptor (TLR) Dysregulation,1848,false
S-glycoprotein,[NCBIGene:6295],320,Increased SARS-CoV-2 production,1847,false
S-glycoprotein,[NCBIGene:6295],320,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
S-glycoprotein,[NCBIGene:6295],320,Increased Mortality,351,false
S1,[NCBIGene:5707],320,"Increased, secretion of proinflammatory mediators",1496,false
S1,[NCBIGene:5707],320,SARS-CoV-2 cell entry,1738,false
S1,[NCBIGene:5707],320,Binding to ACE2,1739,true
S1,[NCBIGene:5707],320,"Increase, the risk of acute respiratory failure",1748,false
S1,[NCBIGene:5707],320,Increased inflammatory immune responses,1750,false
S1,[NCBIGene:5707],320,Toll Like Receptor (TLR) Dysregulation,1848,false
S1,[NCBIGene:5707],320,Increased SARS-CoV-2 production,1847,false
S1,[NCBIGene:5707],320,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
S1,[NCBIGene:5707],320,Increased Mortality,351,false
S2,"[NCBIGene:5708, 6187]",320,"Increased, secretion of proinflammatory mediators",1496,false
S2,"[NCBIGene:5708, 6187]",320,SARS-CoV-2 cell entry,1738,false
S2,"[NCBIGene:5708, 6187]",320,Binding to ACE2,1739,true
S2,"[NCBIGene:5708, 6187]",320,"Increase, the risk of acute respiratory failure",1748,false
S2,"[NCBIGene:5708, 6187]",320,Increased inflammatory immune responses,1750,false
S2,"[NCBIGene:5708, 6187]",320,Toll Like Receptor (TLR) Dysregulation,1848,false
S2,"[NCBIGene:5708, 6187]",320,Increased SARS-CoV-2 production,1847,false
S2,"[NCBIGene:5708, 6187]",320,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
S2,"[NCBIGene:5708, 6187]",320,Increased Mortality,351,false
TMPRSS2,[NCBIGene:7113],320,"Increased, secretion of proinflammatory mediators",1496,false
TMPRSS2,[NCBIGene:7113],320,SARS-CoV-2 cell entry,1738,false
TMPRSS2,[NCBIGene:7113],320,Binding to ACE2,1739,true
TMPRSS2,[NCBIGene:7113],320,"Increase, the risk of acute respiratory failure",1748,false
TMPRSS2,[NCBIGene:7113],320,Increased inflammatory immune responses,1750,false
TMPRSS2,[NCBIGene:7113],320,Toll Like Receptor (TLR) Dysregulation,1848,false
TMPRSS2,[NCBIGene:7113],320,Increased SARS-CoV-2 production,1847,false
TMPRSS2,[NCBIGene:7113],320,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
TMPRSS2,[NCBIGene:7113],320,Increased Mortality,351,false
angiotensin,[NCBIGene:183],320,"Increased, secretion of proinflammatory mediators",1496,false
angiotensin,[NCBIGene:183],320,SARS-CoV-2 cell entry,1738,false
angiotensin,[NCBIGene:183],320,Binding to ACE2,1739,true
angiotensin,[NCBIGene:183],320,"Increase, the risk of acute respiratory failure",1748,false
angiotensin,[NCBIGene:183],320,Increased inflammatory immune responses,1750,false
angiotensin,[NCBIGene:183],320,Toll Like Receptor (TLR) Dysregulation,1848,false
angiotensin,[NCBIGene:183],320,Increased SARS-CoV-2 production,1847,false
angiotensin,[NCBIGene:183],320,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
angiotensin,[NCBIGene:183],320,Increased Mortality,351,false
capsid(S) glycoprotein,[NCBIGene:7448],320,"Increased, secretion of proinflammatory mediators",1496,false
capsid(S) glycoprotein,[NCBIGene:7448],320,SARS-CoV-2 cell entry,1738,false
capsid(S) glycoprotein,[NCBIGene:7448],320,Binding to ACE2,1739,true
capsid(S) glycoprotein,[NCBIGene:7448],320,"Increase, the risk of acute respiratory failure",1748,false
capsid(S) glycoprotein,[NCBIGene:7448],320,Increased inflammatory immune responses,1750,false
capsid(S) glycoprotein,[NCBIGene:7448],320,Toll Like Receptor (TLR) Dysregulation,1848,false
capsid(S) glycoprotein,[NCBIGene:7448],320,Increased SARS-CoV-2 production,1847,false
capsid(S) glycoprotein,[NCBIGene:7448],320,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
capsid(S) glycoprotein,[NCBIGene:7448],320,Increased Mortality,351,false
human cell surface serine protease,[NCBIGene:2191],320,"Increased, secretion of proinflammatory mediators",1496,false
human cell surface serine protease,[NCBIGene:2191],320,SARS-CoV-2 cell entry,1738,false
human cell surface serine protease,[NCBIGene:2191],320,Binding to ACE2,1739,true
human cell surface serine protease,[NCBIGene:2191],320,"Increase, the risk of acute respiratory failure",1748,false
human cell surface serine protease,[NCBIGene:2191],320,Increased inflammatory immune responses,1750,false
human cell surface serine protease,[NCBIGene:2191],320,Toll Like Receptor (TLR) Dysregulation,1848,false
human cell surface serine protease,[NCBIGene:2191],320,Increased SARS-CoV-2 production,1847,false
human cell surface serine protease,[NCBIGene:2191],320,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
human cell surface serine protease,[NCBIGene:2191],320,Increased Mortality,351,false
renin,[NCBIGene:5972],320,"Increased, secretion of proinflammatory mediators",1496,false
renin,[NCBIGene:5972],320,SARS-CoV-2 cell entry,1738,false
renin,[NCBIGene:5972],320,Binding to ACE2,1739,true
renin,[NCBIGene:5972],320,"Increase, the risk of acute respiratory failure",1748,false
renin,[NCBIGene:5972],320,Increased inflammatory immune responses,1750,false
renin,[NCBIGene:5972],320,Toll Like Receptor (TLR) Dysregulation,1848,false
renin,[NCBIGene:5972],320,Increased SARS-CoV-2 production,1847,false
renin,[NCBIGene:5972],320,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
renin,[NCBIGene:5972],320,Increased Mortality,351,false
viral capsidin,[NCBIGene:5212],320,"Increased, secretion of proinflammatory mediators",1496,false
viral capsidin,[NCBIGene:5212],320,SARS-CoV-2 cell entry,1738,false
viral capsidin,[NCBIGene:5212],320,Binding to ACE2,1739,true
viral capsidin,[NCBIGene:5212],320,"Increase, the risk of acute respiratory failure",1748,false
viral capsidin,[NCBIGene:5212],320,Increased inflammatory immune responses,1750,false
viral capsidin,[NCBIGene:5212],320,Toll Like Receptor (TLR) Dysregulation,1848,false
viral capsidin,[NCBIGene:5212],320,Increased SARS-CoV-2 production,1847,false
viral capsidin,[NCBIGene:5212],320,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
viral capsidin,[NCBIGene:5212],320,Increased Mortality,351,false
PPAR,[NCBIGene:5465],323,"Decreased, cholesterol",807,false
PPAR,[NCBIGene:5465],323,"Decreased,  plasma 11-ketotestosterone level",1756,false
PPAR,[NCBIGene:5465],323,"Impaired, Spermatogenesis",1758,false
PPAR,[NCBIGene:5465],323,"Decreased, Viable Offspring",2147,false
PPAR,[NCBIGene:5465],323,"Activation, PPARα",227,true
PPAR,[NCBIGene:5465],323,"Decrease, Population growth rate",360,false
retinoid X receptor,[NCBIGene:6256],323,"Decreased, cholesterol",807,false
retinoid X receptor,[NCBIGene:6256],323,"Decreased,  plasma 11-ketotestosterone level",1756,false
retinoid X receptor,[NCBIGene:6256],323,"Impaired, Spermatogenesis",1758,false
retinoid X receptor,[NCBIGene:6256],323,"Decreased, Viable Offspring",2147,false
retinoid X receptor,[NCBIGene:6256],323,"Activation, PPARα",227,true
retinoid X receptor,[NCBIGene:6256],323,"Decrease, Population growth rate",360,false
cytochrome P450 enzymes,[NCBIGene:4051],324,"Increase, Reactive oxygen species",1115,true
cytochrome P450 enzymes,[NCBIGene:4051],324,"Increase, Oxidative DNA damage",1634,false
cytochrome P450 enzymes,[NCBIGene:4051],324,"Increase, Cell injury/death",55,false
cytochrome P450 enzymes,[NCBIGene:4051],324,"Decrease, Growth",1521,false
cytochrome P450 enzymes,[NCBIGene:4051],325,"Increase, Reactive oxygen species",1115,true
cytochrome P450 enzymes,[NCBIGene:4051],325,"Increase, Lipid peroxidation",1445,false
cytochrome P450 enzymes,[NCBIGene:4051],325,"Increase, Cell injury/death",55,false
cytochrome P450 enzymes,[NCBIGene:4051],325,"Decrease, Growth",1521,false
cytochrome P450 enzymes,[NCBIGene:4051],326,"Increase, Reactive oxygen species",1115,true
cytochrome P450 enzymes,[NCBIGene:4051],326,"Increase, Protein oxidation",1767,false
cytochrome P450 enzymes,[NCBIGene:4051],326,"Increase, Cell injury/death",55,false
cytochrome P450 enzymes,[NCBIGene:4051],326,"Decrease, Growth",1521,false
5HT2C,[NCBIGene:3358],33,"N/A, Unknown",294,false
5HT2C,[NCBIGene:3358],33,"Activation, 5HT2c",9,true
5HT2C,[NCBIGene:3358],33,"Increased, Kidney Failure",759,false
ER,"[NCBIGene:2099, 2069]",334,"Inhibition, Fin regeneration",1761,false
ER,"[NCBIGene:2099, 2069]",334,Altered Cell Differentiation Signaling,2245,false
ER,"[NCBIGene:2099, 2069]",334,Altered Bone Cell Homeostasis,2089,false
ER,"[NCBIGene:2099, 2069]",334,"Reduced, Swimming performance",1005,false
ER,"[NCBIGene:2099, 2069]",334,"Decrease, Population growth rate",360,false
ER,"[NCBIGene:2099, 2069]",334,"Activation, Glucocorticoid Receptor",122,true
Glucocorticoid Receptor,[NCBIGene:2908],334,"Inhibition, Fin regeneration",1761,false
Glucocorticoid Receptor,[NCBIGene:2908],334,Altered Cell Differentiation Signaling,2245,false
Glucocorticoid Receptor,[NCBIGene:2908],334,Altered Bone Cell Homeostasis,2089,false
Glucocorticoid Receptor,[NCBIGene:2908],334,"Reduced, Swimming performance",1005,false
Glucocorticoid Receptor,[NCBIGene:2908],334,"Decrease, Population growth rate",360,false
Glucocorticoid Receptor,[NCBIGene:2908],334,"Activation, Glucocorticoid Receptor",122,true
DNA methyltransferase,[NCBIGene:1786],336,"Increase, DNA methyltransferase inhibition",1619,true
DNA methyltransferase,[NCBIGene:1786],336,"Decrease, Global DNA methylation",1773,false
DNA methyltransferase,[NCBIGene:1786],336,"Increase, Caspase transcription",1774,false
DNA methyltransferase,[NCBIGene:1786],336,"Decrease, Fecundity",328,false
DNA methyltransferase,[NCBIGene:1786],336,"Decrease, Oogenesis",1366,false
DNA methyltransferase,[NCBIGene:1786],336,"Decrease, Population growth rate",360,false
DNA methyltransferase,[NCBIGene:1786],336,"Increase, Oocyte apoptosis",1775,false
DNA methyltransferase,[NCBIGene:1786],337,"Increase, DNA methyltransferase inhibition",1619,true
DNA methyltransferase,[NCBIGene:1786],337,"Decrease, Global DNA methylation",1773,false
DNA methyltransferase,[NCBIGene:1786],337,"Increase, Caspase transcription",1774,false
DNA methyltransferase,[NCBIGene:1786],337,"Decrease, Fecundity",328,false
DNA methyltransferase,[NCBIGene:1786],337,"Increase, Ovarian somatic cell apoptosis",1776,false
DNA methyltransferase,[NCBIGene:1786],337,"Increase, Ovarian follicle breakdown",1777,false
DNA methyltransferase,[NCBIGene:1786],337,"Decrease, Oogenesis",1366,false
DNA methyltransferase,[NCBIGene:1786],337,"Decrease, Population growth rate",360,false
DNA methyltransferase,[NCBIGene:1786],338,"Increase, DNA double-strand breaks",1461,false
DNA methyltransferase,[NCBIGene:1786],338,"Increase, DNA methyltransferase inhibition",1619,true
DNA methyltransferase,[NCBIGene:1786],338,"Increase, Caspase transcription",1774,false
DNA methyltransferase,[NCBIGene:1786],338,"Decrease, Fecundity",328,false
DNA methyltransferase,[NCBIGene:1786],338,"Decrease, Oogenesis",1366,false
DNA methyltransferase,[NCBIGene:1786],338,"Decrease, Population growth rate",360,false
DNA methyltransferase,[NCBIGene:1786],338,"Increase, Oocyte apoptosis",1775,false
DNA methyltransferase,[NCBIGene:1786],339,"Increase, DNA double-strand breaks",1461,false
DNA methyltransferase,[NCBIGene:1786],339,"Increase, DNA methyltransferase inhibition",1619,true
DNA methyltransferase,[NCBIGene:1786],339,"Increase, Caspase transcription",1774,false
DNA methyltransferase,[NCBIGene:1786],339,"Decrease, Fecundity",328,false
DNA methyltransferase,[NCBIGene:1786],339,"Increase, Ovarian somatic cell apoptosis",1776,false
DNA methyltransferase,[NCBIGene:1786],339,"Increase, Ovarian follicle breakdown",1777,false
DNA methyltransferase,[NCBIGene:1786],339,"Decrease, Oogenesis",1366,false
DNA methyltransferase,[NCBIGene:1786],339,"Decrease, Population growth rate",360,false
ChREBP,[NCBIGene:51085],34,"Activation, ChREBP",66,false
ChREBP,[NCBIGene:51085],34,"Accumulation, Triglyceride",291,false
ChREBP,[NCBIGene:51085],34,Mitochondrial dysfunction,177,false
ChREBP,[NCBIGene:51085],34,"Activation, LXR",167,true
ChREBP,[NCBIGene:51085],34,"Up Regulation, CD36",54,false
ChREBP,[NCBIGene:51085],34,"Increase, FA Influx",115,false
ChREBP,[NCBIGene:51085],34,"Activation, SREBP-1c",264,false
ChREBP,[NCBIGene:51085],34,"Activation, FAS",116,false
ChREBP,[NCBIGene:51085],34,"Activation, SCD-1",258,false
ChREBP,[NCBIGene:51085],34,"Synthesis, De Novo Fatty Acid (FA)",89,false
ChREBP,[NCBIGene:51085],34,"N/A, Liver Steatosis",345,false
ChREBP,[NCBIGene:51085],34,peroxisome proliferator activated receptor promoter demethylation,228,true
FAS,"[NCBIGene:355, 2194]",34,"Activation, ChREBP",66,false
FAS,"[NCBIGene:355, 2194]",34,"Accumulation, Triglyceride",291,false
FAS,"[NCBIGene:355, 2194]",34,Mitochondrial dysfunction,177,false
FAS,"[NCBIGene:355, 2194]",34,"Activation, LXR",167,true
FAS,"[NCBIGene:355, 2194]",34,"Up Regulation, CD36",54,false
FAS,"[NCBIGene:355, 2194]",34,"Increase, FA Influx",115,false
FAS,"[NCBIGene:355, 2194]",34,"Activation, SREBP-1c",264,false
FAS,"[NCBIGene:355, 2194]",34,"Activation, FAS",116,false
FAS,"[NCBIGene:355, 2194]",34,"Activation, SCD-1",258,false
FAS,"[NCBIGene:355, 2194]",34,"Synthesis, De Novo Fatty Acid (FA)",89,false
FAS,"[NCBIGene:355, 2194]",34,"N/A, Liver Steatosis",345,false
FAS,"[NCBIGene:355, 2194]",34,peroxisome proliferator activated receptor promoter demethylation,228,true
FAT,[NCBIGene:948],34,"Activation, ChREBP",66,false
FAT,[NCBIGene:948],34,"Accumulation, Triglyceride",291,false
FAT,[NCBIGene:948],34,Mitochondrial dysfunction,177,false
FAT,[NCBIGene:948],34,"Activation, LXR",167,true
FAT,[NCBIGene:948],34,"Up Regulation, CD36",54,false
FAT,[NCBIGene:948],34,"Increase, FA Influx",115,false
FAT,[NCBIGene:948],34,"Activation, SREBP-1c",264,false
FAT,[NCBIGene:948],34,"Activation, FAS",116,false
FAT,[NCBIGene:948],34,"Activation, SCD-1",258,false
FAT,[NCBIGene:948],34,"Synthesis, De Novo Fatty Acid (FA)",89,false
FAT,[NCBIGene:948],34,"N/A, Liver Steatosis",345,false
FAT,[NCBIGene:948],34,peroxisome proliferator activated receptor promoter demethylation,228,true
LXR,[NCBIGene:10062],34,"Activation, ChREBP",66,false
LXR,[NCBIGene:10062],34,"Accumulation, Triglyceride",291,false
LXR,[NCBIGene:10062],34,Mitochondrial dysfunction,177,false
LXR,[NCBIGene:10062],34,"Activation, LXR",167,true
LXR,[NCBIGene:10062],34,"Up Regulation, CD36",54,false
LXR,[NCBIGene:10062],34,"Increase, FA Influx",115,false
LXR,[NCBIGene:10062],34,"Activation, SREBP-1c",264,false
LXR,[NCBIGene:10062],34,"Activation, FAS",116,false
LXR,[NCBIGene:10062],34,"Activation, SCD-1",258,false
LXR,[NCBIGene:10062],34,"Synthesis, De Novo Fatty Acid (FA)",89,false
LXR,[NCBIGene:10062],34,"N/A, Liver Steatosis",345,false
LXR,[NCBIGene:10062],34,peroxisome proliferator activated receptor promoter demethylation,228,true
PPAR gamma,[NCBIGene:5468],34,"Activation, ChREBP",66,false
PPAR gamma,[NCBIGene:5468],34,"Accumulation, Triglyceride",291,false
PPAR gamma,[NCBIGene:5468],34,Mitochondrial dysfunction,177,false
PPAR gamma,[NCBIGene:5468],34,"Activation, LXR",167,true
PPAR gamma,[NCBIGene:5468],34,"Up Regulation, CD36",54,false
PPAR gamma,[NCBIGene:5468],34,"Increase, FA Influx",115,false
PPAR gamma,[NCBIGene:5468],34,"Activation, SREBP-1c",264,false
PPAR gamma,[NCBIGene:5468],34,"Activation, FAS",116,false
PPAR gamma,[NCBIGene:5468],34,"Activation, SCD-1",258,false
PPAR gamma,[NCBIGene:5468],34,"Synthesis, De Novo Fatty Acid (FA)",89,false
PPAR gamma,[NCBIGene:5468],34,"N/A, Liver Steatosis",345,false
PPAR gamma,[NCBIGene:5468],34,peroxisome proliferator activated receptor promoter demethylation,228,true
SREBP-1c,[NCBIGene:6720],34,"Activation, ChREBP",66,false
SREBP-1c,[NCBIGene:6720],34,"Accumulation, Triglyceride",291,false
SREBP-1c,[NCBIGene:6720],34,Mitochondrial dysfunction,177,false
SREBP-1c,[NCBIGene:6720],34,"Activation, LXR",167,true
SREBP-1c,[NCBIGene:6720],34,"Up Regulation, CD36",54,false
SREBP-1c,[NCBIGene:6720],34,"Increase, FA Influx",115,false
SREBP-1c,[NCBIGene:6720],34,"Activation, SREBP-1c",264,false
SREBP-1c,[NCBIGene:6720],34,"Activation, FAS",116,false
SREBP-1c,[NCBIGene:6720],34,"Activation, SCD-1",258,false
SREBP-1c,[NCBIGene:6720],34,"Synthesis, De Novo Fatty Acid (FA)",89,false
SREBP-1c,[NCBIGene:6720],34,"N/A, Liver Steatosis",345,false
SREBP-1c,[NCBIGene:6720],34,peroxisome proliferator activated receptor promoter demethylation,228,true
fatty acid synthase,[NCBIGene:2194],34,"Activation, ChREBP",66,false
fatty acid synthase,[NCBIGene:2194],34,"Accumulation, Triglyceride",291,false
fatty acid synthase,[NCBIGene:2194],34,Mitochondrial dysfunction,177,false
fatty acid synthase,[NCBIGene:2194],34,"Activation, LXR",167,true
fatty acid synthase,[NCBIGene:2194],34,"Up Regulation, CD36",54,false
fatty acid synthase,[NCBIGene:2194],34,"Increase, FA Influx",115,false
fatty acid synthase,[NCBIGene:2194],34,"Activation, SREBP-1c",264,false
fatty acid synthase,[NCBIGene:2194],34,"Activation, FAS",116,false
fatty acid synthase,[NCBIGene:2194],34,"Activation, SCD-1",258,false
fatty acid synthase,[NCBIGene:2194],34,"Synthesis, De Novo Fatty Acid (FA)",89,false
fatty acid synthase,[NCBIGene:2194],34,"N/A, Liver Steatosis",345,false
fatty acid synthase,[NCBIGene:2194],34,peroxisome proliferator activated receptor promoter demethylation,228,true
stearoyl-CoA desaturase 1,[NCBIGene:6319],34,"Activation, ChREBP",66,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],34,"Accumulation, Triglyceride",291,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],34,Mitochondrial dysfunction,177,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],34,"Activation, LXR",167,true
stearoyl-CoA desaturase 1,[NCBIGene:6319],34,"Up Regulation, CD36",54,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],34,"Increase, FA Influx",115,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],34,"Activation, SREBP-1c",264,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],34,"Activation, FAS",116,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],34,"Activation, SCD-1",258,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],34,"Synthesis, De Novo Fatty Acid (FA)",89,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],34,"N/A, Liver Steatosis",345,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],34,peroxisome proliferator activated receptor promoter demethylation,228,true
sterol response element binding protein 1c,[NCBIGene:51474],34,"Activation, ChREBP",66,false
sterol response element binding protein 1c,[NCBIGene:51474],34,"Accumulation, Triglyceride",291,false
sterol response element binding protein 1c,[NCBIGene:51474],34,Mitochondrial dysfunction,177,false
sterol response element binding protein 1c,[NCBIGene:51474],34,"Activation, LXR",167,true
sterol response element binding protein 1c,[NCBIGene:51474],34,"Up Regulation, CD36",54,false
sterol response element binding protein 1c,[NCBIGene:51474],34,"Increase, FA Influx",115,false
sterol response element binding protein 1c,[NCBIGene:51474],34,"Activation, SREBP-1c",264,false
sterol response element binding protein 1c,[NCBIGene:51474],34,"Activation, FAS",116,false
sterol response element binding protein 1c,[NCBIGene:51474],34,"Activation, SCD-1",258,false
sterol response element binding protein 1c,[NCBIGene:51474],34,"Synthesis, De Novo Fatty Acid (FA)",89,false
sterol response element binding protein 1c,[NCBIGene:51474],34,"N/A, Liver Steatosis",345,false
sterol response element binding protein 1c,[NCBIGene:51474],34,peroxisome proliferator activated receptor promoter demethylation,228,true
very low-density lipoprotein,[NCBIGene:7436],34,"Activation, ChREBP",66,false
very low-density lipoprotein,[NCBIGene:7436],34,"Accumulation, Triglyceride",291,false
very low-density lipoprotein,[NCBIGene:7436],34,Mitochondrial dysfunction,177,false
very low-density lipoprotein,[NCBIGene:7436],34,"Activation, LXR",167,true
very low-density lipoprotein,[NCBIGene:7436],34,"Up Regulation, CD36",54,false
very low-density lipoprotein,[NCBIGene:7436],34,"Increase, FA Influx",115,false
very low-density lipoprotein,[NCBIGene:7436],34,"Activation, SREBP-1c",264,false
very low-density lipoprotein,[NCBIGene:7436],34,"Activation, FAS",116,false
very low-density lipoprotein,[NCBIGene:7436],34,"Activation, SCD-1",258,false
very low-density lipoprotein,[NCBIGene:7436],34,"Synthesis, De Novo Fatty Acid (FA)",89,false
very low-density lipoprotein,[NCBIGene:7436],34,"N/A, Liver Steatosis",345,false
very low-density lipoprotein,[NCBIGene:7436],34,peroxisome proliferator activated receptor promoter demethylation,228,true
DNA methyltransferase,[NCBIGene:1786],340,"Increase, DNA methyltransferase inhibition",1619,true
DNA methyltransferase,[NCBIGene:1786],340,"Decrease, Global DNA methylation",1773,false
DNA methyltransferase,[NCBIGene:1786],340,"Decrease, Heritable DNA methylation (F3)",1778,false
DNA methyltransferase,[NCBIGene:1786],340,"Increase, Caspase transcription (F3)",1779,false
DNA methyltransferase,[NCBIGene:1786],340,"Increase, Oocyte apoptosis (F3)",1780,false
DNA methyltransferase,[NCBIGene:1786],340,"Decrease, Fecundity (F3)",1781,false
DNA methyltransferase,[NCBIGene:1786],340,"Decrease, Oogenesis (F3)",1782,false
DNA methyltransferase,[NCBIGene:1786],340,"Decrease, Population growth rate",360,false
DNA methyltransferase,[NCBIGene:1786],341,"Increase, DNA methyltransferase inhibition",1619,true
DNA methyltransferase,[NCBIGene:1786],341,"Decrease, Global DNA methylation",1773,false
DNA methyltransferase,[NCBIGene:1786],341,"Decrease, Heritable DNA methylation (F3)",1778,false
DNA methyltransferase,[NCBIGene:1786],341,"Increase, Caspase transcription (F3)",1779,false
DNA methyltransferase,[NCBIGene:1786],341,"Decrease, Fecundity (F3)",1781,false
DNA methyltransferase,[NCBIGene:1786],341,"Decrease, Oogenesis (F3)",1782,false
DNA methyltransferase,[NCBIGene:1786],341,"Increase, Ovarian somatic cell apoptosis (F3)",1783,false
DNA methyltransferase,[NCBIGene:1786],341,"Increase, Ovarian follicle breakdown (F3)",1784,false
DNA methyltransferase,[NCBIGene:1786],341,"Decrease, Population growth rate",360,false
5-reductase,[NCBIGene:6715],344,"Decrease, androgen receptor activation",1614,false
5-reductase,[NCBIGene:6715],344,"Nipple retention (NR), increased",1786,false
5-reductase,[NCBIGene:6715],344,"Antagonism, Androgen receptor",26,true
5-reductase,[NCBIGene:6715],344,"Altered, Transcription of genes by the androgen receptor",286,false
AR,"[NCBIGene:367, 231, 2232]",344,"Decrease, androgen receptor activation",1614,false
AR,"[NCBIGene:367, 231, 2232]",344,"Nipple retention (NR), increased",1786,false
AR,"[NCBIGene:367, 231, 2232]",344,"Antagonism, Androgen receptor",26,true
AR,"[NCBIGene:367, 231, 2232]",344,"Altered, Transcription of genes by the androgen receptor",286,false
NR,[NCBIGene:10901],344,"Decrease, androgen receptor activation",1614,false
NR,[NCBIGene:10901],344,"Nipple retention (NR), increased",1786,false
NR,[NCBIGene:10901],344,"Antagonism, Androgen receptor",26,true
NR,[NCBIGene:10901],344,"Altered, Transcription of genes by the androgen receptor",286,false
AKT,[NCBIGene:207],345,"Decrease, androgen receptor activation",1614,false
AKT,[NCBIGene:207],345,"Granulosa cell proliferation of gonadotropin-independent follicles, Reduced",1800,false
AKT,[NCBIGene:207],345,"Antagonism, Androgen receptor",26,true
AKT,[NCBIGene:207],345,"Altered, Transcription of genes by the androgen receptor",286,false
AKT,[NCBIGene:207],345,"decreased, Fertility",406,false
AKT,[NCBIGene:207],345,"disrupted, ovarian cycle",405,false
AR,"[NCBIGene:367, 231, 2232]",345,"Decrease, androgen receptor activation",1614,false
AR,"[NCBIGene:367, 231, 2232]",345,"Granulosa cell proliferation of gonadotropin-independent follicles, Reduced",1800,false
AR,"[NCBIGene:367, 231, 2232]",345,"Antagonism, Androgen receptor",26,true
AR,"[NCBIGene:367, 231, 2232]",345,"Altered, Transcription of genes by the androgen receptor",286,false
AR,"[NCBIGene:367, 231, 2232]",345,"decreased, Fertility",406,false
AR,"[NCBIGene:367, 231, 2232]",345,"disrupted, ovarian cycle",405,false
PI3K,[NCBIGene:5290],345,"Decrease, androgen receptor activation",1614,false
PI3K,[NCBIGene:5290],345,"Granulosa cell proliferation of gonadotropin-independent follicles, Reduced",1800,false
PI3K,[NCBIGene:5290],345,"Antagonism, Androgen receptor",26,true
PI3K,[NCBIGene:5290],345,"Altered, Transcription of genes by the androgen receptor",286,false
PI3K,[NCBIGene:5290],345,"decreased, Fertility",406,false
PI3K,[NCBIGene:5290],345,"disrupted, ovarian cycle",405,false
growth differentiation factor 9,[NCBIGene:2661],345,"Decrease, androgen receptor activation",1614,false
growth differentiation factor 9,[NCBIGene:2661],345,"Granulosa cell proliferation of gonadotropin-independent follicles, Reduced",1800,false
growth differentiation factor 9,[NCBIGene:2661],345,"Antagonism, Androgen receptor",26,true
growth differentiation factor 9,[NCBIGene:2661],345,"Altered, Transcription of genes by the androgen receptor",286,false
growth differentiation factor 9,[NCBIGene:2661],345,"decreased, Fertility",406,false
growth differentiation factor 9,[NCBIGene:2661],345,"disrupted, ovarian cycle",405,false
kit-ligand,[NCBIGene:4254],345,"Decrease, androgen receptor activation",1614,false
kit-ligand,[NCBIGene:4254],345,"Granulosa cell proliferation of gonadotropin-independent follicles, Reduced",1800,false
kit-ligand,[NCBIGene:4254],345,"Antagonism, Androgen receptor",26,true
kit-ligand,[NCBIGene:4254],345,"Altered, Transcription of genes by the androgen receptor",286,false
kit-ligand,[NCBIGene:4254],345,"decreased, Fertility",406,false
kit-ligand,[NCBIGene:4254],345,"disrupted, ovarian cycle",405,false
Aromatase,[NCBIGene:1588],346,"Reduction, 17beta-estradiol synthesis by the undifferentiated gonad",1789,false
Aromatase,[NCBIGene:1588],346,"Increased, Differentiation to Testis",1790,false
Aromatase,[NCBIGene:1588],346,"Increased, Male Biased Sex Ratio",1791,false
Aromatase,[NCBIGene:1588],346,"Inhibition, Aromatase",36,true
Aromatase,[NCBIGene:1588],346,"Decrease, Population growth rate",360,false
PPAR gamma,[NCBIGene:5468],347,Pin-1 activation,1794,false
PPAR gamma,[NCBIGene:5468],347,Inactivation of PPARγ,1270,true
PPAR gamma,[NCBIGene:5468],347,Epithelial Mesenchymal Transition,1457,false
PPAR gamma,[NCBIGene:5468],347,"Activation, TGF-beta pathway",1283,false
PPAR gamma,[NCBIGene:5468],347,"Activation, JNK",1292,false
PPAR gamma,[NCBIGene:5468],347,Toll-like receptor 4 activation,1792,true
PPAR gamma,[NCBIGene:5468],347,Activator protein 1 activation,1793,false
PPAR gamma,[NCBIGene:5468],347,Latent Transforming growth Factor beta expression,1795,false
PPAR gamma,[NCBIGene:5468],347,Pulmonary fibrosis,1458,false
Toll-like receptor 4,[NCBIGene:7099],347,Pin-1 activation,1794,false
Toll-like receptor 4,[NCBIGene:7099],347,Inactivation of PPARγ,1270,true
Toll-like receptor 4,[NCBIGene:7099],347,Epithelial Mesenchymal Transition,1457,false
Toll-like receptor 4,[NCBIGene:7099],347,"Activation, TGF-beta pathway",1283,false
Toll-like receptor 4,[NCBIGene:7099],347,"Activation, JNK",1292,false
Toll-like receptor 4,[NCBIGene:7099],347,Toll-like receptor 4 activation,1792,true
Toll-like receptor 4,[NCBIGene:7099],347,Activator protein 1 activation,1793,false
Toll-like receptor 4,[NCBIGene:7099],347,Latent Transforming growth Factor beta expression,1795,false
Toll-like receptor 4,[NCBIGene:7099],347,Pulmonary fibrosis,1458,false
11-Hydroxysteroid Dehydrogenase,[NCBIGene:3291],348,"Decreased,  plasma 11-ketotestosterone level",1756,false
11-Hydroxysteroid Dehydrogenase,[NCBIGene:3291],348,"Impaired, Spermatogenesis",1758,false
11-Hydroxysteroid Dehydrogenase,[NCBIGene:3291],348,Inhibition of 11β-HSD,1799,true
11-Hydroxysteroid Dehydrogenase,[NCBIGene:3291],348,"Decrease, Population growth rate",360,false
11-Hydroxysteroid Dehydrogenase,[NCBIGene:3291],348,"decreased, Fertility",406,false
11HSD,[NCBIGene:3290],348,"Decreased,  plasma 11-ketotestosterone level",1756,false
11HSD,[NCBIGene:3290],348,"Impaired, Spermatogenesis",1758,false
11HSD,[NCBIGene:3290],348,Inhibition of 11β-HSD,1799,true
11HSD,[NCBIGene:3290],348,"Decrease, Population growth rate",360,false
11HSD,[NCBIGene:3290],348,"decreased, Fertility",406,false
"C 10,20-lyase",[NCBIGene:1583],348,"Decreased,  plasma 11-ketotestosterone level",1756,false
"C 10,20-lyase",[NCBIGene:1583],348,"Impaired, Spermatogenesis",1758,false
"C 10,20-lyase",[NCBIGene:1583],348,Inhibition of 11β-HSD,1799,true
"C 10,20-lyase",[NCBIGene:1583],348,"Decrease, Population growth rate",360,false
"C 10,20-lyase",[NCBIGene:1583],348,"decreased, Fertility",406,false
Glucocorticoid Receptor,[NCBIGene:2908],348,"Decreased,  plasma 11-ketotestosterone level",1756,false
Glucocorticoid Receptor,[NCBIGene:2908],348,"Impaired, Spermatogenesis",1758,false
Glucocorticoid Receptor,[NCBIGene:2908],348,Inhibition of 11β-HSD,1799,true
Glucocorticoid Receptor,[NCBIGene:2908],348,"Decrease, Population growth rate",360,false
Glucocorticoid Receptor,[NCBIGene:2908],348,"decreased, Fertility",406,false
11-hydroxylase,[NCBIGene:1584],349,"Decreased,  plasma 11-ketotestosterone level",1756,false
11-hydroxylase,[NCBIGene:1584],349,11β-hydroxylase inhibition,1796,true
11-hydroxylase,[NCBIGene:1584],349,Decreased spermatogenesis,1798,false
11-hydroxylase,[NCBIGene:1584],349,Cortisol and 11β-(OH) testosterone decreased,1835,false
11-hydroxylase,[NCBIGene:1584],349,Decreased plasma Cortisol level,1836,false
11-hydroxylase,[NCBIGene:1584],349,decreased oocyte maturation,1837,false
11-hydroxylase,[NCBIGene:1584],349,"Decrease, Population growth rate",360,false
11-hydroxylase,[NCBIGene:1584],349,"decreased, Fertility",406,false
"C 10,20-lyase",[NCBIGene:1583],349,"Decreased,  plasma 11-ketotestosterone level",1756,false
"C 10,20-lyase",[NCBIGene:1583],349,11β-hydroxylase inhibition,1796,true
"C 10,20-lyase",[NCBIGene:1583],349,Decreased spermatogenesis,1798,false
"C 10,20-lyase",[NCBIGene:1583],349,Cortisol and 11β-(OH) testosterone decreased,1835,false
"C 10,20-lyase",[NCBIGene:1583],349,Decreased plasma Cortisol level,1836,false
"C 10,20-lyase",[NCBIGene:1583],349,decreased oocyte maturation,1837,false
"C 10,20-lyase",[NCBIGene:1583],349,"Decrease, Population growth rate",360,false
"C 10,20-lyase",[NCBIGene:1583],349,"decreased, Fertility",406,false
Chitinase,[NCBIGene:1118],358,"Increase, Mortality",350,false
Chitinase,[NCBIGene:1118],358,"Increase, Premature molting",1524,false
Chitinase,[NCBIGene:1118],358,"Inhibition, Chitinase",1806,true
Chitinase,[NCBIGene:1118],358,"Decrease, Digestion of old cuticle",996,false
Chitobiase,[NCBIGene:1486],359,"Increase, Mortality",350,false
Chitobiase,[NCBIGene:1486],359,"Increase, Premature molting",1524,false
Chitobiase,[NCBIGene:1486],359,"Decrease, Digestion of old cuticle",996,false
Chitobiase,[NCBIGene:1486],359,"Inhibition, Chitobiase",1807,true
CHS-1,[NCBIGene:1130],360,"Increase, Mortality",350,false
CHS-1,[NCBIGene:1130],360,"Inhibition, Chitin synthase 1",1522,true
CHS-1,[NCBIGene:1130],360,"Decrease, Cuticular chitin content",1523,false
CHS-1,[NCBIGene:1130],360,"Increase, Premature molting",1524,false
Chitin synthase 1,[NCBIGene:22856],360,"Increase, Mortality",350,false
Chitin synthase 1,[NCBIGene:22856],360,"Inhibition, Chitin synthase 1",1522,true
Chitin synthase 1,[NCBIGene:22856],360,"Decrease, Cuticular chitin content",1523,false
Chitin synthase 1,[NCBIGene:22856],360,"Increase, Premature molting",1524,false
Chitinase,[NCBIGene:1118],360,"Increase, Mortality",350,false
Chitinase,[NCBIGene:1118],360,"Inhibition, Chitin synthase 1",1522,true
Chitinase,[NCBIGene:1118],360,"Decrease, Cuticular chitin content",1523,false
Chitinase,[NCBIGene:1118],360,"Increase, Premature molting",1524,false
SUR,[NCBIGene:6833],361,"Increase, Mortality",350,false
SUR,[NCBIGene:6833],361,"Increase, Cell membrane depolarization",1527,false
SUR,[NCBIGene:6833],361,"Decrease, Cuticular chitin content",1523,false
SUR,[NCBIGene:6833],361,"Increase, Premature molting",1524,false
SUR,[NCBIGene:6833],361,"Increase, Sulfonylurea receptor binding",1525,true
SUR,[NCBIGene:6833],361,"Increase, Opening of voltage-dependent calcium channel",1526,false
CYP monooxygenase,[NCBIGene:57404],362,Mitochondrial dysfunction,177,false
CYP monooxygenase,[NCBIGene:57404],362,benzoquinone imine and acylglucuronide metabolites,1814,true
CYP monooxygenase,[NCBIGene:57404],362,Apoptotic cell death,1817,false
CYP monooxygenase,[NCBIGene:57404],362,Immune cell activation,1818,false
CYP monooxygenase,[NCBIGene:57404],362,IFNγ signaling,1819,false
CYP monooxygenase,[NCBIGene:57404],362,Increase in inflammation,1633,false
CYP monooxygenase,[NCBIGene:57404],362,Immune mediated hepatitis,1820,false
CYP monooxygenase,[NCBIGene:57404],362,Activation of ER stress,1815,false
adipocytokine,[NCBIGene:117178],362,Mitochondrial dysfunction,177,false
adipocytokine,[NCBIGene:117178],362,benzoquinone imine and acylglucuronide metabolites,1814,true
adipocytokine,[NCBIGene:117178],362,Apoptotic cell death,1817,false
adipocytokine,[NCBIGene:117178],362,Immune cell activation,1818,false
adipocytokine,[NCBIGene:117178],362,IFNγ signaling,1819,false
adipocytokine,[NCBIGene:117178],362,Increase in inflammation,1633,false
adipocytokine,[NCBIGene:117178],362,Immune mediated hepatitis,1820,false
adipocytokine,[NCBIGene:117178],362,Activation of ER stress,1815,false
interferon gamma,[NCBIGene:3458],362,Mitochondrial dysfunction,177,false
interferon gamma,[NCBIGene:3458],362,benzoquinone imine and acylglucuronide metabolites,1814,true
interferon gamma,[NCBIGene:3458],362,Apoptotic cell death,1817,false
interferon gamma,[NCBIGene:3458],362,Immune cell activation,1818,false
interferon gamma,[NCBIGene:3458],362,IFNγ signaling,1819,false
interferon gamma,[NCBIGene:3458],362,Increase in inflammation,1633,false
interferon gamma,[NCBIGene:3458],362,Immune mediated hepatitis,1820,false
interferon gamma,[NCBIGene:3458],362,Activation of ER stress,1815,false
myeloperoxidases,[NCBIGene:4353],362,Mitochondrial dysfunction,177,false
myeloperoxidases,[NCBIGene:4353],362,benzoquinone imine and acylglucuronide metabolites,1814,true
myeloperoxidases,[NCBIGene:4353],362,Apoptotic cell death,1817,false
myeloperoxidases,[NCBIGene:4353],362,Immune cell activation,1818,false
myeloperoxidases,[NCBIGene:4353],362,IFNγ signaling,1819,false
myeloperoxidases,[NCBIGene:4353],362,Increase in inflammation,1633,false
myeloperoxidases,[NCBIGene:4353],362,Immune mediated hepatitis,1820,false
myeloperoxidases,[NCBIGene:4353],362,Activation of ER stress,1815,false
Thyroperoxidase,[NCBIGene:7173],363,"Thyroperoxidase, Inhibition",279,true
Thyroperoxidase,[NCBIGene:7173],363,"Thyroid hormone synthesis, Decreased",277,false
Thyroperoxidase,[NCBIGene:7173],363,"Altered, retinal layer structure",1877,false
Thyroperoxidase,[NCBIGene:7173],363,"Decreased, Triiodothyronine (T3)",1003,false
Thyroperoxidase,[NCBIGene:7173],363,"Altered, Visual function",1643,false
Thyroperoxidase,[NCBIGene:7173],363,"Decrease, Population growth rate",360,false
Thyroperoxidase,[NCBIGene:7173],363,Increased Mortality,351,false
Thyroperoxidase,[NCBIGene:7173],363,"Thyroxine (T4) in serum, Decreased",281,false
Thyroperoxidase,[NCBIGene:7173],364,"Thyroperoxidase, Inhibition",279,true
Thyroperoxidase,[NCBIGene:7173],364,"Thyroid hormone synthesis, Decreased",277,false
Thyroperoxidase,[NCBIGene:7173],364,"Decreased, Triiodothyronine (T3)",1003,false
Thyroperoxidase,[NCBIGene:7173],364,"Decreased, Eye size",1878,false
Thyroperoxidase,[NCBIGene:7173],364,"Altered, Visual function",1643,false
Thyroperoxidase,[NCBIGene:7173],364,"Decrease, Population growth rate",360,false
Thyroperoxidase,[NCBIGene:7173],364,Increased Mortality,351,false
Thyroperoxidase,[NCBIGene:7173],364,"Thyroxine (T4) in serum, Decreased",281,false
Thyroperoxidase,[NCBIGene:7173],365,"Thyroperoxidase, Inhibition",279,true
Thyroperoxidase,[NCBIGene:7173],365,"Thyroid hormone synthesis, Decreased",277,false
Thyroperoxidase,[NCBIGene:7173],365,"Decreased, Triiodothyronine (T3)",1003,false
Thyroperoxidase,[NCBIGene:7173],365,"Altered, Photoreceptor patterning",1640,false
Thyroperoxidase,[NCBIGene:7173],365,"Altered, Visual function",1643,false
Thyroperoxidase,[NCBIGene:7173],365,"Decrease, Population growth rate",360,false
Thyroperoxidase,[NCBIGene:7173],365,Increased Mortality,351,false
Thyroperoxidase,[NCBIGene:7173],365,"Thyroxine (T4) in serum, Decreased",281,false
TH,[NCBIGene:7054],366,"Binding, Transthyretin in serum",957,true
TH,[NCBIGene:7054],366,"Increased, Free serum thyroxine (T4)",959,false
TH,[NCBIGene:7054],366,"Displacement, Serum thyroxine (T4) from carrier protein",1830,false
TH,[NCBIGene:7054],366,"Altered, Amphibian metamorphosis",1101,false
TH,[NCBIGene:7054],366,"Increased, Hepatic thyroid hormone uptake/transport",1158,false
TH,[NCBIGene:7054],366,"Thyroxine (T4) in serum, Decreased",281,false
TH,[NCBIGene:7054],366,"Increased, Clearance of thyroxine from serum",961,false
thyroid serum binding protein transthyretin,[NCBIGene:7276],366,"Binding, Transthyretin in serum",957,true
thyroid serum binding protein transthyretin,[NCBIGene:7276],366,"Increased, Free serum thyroxine (T4)",959,false
thyroid serum binding protein transthyretin,[NCBIGene:7276],366,"Displacement, Serum thyroxine (T4) from carrier protein",1830,false
thyroid serum binding protein transthyretin,[NCBIGene:7276],366,"Altered, Amphibian metamorphosis",1101,false
thyroid serum binding protein transthyretin,[NCBIGene:7276],366,"Increased, Hepatic thyroid hormone uptake/transport",1158,false
thyroid serum binding protein transthyretin,[NCBIGene:7276],366,"Thyroxine (T4) in serum, Decreased",281,false
thyroid serum binding protein transthyretin,[NCBIGene:7276],366,"Increased, Clearance of thyroxine from serum",961,false
thyroxine-binding globulin,[NCBIGene:6906],367,"Binding, Thyroid binding globulin in serum",1831,true
thyroxine-binding globulin,[NCBIGene:6906],367,"Increased, Free serum thyroxine (T4)",959,false
thyroxine-binding globulin,[NCBIGene:6906],367,"Displacement, Serum thyroxine (T4) from carrier protein",1830,false
thyroxine-binding globulin,[NCBIGene:6906],367,"Altered, Amphibian metamorphosis",1101,false
thyroxine-binding globulin,[NCBIGene:6906],367,"Increased, Hepatic thyroid hormone uptake/transport",1158,false
thyroxine-binding globulin,[NCBIGene:6906],367,"Thyroxine (T4) in serum, Decreased",281,false
thyroxine-binding globulin,[NCBIGene:6906],367,"Increased, Clearance of thyroxine from serum",961,false
Cytochrome oxidase,"[NCBIGene:6775083, 8923218]",368,"Increase, Cell death",1825,false
Cytochrome oxidase,"[NCBIGene:6775083, 8923218]",368,"Inhibition, cytochrome oxidase",1840,true
Cytochrome oxidase,"[NCBIGene:6775083, 8923218]",368,"Increased, nasal lesions",2312,false
NF-kB,[NCBIGene:4790],37,"Increase, Phenotypic enzyme activity",1170,false
NF-kB,[NCBIGene:4790],37,"Increase, cell proliferation (hepatocytes)",716,false
NF-kB,[NCBIGene:4790],37,"Increase, Clonal Expansion of Altered Hepatic Foci",1171,false
NF-kB,[NCBIGene:4790],37,"Increase, hepatocellular adenomas and carcinomas",719,false
NF-kB,[NCBIGene:4790],37,"Activation, PPARα",227,true
PPAR,[NCBIGene:5465],37,"Increase, Phenotypic enzyme activity",1170,false
PPAR,[NCBIGene:5465],37,"Increase, cell proliferation (hepatocytes)",716,false
PPAR,[NCBIGene:5465],37,"Increase, Clonal Expansion of Altered Hepatic Foci",1171,false
PPAR,[NCBIGene:5465],37,"Increase, hepatocellular adenomas and carcinomas",719,false
PPAR,[NCBIGene:5465],37,"Activation, PPARα",227,true
PPAR gamma,[NCBIGene:5468],37,"Increase, Phenotypic enzyme activity",1170,false
PPAR gamma,[NCBIGene:5468],37,"Increase, cell proliferation (hepatocytes)",716,false
PPAR gamma,[NCBIGene:5468],37,"Increase, Clonal Expansion of Altered Hepatic Foci",1171,false
PPAR gamma,[NCBIGene:5468],37,"Increase, hepatocellular adenomas and carcinomas",719,false
PPAR gamma,[NCBIGene:5468],37,"Activation, PPARα",227,true
PPARb/d,[NCBIGene:5467],37,"Increase, Phenotypic enzyme activity",1170,false
PPARb/d,[NCBIGene:5467],37,"Increase, cell proliferation (hepatocytes)",716,false
PPARb/d,[NCBIGene:5467],37,"Increase, Clonal Expansion of Altered Hepatic Foci",1171,false
PPARb/d,[NCBIGene:5467],37,"Increase, hepatocellular adenomas and carcinomas",719,false
PPARb/d,[NCBIGene:5467],37,"Activation, PPARα",227,true
PPREs,[NCBIGene:100528023],37,"Increase, Phenotypic enzyme activity",1170,false
PPREs,[NCBIGene:100528023],37,"Increase, cell proliferation (hepatocytes)",716,false
PPREs,[NCBIGene:100528023],37,"Increase, Clonal Expansion of Altered Hepatic Foci",1171,false
PPREs,[NCBIGene:100528023],37,"Increase, hepatocellular adenomas and carcinomas",719,false
PPREs,[NCBIGene:100528023],37,"Activation, PPARα",227,true
retinoid X receptor,[NCBIGene:6256],37,"Increase, Phenotypic enzyme activity",1170,false
retinoid X receptor,[NCBIGene:6256],37,"Increase, cell proliferation (hepatocytes)",716,false
retinoid X receptor,[NCBIGene:6256],37,"Increase, Clonal Expansion of Altered Hepatic Foci",1171,false
retinoid X receptor,[NCBIGene:6256],37,"Increase, hepatocellular adenomas and carcinomas",719,false
retinoid X receptor,[NCBIGene:6256],37,"Activation, PPARα",227,true
AR,"[NCBIGene:367, 231, 2232]",372,"Decrease, androgen receptor activation",1614,false
AR,"[NCBIGene:367, 231, 2232]",372,"Malformation, cryptorchidism - maldescended testis",1616,false
AR,"[NCBIGene:367, 231, 2232]",372,"Antagonism, Androgen receptor",26,true
AR,"[NCBIGene:367, 231, 2232]",372,"Altered, Transcription of genes by the androgen receptor",286,false
AR,"[NCBIGene:367, 231, 2232]",372,Testicular Cancer,1839,false
ACE 2 receptors,[NCBIGene:186],374,Neuroinflammation,188,false
ACE 2 receptors,[NCBIGene:186],374,Binding to ACE2,1739,true
ACE 2 receptors,[NCBIGene:186],374,Encephalitis,1841,false
ACE 2 receptors,[NCBIGene:186],374,"N/A, Neurodegeneration",352,false
ACE2 receptor,[NCBIGene:340485],374,Neuroinflammation,188,false
ACE2 receptor,[NCBIGene:340485],374,Binding to ACE2,1739,true
ACE2 receptor,[NCBIGene:340485],374,Encephalitis,1841,false
ACE2 receptor,[NCBIGene:340485],374,"N/A, Neurodegeneration",352,false
Sars,[NCBIGene:6301],374,Neuroinflammation,188,false
Sars,[NCBIGene:6301],374,Binding to ACE2,1739,true
Sars,[NCBIGene:6301],374,Encephalitis,1841,false
Sars,[NCBIGene:6301],374,"N/A, Neurodegeneration",352,false
Sars-CoV-2 spike protein,[NCBIGene:54938],374,Neuroinflammation,188,false
Sars-CoV-2 spike protein,[NCBIGene:54938],374,Binding to ACE2,1739,true
Sars-CoV-2 spike protein,[NCBIGene:54938],374,Encephalitis,1841,false
Sars-CoV-2 spike protein,[NCBIGene:54938],374,"N/A, Neurodegeneration",352,false
Spike protein,[NCBIGene:124512],374,Neuroinflammation,188,false
Spike protein,[NCBIGene:124512],374,Binding to ACE2,1739,true
Spike protein,[NCBIGene:124512],374,Encephalitis,1841,false
Spike protein,[NCBIGene:124512],374,"N/A, Neurodegeneration",352,false
capsid(S) glycoprotein,[NCBIGene:7448],374,Neuroinflammation,188,false
capsid(S) glycoprotein,[NCBIGene:7448],374,Binding to ACE2,1739,true
capsid(S) glycoprotein,[NCBIGene:7448],374,Encephalitis,1841,false
capsid(S) glycoprotein,[NCBIGene:7448],374,"N/A, Neurodegeneration",352,false
AR,"[NCBIGene:367, 231, 2232]",376,"Increased, Differentiation to Testis",1790,false
AR,"[NCBIGene:367, 231, 2232]",376,"Increased, Male Biased Sex Ratio",1791,false
AR,"[NCBIGene:367, 231, 2232]",376,"Agonism, Androgen receptor",25,true
AR,"[NCBIGene:367, 231, 2232]",376,"Decrease, Population growth rate",360,false
Aromatase,[NCBIGene:1588],376,"Increased, Differentiation to Testis",1790,false
Aromatase,[NCBIGene:1588],376,"Increased, Male Biased Sex Ratio",1791,false
Aromatase,[NCBIGene:1588],376,"Agonism, Androgen receptor",25,true
Aromatase,[NCBIGene:1588],376,"Decrease, Population growth rate",360,false
Toll Like Receptor 9,[NCBIGene:54106],377,"Occurrence, Kidney toxicity",814,false
Toll Like Receptor 9,[NCBIGene:54106],377,"Increased, secretion of proinflammatory mediators",1496,false
Toll Like Receptor 9,[NCBIGene:54106],377,Mitochondrial dysfunction,177,false
Toll Like Receptor 9,[NCBIGene:54106],377,"Release, Cytokine",87,false
Toll Like Receptor 9,[NCBIGene:54106],377,Heart failure,1535,false
Toll Like Receptor 9,[NCBIGene:54106],377,"Increased activation, Nuclear factor kappa B (NF-kB)",1172,false
Toll Like Receptor 9,[NCBIGene:54106],377,"Increase, the risk of acute respiratory failure",1748,false
Toll Like Receptor 9,[NCBIGene:54106],377,Toll Like Receptor (TLR) Dysregulation,1848,false
Toll Like Receptor 9,[NCBIGene:54106],377,"Increased, Kidney Failure",759,false
Toll Like Receptor 9,[NCBIGene:54106],377,"Increase, Cell death",1825,false
Toll Like Receptor 9,[NCBIGene:54106],377,"Increased, recruitment of inflammatory cells",1497,false
Toll Like Receptor 9,[NCBIGene:54106],377,Prolonged TLR9 activation,1842,true
Toll Like Receptor 9,[NCBIGene:54106],377,Multi Organ Failure involving Acute Respiratory Distress Syndrome,1843,false
Toll Like Receptor 9,[NCBIGene:54106],377,systemic inflammatory response syndrome,1844,false
Toll Like Receptor 9,[NCBIGene:54106],377,increased MyD88 activation,1897,false
Toll Like Receptor 9,[NCBIGene:54106],377,Increased Pro-inflammatory mediators,1493,false
Toll Like Receptor 9,[NCBIGene:54106],377,"NLRP3 inflammasome activity, increased",1895,false
Toll Like Receptor 9,[NCBIGene:54106],377,Diminished protective oxidative stress response,1869,false
Toll Like Receptor 9,[NCBIGene:54106],377,increased release of danger/damage associated molecular patterns,1898,false
Toll Like Receptor 9,[NCBIGene:54106],377,Oxidative Stress,1392,false
Toll Like Receptor 9,[NCBIGene:54106],377,"Platelet-neutrophil interactions, Increased",1857,false
Toll Like Receptor 9,[NCBIGene:54106],377,formation of neutrophil extracellular traps (NETs),1899,false
Toll Like Receptor 9,[NCBIGene:54106],377,Hyperinflammation,1868,false
Toll Like Receptor 9,[NCBIGene:54106],377,"Increase, Tissue/organ damage",1809,false
Toll Like Receptor 9,[NCBIGene:54106],377,"Inflammation, Liver",902,false
Toll Like Receptor 9,[NCBIGene:54106],377,increased platelet surface TLR9 expression,1900,false
Toll Like Receptor 9,[NCBIGene:54106],377,Thrombosis and Disseminated Intravascular Coagulation,1846,false
Toll Like Receptor 9,[NCBIGene:54106],377,Increased Mortality,351,false
Toll Like Receptor 9,[NCBIGene:54106],377,"Increase, Cell injury/death",55,false
Toll Like Receptor 9,[NCBIGene:54106],377,Th17 cell migration and inflammation induction,1708,false
TLR,[NCBIGene:286187],378,Toll Like Receptor (TLR) Dysregulation,1848,true
Toll like receptors,[NCBIGene:7096],378,Toll Like Receptor (TLR) Dysregulation,1848,true
ACE2,[NCBIGene:59272],379,SARS-CoV-2 cell entry,1738,false
ACE2,[NCBIGene:59272],379,Binding to ACE2,1739,true
ACE2,[NCBIGene:59272],379,Increased SARS-CoV-2 production,1847,false
ACE2,[NCBIGene:59272],379,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
ACE2,[NCBIGene:59272],379,Diminished protective oxidative stress response,1869,false
ACE2,[NCBIGene:59272],379,Thrombosis and Disseminated Intravascular Coagulation,1846,false
ACE2,[NCBIGene:59272],379,Coagulation,1845,false
RNA-dependent RNA polymerase,[NCBIGene:171568],379,SARS-CoV-2 cell entry,1738,false
RNA-dependent RNA polymerase,[NCBIGene:171568],379,Binding to ACE2,1739,true
RNA-dependent RNA polymerase,[NCBIGene:171568],379,Increased SARS-CoV-2 production,1847,false
RNA-dependent RNA polymerase,[NCBIGene:171568],379,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
RNA-dependent RNA polymerase,[NCBIGene:171568],379,Diminished protective oxidative stress response,1869,false
RNA-dependent RNA polymerase,[NCBIGene:171568],379,Thrombosis and Disseminated Intravascular Coagulation,1846,false
RNA-dependent RNA polymerase,[NCBIGene:171568],379,Coagulation,1845,false
RdRp,[NCBIGene:6510],379,SARS-CoV-2 cell entry,1738,false
RdRp,[NCBIGene:6510],379,Binding to ACE2,1739,true
RdRp,[NCBIGene:6510],379,Increased SARS-CoV-2 production,1847,false
RdRp,[NCBIGene:6510],379,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
RdRp,[NCBIGene:6510],379,Diminished protective oxidative stress response,1869,false
RdRp,[NCBIGene:6510],379,Thrombosis and Disseminated Intravascular Coagulation,1846,false
RdRp,[NCBIGene:6510],379,Coagulation,1845,false
interferon signalling network genes,[NCBIGene:3438],379,SARS-CoV-2 cell entry,1738,false
interferon signalling network genes,[NCBIGene:3438],379,Binding to ACE2,1739,true
interferon signalling network genes,[NCBIGene:3438],379,Increased SARS-CoV-2 production,1847,false
interferon signalling network genes,[NCBIGene:3438],379,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
interferon signalling network genes,[NCBIGene:3438],379,Diminished protective oxidative stress response,1869,false
interferon signalling network genes,[NCBIGene:3438],379,Thrombosis and Disseminated Intravascular Coagulation,1846,false
interferon signalling network genes,[NCBIGene:3438],379,Coagulation,1845,false
TGF-1,[NCBIGene:7040],38,"N/A, Liver fibrosis",344,false
TGF-1,[NCBIGene:7040],38,"Alkylation, Protein",244,true
TGF-1,[NCBIGene:7040],38,"Activation, Stellate cells",265,false
TGF-1,[NCBIGene:7040],38,Increased Pro-inflammatory mediators,1493,false
TGF-1,[NCBIGene:7040],38,Tissue resident cell activation,1492,false
TGF-1,[NCBIGene:7040],38,"Accumulation, Collagen",68,false
TGF-1,[NCBIGene:7040],38,"Increase, Cell injury/death",55,false
collagen,[NCBIGene:1280],38,"N/A, Liver fibrosis",344,false
collagen,[NCBIGene:1280],38,"Alkylation, Protein",244,true
collagen,[NCBIGene:1280],38,"Activation, Stellate cells",265,false
collagen,[NCBIGene:1280],38,Increased Pro-inflammatory mediators,1493,false
collagen,[NCBIGene:1280],38,Tissue resident cell activation,1492,false
collagen,[NCBIGene:1280],38,"Accumulation, Collagen",68,false
collagen,[NCBIGene:1280],38,"Increase, Cell injury/death",55,false
ACE2 receptor,[NCBIGene:340485],381,Increased Angiotensin II,1752,false
ACE2 receptor,[NCBIGene:340485],381,Binding to ACE2,1739,true
ACE2 receptor,[NCBIGene:340485],381,Impaired gustatory nerve,1849,false
ACE2 receptor,[NCBIGene:340485],381,dysgeusia,1850,false
ACE2 receptor,[NCBIGene:340485],381,"Downregulation, ACE2",1787,false
ACE2 receptor,[NCBIGene:340485],381,Imbalanced salty and sweet taste responses,1856,false
S-glycoprotein,[NCBIGene:6295],381,Increased Angiotensin II,1752,false
S-glycoprotein,[NCBIGene:6295],381,Binding to ACE2,1739,true
S-glycoprotein,[NCBIGene:6295],381,Impaired gustatory nerve,1849,false
S-glycoprotein,[NCBIGene:6295],381,dysgeusia,1850,false
S-glycoprotein,[NCBIGene:6295],381,"Downregulation, ACE2",1787,false
S-glycoprotein,[NCBIGene:6295],381,Imbalanced salty and sweet taste responses,1856,false
type 1 angiotensin receptor,[NCBIGene:185],382,"Increased, secretion of proinflammatory mediators",1496,false
type 1 angiotensin receptor,[NCBIGene:185],382,"Increase, Reactive oxygen species",1115,false
type 1 angiotensin receptor,[NCBIGene:185],382,"Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)",1851,true
type 1 angiotensin receptor,[NCBIGene:185],382,"Increased activation, Nuclear factor kappa B (NF-kB)",1172,false
type 1 angiotensin receptor,[NCBIGene:185],382,Lung fibrosis,1276,false
type 1 angiotensin receptor,[NCBIGene:185],382,"Accumulation, Collagen",68,false
ACE2,[NCBIGene:59272],383,"N/A, Liver fibrosis",344,false
ACE2,[NCBIGene:59272],383,"Increase, Reactive oxygen species",1115,false
ACE2,[NCBIGene:59272],383,Induced dysregulation of ACE2,1740,true
ACE2,[NCBIGene:59272],383,Increased Ang II type 1 receptor (AT1R),1852,false
ACE2,[NCBIGene:59272],383,"Increased, extracellular matrix deposition",1501,false
ACE2,[NCBIGene:59272],383,Increase plasma Ang II,1743,false
Ang II,[NCBIGene:285],384,Hyperactivation of ACE/Ang-II/AT1R axis,1853,true
Ang II,[NCBIGene:285],384,Increased Sodium-sensitive hypertension,1855,false
Ang II,[NCBIGene:285],384,"Increase, Reactive oxygen species",1115,false
Ang II,[NCBIGene:285],384,Increased Angiotensin II,1752,false
Ang II,[NCBIGene:285],384,Chronic kidney disease,1603,false
Ang II,[NCBIGene:285],384,Increased Ang II type 1 receptor (AT1R),1852,false
Angiotensin-converting enzyme,[NCBIGene:1636],384,Hyperactivation of ACE/Ang-II/AT1R axis,1853,true
Angiotensin-converting enzyme,[NCBIGene:1636],384,Increased Sodium-sensitive hypertension,1855,false
Angiotensin-converting enzyme,[NCBIGene:1636],384,"Increase, Reactive oxygen species",1115,false
Angiotensin-converting enzyme,[NCBIGene:1636],384,Increased Angiotensin II,1752,false
Angiotensin-converting enzyme,[NCBIGene:1636],384,Chronic kidney disease,1603,false
Angiotensin-converting enzyme,[NCBIGene:1636],384,Increased Ang II type 1 receptor (AT1R),1852,false
type 1 angiotensin receptor,[NCBIGene:185],384,Hyperactivation of ACE/Ang-II/AT1R axis,1853,true
type 1 angiotensin receptor,[NCBIGene:185],384,Increased Sodium-sensitive hypertension,1855,false
type 1 angiotensin receptor,[NCBIGene:185],384,"Increase, Reactive oxygen species",1115,false
type 1 angiotensin receptor,[NCBIGene:185],384,Increased Angiotensin II,1752,false
type 1 angiotensin receptor,[NCBIGene:185],384,Chronic kidney disease,1603,false
type 1 angiotensin receptor,[NCBIGene:185],384,Increased Ang II type 1 receptor (AT1R),1852,false
ACE2,[NCBIGene:59272],385,Increased Angiotensin II,1752,false
ACE2,[NCBIGene:59272],385,"Dysregulation, ACE2 expression and activity",1854,false
ACE2,[NCBIGene:59272],385,Binding to ACE2,1739,true
ACE2,[NCBIGene:59272],385,"Downregulation, ACE2",1787,false
ACE2,[NCBIGene:59272],385,"Occurrence, (Micro)vascular dysfunction",2096,false
Viral spike protein,[NCBIGene:4342],385,Increased Angiotensin II,1752,false
Viral spike protein,[NCBIGene:4342],385,"Dysregulation, ACE2 expression and activity",1854,false
Viral spike protein,[NCBIGene:4342],385,Binding to ACE2,1739,true
Viral spike protein,[NCBIGene:4342],385,"Downregulation, ACE2",1787,false
Viral spike protein,[NCBIGene:4342],385,"Occurrence, (Micro)vascular dysfunction",2096,false
D1 protein,"[NCBIGene:27241, 25802]",386,"Increase, Reactive oxygen species",1115,false
D1 protein,"[NCBIGene:27241, 25802]",386,Deposition of Energy,1686,true
D1 protein,"[NCBIGene:27241, 25802]",386,"Decrease, Population growth rate",360,false
D1 protein,"[NCBIGene:27241, 25802]",386,"Increase, D1 protein deactivation",1861,false
D1 protein,"[NCBIGene:27241, 25802]",386,"Decrease, Photosystem II efficiency",1862,false
D1 protein,"[NCBIGene:27241, 25802]",386,"Decrease, Reproduction",1863,false
D1 protein,"[NCBIGene:27241, 25802]",386,"Decrease, ATP production",1472,false
D1 protein,"[NCBIGene:27241, 25802]",386,"Decrease, Photosynthesis",1475,false
PSII,[NCBIGene:4716],386,"Increase, Reactive oxygen species",1115,false
PSII,[NCBIGene:4716],386,Deposition of Energy,1686,true
PSII,[NCBIGene:4716],386,"Decrease, Population growth rate",360,false
PSII,[NCBIGene:4716],386,"Increase, D1 protein deactivation",1861,false
PSII,[NCBIGene:4716],386,"Decrease, Photosystem II efficiency",1862,false
PSII,[NCBIGene:4716],386,"Decrease, Reproduction",1863,false
PSII,[NCBIGene:4716],386,"Decrease, ATP production",1472,false
PSII,[NCBIGene:4716],386,"Decrease, Photosynthesis",1475,false
Photosystem II,[NCBIGene:7385],386,"Increase, Reactive oxygen species",1115,false
Photosystem II,[NCBIGene:7385],386,Deposition of Energy,1686,true
Photosystem II,[NCBIGene:7385],386,"Decrease, Population growth rate",360,false
Photosystem II,[NCBIGene:7385],386,"Increase, D1 protein deactivation",1861,false
Photosystem II,[NCBIGene:7385],386,"Decrease, Photosystem II efficiency",1862,false
Photosystem II,[NCBIGene:7385],386,"Decrease, Reproduction",1863,false
Photosystem II,[NCBIGene:7385],386,"Decrease, ATP production",1472,false
Photosystem II,[NCBIGene:7385],386,"Decrease, Photosynthesis",1475,false
Oxygen-evolving,[NCBIGene:28893],389,"Decrease, Population growth rate",360,false
Oxygen-evolving,[NCBIGene:28893],389,"Decrease, Photosystem II efficiency",1862,false
Oxygen-evolving,[NCBIGene:28893],389,"Decrease, Reproduction",1863,false
Oxygen-evolving,[NCBIGene:28893],389,"Increase, Oxygen-evolving complex damage",1865,true
Oxygen-evolving,[NCBIGene:28893],389,"Decrease, ATP production",1472,false
Oxygen-evolving,[NCBIGene:28893],389,"Decrease, Photosynthesis",1475,false
Oxygen-evolving,[NCBIGene:28893],389,"Decrease, Leaf development",1479,false
BAD,[NCBIGene:572],393,Apoptosis,1262,false
BAD,[NCBIGene:572],393,"Cell cycle, disrupted",1505,false
BAD,[NCBIGene:572],393,systemic inflammatory response syndrome,1844,false
BAD,[NCBIGene:572],393,"Altered, Thyroid hormone-dependent gene expression",1829,false
BAD,[NCBIGene:572],393,"Increased, Hepatic thyroid hormone uptake/transport",1158,true
BAD,[NCBIGene:572],393,Increase cell proliferation,1555,false
CASP9,[NCBIGene:842],393,Apoptosis,1262,false
CASP9,[NCBIGene:842],393,"Cell cycle, disrupted",1505,false
CASP9,[NCBIGene:842],393,systemic inflammatory response syndrome,1844,false
CASP9,[NCBIGene:842],393,"Altered, Thyroid hormone-dependent gene expression",1829,false
CASP9,[NCBIGene:842],393,"Increased, Hepatic thyroid hormone uptake/transport",1158,true
CASP9,[NCBIGene:842],393,Increase cell proliferation,1555,false
CCND1,[NCBIGene:595],393,Apoptosis,1262,false
CCND1,[NCBIGene:595],393,"Cell cycle, disrupted",1505,false
CCND1,[NCBIGene:595],393,systemic inflammatory response syndrome,1844,false
CCND1,[NCBIGene:595],393,"Altered, Thyroid hormone-dependent gene expression",1829,false
CCND1,[NCBIGene:595],393,"Increased, Hepatic thyroid hormone uptake/transport",1158,true
CCND1,[NCBIGene:595],393,Increase cell proliferation,1555,false
IL1A,[NCBIGene:3552],393,Apoptosis,1262,false
IL1A,[NCBIGene:3552],393,"Cell cycle, disrupted",1505,false
IL1A,[NCBIGene:3552],393,systemic inflammatory response syndrome,1844,false
IL1A,[NCBIGene:3552],393,"Altered, Thyroid hormone-dependent gene expression",1829,false
IL1A,[NCBIGene:3552],393,"Increased, Hepatic thyroid hormone uptake/transport",1158,true
IL1A,[NCBIGene:3552],393,Increase cell proliferation,1555,false
IL6,[NCBIGene:3569],393,Apoptosis,1262,false
IL6,[NCBIGene:3569],393,"Cell cycle, disrupted",1505,false
IL6,[NCBIGene:3569],393,systemic inflammatory response syndrome,1844,false
IL6,[NCBIGene:3569],393,"Altered, Thyroid hormone-dependent gene expression",1829,false
IL6,[NCBIGene:3569],393,"Increased, Hepatic thyroid hormone uptake/transport",1158,true
IL6,[NCBIGene:3569],393,Increase cell proliferation,1555,false
TP53,[NCBIGene:7157],393,Apoptosis,1262,false
TP53,[NCBIGene:7157],393,"Cell cycle, disrupted",1505,false
TP53,[NCBIGene:7157],393,systemic inflammatory response syndrome,1844,false
TP53,[NCBIGene:7157],393,"Altered, Thyroid hormone-dependent gene expression",1829,false
TP53,[NCBIGene:7157],393,"Increased, Hepatic thyroid hormone uptake/transport",1158,true
TP53,[NCBIGene:7157],393,Increase cell proliferation,1555,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",393,Apoptosis,1262,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",393,"Cell cycle, disrupted",1505,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",393,systemic inflammatory response syndrome,1844,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",393,"Altered, Thyroid hormone-dependent gene expression",1829,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",393,"Increased, Hepatic thyroid hormone uptake/transport",1158,true
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",393,Increase cell proliferation,1555,false
thyroid stimulating hormone,[NCBIGene:7253],393,Apoptosis,1262,false
thyroid stimulating hormone,[NCBIGene:7253],393,"Cell cycle, disrupted",1505,false
thyroid stimulating hormone,[NCBIGene:7253],393,systemic inflammatory response syndrome,1844,false
thyroid stimulating hormone,[NCBIGene:7253],393,"Altered, Thyroid hormone-dependent gene expression",1829,false
thyroid stimulating hormone,[NCBIGene:7253],393,"Increased, Hepatic thyroid hormone uptake/transport",1158,true
thyroid stimulating hormone,[NCBIGene:7253],393,Increase cell proliferation,1555,false
ACE2 receptor,[NCBIGene:340485],394,SARS-CoV-2 cell entry,1738,false
ACE2 receptor,[NCBIGene:340485],394,Binding to ACE2,1739,true
ACE2 receptor,[NCBIGene:340485],394,Increased SARS-CoV-2 production,1847,false
ACE2 receptor,[NCBIGene:340485],394,"Sustentacular cells, decrease",1870,false
ACE2 receptor,[NCBIGene:340485],394,"olfactory sensory neurons, decrease",1871,false
ACE2 receptor,[NCBIGene:340485],394,Olfactory epithelium degeneration,1872,false
ACE2 receptor,[NCBIGene:340485],394,impaired olfactory function (anosmia),1873,false
ACE 2 receptors,[NCBIGene:186],395,SARS-CoV-2 cell entry,1738,false
ACE 2 receptors,[NCBIGene:186],395,Binding to ACE2,1739,true
ACE 2 receptors,[NCBIGene:186],395,Thrombosis and Disseminated Intravascular Coagulation,1846,false
ACE 2 receptors,[NCBIGene:186],395,blood brain barrier disruption,1874,false
ACE 2 receptors,[NCBIGene:186],395,Cerebrovascular disease (stroke),1875,false
Sars-CoV-2 spike protein,[NCBIGene:54938],395,SARS-CoV-2 cell entry,1738,false
Sars-CoV-2 spike protein,[NCBIGene:54938],395,Binding to ACE2,1739,true
Sars-CoV-2 spike protein,[NCBIGene:54938],395,Thrombosis and Disseminated Intravascular Coagulation,1846,false
Sars-CoV-2 spike protein,[NCBIGene:54938],395,blood brain barrier disruption,1874,false
Sars-CoV-2 spike protein,[NCBIGene:54938],395,Cerebrovascular disease (stroke),1875,false
ALDH1A2,[NCBIGene:8854],398,"Disrupted, initiation of meiosis of oogonia in the ovary",1882,false
ALDH1A2,[NCBIGene:8854],398,"Decreased, size of the ovarian reserve",1883,false
ALDH1A2,[NCBIGene:8854],398,"decreased, Fertility",406,false
ALDH1A2,[NCBIGene:8854],398,"disrupted, ovarian cycle",405,false
ALDH1A2,[NCBIGene:8854],398,"Decreased, ALDH1A (RALDH) enzyme activity",1880,true
ALDH1A2,[NCBIGene:8854],398,"Decreased, all-trans retinoic acid (atRA) concentration",1881,false
ALDH1A3,[NCBIGene:220],398,"Disrupted, initiation of meiosis of oogonia in the ovary",1882,false
ALDH1A3,[NCBIGene:220],398,"Decreased, size of the ovarian reserve",1883,false
ALDH1A3,[NCBIGene:220],398,"decreased, Fertility",406,false
ALDH1A3,[NCBIGene:220],398,"disrupted, ovarian cycle",405,false
ALDH1A3,[NCBIGene:220],398,"Decreased, ALDH1A (RALDH) enzyme activity",1880,true
ALDH1A3,[NCBIGene:220],398,"Decreased, all-trans retinoic acid (atRA) concentration",1881,false
retinaldehyde dehydrogenase,[NCBIGene:216],398,"Disrupted, initiation of meiosis of oogonia in the ovary",1882,false
retinaldehyde dehydrogenase,[NCBIGene:216],398,"Decreased, size of the ovarian reserve",1883,false
retinaldehyde dehydrogenase,[NCBIGene:216],398,"decreased, Fertility",406,false
retinaldehyde dehydrogenase,[NCBIGene:216],398,"disrupted, ovarian cycle",405,false
retinaldehyde dehydrogenase,[NCBIGene:216],398,"Decreased, ALDH1A (RALDH) enzyme activity",1880,true
retinaldehyde dehydrogenase,[NCBIGene:216],398,"Decreased, all-trans retinoic acid (atRA) concentration",1881,false
retinoic acid receptors,[NCBIGene:10966],398,"Disrupted, initiation of meiosis of oogonia in the ovary",1882,false
retinoic acid receptors,[NCBIGene:10966],398,"Decreased, size of the ovarian reserve",1883,false
retinoic acid receptors,[NCBIGene:10966],398,"decreased, Fertility",406,false
retinoic acid receptors,[NCBIGene:10966],398,"disrupted, ovarian cycle",405,false
retinoic acid receptors,[NCBIGene:10966],398,"Decreased, ALDH1A (RALDH) enzyme activity",1880,true
retinoic acid receptors,[NCBIGene:10966],398,"Decreased, all-trans retinoic acid (atRA) concentration",1881,false
retinoid X receptor,[NCBIGene:6256],398,"Disrupted, initiation of meiosis of oogonia in the ovary",1882,false
retinoid X receptor,[NCBIGene:6256],398,"Decreased, size of the ovarian reserve",1883,false
retinoid X receptor,[NCBIGene:6256],398,"decreased, Fertility",406,false
retinoid X receptor,[NCBIGene:6256],398,"disrupted, ovarian cycle",405,false
retinoid X receptor,[NCBIGene:6256],398,"Decreased, ALDH1A (RALDH) enzyme activity",1880,true
retinoid X receptor,[NCBIGene:6256],398,"Decreased, all-trans retinoic acid (atRA) concentration",1881,false
Fyna,[NCBIGene:2534],399,"Decrease, Cell proliferation",1821,false
Fyna,[NCBIGene:2534],399,"Decreased, Eye size",1878,false
Fyna,[NCBIGene:2534],399,"Altered, Visual function",1643,false
Fyna,[NCBIGene:2534],399,"Decrease, Population growth rate",360,false
Fyna,[NCBIGene:2534],399,Increased Mortality,351,false
Fyna,[NCBIGene:2534],399,Inhibition of Fyna,1884,true
Fyna,[NCBIGene:2534],399,Inhibition of Plxna2,1885,false
Fyna,[NCBIGene:2534],399,Overexpression of rasl11b,1886,false
Plxna2 phosphatase,[NCBIGene:5362],399,"Decrease, Cell proliferation",1821,false
Plxna2 phosphatase,[NCBIGene:5362],399,"Decreased, Eye size",1878,false
Plxna2 phosphatase,[NCBIGene:5362],399,"Altered, Visual function",1643,false
Plxna2 phosphatase,[NCBIGene:5362],399,"Decrease, Population growth rate",360,false
Plxna2 phosphatase,[NCBIGene:5362],399,Increased Mortality,351,false
Plxna2 phosphatase,[NCBIGene:5362],399,Inhibition of Fyna,1884,true
Plxna2 phosphatase,[NCBIGene:5362],399,Inhibition of Plxna2,1885,false
Plxna2 phosphatase,[NCBIGene:5362],399,Overexpression of rasl11b,1886,false
Src family,[NCBIGene:6714],399,"Decrease, Cell proliferation",1821,false
Src family,[NCBIGene:6714],399,"Decreased, Eye size",1878,false
Src family,[NCBIGene:6714],399,"Altered, Visual function",1643,false
Src family,[NCBIGene:6714],399,"Decrease, Population growth rate",360,false
Src family,[NCBIGene:6714],399,Increased Mortality,351,false
Src family,[NCBIGene:6714],399,Inhibition of Fyna,1884,true
Src family,[NCBIGene:6714],399,Inhibition of Plxna2,1885,false
Src family,[NCBIGene:6714],399,Overexpression of rasl11b,1886,false
rasl11b,[NCBIGene:65997],399,"Decrease, Cell proliferation",1821,false
rasl11b,[NCBIGene:65997],399,"Decreased, Eye size",1878,false
rasl11b,[NCBIGene:65997],399,"Altered, Visual function",1643,false
rasl11b,[NCBIGene:65997],399,"Decrease, Population growth rate",360,false
rasl11b,[NCBIGene:65997],399,Increased Mortality,351,false
rasl11b,[NCBIGene:65997],399,Inhibition of Fyna,1884,true
rasl11b,[NCBIGene:65997],399,Inhibition of Plxna2,1885,false
rasl11b,[NCBIGene:65997],399,Overexpression of rasl11b,1886,false
tyrosine kinase A,[NCBIGene:4914],399,"Decrease, Cell proliferation",1821,false
tyrosine kinase A,[NCBIGene:4914],399,"Decreased, Eye size",1878,false
tyrosine kinase A,[NCBIGene:4914],399,"Altered, Visual function",1643,false
tyrosine kinase A,[NCBIGene:4914],399,"Decrease, Population growth rate",360,false
tyrosine kinase A,[NCBIGene:4914],399,Increased Mortality,351,false
tyrosine kinase A,[NCBIGene:4914],399,Inhibition of Fyna,1884,true
tyrosine kinase A,[NCBIGene:4914],399,Inhibition of Plxna2,1885,false
tyrosine kinase A,[NCBIGene:4914],399,Overexpression of rasl11b,1886,false
EcR,[NCBIGene:108383238],4,"Increase, Ecdysone receptor agonism",103,true
EcR,[NCBIGene:108383238],4,"Increase, Mortality",350,false
EcR,[NCBIGene:108383238],4,"Decrease, Excitatory postsynaptic potential",1268,false
EcR,[NCBIGene:108383238],4,"Decrease, Ecdysis motoneuron bursts",1267,false
EcR,[NCBIGene:108383238],4,"Decrease, Circulating crustacean cardioactive peptide",1266,false
EcR,[NCBIGene:108383238],4,"Increase, Fushi tarazu factor-1 gene expression",1265,false
EcR,[NCBIGene:108383238],4,"Increase, Nuclear receptor E75b gene expression",1264,false
EcR,[NCBIGene:108383238],4,"Decrease, Abdominal muscle contraction",993,false
EcR,[NCBIGene:108383238],4,"Increase, Incomplete ecdysis",990,false
EcR,[NCBIGene:108383238],4,"Decrease, Circulating ecdysis triggering hormone",988,false
Ecdysone receptor,[NCBIGene:11319],4,"Increase, Ecdysone receptor agonism",103,true
Ecdysone receptor,[NCBIGene:11319],4,"Increase, Mortality",350,false
Ecdysone receptor,[NCBIGene:11319],4,"Decrease, Excitatory postsynaptic potential",1268,false
Ecdysone receptor,[NCBIGene:11319],4,"Decrease, Ecdysis motoneuron bursts",1267,false
Ecdysone receptor,[NCBIGene:11319],4,"Decrease, Circulating crustacean cardioactive peptide",1266,false
Ecdysone receptor,[NCBIGene:11319],4,"Increase, Fushi tarazu factor-1 gene expression",1265,false
Ecdysone receptor,[NCBIGene:11319],4,"Increase, Nuclear receptor E75b gene expression",1264,false
Ecdysone receptor,[NCBIGene:11319],4,"Decrease, Abdominal muscle contraction",993,false
Ecdysone receptor,[NCBIGene:11319],4,"Increase, Incomplete ecdysis",990,false
Ecdysone receptor,[NCBIGene:11319],4,"Decrease, Circulating ecdysis triggering hormone",988,false
major histocompatibility complex molecules,[NCBIGene:3106],40,"Activation, Dendritic Cells",398,false
major histocompatibility complex molecules,[NCBIGene:3106],40,"Covalent Binding, Protein",396,true
major histocompatibility complex molecules,[NCBIGene:3106],40,"sensitisation, skin",827,false
major histocompatibility complex molecules,[NCBIGene:3106],40,"Activation/Proliferation, T-cells",272,false
major histocompatibility complex molecules,[NCBIGene:3106],40,"Activation, Keratinocytes",826,false
AKT,[NCBIGene:207],401,"Up Regulation, SCD-1",462,false
AKT,[NCBIGene:207],401,"Down Regulation, CPT1A",472,false
AKT,[NCBIGene:207],401,protein-coupled estrogen receptor 1 (GPER) activation,2029,true
AKT,[NCBIGene:207],401,"Activation, PI3K",1310,false
AKT,[NCBIGene:207],401,"Activation, AKT",1299,false
AKT,[NCBIGene:207],401,"Activation, mTORC1",1300,false
AKT,[NCBIGene:207],401,Abnormal lipid metabolism,1995,false
AKT,[NCBIGene:207],401,"Up Regulation, SREBF2",1284,false
AKT,[NCBIGene:207],401,"N/A, Steatohepatisis",1489,false
AKT,[NCBIGene:207],401,"Activation, PPARα",227,false
CPT1A,[NCBIGene:1374],401,"Up Regulation, SCD-1",462,false
CPT1A,[NCBIGene:1374],401,"Down Regulation, CPT1A",472,false
CPT1A,[NCBIGene:1374],401,protein-coupled estrogen receptor 1 (GPER) activation,2029,true
CPT1A,[NCBIGene:1374],401,"Activation, PI3K",1310,false
CPT1A,[NCBIGene:1374],401,"Activation, AKT",1299,false
CPT1A,[NCBIGene:1374],401,"Activation, mTORC1",1300,false
CPT1A,[NCBIGene:1374],401,Abnormal lipid metabolism,1995,false
CPT1A,[NCBIGene:1374],401,"Up Regulation, SREBF2",1284,false
CPT1A,[NCBIGene:1374],401,"N/A, Steatohepatisis",1489,false
CPT1A,[NCBIGene:1374],401,"Activation, PPARα",227,false
CPT2,[NCBIGene:1376],401,"Up Regulation, SCD-1",462,false
CPT2,[NCBIGene:1376],401,"Down Regulation, CPT1A",472,false
CPT2,[NCBIGene:1376],401,protein-coupled estrogen receptor 1 (GPER) activation,2029,true
CPT2,[NCBIGene:1376],401,"Activation, PI3K",1310,false
CPT2,[NCBIGene:1376],401,"Activation, AKT",1299,false
CPT2,[NCBIGene:1376],401,"Activation, mTORC1",1300,false
CPT2,[NCBIGene:1376],401,Abnormal lipid metabolism,1995,false
CPT2,[NCBIGene:1376],401,"Up Regulation, SREBF2",1284,false
CPT2,[NCBIGene:1376],401,"N/A, Steatohepatisis",1489,false
CPT2,[NCBIGene:1376],401,"Activation, PPARα",227,false
G protein-coupled estrogen receptor 1,[NCBIGene:2852],401,"Up Regulation, SCD-1",462,false
G protein-coupled estrogen receptor 1,[NCBIGene:2852],401,"Down Regulation, CPT1A",472,false
G protein-coupled estrogen receptor 1,[NCBIGene:2852],401,protein-coupled estrogen receptor 1 (GPER) activation,2029,true
G protein-coupled estrogen receptor 1,[NCBIGene:2852],401,"Activation, PI3K",1310,false
G protein-coupled estrogen receptor 1,[NCBIGene:2852],401,"Activation, AKT",1299,false
G protein-coupled estrogen receptor 1,[NCBIGene:2852],401,"Activation, mTORC1",1300,false
G protein-coupled estrogen receptor 1,[NCBIGene:2852],401,Abnormal lipid metabolism,1995,false
G protein-coupled estrogen receptor 1,[NCBIGene:2852],401,"Up Regulation, SREBF2",1284,false
G protein-coupled estrogen receptor 1,[NCBIGene:2852],401,"N/A, Steatohepatisis",1489,false
G protein-coupled estrogen receptor 1,[NCBIGene:2852],401,"Activation, PPARα",227,false
LXR,[NCBIGene:10062],401,"Up Regulation, SCD-1",462,false
LXR,[NCBIGene:10062],401,"Down Regulation, CPT1A",472,false
LXR,[NCBIGene:10062],401,protein-coupled estrogen receptor 1 (GPER) activation,2029,true
LXR,[NCBIGene:10062],401,"Activation, PI3K",1310,false
LXR,[NCBIGene:10062],401,"Activation, AKT",1299,false
LXR,[NCBIGene:10062],401,"Activation, mTORC1",1300,false
LXR,[NCBIGene:10062],401,Abnormal lipid metabolism,1995,false
LXR,[NCBIGene:10062],401,"Up Regulation, SREBF2",1284,false
LXR,[NCBIGene:10062],401,"N/A, Steatohepatisis",1489,false
LXR,[NCBIGene:10062],401,"Activation, PPARα",227,false
N-CoR,[NCBIGene:9611],401,"Up Regulation, SCD-1",462,false
N-CoR,[NCBIGene:9611],401,"Down Regulation, CPT1A",472,false
N-CoR,[NCBIGene:9611],401,protein-coupled estrogen receptor 1 (GPER) activation,2029,true
N-CoR,[NCBIGene:9611],401,"Activation, PI3K",1310,false
N-CoR,[NCBIGene:9611],401,"Activation, AKT",1299,false
N-CoR,[NCBIGene:9611],401,"Activation, mTORC1",1300,false
N-CoR,[NCBIGene:9611],401,Abnormal lipid metabolism,1995,false
N-CoR,[NCBIGene:9611],401,"Up Regulation, SREBF2",1284,false
N-CoR,[NCBIGene:9611],401,"N/A, Steatohepatisis",1489,false
N-CoR,[NCBIGene:9611],401,"Activation, PPARα",227,false
PI3K,[NCBIGene:5290],401,"Up Regulation, SCD-1",462,false
PI3K,[NCBIGene:5290],401,"Down Regulation, CPT1A",472,false
PI3K,[NCBIGene:5290],401,protein-coupled estrogen receptor 1 (GPER) activation,2029,true
PI3K,[NCBIGene:5290],401,"Activation, PI3K",1310,false
PI3K,[NCBIGene:5290],401,"Activation, AKT",1299,false
PI3K,[NCBIGene:5290],401,"Activation, mTORC1",1300,false
PI3K,[NCBIGene:5290],401,Abnormal lipid metabolism,1995,false
PI3K,[NCBIGene:5290],401,"Up Regulation, SREBF2",1284,false
PI3K,[NCBIGene:5290],401,"N/A, Steatohepatisis",1489,false
PI3K,[NCBIGene:5290],401,"Activation, PPARα",227,false
PPAR,[NCBIGene:5465],401,"Up Regulation, SCD-1",462,false
PPAR,[NCBIGene:5465],401,"Down Regulation, CPT1A",472,false
PPAR,[NCBIGene:5465],401,protein-coupled estrogen receptor 1 (GPER) activation,2029,true
PPAR,[NCBIGene:5465],401,"Activation, PI3K",1310,false
PPAR,[NCBIGene:5465],401,"Activation, AKT",1299,false
PPAR,[NCBIGene:5465],401,"Activation, mTORC1",1300,false
PPAR,[NCBIGene:5465],401,Abnormal lipid metabolism,1995,false
PPAR,[NCBIGene:5465],401,"Up Regulation, SREBF2",1284,false
PPAR,[NCBIGene:5465],401,"N/A, Steatohepatisis",1489,false
PPAR,[NCBIGene:5465],401,"Activation, PPARα",227,false
S6K2,[NCBIGene:6199],401,"Up Regulation, SCD-1",462,false
S6K2,[NCBIGene:6199],401,"Down Regulation, CPT1A",472,false
S6K2,[NCBIGene:6199],401,protein-coupled estrogen receptor 1 (GPER) activation,2029,true
S6K2,[NCBIGene:6199],401,"Activation, PI3K",1310,false
S6K2,[NCBIGene:6199],401,"Activation, AKT",1299,false
S6K2,[NCBIGene:6199],401,"Activation, mTORC1",1300,false
S6K2,[NCBIGene:6199],401,Abnormal lipid metabolism,1995,false
S6K2,[NCBIGene:6199],401,"Up Regulation, SREBF2",1284,false
S6K2,[NCBIGene:6199],401,"N/A, Steatohepatisis",1489,false
S6K2,[NCBIGene:6199],401,"Activation, PPARα",227,false
liver X receptors,[NCBIGene:9213],401,"Up Regulation, SCD-1",462,false
liver X receptors,[NCBIGene:9213],401,"Down Regulation, CPT1A",472,false
liver X receptors,[NCBIGene:9213],401,protein-coupled estrogen receptor 1 (GPER) activation,2029,true
liver X receptors,[NCBIGene:9213],401,"Activation, PI3K",1310,false
liver X receptors,[NCBIGene:9213],401,"Activation, AKT",1299,false
liver X receptors,[NCBIGene:9213],401,"Activation, mTORC1",1300,false
liver X receptors,[NCBIGene:9213],401,Abnormal lipid metabolism,1995,false
liver X receptors,[NCBIGene:9213],401,"Up Regulation, SREBF2",1284,false
liver X receptors,[NCBIGene:9213],401,"N/A, Steatohepatisis",1489,false
liver X receptors,[NCBIGene:9213],401,"Activation, PPARα",227,false
mTOR,[NCBIGene:2475],401,"Up Regulation, SCD-1",462,false
mTOR,[NCBIGene:2475],401,"Down Regulation, CPT1A",472,false
mTOR,[NCBIGene:2475],401,protein-coupled estrogen receptor 1 (GPER) activation,2029,true
mTOR,[NCBIGene:2475],401,"Activation, PI3K",1310,false
mTOR,[NCBIGene:2475],401,"Activation, AKT",1299,false
mTOR,[NCBIGene:2475],401,"Activation, mTORC1",1300,false
mTOR,[NCBIGene:2475],401,Abnormal lipid metabolism,1995,false
mTOR,[NCBIGene:2475],401,"Up Regulation, SREBF2",1284,false
mTOR,[NCBIGene:2475],401,"N/A, Steatohepatisis",1489,false
mTOR,[NCBIGene:2475],401,"Activation, PPARα",227,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],401,"Up Regulation, SCD-1",462,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],401,"Down Regulation, CPT1A",472,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],401,protein-coupled estrogen receptor 1 (GPER) activation,2029,true
stearoyl-CoA desaturase 1,[NCBIGene:6319],401,"Activation, PI3K",1310,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],401,"Activation, AKT",1299,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],401,"Activation, mTORC1",1300,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],401,Abnormal lipid metabolism,1995,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],401,"Up Regulation, SREBF2",1284,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],401,"N/A, Steatohepatisis",1489,false
stearoyl-CoA desaturase 1,[NCBIGene:6319],401,"Activation, PPARα",227,false
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],401,"Up Regulation, SCD-1",462,false
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],401,"Down Regulation, CPT1A",472,false
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],401,protein-coupled estrogen receptor 1 (GPER) activation,2029,true
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],401,"Activation, PI3K",1310,false
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],401,"Activation, AKT",1299,false
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],401,"Activation, mTORC1",1300,false
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],401,Abnormal lipid metabolism,1995,false
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],401,"Up Regulation, SREBF2",1284,false
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],401,"N/A, Steatohepatisis",1489,false
sterol regulatory element binding transcription factor 2,[NCBIGene:6721],401,"Activation, PPARα",227,false
Thyroperoxidase,[NCBIGene:7173],402,"Thyroperoxidase, Inhibition",279,true
Thyroperoxidase,[NCBIGene:7173],402,"Thyroid hormone synthesis, Decreased",277,false
Thyroperoxidase,[NCBIGene:7173],402,Brain thyroid hormone (T4/T3) decreased,2093,false
Thyroperoxidase,[NCBIGene:7173],402,Periventricular heterotopia formation,2095,false
Thyroperoxidase,[NCBIGene:7173],402,"Decrease, Serum thyroid hormone (T4/T3)",771,false
Thyroperoxidase,[NCBIGene:7173],402,"Abnormal, neuroblast migration",2094,false
Thyroperoxidase,[NCBIGene:7173],402,"Increase, seizure",1348,false
Thyroperoxidase,[NCBIGene:7173],402,"Altered, Thyroid hormone-dependent gene expression",1829,false
IL18,[NCBIGene:3606],406,SARS-CoV-2 cell entry,1738,false
IL18,[NCBIGene:3606],406,Binding to ACE2,1739,true
IL18,[NCBIGene:3606],406,Increased SARS-CoV-2 production,1847,false
IL18,[NCBIGene:3606],406,"NLRP3 inflammasome activity, increased",1895,false
IL18,[NCBIGene:3606],406,Diminished protective oxidative stress response,1869,false
IL18,[NCBIGene:3606],406,Hyperinflammation,1868,false
IL1B,[NCBIGene:3553],406,SARS-CoV-2 cell entry,1738,false
IL1B,[NCBIGene:3553],406,Binding to ACE2,1739,true
IL1B,[NCBIGene:3553],406,Increased SARS-CoV-2 production,1847,false
IL1B,[NCBIGene:3553],406,"NLRP3 inflammasome activity, increased",1895,false
IL1B,[NCBIGene:3553],406,Diminished protective oxidative stress response,1869,false
IL1B,[NCBIGene:3553],406,Hyperinflammation,1868,false
NLRP3 inflammasome,[NCBIGene:114548],406,SARS-CoV-2 cell entry,1738,false
NLRP3 inflammasome,[NCBIGene:114548],406,Binding to ACE2,1739,true
NLRP3 inflammasome,[NCBIGene:114548],406,Increased SARS-CoV-2 production,1847,false
NLRP3 inflammasome,[NCBIGene:114548],406,"NLRP3 inflammasome activity, increased",1895,false
NLRP3 inflammasome,[NCBIGene:114548],406,Diminished protective oxidative stress response,1869,false
NLRP3 inflammasome,[NCBIGene:114548],406,Hyperinflammation,1868,false
BAP1,[NCBIGene:8314],409,"Increased, secretion of proinflammatory mediators",1496,false
BAP1,[NCBIGene:8314],409,Genomic instability,1896,false
BAP1,[NCBIGene:8314],409,"Increase, Reactive oxygen species",1115,false
BAP1,[NCBIGene:8314],409,"Increase, Cell Proliferation",870,false
BAP1,[NCBIGene:8314],409,"Increased, mesotheliomas",1090,false
BAP1,[NCBIGene:8314],409,"Increased, recruitment of inflammatory cells",1497,false
BAP1,[NCBIGene:8314],409,Frustrated phagocytosis,1668,true
BAP1,[NCBIGene:8314],409,"Increased, DNA damage and mutation",1669,false
AhR,[NCBIGene:196],41,"N/A, Hepatotoxicity, Hepatopathy, including a constellation of observable effects",139,false
AhR,[NCBIGene:196],41,"Activation, Long term AHR receptor driven direct and indirect gene expression changes",165,true
AhR,[NCBIGene:196],41,"Changes/Inhibition, Cellular Homeostasis and Apoptosis",853,false
AhR,[NCBIGene:196],41,"Alterations, Cellular proliferation / hyperplasia",854,false
AhR,[NCBIGene:196],41,"Formation, Hepatocellular and Bile duct tumors",856,false
GSK3beta,[NCBIGene:2932],410,"foxi1 expression, increased",1903,false
GSK3beta,[NCBIGene:2932],410,"six1b expression, increased",1904,false
GSK3beta,[NCBIGene:2932],410,"eya1 expression, inhibited",1905,false
GSK3beta,[NCBIGene:2932],410,"altered, inner ear development",1930,false
GSK3beta,[NCBIGene:2932],410,"Reduced, Hearing",1008,false
GSK3beta,[NCBIGene:2932],410,GSK3beta inactivation,1647,true
GSK3beta,[NCBIGene:2932],410,Repression of Gbx2 expression,1902,false
GSK3beta,[NCBIGene:2932],410,"Increase, Cell death",1825,false
GSK3beta,[NCBIGene:2932],410,"Decrease, Population growth rate",360,false
GSK3beta,[NCBIGene:2932],410,Increased Mortality,351,false
eya1,[NCBIGene:2138],410,"foxi1 expression, increased",1903,false
eya1,[NCBIGene:2138],410,"six1b expression, increased",1904,false
eya1,[NCBIGene:2138],410,"eya1 expression, inhibited",1905,false
eya1,[NCBIGene:2138],410,"altered, inner ear development",1930,false
eya1,[NCBIGene:2138],410,"Reduced, Hearing",1008,false
eya1,[NCBIGene:2138],410,GSK3beta inactivation,1647,true
eya1,[NCBIGene:2138],410,Repression of Gbx2 expression,1902,false
eya1,[NCBIGene:2138],410,"Increase, Cell death",1825,false
eya1,[NCBIGene:2138],410,"Decrease, Population growth rate",360,false
eya1,[NCBIGene:2138],410,Increased Mortality,351,false
foxi1,[NCBIGene:2299],410,"foxi1 expression, increased",1903,false
foxi1,[NCBIGene:2299],410,"six1b expression, increased",1904,false
foxi1,[NCBIGene:2299],410,"eya1 expression, inhibited",1905,false
foxi1,[NCBIGene:2299],410,"altered, inner ear development",1930,false
foxi1,[NCBIGene:2299],410,"Reduced, Hearing",1008,false
foxi1,[NCBIGene:2299],410,GSK3beta inactivation,1647,true
foxi1,[NCBIGene:2299],410,Repression of Gbx2 expression,1902,false
foxi1,[NCBIGene:2299],410,"Increase, Cell death",1825,false
foxi1,[NCBIGene:2299],410,"Decrease, Population growth rate",360,false
foxi1,[NCBIGene:2299],410,Increased Mortality,351,false
gbx2,[NCBIGene:2637],410,"foxi1 expression, increased",1903,false
gbx2,[NCBIGene:2637],410,"six1b expression, increased",1904,false
gbx2,[NCBIGene:2637],410,"eya1 expression, inhibited",1905,false
gbx2,[NCBIGene:2637],410,"altered, inner ear development",1930,false
gbx2,[NCBIGene:2637],410,"Reduced, Hearing",1008,false
gbx2,[NCBIGene:2637],410,GSK3beta inactivation,1647,true
gbx2,[NCBIGene:2637],410,Repression of Gbx2 expression,1902,false
gbx2,[NCBIGene:2637],410,"Increase, Cell death",1825,false
gbx2,[NCBIGene:2637],410,"Decrease, Population growth rate",360,false
gbx2,[NCBIGene:2637],410,Increased Mortality,351,false
six1b,[NCBIGene:317761],410,"foxi1 expression, increased",1903,false
six1b,[NCBIGene:317761],410,"six1b expression, increased",1904,false
six1b,[NCBIGene:317761],410,"eya1 expression, inhibited",1905,false
six1b,[NCBIGene:317761],410,"altered, inner ear development",1930,false
six1b,[NCBIGene:317761],410,"Reduced, Hearing",1008,false
six1b,[NCBIGene:317761],410,GSK3beta inactivation,1647,true
six1b,[NCBIGene:317761],410,Repression of Gbx2 expression,1902,false
six1b,[NCBIGene:317761],410,"Increase, Cell death",1825,false
six1b,[NCBIGene:317761],410,"Decrease, Population growth rate",360,false
six1b,[NCBIGene:317761],410,Increased Mortality,351,false
AhR,[NCBIGene:196],414,"Altered gene expression, TGF-β dependent fibrosis pathway",1920,false
AhR,[NCBIGene:196],414,Lung fibrosis,1276,false
AhR,[NCBIGene:196],414,Epithelial Mesenchymal Transition,1457,false
AhR,[NCBIGene:196],414,"Activation, AhR",18,true
AhR,[NCBIGene:196],414,"Increased, extracellular matrix deposition",1501,false
transforming growth factor,[NCBIGene:7039],414,"Altered gene expression, TGF-β dependent fibrosis pathway",1920,false
transforming growth factor,[NCBIGene:7039],414,Lung fibrosis,1276,false
transforming growth factor,[NCBIGene:7039],414,Epithelial Mesenchymal Transition,1457,false
transforming growth factor,[NCBIGene:7039],414,"Activation, AhR",18,true
transforming growth factor,[NCBIGene:7039],414,"Increased, extracellular matrix deposition",1501,false
AhR,[NCBIGene:196],415,"Altered gene expression, NF-kB dependent Interleukin-6 pathway",1921,false
AhR,[NCBIGene:196],415,Lung fibrosis,1276,false
AhR,[NCBIGene:196],415,Epithelial Mesenchymal Transition,1457,false
AhR,[NCBIGene:196],415,"Activation, AhR",18,true
AhR,[NCBIGene:196],415,"Increased, extracellular matrix deposition",1501,false
IL6,[NCBIGene:3569],415,"Altered gene expression, NF-kB dependent Interleukin-6 pathway",1921,false
IL6,[NCBIGene:3569],415,Lung fibrosis,1276,false
IL6,[NCBIGene:3569],415,Epithelial Mesenchymal Transition,1457,false
IL6,[NCBIGene:3569],415,"Activation, AhR",18,true
IL6,[NCBIGene:3569],415,"Increased, extracellular matrix deposition",1501,false
AhR,[NCBIGene:196],416,"Altered gene expression, NF-kB dependent Interleukin-6 pathway",1921,false
AhR,[NCBIGene:196],416,"Increased, Interleukin-6 production",1933,false
AhR,[NCBIGene:196],416,"Increase, Reactive oxygen species",1115,false
AhR,[NCBIGene:196],416,"Activation, AhR",18,true
AhR,[NCBIGene:196],416,"Increased, DNA damage and mutation",1669,false
AhR,[NCBIGene:196],416,Lung cancer,1670,false
IL6,[NCBIGene:3569],416,"Altered gene expression, NF-kB dependent Interleukin-6 pathway",1921,false
IL6,[NCBIGene:3569],416,"Increased, Interleukin-6 production",1933,false
IL6,[NCBIGene:3569],416,"Increase, Reactive oxygen species",1115,false
IL6,[NCBIGene:3569],416,"Activation, AhR",18,true
IL6,[NCBIGene:3569],416,"Increased, DNA damage and mutation",1669,false
IL6,[NCBIGene:3569],416,Lung cancer,1670,false
ARNT,[NCBIGene:405],417,"Increased, Reactive metabolites production",1922,false
ARNT,[NCBIGene:405],417,"Altered gene expression, AHR nuclear translocator (ARNT)-dependent pathway",17,false
ARNT,[NCBIGene:405],417,"Activation, AhR",18,true
ARNT,[NCBIGene:405],417,"Increased, DNA damage and mutation",1669,false
ARNT,[NCBIGene:405],417,Lung cancer,1670,false
AhR,[NCBIGene:196],417,"Increased, Reactive metabolites production",1922,false
AhR,[NCBIGene:196],417,"Altered gene expression, AHR nuclear translocator (ARNT)-dependent pathway",17,false
AhR,[NCBIGene:196],417,"Activation, AhR",18,true
AhR,[NCBIGene:196],417,"Increased, DNA damage and mutation",1669,false
AhR,[NCBIGene:196],417,Lung cancer,1670,false
ARNT,[NCBIGene:405],418,"Decrease, Lung function",1250,false
ARNT,[NCBIGene:405],418,"Altered gene expression, AHR nuclear translocator (ARNT)-dependent pathway",17,false
ARNT,[NCBIGene:405],418,"Increase, Reactive oxygen species",1115,false
ARNT,[NCBIGene:405],418,"Increase, Cell death",1825,false
ARNT,[NCBIGene:405],418,"Activation, AhR",18,false
AhR,[NCBIGene:196],418,"Decrease, Lung function",1250,false
AhR,[NCBIGene:196],418,"Altered gene expression, AHR nuclear translocator (ARNT)-dependent pathway",17,false
AhR,[NCBIGene:196],418,"Increase, Reactive oxygen species",1115,false
AhR,[NCBIGene:196],418,"Increase, Cell death",1825,false
AhR,[NCBIGene:196],418,"Activation, AhR",18,false
AhR,[NCBIGene:196],419,"Decrease, Lung function",1250,false
AhR,[NCBIGene:196],419,"Altered gene expression, P53 dependent apoptosis pathway",1923,false
AhR,[NCBIGene:196],419,Apoptosis,1262,false
AhR,[NCBIGene:196],419,"Activation, AhR",18,false
TP53,[NCBIGene:7157],419,"Decrease, Lung function",1250,false
TP53,[NCBIGene:7157],419,"Altered gene expression, P53 dependent apoptosis pathway",1923,false
TP53,[NCBIGene:7157],419,Apoptosis,1262,false
TP53,[NCBIGene:7157],419,"Activation, AhR",18,false
TSH,"[NCBIGene:10194, 79896]",42,"Thyroperoxidase, Inhibition",279,true
TSH,"[NCBIGene:10194, 79896]",42,"Thyroid hormone synthesis, Decreased",277,false
TSH,"[NCBIGene:10194, 79896]",42,"Cognitive function, decreased",402,false
TSH,"[NCBIGene:10194, 79896]",42,"Hippocampal gene expression, Altered",756,false
TSH,"[NCBIGene:10194, 79896]",42,"Thyroxine (T4) in neuronal tissue, Decreased",280,false
TSH,"[NCBIGene:10194, 79896]",42,"Thyroxine (T4) in serum, Decreased",281,false
TSH,"[NCBIGene:10194, 79896]",42,"Hippocampal anatomy, Altered",757,false
TSH,"[NCBIGene:10194, 79896]",42,"Hippocampal Physiology, Altered",758,false
Thyroperoxidase,[NCBIGene:7173],42,"Thyroperoxidase, Inhibition",279,true
Thyroperoxidase,[NCBIGene:7173],42,"Thyroid hormone synthesis, Decreased",277,false
Thyroperoxidase,[NCBIGene:7173],42,"Cognitive function, decreased",402,false
Thyroperoxidase,[NCBIGene:7173],42,"Hippocampal gene expression, Altered",756,false
Thyroperoxidase,[NCBIGene:7173],42,"Thyroxine (T4) in neuronal tissue, Decreased",280,false
Thyroperoxidase,[NCBIGene:7173],42,"Thyroxine (T4) in serum, Decreased",281,false
Thyroperoxidase,[NCBIGene:7173],42,"Hippocampal anatomy, Altered",757,false
Thyroperoxidase,[NCBIGene:7173],42,"Hippocampal Physiology, Altered",758,false
thyroid stimulating hormone,[NCBIGene:7253],42,"Thyroperoxidase, Inhibition",279,true
thyroid stimulating hormone,[NCBIGene:7253],42,"Thyroid hormone synthesis, Decreased",277,false
thyroid stimulating hormone,[NCBIGene:7253],42,"Cognitive function, decreased",402,false
thyroid stimulating hormone,[NCBIGene:7253],42,"Hippocampal gene expression, Altered",756,false
thyroid stimulating hormone,[NCBIGene:7253],42,"Thyroxine (T4) in neuronal tissue, Decreased",280,false
thyroid stimulating hormone,[NCBIGene:7253],42,"Thyroxine (T4) in serum, Decreased",281,false
thyroid stimulating hormone,[NCBIGene:7253],42,"Hippocampal anatomy, Altered",757,false
thyroid stimulating hormone,[NCBIGene:7253],42,"Hippocampal Physiology, Altered",758,false
AhR,[NCBIGene:196],420,"Altered gene expression, NRF2 dependent antioxidant pathway",1917,false
AhR,[NCBIGene:196],420,"Increase, Cell Proliferation",870,false
AhR,[NCBIGene:196],420,"Activation, AhR",18,true
AhR,[NCBIGene:196],420,Lung cancer,1670,false
Nrf2,[NCBIGene:4780],420,"Altered gene expression, NRF2 dependent antioxidant pathway",1917,false
Nrf2,[NCBIGene:4780],420,"Increase, Cell Proliferation",870,false
Nrf2,[NCBIGene:4780],420,"Activation, AhR",18,true
Nrf2,[NCBIGene:4780],420,Lung cancer,1670,false
PPAR gamma,[NCBIGene:5468],421,"Altered gene expression, NRF2 dependent antioxidant pathway",1917,false
ACE2,[NCBIGene:59272],422,"Intestinal barrier, disruption",1931,false
ACE2,[NCBIGene:59272],422,SARS-CoV-2 cell entry,1738,false
ACE2,[NCBIGene:59272],422,Binding to ACE2,1739,true
ACE2,[NCBIGene:59272],422,Increased SARS-CoV-2 production,1847,false
ACE2,[NCBIGene:59272],422,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
AIF,[NCBIGene:9131],423,Mitochondrial dysfunction,177,false
AIF,[NCBIGene:9131],423,"Activation, PARP1",2030,true
AIF,[NCBIGene:9131],423,"Releasing, Apoptosis-Inducing Factor (AIF)",2031,false
AIF,[NCBIGene:9131],423,"Increase, Reactive oxygen species",1115,true
AIF,[NCBIGene:9131],423,"Increase, DNA damage",1194,false
AIF,[NCBIGene:9131],423,Apoptotic cell death,1817,false
PARP1,[NCBIGene:142],423,Mitochondrial dysfunction,177,false
PARP1,[NCBIGene:142],423,"Activation, PARP1",2030,true
PARP1,[NCBIGene:142],423,"Releasing, Apoptosis-Inducing Factor (AIF)",2031,false
PARP1,[NCBIGene:142],423,"Increase, Reactive oxygen species",1115,true
PARP1,[NCBIGene:142],423,"Increase, DNA damage",1194,false
PARP1,[NCBIGene:142],423,Apoptotic cell death,1817,false
ASL,[NCBIGene:435],424,"Decrease, Lung function",1250,false
ASL,[NCBIGene:435],424,"Cilia Beat Frequency, Decreased",1908,false
ASL,[NCBIGene:435],424,"Mucociliary Clearance, Decreased",1909,false
ASL,[NCBIGene:435],424,"Cystic Fibrosis Transmembrane Regulator Function, Decreased",1906,false
ASL,[NCBIGene:435],424,"Airway Surface Liquid Height, Decreased",1907,false
ASL,[NCBIGene:435],424,Oxidative Stress,1392,true
CFTR,[NCBIGene:1080],424,"Decrease, Lung function",1250,false
CFTR,[NCBIGene:1080],424,"Cilia Beat Frequency, Decreased",1908,false
CFTR,[NCBIGene:1080],424,"Mucociliary Clearance, Decreased",1909,false
CFTR,[NCBIGene:1080],424,"Cystic Fibrosis Transmembrane Regulator Function, Decreased",1906,false
CFTR,[NCBIGene:1080],424,"Airway Surface Liquid Height, Decreased",1907,false
CFTR,[NCBIGene:1080],424,Oxidative Stress,1392,true
FOXJ1,[NCBIGene:2302],425,"Decrease, Lung function",1250,false
FOXJ1,[NCBIGene:2302],425,"Cilia Beat Frequency, Decreased",1908,false
FOXJ1,[NCBIGene:2302],425,"Mucociliary Clearance, Decreased",1909,false
FOXJ1,[NCBIGene:2302],425,"FOXJ1 Protein, Decreased",1911,false
FOXJ1,[NCBIGene:2302],425,"Motile Cilia Number/Length, Decreased",1912,false
FOXJ1,[NCBIGene:2302],425,Oxidative Stress,1392,true
ACE2 receptor,[NCBIGene:340485],426,Endothelial cell dysfunction,1913,false
ACE2 receptor,[NCBIGene:340485],426,Myocardial Infarction,1934,false
ACE2 receptor,[NCBIGene:340485],426,Impaired mechanotransduction of pericytes,1946,false
ACE2 receptor,[NCBIGene:340485],426,Pericyte dysfunction,1947,false
ACE2 receptor,[NCBIGene:340485],426,Increased ACE2 expression,1948,false
ACE2 receptor,[NCBIGene:340485],426,Heart failure,1535,false
ACE2 receptor,[NCBIGene:340485],426,SARS-CoV-2 cell entry,1738,false
ACE2 receptor,[NCBIGene:340485],426,Binding to ACE2,1739,true
ACE2 receptor,[NCBIGene:340485],426,Increased inflammatory immune responses,1750,false
ACE2 receptor,[NCBIGene:340485],426,"Induced, dysfunction of microcirculation",1666,false
Sars-CoV-2 spike protein,[NCBIGene:54938],426,Endothelial cell dysfunction,1913,false
Sars-CoV-2 spike protein,[NCBIGene:54938],426,Myocardial Infarction,1934,false
Sars-CoV-2 spike protein,[NCBIGene:54938],426,Impaired mechanotransduction of pericytes,1946,false
Sars-CoV-2 spike protein,[NCBIGene:54938],426,Pericyte dysfunction,1947,false
Sars-CoV-2 spike protein,[NCBIGene:54938],426,Increased ACE2 expression,1948,false
Sars-CoV-2 spike protein,[NCBIGene:54938],426,Heart failure,1535,false
Sars-CoV-2 spike protein,[NCBIGene:54938],426,SARS-CoV-2 cell entry,1738,false
Sars-CoV-2 spike protein,[NCBIGene:54938],426,Binding to ACE2,1739,true
Sars-CoV-2 spike protein,[NCBIGene:54938],426,Increased inflammatory immune responses,1750,false
Sars-CoV-2 spike protein,[NCBIGene:54938],426,"Induced, dysfunction of microcirculation",1666,false
ACE2,[NCBIGene:59272],427,Hyperactivation of ACE/Ang-II/AT1R axis,1853,false
ACE2,[NCBIGene:59272],427,Angiotensin (1-7) levels diminished,1935,false
ACE2,[NCBIGene:59272],427,"Induced, Angiotensin (Ang) II accumulation",1741,false
ACE2,[NCBIGene:59272],427,Angiotensin II degradation reduced,1936,false
ACE2,[NCBIGene:59272],427,ADAM17 expression induction,1937,false
ACE2,[NCBIGene:59272],427,ACE2 increased shedding,1938,false
ACE2,[NCBIGene:59272],427,Heart failure,1535,false
ACE2,[NCBIGene:59272],427,Binding to ACE2,1739,true
ACE2,[NCBIGene:59272],427,"Downregulation, ACE2",1787,false
ACE2,[NCBIGene:59272],428,"Gut microbiota, alteration",1954,false
ACE2,[NCBIGene:59272],428,"Dysregulation, ACE2 expression and activity",1854,false
ACE2,[NCBIGene:59272],428,Binding to ACE2,1739,true
ACE2 receptor,[NCBIGene:340485],428,"Gut microbiota, alteration",1954,false
ACE2 receptor,[NCBIGene:340485],428,"Dysregulation, ACE2 expression and activity",1854,false
ACE2 receptor,[NCBIGene:340485],428,Binding to ACE2,1739,true
Slc6a19,[NCBIGene:340024],428,"Gut microbiota, alteration",1954,false
Slc6a19,[NCBIGene:340024],428,"Dysregulation, ACE2 expression and activity",1854,false
Slc6a19,[NCBIGene:340024],428,Binding to ACE2,1739,true
angiotensin,[NCBIGene:183],428,"Gut microbiota, alteration",1954,false
angiotensin,[NCBIGene:183],428,"Dysregulation, ACE2 expression and activity",1854,false
angiotensin,[NCBIGene:183],428,Binding to ACE2,1739,true
capsid(S) glycoprotein,[NCBIGene:7448],428,"Gut microbiota, alteration",1954,false
capsid(S) glycoprotein,[NCBIGene:7448],428,"Dysregulation, ACE2 expression and activity",1854,false
capsid(S) glycoprotein,[NCBIGene:7448],428,Binding to ACE2,1739,true
renin,[NCBIGene:5972],428,"Gut microbiota, alteration",1954,false
renin,[NCBIGene:5972],428,"Dysregulation, ACE2 expression and activity",1854,false
renin,[NCBIGene:5972],428,Binding to ACE2,1739,true
tryptophan transporter B0AT1,[NCBIGene:11254],428,"Gut microbiota, alteration",1954,false
tryptophan transporter B0AT1,[NCBIGene:11254],428,"Dysregulation, ACE2 expression and activity",1854,false
tryptophan transporter B0AT1,[NCBIGene:11254],428,Binding to ACE2,1739,true
A-beta,[NCBIGene:8803],429,Neuroinflammation,188,false
A-beta,[NCBIGene:8803],429,Mitochondrial dysfunction EMPTY,1816,false
A-beta,[NCBIGene:8803],429,Memory Loss,1941,false
A-beta,[NCBIGene:8803],429,"Accumulation, Cytosolic toxic Tau oligomers",1942,false
A-beta,[NCBIGene:8803],429,Hyperphosphorylation of Tau,1943,false
A-beta,[NCBIGene:8803],429,Dysfunctional Autophagy,1945,false
A-beta,[NCBIGene:8803],429,Synaptic dysfunction,1944,false
A-beta,[NCBIGene:8803],429,Impaired axonial transport,1582,false
A-beta,[NCBIGene:8803],429,Oxidative Stress,1392,false
A-beta,[NCBIGene:8803],429,Decrease of neuronal network function,386,false
tau,[NCBIGene:4137],429,Neuroinflammation,188,false
tau,[NCBIGene:4137],429,Mitochondrial dysfunction EMPTY,1816,false
tau,[NCBIGene:4137],429,Memory Loss,1941,false
tau,[NCBIGene:4137],429,"Accumulation, Cytosolic toxic Tau oligomers",1942,false
tau,[NCBIGene:4137],429,Hyperphosphorylation of Tau,1943,false
tau,[NCBIGene:4137],429,Dysfunctional Autophagy,1945,false
tau,[NCBIGene:4137],429,Synaptic dysfunction,1944,false
tau,[NCBIGene:4137],429,Impaired axonial transport,1582,false
tau,[NCBIGene:4137],429,Oxidative Stress,1392,false
tau,[NCBIGene:4137],429,Decrease of neuronal network function,386,false
ACE2,[NCBIGene:59272],430,"Viral infection and host-to-host transmission, proliferated",1939,false
ACE2,[NCBIGene:59272],430,SARS-CoV-2 cell entry,1738,false
ACE2,[NCBIGene:59272],430,Binding to ACE2,1739,true
ACE2,[NCBIGene:59272],430,Increased SARS-CoV-2 production,1847,false
ACE2,[NCBIGene:59272],430,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
ACE2 receptor,[NCBIGene:340485],430,"Viral infection and host-to-host transmission, proliferated",1939,false
ACE2 receptor,[NCBIGene:340485],430,SARS-CoV-2 cell entry,1738,false
ACE2 receptor,[NCBIGene:340485],430,Binding to ACE2,1739,true
ACE2 receptor,[NCBIGene:340485],430,Increased SARS-CoV-2 production,1847,false
ACE2 receptor,[NCBIGene:340485],430,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
Sars-CoV-2 spike protein,[NCBIGene:54938],430,"Viral infection and host-to-host transmission, proliferated",1939,false
Sars-CoV-2 spike protein,[NCBIGene:54938],430,SARS-CoV-2 cell entry,1738,false
Sars-CoV-2 spike protein,[NCBIGene:54938],430,Binding to ACE2,1739,true
Sars-CoV-2 spike protein,[NCBIGene:54938],430,Increased SARS-CoV-2 production,1847,false
Sars-CoV-2 spike protein,[NCBIGene:54938],430,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
interferon signalling network genes,[NCBIGene:3438],430,"Viral infection and host-to-host transmission, proliferated",1939,false
interferon signalling network genes,[NCBIGene:3438],430,SARS-CoV-2 cell entry,1738,false
interferon signalling network genes,[NCBIGene:3438],430,Binding to ACE2,1739,true
interferon signalling network genes,[NCBIGene:3438],430,Increased SARS-CoV-2 production,1847,false
interferon signalling network genes,[NCBIGene:3438],430,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
nsps,"[NCBIGene:57142, 6252, 9372, 92521]",430,"Viral infection and host-to-host transmission, proliferated",1939,false
nsps,"[NCBIGene:57142, 6252, 9372, 92521]",430,SARS-CoV-2 cell entry,1738,false
nsps,"[NCBIGene:57142, 6252, 9372, 92521]",430,Binding to ACE2,1739,true
nsps,"[NCBIGene:57142, 6252, 9372, 92521]",430,Increased SARS-CoV-2 production,1847,false
nsps,"[NCBIGene:57142, 6252, 9372, 92521]",430,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
TNFalpha,[NCBIGene:7124],431,Gestational diabetes mellitus,1953,false
TNFalpha,[NCBIGene:7124],431,"Increase, TNF",1950,true
TNFalpha,[NCBIGene:7124],431,"Decrease, GLUT4",1949,false
TNFalpha,[NCBIGene:7124],431,"Decrease, Glucose uptake",1951,false
TNFalpha,[NCBIGene:7124],431,"Abnormal, Glucose homeostasis",1952,false
glucose transporter type 4,[NCBIGene:6517],431,Gestational diabetes mellitus,1953,false
glucose transporter type 4,[NCBIGene:6517],431,"Increase, TNF",1950,true
glucose transporter type 4,[NCBIGene:6517],431,"Decrease, GLUT4",1949,false
glucose transporter type 4,[NCBIGene:6517],431,"Decrease, Glucose uptake",1951,false
glucose transporter type 4,[NCBIGene:6517],431,"Abnormal, Glucose homeostasis",1952,false
hERG,[NCBIGene:3757],433,hERG channel blockade,2099,true
hERG,[NCBIGene:3757],433,Inhibition of rapid delayed rectifying potassium current,2100,false
hERG,[NCBIGene:3757],433,Prolongation of Action Potential Duration,1961,false
hERG,[NCBIGene:3757],433,Prolongation of QT interval,1962,false
hERG,[NCBIGene:3757],433,Torsades de Pointes,1963,false
hERG,[NCBIGene:3757],433,Sudden cardiac death,1964,false
ER,"[NCBIGene:2099, 2069]",440,"Increased, Steroidogenic acute regulatory protein (StAR)",1972,false
ER,"[NCBIGene:2099, 2069]",440,"Increased, estrogens",1973,false
ER,"[NCBIGene:2099, 2069]",440,"Promotion, Ovarian Cancer",2092,false
ER,"[NCBIGene:2099, 2069]",440,"Increased, circulating estrogen levels",1076,false
ER,"[NCBIGene:2099, 2069]",440,"Suppression, Estrogen receptor (ER) activity",1046,true
ER,"[NCBIGene:2099, 2069]",440,"Increased, secretion of GnRH from hypothalamus",1047,false
ER,"[NCBIGene:2099, 2069]",440,"Increased, secretion of LH from anterior pituitary",1050,false
ER,"[NCBIGene:2099, 2069]",440,"Hyperplasia, ovarian epithelium",1052,false
ER,"[NCBIGene:2099, 2069]",440,"Promotion, ovarian adenomas",1053,false
GnRH,[NCBIGene:2796],440,"Increased, Steroidogenic acute regulatory protein (StAR)",1972,false
GnRH,[NCBIGene:2796],440,"Increased, estrogens",1973,false
GnRH,[NCBIGene:2796],440,"Promotion, Ovarian Cancer",2092,false
GnRH,[NCBIGene:2796],440,"Increased, circulating estrogen levels",1076,false
GnRH,[NCBIGene:2796],440,"Suppression, Estrogen receptor (ER) activity",1046,true
GnRH,[NCBIGene:2796],440,"Increased, secretion of GnRH from hypothalamus",1047,false
GnRH,[NCBIGene:2796],440,"Increased, secretion of LH from anterior pituitary",1050,false
GnRH,[NCBIGene:2796],440,"Hyperplasia, ovarian epithelium",1052,false
GnRH,[NCBIGene:2796],440,"Promotion, ovarian adenomas",1053,false
Luteinizing,[NCBIGene:5351],440,"Increased, Steroidogenic acute regulatory protein (StAR)",1972,false
Luteinizing,[NCBIGene:5351],440,"Increased, estrogens",1973,false
Luteinizing,[NCBIGene:5351],440,"Promotion, Ovarian Cancer",2092,false
Luteinizing,[NCBIGene:5351],440,"Increased, circulating estrogen levels",1076,false
Luteinizing,[NCBIGene:5351],440,"Suppression, Estrogen receptor (ER) activity",1046,true
Luteinizing,[NCBIGene:5351],440,"Increased, secretion of GnRH from hypothalamus",1047,false
Luteinizing,[NCBIGene:5351],440,"Increased, secretion of LH from anterior pituitary",1050,false
Luteinizing,[NCBIGene:5351],440,"Hyperplasia, ovarian epithelium",1052,false
Luteinizing,[NCBIGene:5351],440,"Promotion, ovarian adenomas",1053,false
TP53,[NCBIGene:7157],441,"Increase, DNA damage",1194,false
TP53,[NCBIGene:7157],441,Activation of Tumor Protein 53,1974,false
TP53,[NCBIGene:7157],441,"Increase risk, microcephaly",1978,false
TP53,[NCBIGene:7157],441,Premature cell differentiation,1979,false
TP53,[NCBIGene:7157],441,"decline, neural progenitor cells",2200,false
TP53,[NCBIGene:7157],441,Apoptosis,1262,false
TP53,[NCBIGene:7157],441,Deposition of Energy,1686,true
Sodium channel,[NCBIGene:6335],442,"Cognitive function, decreased",402,false
Sodium channel,[NCBIGene:6335],442,Disruption of sodium channel gating kinetics,1977,false
Sodium channel,[NCBIGene:6335],442,"Disruption, action potential generation",1983,false
Sodium channel,[NCBIGene:6335],442,Altered neurotransmission in development,2005,false
Sodium channel,[NCBIGene:6335],442,Binding to voltage-gated sodium channel,1353,true
Sodium channel,[NCBIGene:6335],442,"Hippocampal anatomy, Altered",757,false
Sodium channel,[NCBIGene:6335],442,"Hippocampal Physiology, Altered",758,false
VGSC,[NCBIGene:654],442,"Cognitive function, decreased",402,false
VGSC,[NCBIGene:654],442,Disruption of sodium channel gating kinetics,1977,false
VGSC,[NCBIGene:654],442,"Disruption, action potential generation",1983,false
VGSC,[NCBIGene:654],442,Altered neurotransmission in development,2005,false
VGSC,[NCBIGene:654],442,Binding to voltage-gated sodium channel,1353,true
VGSC,[NCBIGene:654],442,"Hippocampal anatomy, Altered",757,false
VGSC,[NCBIGene:654],442,"Hippocampal Physiology, Altered",758,false
VGSCs,[NCBIGene:105031671],442,"Cognitive function, decreased",402,false
VGSCs,[NCBIGene:105031671],442,Disruption of sodium channel gating kinetics,1977,false
VGSCs,[NCBIGene:105031671],442,"Disruption, action potential generation",1983,false
VGSCs,[NCBIGene:105031671],442,Altered neurotransmission in development,2005,false
VGSCs,[NCBIGene:105031671],442,Binding to voltage-gated sodium channel,1353,true
VGSCs,[NCBIGene:105031671],442,"Hippocampal anatomy, Altered",757,false
VGSCs,[NCBIGene:105031671],442,"Hippocampal Physiology, Altered",758,false
ER,"[NCBIGene:2099, 2069]",445,"Increased, Kisspeptin signalling",1985,false
ER,"[NCBIGene:2099, 2069]",445,"Decreased, Gonadotropins",1986,false
ER,"[NCBIGene:2099, 2069]",445,"Decreased, Androgen and Progestin",1987,false
ER,"[NCBIGene:2099, 2069]",445,"Decreased, Maturation Inducing Steroid Surge by Granulosa cells",1988,false
ER,"[NCBIGene:2099, 2069]",445,"Impaired, Oocyte maturation and ovulation",1989,false
ER,"[NCBIGene:2099, 2069]",445,"Increased, Oocyte Atresia",1990,false
ER,"[NCBIGene:2099, 2069]",445,"Impaired, Reproduction",1991,false
ER,"[NCBIGene:2099, 2069]",445,"Activation, estrogen receptor alpha",1065,true
GnRH,[NCBIGene:2796],445,"Increased, Kisspeptin signalling",1985,false
GnRH,[NCBIGene:2796],445,"Decreased, Gonadotropins",1986,false
GnRH,[NCBIGene:2796],445,"Decreased, Androgen and Progestin",1987,false
GnRH,[NCBIGene:2796],445,"Decreased, Maturation Inducing Steroid Surge by Granulosa cells",1988,false
GnRH,[NCBIGene:2796],445,"Impaired, Oocyte maturation and ovulation",1989,false
GnRH,[NCBIGene:2796],445,"Increased, Oocyte Atresia",1990,false
GnRH,[NCBIGene:2796],445,"Impaired, Reproduction",1991,false
GnRH,[NCBIGene:2796],445,"Activation, estrogen receptor alpha",1065,true
gonadotropins,[NCBIGene:59352],445,"Increased, Kisspeptin signalling",1985,false
gonadotropins,[NCBIGene:59352],445,"Decreased, Gonadotropins",1986,false
gonadotropins,[NCBIGene:59352],445,"Decreased, Androgen and Progestin",1987,false
gonadotropins,[NCBIGene:59352],445,"Decreased, Maturation Inducing Steroid Surge by Granulosa cells",1988,false
gonadotropins,[NCBIGene:59352],445,"Impaired, Oocyte maturation and ovulation",1989,false
gonadotropins,[NCBIGene:59352],445,"Increased, Oocyte Atresia",1990,false
gonadotropins,[NCBIGene:59352],445,"Impaired, Reproduction",1991,false
gonadotropins,[NCBIGene:59352],445,"Activation, estrogen receptor alpha",1065,true
kisspeptin,[NCBIGene:3814],445,"Increased, Kisspeptin signalling",1985,false
kisspeptin,[NCBIGene:3814],445,"Decreased, Gonadotropins",1986,false
kisspeptin,[NCBIGene:3814],445,"Decreased, Androgen and Progestin",1987,false
kisspeptin,[NCBIGene:3814],445,"Decreased, Maturation Inducing Steroid Surge by Granulosa cells",1988,false
kisspeptin,[NCBIGene:3814],445,"Impaired, Oocyte maturation and ovulation",1989,false
kisspeptin,[NCBIGene:3814],445,"Increased, Oocyte Atresia",1990,false
kisspeptin,[NCBIGene:3814],445,"Impaired, Reproduction",1991,false
kisspeptin,[NCBIGene:3814],445,"Activation, estrogen receptor alpha",1065,true
NF-B,[NCBIGene:4781],447,"Occurrence, Kidney toxicity",814,false
NF-B,[NCBIGene:4781],447,"Occurrence, renal proximal tubular necrosis",1097,false
NF-B,[NCBIGene:4781],447,Mitochondrial dysfunction,177,false
NF-B,[NCBIGene:4781],447,"Altered gene expression, NRF2 dependent antioxidant pathway",1917,false
NF-B,[NCBIGene:4781],447,"Inhibition, Mitochondrial Electron Transport Chain Complexes",105,false
NF-B,[NCBIGene:4781],447,"Increase, Apoptosis",1365,false
NF-B,[NCBIGene:4781],447,"Decrease, Mitochondrial membrane potential",1770,false
NF-B,[NCBIGene:4781],447,"Increased, Kidney Failure",759,false
NF-B,[NCBIGene:4781],447,Increase in inflammation,1633,false
NF-B,[NCBIGene:4781],447,Activation of ER stress,1815,false
NF-B,[NCBIGene:4781],447,Oxidative Stress,1392,false
NF-B,[NCBIGene:4781],447,"Inhibition, Nuclear factor kappa B (NF-kB)",202,false
Nrf2,[NCBIGene:4780],447,"Occurrence, Kidney toxicity",814,false
Nrf2,[NCBIGene:4780],447,"Occurrence, renal proximal tubular necrosis",1097,false
Nrf2,[NCBIGene:4780],447,Mitochondrial dysfunction,177,false
Nrf2,[NCBIGene:4780],447,"Altered gene expression, NRF2 dependent antioxidant pathway",1917,false
Nrf2,[NCBIGene:4780],447,"Inhibition, Mitochondrial Electron Transport Chain Complexes",105,false
Nrf2,[NCBIGene:4780],447,"Increase, Apoptosis",1365,false
Nrf2,[NCBIGene:4780],447,"Decrease, Mitochondrial membrane potential",1770,false
Nrf2,[NCBIGene:4780],447,"Increased, Kidney Failure",759,false
Nrf2,[NCBIGene:4780],447,Increase in inflammation,1633,false
Nrf2,[NCBIGene:4780],447,Activation of ER stress,1815,false
Nrf2,[NCBIGene:4780],447,Oxidative Stress,1392,false
Nrf2,[NCBIGene:4780],447,"Inhibition, Nuclear factor kappa B (NF-kB)",202,false
sodium-dependent phosphate co-transporter,[NCBIGene:6569],447,"Occurrence, Kidney toxicity",814,false
sodium-dependent phosphate co-transporter,[NCBIGene:6569],447,"Occurrence, renal proximal tubular necrosis",1097,false
sodium-dependent phosphate co-transporter,[NCBIGene:6569],447,Mitochondrial dysfunction,177,false
sodium-dependent phosphate co-transporter,[NCBIGene:6569],447,"Altered gene expression, NRF2 dependent antioxidant pathway",1917,false
sodium-dependent phosphate co-transporter,[NCBIGene:6569],447,"Inhibition, Mitochondrial Electron Transport Chain Complexes",105,false
sodium-dependent phosphate co-transporter,[NCBIGene:6569],447,"Increase, Apoptosis",1365,false
sodium-dependent phosphate co-transporter,[NCBIGene:6569],447,"Decrease, Mitochondrial membrane potential",1770,false
sodium-dependent phosphate co-transporter,[NCBIGene:6569],447,"Increased, Kidney Failure",759,false
sodium-dependent phosphate co-transporter,[NCBIGene:6569],447,Increase in inflammation,1633,false
sodium-dependent phosphate co-transporter,[NCBIGene:6569],447,Activation of ER stress,1815,false
sodium-dependent phosphate co-transporter,[NCBIGene:6569],447,Oxidative Stress,1392,false
sodium-dependent phosphate co-transporter,[NCBIGene:6569],447,"Inhibition, Nuclear factor kappa B (NF-kB)",202,false
CerS,"[NCBIGene:2657, 10715]",449,Inhibition of Ceramide Synthase,2023,true
CerS,"[NCBIGene:2657, 10715]",449,Reduced complex sphingolipids,2024,false
CerS,"[NCBIGene:2657, 10715]",449,Affected folate transporter,2025,false
CerS,"[NCBIGene:2657, 10715]",449,decreased folate uptake,2026,false
CerS,"[NCBIGene:2657, 10715]",449,Increased sphingolipid-1-phosphate,2033,false
CerS,"[NCBIGene:2657, 10715]",449,Neural tube defects,1561,false
CerS,"[NCBIGene:2657, 10715]",449,Histone deacetylase inhibition,1502,false
Ceramide synthase,[NCBIGene:83723],449,Inhibition of Ceramide Synthase,2023,true
Ceramide synthase,[NCBIGene:83723],449,Reduced complex sphingolipids,2024,false
Ceramide synthase,[NCBIGene:83723],449,Affected folate transporter,2025,false
Ceramide synthase,[NCBIGene:83723],449,decreased folate uptake,2026,false
Ceramide synthase,[NCBIGene:83723],449,Increased sphingolipid-1-phosphate,2033,false
Ceramide synthase,[NCBIGene:83723],449,Neural tube defects,1561,false
Ceramide synthase,[NCBIGene:83723],449,Histone deacetylase inhibition,1502,false
HDAC,[NCBIGene:9734],449,Inhibition of Ceramide Synthase,2023,true
HDAC,[NCBIGene:9734],449,Reduced complex sphingolipids,2024,false
HDAC,[NCBIGene:9734],449,Affected folate transporter,2025,false
HDAC,[NCBIGene:9734],449,decreased folate uptake,2026,false
HDAC,[NCBIGene:9734],449,Increased sphingolipid-1-phosphate,2033,false
HDAC,[NCBIGene:9734],449,Neural tube defects,1561,false
HDAC,[NCBIGene:9734],449,Histone deacetylase inhibition,1502,false
Histone deacetylase,[NCBIGene:3065],449,Inhibition of Ceramide Synthase,2023,true
Histone deacetylase,[NCBIGene:3065],449,Reduced complex sphingolipids,2024,false
Histone deacetylase,[NCBIGene:3065],449,Affected folate transporter,2025,false
Histone deacetylase,[NCBIGene:3065],449,decreased folate uptake,2026,false
Histone deacetylase,[NCBIGene:3065],449,Increased sphingolipid-1-phosphate,2033,false
Histone deacetylase,[NCBIGene:3065],449,Neural tube defects,1561,false
Histone deacetylase,[NCBIGene:3065],449,Histone deacetylase inhibition,1502,false
Acetylcholinesterase,[NCBIGene:43],450,"Decreased, Neuronal network function in adult brain",618,false
Acetylcholinesterase,[NCBIGene:43],450,Sensory axonal peripheral neuropathy,1583,false
Acetylcholinesterase,[NCBIGene:43],450,Activation of Cyp2E1,1391,false
Acetylcholinesterase,[NCBIGene:43],450,Oxidative Stress,1392,false
Acetylcholinesterase,[NCBIGene:43],450,Acetylcholinesterase (AchE) Inhibition,12,true
Acetylcholinesterase,[NCBIGene:43],450,Increased Mortality,351,false
Acetylcholinesterase,[NCBIGene:43],450,"N/A, Neurodegeneration",352,false
CYP2E1,[NCBIGene:1571],450,"Decreased, Neuronal network function in adult brain",618,false
CYP2E1,[NCBIGene:1571],450,Sensory axonal peripheral neuropathy,1583,false
CYP2E1,[NCBIGene:1571],450,Activation of Cyp2E1,1391,false
CYP2E1,[NCBIGene:1571],450,Oxidative Stress,1392,false
CYP2E1,[NCBIGene:1571],450,Acetylcholinesterase (AchE) Inhibition,12,true
CYP2E1,[NCBIGene:1571],450,Increased Mortality,351,false
CYP2E1,[NCBIGene:1571],450,"N/A, Neurodegeneration",352,false
c-Jun N-terminal kinase,[NCBIGene:5599],450,"Decreased, Neuronal network function in adult brain",618,false
c-Jun N-terminal kinase,[NCBIGene:5599],450,Sensory axonal peripheral neuropathy,1583,false
c-Jun N-terminal kinase,[NCBIGene:5599],450,Activation of Cyp2E1,1391,false
c-Jun N-terminal kinase,[NCBIGene:5599],450,Oxidative Stress,1392,false
c-Jun N-terminal kinase,[NCBIGene:5599],450,Acetylcholinesterase (AchE) Inhibition,12,true
c-Jun N-terminal kinase,[NCBIGene:5599],450,Increased Mortality,351,false
c-Jun N-terminal kinase,[NCBIGene:5599],450,"N/A, Neurodegeneration",352,false
serine esterases,[NCBIGene:1066],450,"Decreased, Neuronal network function in adult brain",618,false
serine esterases,[NCBIGene:1066],450,Sensory axonal peripheral neuropathy,1583,false
serine esterases,[NCBIGene:1066],450,Activation of Cyp2E1,1391,false
serine esterases,[NCBIGene:1066],450,Oxidative Stress,1392,false
serine esterases,[NCBIGene:1066],450,Acetylcholinesterase (AchE) Inhibition,12,true
serine esterases,[NCBIGene:1066],450,Increased Mortality,351,false
serine esterases,[NCBIGene:1066],450,"N/A, Neurodegeneration",352,false
Succinate dehydrogenase,[NCBIGene:6392],457,"Thyroid hormone synthesis, Decreased",277,false
Succinate dehydrogenase,[NCBIGene:6392],457,"Succinate dehydrogenase, inhibited",2118,true
Succinate dehydrogenase,[NCBIGene:6392],457,"Insulin resistance, increased",2119,false
Succinate dehydrogenase,[NCBIGene:6392],457,"Superoxide generation, increased",2120,false
Succinate dehydrogenase,[NCBIGene:6392],457,Oxidative Stress,1392,false
Succinate dehydrogenase,[NCBIGene:6392],457,"Thyroxine (T4) in serum, Decreased",281,false
insulin,[NCBIGene:3630],457,"Thyroid hormone synthesis, Decreased",277,false
insulin,[NCBIGene:3630],457,"Succinate dehydrogenase, inhibited",2118,true
insulin,[NCBIGene:3630],457,"Insulin resistance, increased",2119,false
insulin,[NCBIGene:3630],457,"Superoxide generation, increased",2120,false
insulin,[NCBIGene:3630],457,Oxidative Stress,1392,false
insulin,[NCBIGene:3630],457,"Thyroxine (T4) in serum, Decreased",281,false
AhR,[NCBIGene:196],458,"Cognitive function, decreased",402,false
AhR,[NCBIGene:196],458,"Hippocampal gene expression, Altered",756,false
AhR,[NCBIGene:196],458,"Activation, AhR",18,true
AhR,[NCBIGene:196],458,"Thyroxine (T4) in neuronal tissue, Decreased",280,false
AhR,[NCBIGene:196],458,"Thyroxine (T4) in serum, Decreased",281,false
AhR,[NCBIGene:196],458,"Induction, Upregulation of glucuronyltransferase activity",295,false
AhR,[NCBIGene:196],458,"Hippocampal Physiology, Altered",758,false
AhR,[NCBIGene:196],458,"Increased, Clearance of thyroxine from serum",961,false
UGT,[NCBIGene:7361],458,"Cognitive function, decreased",402,false
UGT,[NCBIGene:7361],458,"Hippocampal gene expression, Altered",756,false
UGT,[NCBIGene:7361],458,"Activation, AhR",18,true
UGT,[NCBIGene:7361],458,"Thyroxine (T4) in neuronal tissue, Decreased",280,false
UGT,[NCBIGene:7361],458,"Thyroxine (T4) in serum, Decreased",281,false
UGT,[NCBIGene:7361],458,"Induction, Upregulation of glucuronyltransferase activity",295,false
UGT,[NCBIGene:7361],458,"Hippocampal Physiology, Altered",758,false
UGT,[NCBIGene:7361],458,"Increased, Clearance of thyroxine from serum",961,false
AhR,[NCBIGene:196],459,"Thyroid hormone synthesis, Decreased",277,false
AhR,[NCBIGene:196],459,"Cognitive function, decreased",402,false
AhR,[NCBIGene:196],459,"Induction, CYP1A2/CYP1A5",850,false
AhR,[NCBIGene:196],459,"Hippocampal gene expression, Altered",756,false
AhR,[NCBIGene:196],459,"Activation, AhR",18,true
AhR,[NCBIGene:196],459,Oxidative Stress,1392,false
AhR,[NCBIGene:196],459,"Thyroxine (T4) in neuronal tissue, Decreased",280,false
AhR,[NCBIGene:196],459,"Thyroxine (T4) in serum, Decreased",281,false
AhR,[NCBIGene:196],459,"Hippocampal Physiology, Altered",758,false
CYP enzymes,[NCBIGene:9360],459,"Thyroid hormone synthesis, Decreased",277,false
CYP enzymes,[NCBIGene:9360],459,"Cognitive function, decreased",402,false
CYP enzymes,[NCBIGene:9360],459,"Induction, CYP1A2/CYP1A5",850,false
CYP enzymes,[NCBIGene:9360],459,"Hippocampal gene expression, Altered",756,false
CYP enzymes,[NCBIGene:9360],459,"Activation, AhR",18,true
CYP enzymes,[NCBIGene:9360],459,Oxidative Stress,1392,false
CYP enzymes,[NCBIGene:9360],459,"Thyroxine (T4) in neuronal tissue, Decreased",280,false
CYP enzymes,[NCBIGene:9360],459,"Thyroxine (T4) in serum, Decreased",281,false
CYP enzymes,[NCBIGene:9360],459,"Hippocampal Physiology, Altered",758,false
UGT,[NCBIGene:7361],459,"Thyroid hormone synthesis, Decreased",277,false
UGT,[NCBIGene:7361],459,"Cognitive function, decreased",402,false
UGT,[NCBIGene:7361],459,"Induction, CYP1A2/CYP1A5",850,false
UGT,[NCBIGene:7361],459,"Hippocampal gene expression, Altered",756,false
UGT,[NCBIGene:7361],459,"Activation, AhR",18,true
UGT,[NCBIGene:7361],459,Oxidative Stress,1392,false
UGT,[NCBIGene:7361],459,"Thyroxine (T4) in neuronal tissue, Decreased",280,false
UGT,[NCBIGene:7361],459,"Thyroxine (T4) in serum, Decreased",281,false
UGT,[NCBIGene:7361],459,"Hippocampal Physiology, Altered",758,false
BMP,[NCBIGene:649],460,"Decrease, Cell proliferation",1821,false
BMP,[NCBIGene:649],460,Apoptosis,1262,false
BMP,[NCBIGene:649],460,"Antagonism, Smoothened receptor",2027,true
BMP,[NCBIGene:649],460,"Decrease, GLI1/2 translocation to nucleus",2028,false
BMP,[NCBIGene:649],460,"Decrease, GLI1/2 target gene expression",2040,false
BMP,[NCBIGene:649],460,"Decrease, facial prominence outgrowth",2041,false
BMP,[NCBIGene:649],460,"Increase, Orofacial clefting",2042,false
BMP,[NCBIGene:649],460,"Decrease, Sonic Hedgehog second messenger production",2043,false
BMP,[NCBIGene:649],460,"Decrease, Smoothend relocation and activation",2044,false
Fgf10,[NCBIGene:2255],460,"Decrease, Cell proliferation",1821,false
Fgf10,[NCBIGene:2255],460,Apoptosis,1262,false
Fgf10,[NCBIGene:2255],460,"Antagonism, Smoothened receptor",2027,true
Fgf10,[NCBIGene:2255],460,"Decrease, GLI1/2 translocation to nucleus",2028,false
Fgf10,[NCBIGene:2255],460,"Decrease, GLI1/2 target gene expression",2040,false
Fgf10,[NCBIGene:2255],460,"Decrease, facial prominence outgrowth",2041,false
Fgf10,[NCBIGene:2255],460,"Increase, Orofacial clefting",2042,false
Fgf10,[NCBIGene:2255],460,"Decrease, Sonic Hedgehog second messenger production",2043,false
Fgf10,[NCBIGene:2255],460,"Decrease, Smoothend relocation and activation",2044,false
GLI1,[NCBIGene:2735],460,"Decrease, Cell proliferation",1821,false
GLI1,[NCBIGene:2735],460,Apoptosis,1262,false
GLI1,[NCBIGene:2735],460,"Antagonism, Smoothened receptor",2027,true
GLI1,[NCBIGene:2735],460,"Decrease, GLI1/2 translocation to nucleus",2028,false
GLI1,[NCBIGene:2735],460,"Decrease, GLI1/2 target gene expression",2040,false
GLI1,[NCBIGene:2735],460,"Decrease, facial prominence outgrowth",2041,false
GLI1,[NCBIGene:2735],460,"Increase, Orofacial clefting",2042,false
GLI1,[NCBIGene:2735],460,"Decrease, Sonic Hedgehog second messenger production",2043,false
GLI1,[NCBIGene:2735],460,"Decrease, Smoothend relocation and activation",2044,false
GLI1/2 transcription factors,[NCBIGene:2736],460,"Decrease, Cell proliferation",1821,false
GLI1/2 transcription factors,[NCBIGene:2736],460,Apoptosis,1262,false
GLI1/2 transcription factors,[NCBIGene:2736],460,"Antagonism, Smoothened receptor",2027,true
GLI1/2 transcription factors,[NCBIGene:2736],460,"Decrease, GLI1/2 translocation to nucleus",2028,false
GLI1/2 transcription factors,[NCBIGene:2736],460,"Decrease, GLI1/2 target gene expression",2040,false
GLI1/2 transcription factors,[NCBIGene:2736],460,"Decrease, facial prominence outgrowth",2041,false
GLI1/2 transcription factors,[NCBIGene:2736],460,"Increase, Orofacial clefting",2042,false
GLI1/2 transcription factors,[NCBIGene:2736],460,"Decrease, Sonic Hedgehog second messenger production",2043,false
GLI1/2 transcription factors,[NCBIGene:2736],460,"Decrease, Smoothend relocation and activation",2044,false
Patched1,[NCBIGene:5727],460,"Decrease, Cell proliferation",1821,false
Patched1,[NCBIGene:5727],460,Apoptosis,1262,false
Patched1,[NCBIGene:5727],460,"Antagonism, Smoothened receptor",2027,true
Patched1,[NCBIGene:5727],460,"Decrease, GLI1/2 translocation to nucleus",2028,false
Patched1,[NCBIGene:5727],460,"Decrease, GLI1/2 target gene expression",2040,false
Patched1,[NCBIGene:5727],460,"Decrease, facial prominence outgrowth",2041,false
Patched1,[NCBIGene:5727],460,"Increase, Orofacial clefting",2042,false
Patched1,[NCBIGene:5727],460,"Decrease, Sonic Hedgehog second messenger production",2043,false
Patched1,[NCBIGene:5727],460,"Decrease, Smoothend relocation and activation",2044,false
Smoothened receptor,[NCBIGene:6608],460,"Decrease, Cell proliferation",1821,false
Smoothened receptor,[NCBIGene:6608],460,Apoptosis,1262,false
Smoothened receptor,[NCBIGene:6608],460,"Antagonism, Smoothened receptor",2027,true
Smoothened receptor,[NCBIGene:6608],460,"Decrease, GLI1/2 translocation to nucleus",2028,false
Smoothened receptor,[NCBIGene:6608],460,"Decrease, GLI1/2 target gene expression",2040,false
Smoothened receptor,[NCBIGene:6608],460,"Decrease, facial prominence outgrowth",2041,false
Smoothened receptor,[NCBIGene:6608],460,"Increase, Orofacial clefting",2042,false
Smoothened receptor,[NCBIGene:6608],460,"Decrease, Sonic Hedgehog second messenger production",2043,false
Smoothened receptor,[NCBIGene:6608],460,"Decrease, Smoothend relocation and activation",2044,false
Sonic Hedgehog,[NCBIGene:6469],460,"Decrease, Cell proliferation",1821,false
Sonic Hedgehog,[NCBIGene:6469],460,Apoptosis,1262,false
Sonic Hedgehog,[NCBIGene:6469],460,"Antagonism, Smoothened receptor",2027,true
Sonic Hedgehog,[NCBIGene:6469],460,"Decrease, GLI1/2 translocation to nucleus",2028,false
Sonic Hedgehog,[NCBIGene:6469],460,"Decrease, GLI1/2 target gene expression",2040,false
Sonic Hedgehog,[NCBIGene:6469],460,"Decrease, facial prominence outgrowth",2041,false
Sonic Hedgehog,[NCBIGene:6469],460,"Increase, Orofacial clefting",2042,false
Sonic Hedgehog,[NCBIGene:6469],460,"Decrease, Sonic Hedgehog second messenger production",2043,false
Sonic Hedgehog,[NCBIGene:6469],460,"Decrease, Smoothend relocation and activation",2044,false
collagen,[NCBIGene:1280],462,"Increased, LDL uptake",467,false
collagen,[NCBIGene:1280],462,"Increase, Reactive oxygen species",1115,true
collagen,[NCBIGene:1280],462,"Activation, Macrophages",1198,false
collagen,[NCBIGene:1280],462,"Increase, Endothelial Dysfunction",2068,false
collagen,[NCBIGene:1280],462,"Infiltration, Inflammatory cells",901,false
collagen,[NCBIGene:1280],462,Foam cell formation,1442,false
collagen,[NCBIGene:1280],462,Oxidative Stress,1392,false
collagenase,[NCBIGene:4312],462,"Increased, LDL uptake",467,false
collagenase,[NCBIGene:4312],462,"Increase, Reactive oxygen species",1115,true
collagenase,[NCBIGene:4312],462,"Activation, Macrophages",1198,false
collagenase,[NCBIGene:4312],462,"Increase, Endothelial Dysfunction",2068,false
collagenase,[NCBIGene:4312],462,"Infiltration, Inflammatory cells",901,false
collagenase,[NCBIGene:4312],462,Foam cell formation,1442,false
collagenase,[NCBIGene:4312],462,Oxidative Stress,1392,false
low-density lipoprotein,[NCBIGene:3949],462,"Increased, LDL uptake",467,false
low-density lipoprotein,[NCBIGene:3949],462,"Increase, Reactive oxygen species",1115,true
low-density lipoprotein,[NCBIGene:3949],462,"Activation, Macrophages",1198,false
low-density lipoprotein,[NCBIGene:3949],462,"Increase, Endothelial Dysfunction",2068,false
low-density lipoprotein,[NCBIGene:3949],462,"Infiltration, Inflammatory cells",901,false
low-density lipoprotein,[NCBIGene:3949],462,Foam cell formation,1442,false
low-density lipoprotein,[NCBIGene:3949],462,Oxidative Stress,1392,false
oxidized LDL,[NCBIGene:4973],462,"Increased, LDL uptake",467,false
oxidized LDL,[NCBIGene:4973],462,"Increase, Reactive oxygen species",1115,true
oxidized LDL,[NCBIGene:4973],462,"Activation, Macrophages",1198,false
oxidized LDL,[NCBIGene:4973],462,"Increase, Endothelial Dysfunction",2068,false
oxidized LDL,[NCBIGene:4973],462,"Infiltration, Inflammatory cells",901,false
oxidized LDL,[NCBIGene:4973],462,Foam cell formation,1442,false
oxidized LDL,[NCBIGene:4973],462,Oxidative Stress,1392,false
ADH,[NCBIGene:124],465,"Increase, Mortality",350,false
ADH,[NCBIGene:124],465,"Increase, Alcohol dehydrogenase",2045,true
ADH,[NCBIGene:124],465,"Increased, Estrogen receptor (ER) activity",748,false
ADH,[NCBIGene:124],465,"Increase, Vitellogenin mRNA",2046,false
ADH,[NCBIGene:124],465,"Delay, Ovarian maturation",2047,false
ADH,[NCBIGene:124],465,"Increase, Body volume of female adults",2048,false
ADH,[NCBIGene:124],465,"Increase, sex ratio (F/M)",2049,false
ADH,[NCBIGene:124],465,"Increase, developmental abnormalities",2050,false
Alcohol dehydrogenase,[NCBIGene:10327],465,"Increase, Mortality",350,false
Alcohol dehydrogenase,[NCBIGene:10327],465,"Increase, Alcohol dehydrogenase",2045,true
Alcohol dehydrogenase,[NCBIGene:10327],465,"Increased, Estrogen receptor (ER) activity",748,false
Alcohol dehydrogenase,[NCBIGene:10327],465,"Increase, Vitellogenin mRNA",2046,false
Alcohol dehydrogenase,[NCBIGene:10327],465,"Delay, Ovarian maturation",2047,false
Alcohol dehydrogenase,[NCBIGene:10327],465,"Increase, Body volume of female adults",2048,false
Alcohol dehydrogenase,[NCBIGene:10327],465,"Increase, sex ratio (F/M)",2049,false
Alcohol dehydrogenase,[NCBIGene:10327],465,"Increase, developmental abnormalities",2050,false
ERR,[NCBIGene:6541],465,"Increase, Mortality",350,false
ERR,[NCBIGene:6541],465,"Increase, Alcohol dehydrogenase",2045,true
ERR,[NCBIGene:6541],465,"Increased, Estrogen receptor (ER) activity",748,false
ERR,[NCBIGene:6541],465,"Increase, Vitellogenin mRNA",2046,false
ERR,[NCBIGene:6541],465,"Delay, Ovarian maturation",2047,false
ERR,[NCBIGene:6541],465,"Increase, Body volume of female adults",2048,false
ERR,[NCBIGene:6541],465,"Increase, sex ratio (F/M)",2049,false
ERR,[NCBIGene:6541],465,"Increase, developmental abnormalities",2050,false
Vitellogenin mRNA,[NCBIGene:3933],465,"Increase, Mortality",350,false
Vitellogenin mRNA,[NCBIGene:3933],465,"Increase, Alcohol dehydrogenase",2045,true
Vitellogenin mRNA,[NCBIGene:3933],465,"Increased, Estrogen receptor (ER) activity",748,false
Vitellogenin mRNA,[NCBIGene:3933],465,"Increase, Vitellogenin mRNA",2046,false
Vitellogenin mRNA,[NCBIGene:3933],465,"Delay, Ovarian maturation",2047,false
Vitellogenin mRNA,[NCBIGene:3933],465,"Increase, Body volume of female adults",2048,false
Vitellogenin mRNA,[NCBIGene:3933],465,"Increase, sex ratio (F/M)",2049,false
Vitellogenin mRNA,[NCBIGene:3933],465,"Increase, developmental abnormalities",2050,false
estrogen-associated receptor gene,[NCBIGene:2101],465,"Increase, Mortality",350,false
estrogen-associated receptor gene,[NCBIGene:2101],465,"Increase, Alcohol dehydrogenase",2045,true
estrogen-associated receptor gene,[NCBIGene:2101],465,"Increased, Estrogen receptor (ER) activity",748,false
estrogen-associated receptor gene,[NCBIGene:2101],465,"Increase, Vitellogenin mRNA",2046,false
estrogen-associated receptor gene,[NCBIGene:2101],465,"Delay, Ovarian maturation",2047,false
estrogen-associated receptor gene,[NCBIGene:2101],465,"Increase, Body volume of female adults",2048,false
estrogen-associated receptor gene,[NCBIGene:2101],465,"Increase, sex ratio (F/M)",2049,false
estrogen-associated receptor gene,[NCBIGene:2101],465,"Increase, developmental abnormalities",2050,false
DOPA decarboxylase,[NCBIGene:1644],466,"Increase, Mortality",350,false
DOPA decarboxylase,[NCBIGene:1644],466,"Increase, Incomplete ecdysis",990,false
DOPA decarboxylase,[NCBIGene:1644],466,"Decrease, Tyrosine",2051,true
DOPA decarboxylase,[NCBIGene:1644],466,"Decrease, dopa decarboxylase",2052,false
DOPA decarboxylase,[NCBIGene:1644],466,"Increase, Defects in tanning of new cuticle",2053,false
DOPA decarboxylase,[NCBIGene:1644],466,"Increase,  impairment of cuticle sclerotization",2054,false
DOPA decarboxylase,[NCBIGene:1644],466,"Increase,  pigmentation",2055,false
DOPA decarboxylase,[NCBIGene:1644],466,"Increase,  delay in oviposition",2056,false
DOPA decarboxylase,[NCBIGene:1644],466,"Decrease,  hatching of egg",2057,false
Doda decarboxylase,[NCBIGene:81889],466,"Increase, Mortality",350,false
Doda decarboxylase,[NCBIGene:81889],466,"Increase, Incomplete ecdysis",990,false
Doda decarboxylase,[NCBIGene:81889],466,"Decrease, Tyrosine",2051,true
Doda decarboxylase,[NCBIGene:81889],466,"Decrease, dopa decarboxylase",2052,false
Doda decarboxylase,[NCBIGene:81889],466,"Increase, Defects in tanning of new cuticle",2053,false
Doda decarboxylase,[NCBIGene:81889],466,"Increase,  impairment of cuticle sclerotization",2054,false
Doda decarboxylase,[NCBIGene:81889],466,"Increase,  pigmentation",2055,false
Doda decarboxylase,[NCBIGene:81889],466,"Increase,  delay in oviposition",2056,false
Doda decarboxylase,[NCBIGene:81889],466,"Decrease,  hatching of egg",2057,false
Chitinase,[NCBIGene:1118],467,"Increase, Mortality",350,false
Chitinase,[NCBIGene:1118],467,"Increase, Incomplete ecdysis",990,false
Chitinase,[NCBIGene:1118],467,"Increase, developmental abnormalities",2050,false
Chitinase,[NCBIGene:1118],467,"Decrease, 20-hydroxyecdysone",2058,true
Chitinase,[NCBIGene:1118],467,"Decrease, knickkopf gene",2059,false
Chitinase,[NCBIGene:1118],467,"Decrease, Chitin laminar organization",2060,false
Chitinase,[NCBIGene:1118],467,"Decrease, Prevent chitin degradation by chitinases",2061,false
Chitinase,[NCBIGene:1118],467,"Weak, Procuticle protection",2062,false
Chitinase,[NCBIGene:1118],467,"Decrease, New cuticle secretion",2063,false
Knk,[NCBIGene:1378],467,"Increase, Mortality",350,false
Knk,[NCBIGene:1378],467,"Increase, Incomplete ecdysis",990,false
Knk,[NCBIGene:1378],467,"Increase, developmental abnormalities",2050,false
Knk,[NCBIGene:1378],467,"Decrease, 20-hydroxyecdysone",2058,true
Knk,[NCBIGene:1378],467,"Decrease, knickkopf gene",2059,false
Knk,[NCBIGene:1378],467,"Decrease, Chitin laminar organization",2060,false
Knk,[NCBIGene:1378],467,"Decrease, Prevent chitin degradation by chitinases",2061,false
Knk,[NCBIGene:1378],467,"Weak, Procuticle protection",2062,false
Knk,[NCBIGene:1378],467,"Decrease, New cuticle secretion",2063,false
chitin-binding protein Knickkopf,[NCBIGene:26128],467,"Increase, Mortality",350,false
chitin-binding protein Knickkopf,[NCBIGene:26128],467,"Increase, Incomplete ecdysis",990,false
chitin-binding protein Knickkopf,[NCBIGene:26128],467,"Increase, developmental abnormalities",2050,false
chitin-binding protein Knickkopf,[NCBIGene:26128],467,"Decrease, 20-hydroxyecdysone",2058,true
chitin-binding protein Knickkopf,[NCBIGene:26128],467,"Decrease, knickkopf gene",2059,false
chitin-binding protein Knickkopf,[NCBIGene:26128],467,"Decrease, Chitin laminar organization",2060,false
chitin-binding protein Knickkopf,[NCBIGene:26128],467,"Decrease, Prevent chitin degradation by chitinases",2061,false
chitin-binding protein Knickkopf,[NCBIGene:26128],467,"Weak, Procuticle protection",2062,false
chitin-binding protein Knickkopf,[NCBIGene:26128],467,"Decrease, New cuticle secretion",2063,false
ACE 2 receptors,[NCBIGene:186],468,"Increased, secretion of proinflammatory mediators",1496,false
ACE 2 receptors,[NCBIGene:186],468,SARS-CoV-2 cell entry,1738,false
ACE 2 receptors,[NCBIGene:186],468,Binding to ACE2,1739,true
ACE 2 receptors,[NCBIGene:186],468,Increased SARS-CoV-2 production,1847,false
ACE 2 receptors,[NCBIGene:186],468,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
ACE 2 receptors,[NCBIGene:186],468,"Increase, Cell death",1825,false
ACE 2 receptors,[NCBIGene:186],468,"Increased, recruitment of inflammatory cells",1497,false
ACE 2 receptors,[NCBIGene:186],468,Hyperinflammation,1868,false
ACE2,[NCBIGene:59272],468,"Increased, secretion of proinflammatory mediators",1496,false
ACE2,[NCBIGene:59272],468,SARS-CoV-2 cell entry,1738,false
ACE2,[NCBIGene:59272],468,Binding to ACE2,1739,true
ACE2,[NCBIGene:59272],468,Increased SARS-CoV-2 production,1847,false
ACE2,[NCBIGene:59272],468,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
ACE2,[NCBIGene:59272],468,"Increase, Cell death",1825,false
ACE2,[NCBIGene:59272],468,"Increased, recruitment of inflammatory cells",1497,false
ACE2,[NCBIGene:59272],468,Hyperinflammation,1868,false
C-reactive protein,[NCBIGene:1401],468,"Increased, secretion of proinflammatory mediators",1496,false
C-reactive protein,[NCBIGene:1401],468,SARS-CoV-2 cell entry,1738,false
C-reactive protein,[NCBIGene:1401],468,Binding to ACE2,1739,true
C-reactive protein,[NCBIGene:1401],468,Increased SARS-CoV-2 production,1847,false
C-reactive protein,[NCBIGene:1401],468,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
C-reactive protein,[NCBIGene:1401],468,"Increase, Cell death",1825,false
C-reactive protein,[NCBIGene:1401],468,"Increased, recruitment of inflammatory cells",1497,false
C-reactive protein,[NCBIGene:1401],468,Hyperinflammation,1868,false
CXCL8,[NCBIGene:3576],468,"Increased, secretion of proinflammatory mediators",1496,false
CXCL8,[NCBIGene:3576],468,SARS-CoV-2 cell entry,1738,false
CXCL8,[NCBIGene:3576],468,Binding to ACE2,1739,true
CXCL8,[NCBIGene:3576],468,Increased SARS-CoV-2 production,1847,false
CXCL8,[NCBIGene:3576],468,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
CXCL8,[NCBIGene:3576],468,"Increase, Cell death",1825,false
CXCL8,[NCBIGene:3576],468,"Increased, recruitment of inflammatory cells",1497,false
CXCL8,[NCBIGene:3576],468,Hyperinflammation,1868,false
IL6,[NCBIGene:3569],468,"Increased, secretion of proinflammatory mediators",1496,false
IL6,[NCBIGene:3569],468,SARS-CoV-2 cell entry,1738,false
IL6,[NCBIGene:3569],468,Binding to ACE2,1739,true
IL6,[NCBIGene:3569],468,Increased SARS-CoV-2 production,1847,false
IL6,[NCBIGene:3569],468,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
IL6,[NCBIGene:3569],468,"Increase, Cell death",1825,false
IL6,[NCBIGene:3569],468,"Increased, recruitment of inflammatory cells",1497,false
IL6,[NCBIGene:3569],468,Hyperinflammation,1868,false
S protein subunits,[NCBIGene:5627],468,"Increased, secretion of proinflammatory mediators",1496,false
S protein subunits,[NCBIGene:5627],468,SARS-CoV-2 cell entry,1738,false
S protein subunits,[NCBIGene:5627],468,Binding to ACE2,1739,true
S protein subunits,[NCBIGene:5627],468,Increased SARS-CoV-2 production,1847,false
S protein subunits,[NCBIGene:5627],468,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
S protein subunits,[NCBIGene:5627],468,"Increase, Cell death",1825,false
S protein subunits,[NCBIGene:5627],468,"Increased, recruitment of inflammatory cells",1497,false
S protein subunits,[NCBIGene:5627],468,Hyperinflammation,1868,false
Sars-CoV-2 spike protein,[NCBIGene:54938],468,"Increased, secretion of proinflammatory mediators",1496,false
Sars-CoV-2 spike protein,[NCBIGene:54938],468,SARS-CoV-2 cell entry,1738,false
Sars-CoV-2 spike protein,[NCBIGene:54938],468,Binding to ACE2,1739,true
Sars-CoV-2 spike protein,[NCBIGene:54938],468,Increased SARS-CoV-2 production,1847,false
Sars-CoV-2 spike protein,[NCBIGene:54938],468,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
Sars-CoV-2 spike protein,[NCBIGene:54938],468,"Increase, Cell death",1825,false
Sars-CoV-2 spike protein,[NCBIGene:54938],468,"Increased, recruitment of inflammatory cells",1497,false
Sars-CoV-2 spike protein,[NCBIGene:54938],468,Hyperinflammation,1868,false
TNFalpha,[NCBIGene:7124],468,"Increased, secretion of proinflammatory mediators",1496,false
TNFalpha,[NCBIGene:7124],468,SARS-CoV-2 cell entry,1738,false
TNFalpha,[NCBIGene:7124],468,Binding to ACE2,1739,true
TNFalpha,[NCBIGene:7124],468,Increased SARS-CoV-2 production,1847,false
TNFalpha,[NCBIGene:7124],468,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
TNFalpha,[NCBIGene:7124],468,"Increase, Cell death",1825,false
TNFalpha,[NCBIGene:7124],468,"Increased, recruitment of inflammatory cells",1497,false
TNFalpha,[NCBIGene:7124],468,Hyperinflammation,1868,false
interferon alpha,[NCBIGene:3439],468,"Increased, secretion of proinflammatory mediators",1496,false
interferon alpha,[NCBIGene:3439],468,SARS-CoV-2 cell entry,1738,false
interferon alpha,[NCBIGene:3439],468,Binding to ACE2,1739,true
interferon alpha,[NCBIGene:3439],468,Increased SARS-CoV-2 production,1847,false
interferon alpha,[NCBIGene:3439],468,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
interferon alpha,[NCBIGene:3439],468,"Increase, Cell death",1825,false
interferon alpha,[NCBIGene:3439],468,"Increased, recruitment of inflammatory cells",1497,false
interferon alpha,[NCBIGene:3439],468,Hyperinflammation,1868,false
interferon signalling network genes,[NCBIGene:3438],468,"Increased, secretion of proinflammatory mediators",1496,false
interferon signalling network genes,[NCBIGene:3438],468,SARS-CoV-2 cell entry,1738,false
interferon signalling network genes,[NCBIGene:3438],468,Binding to ACE2,1739,true
interferon signalling network genes,[NCBIGene:3438],468,Increased SARS-CoV-2 production,1847,false
interferon signalling network genes,[NCBIGene:3438],468,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
interferon signalling network genes,[NCBIGene:3438],468,"Increase, Cell death",1825,false
interferon signalling network genes,[NCBIGene:3438],468,"Increased, recruitment of inflammatory cells",1497,false
interferon signalling network genes,[NCBIGene:3438],468,Hyperinflammation,1868,false
type I interferon,[NCBIGene:3451],468,"Increased, secretion of proinflammatory mediators",1496,false
type I interferon,[NCBIGene:3451],468,SARS-CoV-2 cell entry,1738,false
type I interferon,[NCBIGene:3451],468,Binding to ACE2,1739,true
type I interferon,[NCBIGene:3451],468,Increased SARS-CoV-2 production,1847,false
type I interferon,[NCBIGene:3451],468,"Interferon-I antiviral response, antagonized by SARS-CoV-2",1901,false
type I interferon,[NCBIGene:3451],468,"Increase, Cell death",1825,false
type I interferon,[NCBIGene:3451],468,"Increased, recruitment of inflammatory cells",1497,false
type I interferon,[NCBIGene:3451],468,Hyperinflammation,1868,false
DomA,[NCBIGene:6663],471,"Overactivation, NMDARs",388,false
DomA,[NCBIGene:6663],471,"Decreased, Neuronal network function in adult brain",618,false
DomA,[NCBIGene:6663],471,Degeneration of dopaminergic neurons of the nigrostriatal pathway,890,false
DomA,[NCBIGene:6663],471,Parkinsonian motor deficits,896,false
DomA,[NCBIGene:6663],471,Neuroinflammation,188,false
DomA,[NCBIGene:6663],471,"Increase, Mortality",350,false
DomA,[NCBIGene:6663],471,Synaptic dysfunction,1944,false
DomA,[NCBIGene:6663],471,"Increase, CNS Neural cell death",2195,true
DomA,[NCBIGene:6663],471,"Increase, seizure",1348,false
DomA,[NCBIGene:6663],471,"Decrease, elavl3",2196,false
DomA,[NCBIGene:6663],471,"Activated, presynaptic neuron 1",1349,false
DomA,[NCBIGene:6663],471,"Decrease, sox10",2197,false
DomA,[NCBIGene:6663],471,"Decrease, mbp",2198,false
DomA,[NCBIGene:6663],471,Neurological disorder,2150,false
DomA,[NCBIGene:6663],471,Neuronal dysfunction,191,false
DomA,[NCBIGene:6663],471,"impaired, Learning and memory",637,false
DomA,[NCBIGene:6663],471,Loss of drebrin,2078,false
DomA,[NCBIGene:6663],471,"Disruption, neurotransmitter release",2151,false
DomA,[NCBIGene:6663],471,"Decreased, Ionotropic GABA receptor chloride channel conductance",1177,false
DomA,[NCBIGene:6663],471,"Increased, epilepsy",1363,false
DomA,[NCBIGene:6663],471,Impaired axonial transport,1582,false
DomA,[NCBIGene:6663],471,Sensory axonal peripheral neuropathy,1583,false
DomA,[NCBIGene:6663],471,"Increased, Inhibitory postsynaptic potential",1012,false
DomA,[NCBIGene:6663],471,Encephalitis,1841,false
DomA,[NCBIGene:6663],471,"Induction, Somatic muscle paralysis",1014,false
DomA,[NCBIGene:6663],471,"Increased, Neuronal synaptic inhibition",1015,false
DomA,[NCBIGene:6663],471,"Inhibition, Feeding",1016,false
DomA,[NCBIGene:6663],471,"Activation, Glutamate-gated chloride channels",1018,false
DomA,[NCBIGene:6663],471,Oxidative Stress,1392,false
DomA,[NCBIGene:6663],471,Acetylcholine accumulation in synapses,10,false
DomA,[NCBIGene:6663],471,Acetylcholinesterase (AchE) Inhibition,12,false
DomA,[NCBIGene:6663],471,"N/A, Neurodegeneration",352,false
elavl3,[NCBIGene:1995],471,"Overactivation, NMDARs",388,false
elavl3,[NCBIGene:1995],471,"Decreased, Neuronal network function in adult brain",618,false
elavl3,[NCBIGene:1995],471,Degeneration of dopaminergic neurons of the nigrostriatal pathway,890,false
elavl3,[NCBIGene:1995],471,Parkinsonian motor deficits,896,false
elavl3,[NCBIGene:1995],471,Neuroinflammation,188,false
elavl3,[NCBIGene:1995],471,"Increase, Mortality",350,false
elavl3,[NCBIGene:1995],471,Synaptic dysfunction,1944,false
elavl3,[NCBIGene:1995],471,"Increase, CNS Neural cell death",2195,true
elavl3,[NCBIGene:1995],471,"Increase, seizure",1348,false
elavl3,[NCBIGene:1995],471,"Decrease, elavl3",2196,false
elavl3,[NCBIGene:1995],471,"Activated, presynaptic neuron 1",1349,false
elavl3,[NCBIGene:1995],471,"Decrease, sox10",2197,false
elavl3,[NCBIGene:1995],471,"Decrease, mbp",2198,false
elavl3,[NCBIGene:1995],471,Neurological disorder,2150,false
elavl3,[NCBIGene:1995],471,Neuronal dysfunction,191,false
elavl3,[NCBIGene:1995],471,"impaired, Learning and memory",637,false
elavl3,[NCBIGene:1995],471,Loss of drebrin,2078,false
elavl3,[NCBIGene:1995],471,"Disruption, neurotransmitter release",2151,false
elavl3,[NCBIGene:1995],471,"Decreased, Ionotropic GABA receptor chloride channel conductance",1177,false
elavl3,[NCBIGene:1995],471,"Increased, epilepsy",1363,false
elavl3,[NCBIGene:1995],471,Impaired axonial transport,1582,false
elavl3,[NCBIGene:1995],471,Sensory axonal peripheral neuropathy,1583,false
elavl3,[NCBIGene:1995],471,"Increased, Inhibitory postsynaptic potential",1012,false
elavl3,[NCBIGene:1995],471,Encephalitis,1841,false
elavl3,[NCBIGene:1995],471,"Induction, Somatic muscle paralysis",1014,false
elavl3,[NCBIGene:1995],471,"Increased, Neuronal synaptic inhibition",1015,false
elavl3,[NCBIGene:1995],471,"Inhibition, Feeding",1016,false
elavl3,[NCBIGene:1995],471,"Activation, Glutamate-gated chloride channels",1018,false
elavl3,[NCBIGene:1995],471,Oxidative Stress,1392,false
elavl3,[NCBIGene:1995],471,Acetylcholine accumulation in synapses,10,false
elavl3,[NCBIGene:1995],471,Acetylcholinesterase (AchE) Inhibition,12,false
elavl3,[NCBIGene:1995],471,"N/A, Neurodegeneration",352,false
mbp,[NCBIGene:4155],471,"Overactivation, NMDARs",388,false
mbp,[NCBIGene:4155],471,"Decreased, Neuronal network function in adult brain",618,false
mbp,[NCBIGene:4155],471,Degeneration of dopaminergic neurons of the nigrostriatal pathway,890,false
mbp,[NCBIGene:4155],471,Parkinsonian motor deficits,896,false
mbp,[NCBIGene:4155],471,Neuroinflammation,188,false
mbp,[NCBIGene:4155],471,"Increase, Mortality",350,false
mbp,[NCBIGene:4155],471,Synaptic dysfunction,1944,false
mbp,[NCBIGene:4155],471,"Increase, CNS Neural cell death",2195,true
mbp,[NCBIGene:4155],471,"Increase, seizure",1348,false
mbp,[NCBIGene:4155],471,"Decrease, elavl3",2196,false
mbp,[NCBIGene:4155],471,"Activated, presynaptic neuron 1",1349,false
mbp,[NCBIGene:4155],471,"Decrease, sox10",2197,false
mbp,[NCBIGene:4155],471,"Decrease, mbp",2198,false
mbp,[NCBIGene:4155],471,Neurological disorder,2150,false
mbp,[NCBIGene:4155],471,Neuronal dysfunction,191,false
mbp,[NCBIGene:4155],471,"impaired, Learning and memory",637,false
mbp,[NCBIGene:4155],471,Loss of drebrin,2078,false
mbp,[NCBIGene:4155],471,"Disruption, neurotransmitter release",2151,false
mbp,[NCBIGene:4155],471,"Decreased, Ionotropic GABA receptor chloride channel conductance",1177,false
mbp,[NCBIGene:4155],471,"Increased, epilepsy",1363,false
mbp,[NCBIGene:4155],471,Impaired axonial transport,1582,false
mbp,[NCBIGene:4155],471,Sensory axonal peripheral neuropathy,1583,false
mbp,[NCBIGene:4155],471,"Increased, Inhibitory postsynaptic potential",1012,false
mbp,[NCBIGene:4155],471,Encephalitis,1841,false
mbp,[NCBIGene:4155],471,"Induction, Somatic muscle paralysis",1014,false
mbp,[NCBIGene:4155],471,"Increased, Neuronal synaptic inhibition",1015,false
mbp,[NCBIGene:4155],471,"Inhibition, Feeding",1016,false
mbp,[NCBIGene:4155],471,"Activation, Glutamate-gated chloride channels",1018,false
mbp,[NCBIGene:4155],471,Oxidative Stress,1392,false
mbp,[NCBIGene:4155],471,Acetylcholine accumulation in synapses,10,false
mbp,[NCBIGene:4155],471,Acetylcholinesterase (AchE) Inhibition,12,false
mbp,[NCBIGene:4155],471,"N/A, Neurodegeneration",352,false
hemocyanin,[NCBIGene:7909],473,"Decreased, Reproductive Success",1141,false
hemocyanin,[NCBIGene:7909],473,increase oxidation of the di-copper moiety of the hemocyanin active site,2073,false
hemocyanin,[NCBIGene:7909],473,"Decreased, oxygen binding capacity by hemocyanin",2074,false
hemocyanin,[NCBIGene:7909],473,"Cognitive, sensed as hypoxic/low oxygen environment",2075,false
hemocyanin,[NCBIGene:7909],473,"Increase, hemocyanin mRNA",2076,false
hemocyanin,[NCBIGene:7909],473,"Increase, pulmonate breathing",2077,false
hemocyanin,[NCBIGene:7909],473,Deposition of Energy,1686,true
hemocyanin,[NCBIGene:7909],473,Increase in reactive oxygen and nitrogen species (RONS),1632,false
hemocyanin,[NCBIGene:7909],473,"Decrease, Growth",1521,false
DNA methyltransferase,[NCBIGene:1786],474,"Increase, Cancer",885,false
DNA methyltransferase,[NCBIGene:1786],474,"Succinate dehydrogenase, inhibited",2118,true
DNA methyltransferase,[NCBIGene:1786],474,Epithelial Mesenchymal Transition,1457,false
DNA methyltransferase,[NCBIGene:1786],474,"Increase, DNA methyltransferase inhibition",1619,false
DNA methyltransferase,[NCBIGene:1786],474,Succinate Accumulation,2243,false
SDH,[NCBIGene:6390],474,"Increase, Cancer",885,false
SDH,[NCBIGene:6390],474,"Succinate dehydrogenase, inhibited",2118,true
SDH,[NCBIGene:6390],474,Epithelial Mesenchymal Transition,1457,false
SDH,[NCBIGene:6390],474,"Increase, DNA methyltransferase inhibition",1619,false
SDH,[NCBIGene:6390],474,Succinate Accumulation,2243,false
Succinate dehydrogenase,[NCBIGene:6392],474,"Increase, Cancer",885,false
Succinate dehydrogenase,[NCBIGene:6392],474,"Succinate dehydrogenase, inhibited",2118,true
Succinate dehydrogenase,[NCBIGene:6392],474,Epithelial Mesenchymal Transition,1457,false
Succinate dehydrogenase,[NCBIGene:6392],474,"Increase, DNA methyltransferase inhibition",1619,false
Succinate dehydrogenase,[NCBIGene:6392],474,Succinate Accumulation,2243,false
AR,"[NCBIGene:367, 231, 2232]",477,"Decrease, androgen receptor activation",1614,false
AR,"[NCBIGene:367, 231, 2232]",477,"Hypospadias, increased",2082,false
AR,"[NCBIGene:367, 231, 2232]",477,"Antagonism, Androgen receptor",26,true
DomA,[NCBIGene:6663],48,"Overactivation, NMDARs",388,false
DomA,[NCBIGene:6663],48,"Increased, Intracellular Calcium overload",389,false
DomA,[NCBIGene:6663],48,"Decreased, Neuronal network function in adult brain",618,false
DomA,[NCBIGene:6663],48,Neuroinflammation,188,false
DomA,[NCBIGene:6663],48,Mitochondrial dysfunction,177,false
DomA,[NCBIGene:6663],48,"Binding of agonist, Ionotropic glutamate receptors",875,true
DomA,[NCBIGene:6663],48,"Impairment, Learning and memory",341,false
DomA,[NCBIGene:6663],48,"Increase, Cell injury/death",55,false
DomA,[NCBIGene:6663],48,"N/A, Neurodegeneration",352,false
KARs,[NCBIGene:3735],48,"Overactivation, NMDARs",388,false
KARs,[NCBIGene:3735],48,"Increased, Intracellular Calcium overload",389,false
KARs,[NCBIGene:3735],48,"Decreased, Neuronal network function in adult brain",618,false
KARs,[NCBIGene:3735],48,Neuroinflammation,188,false
KARs,[NCBIGene:3735],48,Mitochondrial dysfunction,177,false
KARs,[NCBIGene:3735],48,"Binding of agonist, Ionotropic glutamate receptors",875,true
KARs,[NCBIGene:3735],48,"Impairment, Learning and memory",341,false
KARs,[NCBIGene:3735],48,"Increase, Cell injury/death",55,false
KARs,[NCBIGene:3735],48,"N/A, Neurodegeneration",352,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],48,"Overactivation, NMDARs",388,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],48,"Increased, Intracellular Calcium overload",389,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],48,"Decreased, Neuronal network function in adult brain",618,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],48,Neuroinflammation,188,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],48,Mitochondrial dysfunction,177,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],48,"Binding of agonist, Ionotropic glutamate receptors",875,true
N-methyl-D-aspartate receptors,[NCBIGene:2902],48,"Impairment, Learning and memory",341,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],48,"Increase, Cell injury/death",55,false
N-methyl-D-aspartate receptors,[NCBIGene:2902],48,"N/A, Neurodegeneration",352,false
ionotropic glutamate receptors,[NCBIGene:2890],48,"Overactivation, NMDARs",388,false
ionotropic glutamate receptors,[NCBIGene:2890],48,"Increased, Intracellular Calcium overload",389,false
ionotropic glutamate receptors,[NCBIGene:2890],48,"Decreased, Neuronal network function in adult brain",618,false
ionotropic glutamate receptors,[NCBIGene:2890],48,Neuroinflammation,188,false
ionotropic glutamate receptors,[NCBIGene:2890],48,Mitochondrial dysfunction,177,false
ionotropic glutamate receptors,[NCBIGene:2890],48,"Binding of agonist, Ionotropic glutamate receptors",875,true
ionotropic glutamate receptors,[NCBIGene:2890],48,"Impairment, Learning and memory",341,false
ionotropic glutamate receptors,[NCBIGene:2890],48,"Increase, Cell injury/death",55,false
ionotropic glutamate receptors,[NCBIGene:2890],48,"N/A, Neurodegeneration",352,false
/-catenin,"[NCBIGene:1500, 100528016]",482,Altered Cell Differentiation Signaling,2245,false
/-catenin,"[NCBIGene:1500, 100528016]",482,Altered Bone Cell Homeostasis,2089,false
/-catenin,"[NCBIGene:1500, 100528016]",482,Deposition of Energy,1686,true
/-catenin,"[NCBIGene:1500, 100528016]",482,"Increase, Bone Remodeling",2090,false
/-catenin,"[NCBIGene:1500, 100528016]",482,"Occurrence, Bone Loss",2091,false
/-catenin,"[NCBIGene:1500, 100528016]",482,"Increase, Cell death",1825,false
/-catenin,"[NCBIGene:1500, 100528016]",482,Oxidative Stress,1392,false
WNT,[NCBIGene:7471],482,Altered Cell Differentiation Signaling,2245,false
WNT,[NCBIGene:7471],482,Altered Bone Cell Homeostasis,2089,false
WNT,[NCBIGene:7471],482,Deposition of Energy,1686,true
WNT,[NCBIGene:7471],482,"Increase, Bone Remodeling",2090,false
WNT,[NCBIGene:7471],482,"Occurrence, Bone Loss",2091,false
WNT,[NCBIGene:7471],482,"Increase, Cell death",1825,false
WNT,[NCBIGene:7471],482,Oxidative Stress,1392,false
receptor activator of nuclear factor kappa B ligand,[NCBIGene:8600],482,Altered Cell Differentiation Signaling,2245,false
receptor activator of nuclear factor kappa B ligand,[NCBIGene:8600],482,Altered Bone Cell Homeostasis,2089,false
receptor activator of nuclear factor kappa B ligand,[NCBIGene:8600],482,Deposition of Energy,1686,true
receptor activator of nuclear factor kappa B ligand,[NCBIGene:8600],482,"Increase, Bone Remodeling",2090,false
receptor activator of nuclear factor kappa B ligand,[NCBIGene:8600],482,"Occurrence, Bone Loss",2091,false
receptor activator of nuclear factor kappa B ligand,[NCBIGene:8600],482,"Increase, Cell death",1825,false
receptor activator of nuclear factor kappa B ligand,[NCBIGene:8600],482,Oxidative Stress,1392,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",485,"Cognitive function, decreased",402,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",485,"Decreased, thyroid hormone binding to thyroid hormone receptor",2104,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",485,"Decreased, myelin basic protein expression in oligodendrocytes",2105,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",485,"Impaired, oligodendrocyte maturation",2106,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",485,Hypomyelination,2107,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",485,"Altered, white brain matter",2108,false
TR,"[NCBIGene:7037, 2149, 7012, 7296, 23671, 10587]",485,"Antagonism, Thyroid Receptor",1656,true
laminin,[NCBIGene:3913],486,"Cognitive function, decreased",402,false
laminin,[NCBIGene:3913],486,"Binding, extracellular matrix protein laminin",2109,true
laminin,[NCBIGene:3913],486,"Disrupted binding, laminin-beta1-integrin receptors with laminin",2110,false
laminin,[NCBIGene:3913],486,"Decreased, neural progenitor cell adhesion to laminin",2111,false
laminin,[NCBIGene:3913],486,"Disturbed, radial glia cell alignment and migration",2112,false
laminin,[NCBIGene:3913],486,"Decreased, radial glia cell density",2113,false
laminin,[NCBIGene:3913],486,"Disturbed, cortical architecture",2114,false
voltage-gated sodium channels,[NCBIGene:6328],489,"Cognitive function, decreased",402,false
voltage-gated sodium channels,[NCBIGene:6328],489,"Decreased, oligodendrocyte differentiation",2116,false
voltage-gated sodium channels,[NCBIGene:6328],489,Disruption of sodium channel gating kinetics,1977,false
voltage-gated sodium channels,[NCBIGene:6328],489,Binding to voltage-gated sodium channel,1353,true
voltage-gated sodium channels,[NCBIGene:6328],489,Hypomyelination,2107,false
voltage-gated sodium channels,[NCBIGene:6328],489,"Altered, white brain matter",2108,false
GLI1,[NCBIGene:2735],491,"Decrease, Cell proliferation",1821,false
GLI1,[NCBIGene:2735],491,Apoptosis,1262,false
GLI1,[NCBIGene:2735],491,"Decrease, GLI1/2 target gene expression",2040,true
GLI1,[NCBIGene:2735],491,"Decrease, facial prominence outgrowth",2041,false
GLI1,[NCBIGene:2735],491,"Increase, Orofacial clefting",2042,false
GLI1,[NCBIGene:2735],491,"Decrease, Sonic Hedgehog second messenger production",2043,false
GLI1/2 transcription factors,[NCBIGene:2736],491,"Decrease, Cell proliferation",1821,false
GLI1/2 transcription factors,[NCBIGene:2736],491,Apoptosis,1262,false
GLI1/2 transcription factors,[NCBIGene:2736],491,"Decrease, GLI1/2 target gene expression",2040,true
GLI1/2 transcription factors,[NCBIGene:2736],491,"Decrease, facial prominence outgrowth",2041,false
GLI1/2 transcription factors,[NCBIGene:2736],491,"Increase, Orofacial clefting",2042,false
GLI1/2 transcription factors,[NCBIGene:2736],491,"Decrease, Sonic Hedgehog second messenger production",2043,false
Smoothened receptor,[NCBIGene:6608],491,"Decrease, Cell proliferation",1821,false
Smoothened receptor,[NCBIGene:6608],491,Apoptosis,1262,false
Smoothened receptor,[NCBIGene:6608],491,"Decrease, GLI1/2 target gene expression",2040,true
Smoothened receptor,[NCBIGene:6608],491,"Decrease, facial prominence outgrowth",2041,false
Smoothened receptor,[NCBIGene:6608],491,"Increase, Orofacial clefting",2042,false
Smoothened receptor,[NCBIGene:6608],491,"Decrease, Sonic Hedgehog second messenger production",2043,false
Sonic Hedgehog,[NCBIGene:6469],491,"Decrease, Cell proliferation",1821,false
Sonic Hedgehog,[NCBIGene:6469],491,Apoptosis,1262,false
Sonic Hedgehog,[NCBIGene:6469],491,"Decrease, GLI1/2 target gene expression",2040,true
Sonic Hedgehog,[NCBIGene:6469],491,"Decrease, facial prominence outgrowth",2041,false
Sonic Hedgehog,[NCBIGene:6469],491,"Increase, Orofacial clefting",2042,false
Sonic Hedgehog,[NCBIGene:6469],491,"Decrease, Sonic Hedgehog second messenger production",2043,false
AT,"[NCBIGene:695, 2628]",493,Increased adipocyte size,2127,false
AT,"[NCBIGene:695, 2628]",493,Increased adipocyte numbers,2128,false
AT,"[NCBIGene:695, 2628]",493,Metabolically unhealthy Obesity,2129,false
AT,"[NCBIGene:695, 2628]",493,Increased fat mass,2125,false
AT,"[NCBIGene:695, 2628]",493,Estrogen receptor alpha inactivation,2126,true
AT,"[NCBIGene:695, 2628]",493,increased lipid accumulation,2130,false
AT,"[NCBIGene:695, 2628]",493,Increased pro-inflammatory cytokine expression,2132,false
AT,"[NCBIGene:695, 2628]",493,"Insulin resistance, increased",2119,false
AT,"[NCBIGene:695, 2628]",493,Increase in inflammation,1633,false
AT,"[NCBIGene:695, 2628]",493,"Increased, recruitment of inflammatory cells",1497,false
Aromatase,[NCBIGene:1588],493,Increased adipocyte size,2127,false
Aromatase,[NCBIGene:1588],493,Increased adipocyte numbers,2128,false
Aromatase,[NCBIGene:1588],493,Metabolically unhealthy Obesity,2129,false
Aromatase,[NCBIGene:1588],493,Increased fat mass,2125,false
Aromatase,[NCBIGene:1588],493,Estrogen receptor alpha inactivation,2126,true
Aromatase,[NCBIGene:1588],493,increased lipid accumulation,2130,false
Aromatase,[NCBIGene:1588],493,Increased pro-inflammatory cytokine expression,2132,false
Aromatase,[NCBIGene:1588],493,"Insulin resistance, increased",2119,false
Aromatase,[NCBIGene:1588],493,Increase in inflammation,1633,false
Aromatase,[NCBIGene:1588],493,"Increased, recruitment of inflammatory cells",1497,false
ER,"[NCBIGene:2099, 2069]",493,Increased adipocyte size,2127,false
ER,"[NCBIGene:2099, 2069]",493,Increased adipocyte numbers,2128,false
ER,"[NCBIGene:2099, 2069]",493,Metabolically unhealthy Obesity,2129,false
ER,"[NCBIGene:2099, 2069]",493,Increased fat mass,2125,false
ER,"[NCBIGene:2099, 2069]",493,Estrogen receptor alpha inactivation,2126,true
ER,"[NCBIGene:2099, 2069]",493,increased lipid accumulation,2130,false
ER,"[NCBIGene:2099, 2069]",493,Increased pro-inflammatory cytokine expression,2132,false
ER,"[NCBIGene:2099, 2069]",493,"Insulin resistance, increased",2119,false
ER,"[NCBIGene:2099, 2069]",493,Increase in inflammation,1633,false
ER,"[NCBIGene:2099, 2069]",493,"Increased, recruitment of inflammatory cells",1497,false
ERb,[NCBIGene:2100],493,Increased adipocyte size,2127,false
ERb,[NCBIGene:2100],493,Increased adipocyte numbers,2128,false
ERb,[NCBIGene:2100],493,Metabolically unhealthy Obesity,2129,false
ERb,[NCBIGene:2100],493,Increased fat mass,2125,false
ERb,[NCBIGene:2100],493,Estrogen receptor alpha inactivation,2126,true
ERb,[NCBIGene:2100],493,increased lipid accumulation,2130,false
ERb,[NCBIGene:2100],493,Increased pro-inflammatory cytokine expression,2132,false
ERb,[NCBIGene:2100],493,"Insulin resistance, increased",2119,false
ERb,[NCBIGene:2100],493,Increase in inflammation,1633,false
ERb,[NCBIGene:2100],493,"Increased, recruitment of inflammatory cells",1497,false
insulin,[NCBIGene:3630],493,Increased adipocyte size,2127,false
insulin,[NCBIGene:3630],493,Increased adipocyte numbers,2128,false
insulin,[NCBIGene:3630],493,Metabolically unhealthy Obesity,2129,false
insulin,[NCBIGene:3630],493,Increased fat mass,2125,false
insulin,[NCBIGene:3630],493,Estrogen receptor alpha inactivation,2126,true
insulin,[NCBIGene:3630],493,increased lipid accumulation,2130,false
insulin,[NCBIGene:3630],493,Increased pro-inflammatory cytokine expression,2132,false
insulin,[NCBIGene:3630],493,"Insulin resistance, increased",2119,false
insulin,[NCBIGene:3630],493,Increase in inflammation,1633,false
insulin,[NCBIGene:3630],493,"Increased, recruitment of inflammatory cells",1497,false
-SMA,[NCBIGene:6606],494,"N/A, Liver fibrosis",344,false
-SMA,[NCBIGene:6606],494,"Activation, Stellate cells",265,false
-SMA,[NCBIGene:6606],494,"Increased, Liver Steatosis",459,false
-SMA,[NCBIGene:6606],494,"Activation, AhR",18,true
-SMA,[NCBIGene:6606],494,"Increased, extracellular matrix deposition",1501,false
-SMA,[NCBIGene:6606],494,"Increase, Cell injury/death",55,false
/-catenin,"[NCBIGene:1500, 100528016]",494,"N/A, Liver fibrosis",344,false
/-catenin,"[NCBIGene:1500, 100528016]",494,"Activation, Stellate cells",265,false
/-catenin,"[NCBIGene:1500, 100528016]",494,"Increased, Liver Steatosis",459,false
/-catenin,"[NCBIGene:1500, 100528016]",494,"Activation, AhR",18,true
/-catenin,"[NCBIGene:1500, 100528016]",494,"Increased, extracellular matrix deposition",1501,false
/-catenin,"[NCBIGene:1500, 100528016]",494,"Increase, Cell injury/death",55,false
AhR,[NCBIGene:196],494,"N/A, Liver fibrosis",344,false
AhR,[NCBIGene:196],494,"Activation, Stellate cells",265,false
AhR,[NCBIGene:196],494,"Increased, Liver Steatosis",459,false
AhR,[NCBIGene:196],494,"Activation, AhR",18,true
AhR,[NCBIGene:196],494,"Increased, extracellular matrix deposition",1501,false
AhR,[NCBIGene:196],494,"Increase, Cell injury/death",55,false
COL1A1,[NCBIGene:1277],494,"N/A, Liver fibrosis",344,false
COL1A1,[NCBIGene:1277],494,"Activation, Stellate cells",265,false
COL1A1,[NCBIGene:1277],494,"Increased, Liver Steatosis",459,false
COL1A1,[NCBIGene:1277],494,"Activation, AhR",18,true
COL1A1,[NCBIGene:1277],494,"Increased, extracellular matrix deposition",1501,false
COL1A1,[NCBIGene:1277],494,"Increase, Cell injury/death",55,false
NF-,[NCBIGene:23114],494,"N/A, Liver fibrosis",344,false
NF-,[NCBIGene:23114],494,"Activation, Stellate cells",265,false
NF-,[NCBIGene:23114],494,"Increased, Liver Steatosis",459,false
NF-,[NCBIGene:23114],494,"Activation, AhR",18,true
NF-,[NCBIGene:23114],494,"Increased, extracellular matrix deposition",1501,false
NF-,[NCBIGene:23114],494,"Increase, Cell injury/death",55,false
TGF-1,[NCBIGene:7040],494,"N/A, Liver fibrosis",344,false
TGF-1,[NCBIGene:7040],494,"Activation, Stellate cells",265,false
TGF-1,[NCBIGene:7040],494,"Increased, Liver Steatosis",459,false
TGF-1,[NCBIGene:7040],494,"Activation, AhR",18,true
TGF-1,[NCBIGene:7040],494,"Increased, extracellular matrix deposition",1501,false
TGF-1,[NCBIGene:7040],494,"Increase, Cell injury/death",55,false
WNT,[NCBIGene:7471],494,"N/A, Liver fibrosis",344,false
WNT,[NCBIGene:7471],494,"Activation, Stellate cells",265,false
WNT,[NCBIGene:7471],494,"Increased, Liver Steatosis",459,false
WNT,[NCBIGene:7471],494,"Activation, AhR",18,true
WNT,[NCBIGene:7471],494,"Increased, extracellular matrix deposition",1501,false
WNT,[NCBIGene:7471],494,"Increase, Cell injury/death",55,false
collagen,[NCBIGene:1280],494,"N/A, Liver fibrosis",344,false
collagen,[NCBIGene:1280],494,"Activation, Stellate cells",265,false
collagen,[NCBIGene:1280],494,"Increased, Liver Steatosis",459,false
collagen,[NCBIGene:1280],494,"Activation, AhR",18,true
collagen,[NCBIGene:1280],494,"Increased, extracellular matrix deposition",1501,false
collagen,[NCBIGene:1280],494,"Increase, Cell injury/death",55,false
insulin,[NCBIGene:3630],494,"N/A, Liver fibrosis",344,false
insulin,[NCBIGene:3630],494,"Activation, Stellate cells",265,false
insulin,[NCBIGene:3630],494,"Increased, Liver Steatosis",459,false
insulin,[NCBIGene:3630],494,"Activation, AhR",18,true
insulin,[NCBIGene:3630],494,"Increased, extracellular matrix deposition",1501,false
insulin,[NCBIGene:3630],494,"Increase, Cell injury/death",55,false
AR,"[NCBIGene:367, 231, 2232]",495,"Alterations, Cellular proliferation / hyperplasia",854,false
AR,"[NCBIGene:367, 231, 2232]",495,Inflamatory events in light-exposed tissues,1599,false
AR,"[NCBIGene:367, 231, 2232]",495,"Increased, Invasion",1196,false
AR,"[NCBIGene:367, 231, 2232]",495,"Increase, Androgen receptor protein expression/abundance",2134,false
AR,"[NCBIGene:367, 231, 2232]",495,prostatic intraepithelial neoplasia,2136,false
AR,"[NCBIGene:367, 231, 2232]",495,Prostate cancer,2135,false
AR,"[NCBIGene:367, 231, 2232]",495,"Agonism, Androgen receptor",25,true
AR,"[NCBIGene:367, 231, 2232]",495,"Altered, Transcription of genes by the androgen receptor",286,false
AR,"[NCBIGene:367, 231, 2232]",495,"Decreased, Apoptosis (Epithelial Cells)",1183,false
AR,"[NCBIGene:367, 231, 2232]",496,"Decreased, Population trajectory",442,false
AR,"[NCBIGene:367, 231, 2232]",496,"Increase, Gonadotropins concentration in plasma",2137,false
AR,"[NCBIGene:367, 231, 2232]",496,"Reduction, the ratio of 17beta-estradiol/11-Keto Testosterone in plasma",2139,false
AR,"[NCBIGene:367, 231, 2232]",496,"Decrease, circulating testosterone levels",1690,false
AR,"[NCBIGene:367, 231, 2232]",496,"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development",309,false
AR,"[NCBIGene:367, 231, 2232]",496,"Reduction, Plasma vitellogenin concentrations",221,false
AR,"[NCBIGene:367, 231, 2232]",496,"Reduction, Cumulative fecundity and spawning",78,false
AR,"[NCBIGene:367, 231, 2232]",496,"Agonism, Androgen receptor",25,true
AR,"[NCBIGene:367, 231, 2232]",496,"Altered, Transcription of genes by the androgen receptor",286,false
AR,"[NCBIGene:367, 231, 2232]",496,"Reduction, Plasma 17beta-estradiol concentrations",219,false
Aromatase,[NCBIGene:1588],496,"Decreased, Population trajectory",442,false
Aromatase,[NCBIGene:1588],496,"Increase, Gonadotropins concentration in plasma",2137,false
Aromatase,[NCBIGene:1588],496,"Reduction, the ratio of 17beta-estradiol/11-Keto Testosterone in plasma",2139,false
Aromatase,[NCBIGene:1588],496,"Decrease, circulating testosterone levels",1690,false
Aromatase,[NCBIGene:1588],496,"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development",309,false
Aromatase,[NCBIGene:1588],496,"Reduction, Plasma vitellogenin concentrations",221,false
Aromatase,[NCBIGene:1588],496,"Reduction, Cumulative fecundity and spawning",78,false
Aromatase,[NCBIGene:1588],496,"Agonism, Androgen receptor",25,true
Aromatase,[NCBIGene:1588],496,"Altered, Transcription of genes by the androgen receptor",286,false
Aromatase,[NCBIGene:1588],496,"Reduction, Plasma 17beta-estradiol concentrations",219,false
"C 10,20-lyase",[NCBIGene:1583],496,"Decreased, Population trajectory",442,false
"C 10,20-lyase",[NCBIGene:1583],496,"Increase, Gonadotropins concentration in plasma",2137,false
"C 10,20-lyase",[NCBIGene:1583],496,"Reduction, the ratio of 17beta-estradiol/11-Keto Testosterone in plasma",2139,false
"C 10,20-lyase",[NCBIGene:1583],496,"Decrease, circulating testosterone levels",1690,false
"C 10,20-lyase",[NCBIGene:1583],496,"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development",309,false
"C 10,20-lyase",[NCBIGene:1583],496,"Reduction, Plasma vitellogenin concentrations",221,false
"C 10,20-lyase",[NCBIGene:1583],496,"Reduction, Cumulative fecundity and spawning",78,false
"C 10,20-lyase",[NCBIGene:1583],496,"Agonism, Androgen receptor",25,true
"C 10,20-lyase",[NCBIGene:1583],496,"Altered, Transcription of genes by the androgen receptor",286,false
"C 10,20-lyase",[NCBIGene:1583],496,"Reduction, Plasma 17beta-estradiol concentrations",219,false
GSTA1,[NCBIGene:2938],496,"Decreased, Population trajectory",442,false
GSTA1,[NCBIGene:2938],496,"Increase, Gonadotropins concentration in plasma",2137,false
GSTA1,[NCBIGene:2938],496,"Reduction, the ratio of 17beta-estradiol/11-Keto Testosterone in plasma",2139,false
GSTA1,[NCBIGene:2938],496,"Decrease, circulating testosterone levels",1690,false
GSTA1,[NCBIGene:2938],496,"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development",309,false
GSTA1,[NCBIGene:2938],496,"Reduction, Plasma vitellogenin concentrations",221,false
GSTA1,[NCBIGene:2938],496,"Reduction, Cumulative fecundity and spawning",78,false
GSTA1,[NCBIGene:2938],496,"Agonism, Androgen receptor",25,true
GSTA1,[NCBIGene:2938],496,"Altered, Transcription of genes by the androgen receptor",286,false
GSTA1,[NCBIGene:2938],496,"Reduction, Plasma 17beta-estradiol concentrations",219,false
Aromatase,[NCBIGene:1588],497,Mitochondrial dysfunction,177,false
Aromatase,[NCBIGene:1588],497,"Increase, Reactive oxygen species",1115,false
Aromatase,[NCBIGene:1588],497,Estrogen receptor alpha inactivation,2126,true
Aromatase,[NCBIGene:1588],497,Impaired insulin signaling,2144,false
Aromatase,[NCBIGene:1588],497,Metabolic syndrome,2145,false
Aromatase,[NCBIGene:1588],497,"Insulin resistance, increased",2119,false
Aromatase,[NCBIGene:1588],497,"Decrease, Fatty acid beta-oxidation",179,false
Aromatase,[NCBIGene:1588],497,Oxidative Stress,1392,false
ERa,[NCBIGene:26284],497,Mitochondrial dysfunction,177,false
ERa,[NCBIGene:26284],497,"Increase, Reactive oxygen species",1115,false
ERa,[NCBIGene:26284],497,Estrogen receptor alpha inactivation,2126,true
ERa,[NCBIGene:26284],497,Impaired insulin signaling,2144,false
ERa,[NCBIGene:26284],497,Metabolic syndrome,2145,false
ERa,[NCBIGene:26284],497,"Insulin resistance, increased",2119,false
ERa,[NCBIGene:26284],497,"Decrease, Fatty acid beta-oxidation",179,false
ERa,[NCBIGene:26284],497,Oxidative Stress,1392,false
insulin,[NCBIGene:3630],497,Mitochondrial dysfunction,177,false
insulin,[NCBIGene:3630],497,"Increase, Reactive oxygen species",1115,false
insulin,[NCBIGene:3630],497,Estrogen receptor alpha inactivation,2126,true
insulin,[NCBIGene:3630],497,Impaired insulin signaling,2144,false
insulin,[NCBIGene:3630],497,Metabolic syndrome,2145,false
insulin,[NCBIGene:3630],497,"Insulin resistance, increased",2119,false
insulin,[NCBIGene:3630],497,"Decrease, Fatty acid beta-oxidation",179,false
insulin,[NCBIGene:3630],497,Oxidative Stress,1392,false
LCN2,[NCBIGene:3934],498,Increased LCN2/iron complex  binds to SLC22A17 receptor in neuron,2148,true
LCN2,[NCBIGene:3934],498,Increased intracelluar Iron accumulation,2149,false
LCN2,[NCBIGene:3934],498,Neurological disorder,2150,false
LCN2,[NCBIGene:3934],498,Neuronal dysfunction,191,false
beta-amyloid protein,[NCBIGene:351],498,Increased LCN2/iron complex  binds to SLC22A17 receptor in neuron,2148,true
beta-amyloid protein,[NCBIGene:351],498,Increased intracelluar Iron accumulation,2149,false
beta-amyloid protein,[NCBIGene:351],498,Neurological disorder,2150,false
beta-amyloid protein,[NCBIGene:351],498,Neuronal dysfunction,191,false
mutant huntingtin protein,[NCBIGene:3064],498,Increased LCN2/iron complex  binds to SLC22A17 receptor in neuron,2148,true
mutant huntingtin protein,[NCBIGene:3064],498,Increased intracelluar Iron accumulation,2149,false
mutant huntingtin protein,[NCBIGene:3064],498,Neurological disorder,2150,false
mutant huntingtin protein,[NCBIGene:3064],498,Neuronal dysfunction,191,false
ERK1/2,[NCBIGene:5594],499,"Increase, intracellular calcium",1339,false
ERK1/2,[NCBIGene:5594],499,"Disruption, neurotransmitter release",2151,false
ERK1/2,[NCBIGene:5594],499,"Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2",2146,true
ERK1/2,[NCBIGene:5594],499,"Impairment, Learning and memory",341,false
MEK,[NCBIGene:5609],499,"Increase, intracellular calcium",1339,false
MEK,[NCBIGene:5609],499,"Disruption, neurotransmitter release",2151,false
MEK,[NCBIGene:5609],499,"Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2",2146,true
MEK,[NCBIGene:5609],499,"Impairment, Learning and memory",341,false
ERK1/2,[NCBIGene:5594],500,Mitochondrial dysfunction,177,false
ERK1/2,[NCBIGene:5594],500,"Increase, Reactive oxygen species",1115,false
ERK1/2,[NCBIGene:5594],500,"Increase, intracellular calcium",1339,false
ERK1/2,[NCBIGene:5594],500,Apoptosis,1262,false
ERK1/2,[NCBIGene:5594],500,"Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2",2146,true
ERK1/2,[NCBIGene:5594],500,"Impairment, Learning and memory",341,false
ERK1/2,[NCBIGene:5594],500,"N/A, Neurodegeneration",352,false
MEK,[NCBIGene:5609],500,Mitochondrial dysfunction,177,false
MEK,[NCBIGene:5609],500,"Increase, Reactive oxygen species",1115,false
MEK,[NCBIGene:5609],500,"Increase, intracellular calcium",1339,false
MEK,[NCBIGene:5609],500,Apoptosis,1262,false
MEK,[NCBIGene:5609],500,"Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2",2146,true
MEK,[NCBIGene:5609],500,"Impairment, Learning and memory",341,false
MEK,[NCBIGene:5609],500,"N/A, Neurodegeneration",352,false
SULT,[NCBIGene:6819],504,Inhibition of Sulfotransferase E1 (SULT1E1),2155,true
SULT,[NCBIGene:6819],504,"Estradiol availability, increased",2251,false
SULT,[NCBIGene:6819],504,"Activation, estrogen receptor alpha",1065,false
SULT1E1,[NCBIGene:6783],504,Inhibition of Sulfotransferase E1 (SULT1E1),2155,true
SULT1E1,[NCBIGene:6783],504,"Estradiol availability, increased",2251,false
SULT1E1,[NCBIGene:6783],504,"Activation, estrogen receptor alpha",1065,false
steroid sulfatase,[NCBIGene:412],504,Inhibition of Sulfotransferase E1 (SULT1E1),2155,true
steroid sulfatase,[NCBIGene:412],504,"Estradiol availability, increased",2251,false
steroid sulfatase,[NCBIGene:412],504,"Activation, estrogen receptor alpha",1065,false
IL1B,[NCBIGene:3553],505,"Increase, Cancer",885,false
IL1B,[NCBIGene:3553],505,"Increase, Reactive oxygen species",1115,true
IL1B,[NCBIGene:3553],505,General Apoptosis,1513,false
IL1B,[NCBIGene:3553],505,"Increase, Inflammation",149,false
IL1B,[NCBIGene:3553],505,Oxidative Stress,1392,false
interferon alpha,[NCBIGene:3439],505,"Increase, Cancer",885,false
interferon alpha,[NCBIGene:3439],505,"Increase, Reactive oxygen species",1115,true
interferon alpha,[NCBIGene:3439],505,General Apoptosis,1513,false
interferon alpha,[NCBIGene:3439],505,"Increase, Inflammation",149,false
interferon alpha,[NCBIGene:3439],505,Oxidative Stress,1392,false
Nrf2,[NCBIGene:4780],507,Activation of inflammation pathway,2009,false
Nrf2,[NCBIGene:4780],507,increased，Vascular endothelial dysfunction,1928,false
Nrf2,[NCBIGene:4780],507,"Increase, Vascular disrupting effects",2161,false
Nrf2,[NCBIGene:4780],507,Angiogenesis dysfunction,2181,false
Nrf2,[NCBIGene:4780],507,NFE2/Nrf2 repression,1417,true
Nrf2,[NCBIGene:4780],507,Oxidative Stress,1392,false
Dll4,[NCBIGene:54567],508,increased，Vascular endothelial dysfunction,1928,false
Dll4,[NCBIGene:54567],508,"Increase, Vascular disrupting effects",2161,false
Dll4,[NCBIGene:54567],508,Angiogenesis dysfunction,2181,false
Dll4,[NCBIGene:54567],508,"Activation, HIF1α",2162,false
Dll4,[NCBIGene:54567],508,Activation Sema6A,2163,false
Dll4,[NCBIGene:54567],508,"Activation, Dll4-Notch pathway",2164,false
Dll4,[NCBIGene:54567],508,NFE2/Nrf2 repression,1417,true
HIF-1alpha,[NCBIGene:3091],508,increased，Vascular endothelial dysfunction,1928,false
HIF-1alpha,[NCBIGene:3091],508,"Increase, Vascular disrupting effects",2161,false
HIF-1alpha,[NCBIGene:3091],508,Angiogenesis dysfunction,2181,false
HIF-1alpha,[NCBIGene:3091],508,"Activation, HIF1α",2162,false
HIF-1alpha,[NCBIGene:3091],508,Activation Sema6A,2163,false
HIF-1alpha,[NCBIGene:3091],508,"Activation, Dll4-Notch pathway",2164,false
HIF-1alpha,[NCBIGene:3091],508,NFE2/Nrf2 repression,1417,true
Notch,[NCBIGene:4851],508,increased，Vascular endothelial dysfunction,1928,false
Notch,[NCBIGene:4851],508,"Increase, Vascular disrupting effects",2161,false
Notch,[NCBIGene:4851],508,Angiogenesis dysfunction,2181,false
Notch,[NCBIGene:4851],508,"Activation, HIF1α",2162,false
Notch,[NCBIGene:4851],508,Activation Sema6A,2163,false
Notch,[NCBIGene:4851],508,"Activation, Dll4-Notch pathway",2164,false
Notch,[NCBIGene:4851],508,NFE2/Nrf2 repression,1417,true
Nrf2,[NCBIGene:4780],508,increased，Vascular endothelial dysfunction,1928,false
Nrf2,[NCBIGene:4780],508,"Increase, Vascular disrupting effects",2161,false
Nrf2,[NCBIGene:4780],508,Angiogenesis dysfunction,2181,false
Nrf2,[NCBIGene:4780],508,"Activation, HIF1α",2162,false
Nrf2,[NCBIGene:4780],508,Activation Sema6A,2163,false
Nrf2,[NCBIGene:4780],508,"Activation, Dll4-Notch pathway",2164,false
Nrf2,[NCBIGene:4780],508,NFE2/Nrf2 repression,1417,true
Semaphorin 6A,[NCBIGene:57556],508,increased，Vascular endothelial dysfunction,1928,false
Semaphorin 6A,[NCBIGene:57556],508,"Increase, Vascular disrupting effects",2161,false
Semaphorin 6A,[NCBIGene:57556],508,Angiogenesis dysfunction,2181,false
Semaphorin 6A,[NCBIGene:57556],508,"Activation, HIF1α",2162,false
Semaphorin 6A,[NCBIGene:57556],508,Activation Sema6A,2163,false
Semaphorin 6A,[NCBIGene:57556],508,"Activation, Dll4-Notch pathway",2164,false
Semaphorin 6A,[NCBIGene:57556],508,NFE2/Nrf2 repression,1417,true
Nrf2,[NCBIGene:4780],509,Mitochondrial dysfunction,177,false
Nrf2,[NCBIGene:4780],509,"Increase, Apoptosis",1365,false
Nrf2,[NCBIGene:4780],509,increased，Vascular endothelial dysfunction,1928,false
Nrf2,[NCBIGene:4780],509,"Increase, Vascular disrupting effects",2161,false
Nrf2,[NCBIGene:4780],509,Angiogenesis dysfunction,2181,false
Nrf2,[NCBIGene:4780],509,NFE2/Nrf2 repression,1417,true
Nrf2,[NCBIGene:4780],509,Oxidative Stress,1392,false
PPAR,[NCBIGene:5465],51,"Increase, Luteinizing hormone (LH)",414,false
PPAR,[NCBIGene:5465],51,"Hyperplasia, Leydig cell",415,false
PPAR,[NCBIGene:5465],51,"Increase proliferation, Leydig cell",416,false
PPAR,[NCBIGene:5465],51,"Decrease, circulating testosterone levels",1690,false
PPAR,[NCBIGene:5465],51,"Reduction, Testosterone synthesis in Leydig cells",413,false
PPAR,[NCBIGene:5465],51,"Reduction, Cholesterol transport in mitochondria",447,false
PPAR,[NCBIGene:5465],51,"Activation, PPARα",227,true
PPAR,[NCBIGene:5465],51,"decreased, Fertility",406,false
MMP-2MMP-9,[NCBIGene:4318],510,increased，Vascular endothelial dysfunction,1928,false
MMP-2MMP-9,[NCBIGene:4318],510,"Increase, Vascular disrupting effects",2161,false
MMP-2MMP-9,[NCBIGene:4318],510,Angiogenesis dysfunction,2181,false
MMP-2MMP-9,[NCBIGene:4318],510,Activation of PPAR,2165,false
MMP-2MMP-9,[NCBIGene:4318],510,Abnormal expression of NO,2166,false
MMP-2MMP-9,[NCBIGene:4318],510,Activation of MMP-2 MMP-9,2167,false
MMP-2MMP-9,[NCBIGene:4318],510,peroxisome proliferator activated receptor promoter demethylation,228,true
MMP-2MMP-9,[NCBIGene:4318],510,Activation of angiopoietin like protein 4,2168,false
MMP-2MMP-9,[NCBIGene:4318],510,Activation of Angiogenic cytokines,2169,false
MMP-2MMP-9,[NCBIGene:4318],510,Oxidative Stress,1392,false
Nrf2,[NCBIGene:4780],510,increased，Vascular endothelial dysfunction,1928,false
Nrf2,[NCBIGene:4780],510,"Increase, Vascular disrupting effects",2161,false
Nrf2,[NCBIGene:4780],510,Angiogenesis dysfunction,2181,false
Nrf2,[NCBIGene:4780],510,Activation of PPAR,2165,false
Nrf2,[NCBIGene:4780],510,Abnormal expression of NO,2166,false
Nrf2,[NCBIGene:4780],510,Activation of MMP-2 MMP-9,2167,false
Nrf2,[NCBIGene:4780],510,peroxisome proliferator activated receptor promoter demethylation,228,true
Nrf2,[NCBIGene:4780],510,Activation of angiopoietin like protein 4,2168,false
Nrf2,[NCBIGene:4780],510,Activation of Angiogenic cytokines,2169,false
Nrf2,[NCBIGene:4780],510,Oxidative Stress,1392,false
PPAR,[NCBIGene:5465],510,increased，Vascular endothelial dysfunction,1928,false
PPAR,[NCBIGene:5465],510,"Increase, Vascular disrupting effects",2161,false
PPAR,[NCBIGene:5465],510,Angiogenesis dysfunction,2181,false
PPAR,[NCBIGene:5465],510,Activation of PPAR,2165,false
PPAR,[NCBIGene:5465],510,Abnormal expression of NO,2166,false
PPAR,[NCBIGene:5465],510,Activation of MMP-2 MMP-9,2167,false
PPAR,[NCBIGene:5465],510,peroxisome proliferator activated receptor promoter demethylation,228,true
PPAR,[NCBIGene:5465],510,Activation of angiopoietin like protein 4,2168,false
PPAR,[NCBIGene:5465],510,Activation of Angiogenic cytokines,2169,false
PPAR,[NCBIGene:5465],510,Oxidative Stress,1392,false
angiopoietin like protein 4,[NCBIGene:51129],510,increased，Vascular endothelial dysfunction,1928,false
angiopoietin like protein 4,[NCBIGene:51129],510,"Increase, Vascular disrupting effects",2161,false
angiopoietin like protein 4,[NCBIGene:51129],510,Angiogenesis dysfunction,2181,false
angiopoietin like protein 4,[NCBIGene:51129],510,Activation of PPAR,2165,false
angiopoietin like protein 4,[NCBIGene:51129],510,Abnormal expression of NO,2166,false
angiopoietin like protein 4,[NCBIGene:51129],510,Activation of MMP-2 MMP-9,2167,false
angiopoietin like protein 4,[NCBIGene:51129],510,peroxisome proliferator activated receptor promoter demethylation,228,true
angiopoietin like protein 4,[NCBIGene:51129],510,Activation of angiopoietin like protein 4,2168,false
angiopoietin like protein 4,[NCBIGene:51129],510,Activation of Angiogenic cytokines,2169,false
angiopoietin like protein 4,[NCBIGene:51129],510,Oxidative Stress,1392,false
AKT,[NCBIGene:207],511,"KE4 : Uncoupling, eNOS",932,false
AKT,[NCBIGene:207],511,Mitochondrial dysfunction,177,false
AKT,[NCBIGene:207],511,"Increase, Reactive oxygen species",1115,true
AKT,[NCBIGene:207],511,Activation of inflammation pathway,2009,false
AKT,[NCBIGene:207],511,increased，Vascular endothelial dysfunction,1928,false
AKT,[NCBIGene:207],511,"Increase, Vascular disrupting effects",2161,false
AKT,[NCBIGene:207],511,Angiogenesis dysfunction,2181,false
AKT,[NCBIGene:207],511,"Activation, Dll4-Notch pathway",2164,false
AKT,[NCBIGene:207],511,Activated ANG/Tie2 pathway,2170,false
AKT,[NCBIGene:207],511,Activated BMP/TGF-beta pathway,2171,false
AKT,[NCBIGene:207],511,Activated Wnt/Frizzled pathway,2172,false
AKT,[NCBIGene:207],511,Activated AKT/ERK/PI3K pathway,2173,false
AKT,[NCBIGene:207],511,Inhibition VEGF/VEGFR pathway,2174,false
AKT,[NCBIGene:207],511,Vascular barrier disruption,2178,false
AKT,[NCBIGene:207],511,Impaired Platelet Aggregation,2179,false
AKT,[NCBIGene:207],511,Oxidative Stress,1392,false
ANG,[NCBIGene:283],511,"KE4 : Uncoupling, eNOS",932,false
ANG,[NCBIGene:283],511,Mitochondrial dysfunction,177,false
ANG,[NCBIGene:283],511,"Increase, Reactive oxygen species",1115,true
ANG,[NCBIGene:283],511,Activation of inflammation pathway,2009,false
ANG,[NCBIGene:283],511,increased，Vascular endothelial dysfunction,1928,false
ANG,[NCBIGene:283],511,"Increase, Vascular disrupting effects",2161,false
ANG,[NCBIGene:283],511,Angiogenesis dysfunction,2181,false
ANG,[NCBIGene:283],511,"Activation, Dll4-Notch pathway",2164,false
ANG,[NCBIGene:283],511,Activated ANG/Tie2 pathway,2170,false
ANG,[NCBIGene:283],511,Activated BMP/TGF-beta pathway,2171,false
ANG,[NCBIGene:283],511,Activated Wnt/Frizzled pathway,2172,false
ANG,[NCBIGene:283],511,Activated AKT/ERK/PI3K pathway,2173,false
ANG,[NCBIGene:283],511,Inhibition VEGF/VEGFR pathway,2174,false
ANG,[NCBIGene:283],511,Vascular barrier disruption,2178,false
ANG,[NCBIGene:283],511,Impaired Platelet Aggregation,2179,false
ANG,[NCBIGene:283],511,Oxidative Stress,1392,false
BMP,[NCBIGene:649],511,"KE4 : Uncoupling, eNOS",932,false
BMP,[NCBIGene:649],511,Mitochondrial dysfunction,177,false
BMP,[NCBIGene:649],511,"Increase, Reactive oxygen species",1115,true
BMP,[NCBIGene:649],511,Activation of inflammation pathway,2009,false
BMP,[NCBIGene:649],511,increased，Vascular endothelial dysfunction,1928,false
BMP,[NCBIGene:649],511,"Increase, Vascular disrupting effects",2161,false
BMP,[NCBIGene:649],511,Angiogenesis dysfunction,2181,false
BMP,[NCBIGene:649],511,"Activation, Dll4-Notch pathway",2164,false
BMP,[NCBIGene:649],511,Activated ANG/Tie2 pathway,2170,false
BMP,[NCBIGene:649],511,Activated BMP/TGF-beta pathway,2171,false
BMP,[NCBIGene:649],511,Activated Wnt/Frizzled pathway,2172,false
BMP,[NCBIGene:649],511,Activated AKT/ERK/PI3K pathway,2173,false
BMP,[NCBIGene:649],511,Inhibition VEGF/VEGFR pathway,2174,false
BMP,[NCBIGene:649],511,Vascular barrier disruption,2178,false
BMP,[NCBIGene:649],511,Impaired Platelet Aggregation,2179,false
BMP,[NCBIGene:649],511,Oxidative Stress,1392,false
Dll4,[NCBIGene:54567],511,"KE4 : Uncoupling, eNOS",932,false
Dll4,[NCBIGene:54567],511,Mitochondrial dysfunction,177,false
Dll4,[NCBIGene:54567],511,"Increase, Reactive oxygen species",1115,true
Dll4,[NCBIGene:54567],511,Activation of inflammation pathway,2009,false
Dll4,[NCBIGene:54567],511,increased，Vascular endothelial dysfunction,1928,false
Dll4,[NCBIGene:54567],511,"Increase, Vascular disrupting effects",2161,false
Dll4,[NCBIGene:54567],511,Angiogenesis dysfunction,2181,false
Dll4,[NCBIGene:54567],511,"Activation, Dll4-Notch pathway",2164,false
Dll4,[NCBIGene:54567],511,Activated ANG/Tie2 pathway,2170,false
Dll4,[NCBIGene:54567],511,Activated BMP/TGF-beta pathway,2171,false
Dll4,[NCBIGene:54567],511,Activated Wnt/Frizzled pathway,2172,false
Dll4,[NCBIGene:54567],511,Activated AKT/ERK/PI3K pathway,2173,false
Dll4,[NCBIGene:54567],511,Inhibition VEGF/VEGFR pathway,2174,false
Dll4,[NCBIGene:54567],511,Vascular barrier disruption,2178,false
Dll4,[NCBIGene:54567],511,Impaired Platelet Aggregation,2179,false
Dll4,[NCBIGene:54567],511,Oxidative Stress,1392,false
ERK1/2,[NCBIGene:5594],511,"KE4 : Uncoupling, eNOS",932,false
ERK1/2,[NCBIGene:5594],511,Mitochondrial dysfunction,177,false
ERK1/2,[NCBIGene:5594],511,"Increase, Reactive oxygen species",1115,true
ERK1/2,[NCBIGene:5594],511,Activation of inflammation pathway,2009,false
ERK1/2,[NCBIGene:5594],511,increased，Vascular endothelial dysfunction,1928,false
ERK1/2,[NCBIGene:5594],511,"Increase, Vascular disrupting effects",2161,false
ERK1/2,[NCBIGene:5594],511,Angiogenesis dysfunction,2181,false
ERK1/2,[NCBIGene:5594],511,"Activation, Dll4-Notch pathway",2164,false
ERK1/2,[NCBIGene:5594],511,Activated ANG/Tie2 pathway,2170,false
ERK1/2,[NCBIGene:5594],511,Activated BMP/TGF-beta pathway,2171,false
ERK1/2,[NCBIGene:5594],511,Activated Wnt/Frizzled pathway,2172,false
ERK1/2,[NCBIGene:5594],511,Activated AKT/ERK/PI3K pathway,2173,false
ERK1/2,[NCBIGene:5594],511,Inhibition VEGF/VEGFR pathway,2174,false
ERK1/2,[NCBIGene:5594],511,Vascular barrier disruption,2178,false
ERK1/2,[NCBIGene:5594],511,Impaired Platelet Aggregation,2179,false
ERK1/2,[NCBIGene:5594],511,Oxidative Stress,1392,false
Frizzled,[NCBIGene:8321],511,"KE4 : Uncoupling, eNOS",932,false
Frizzled,[NCBIGene:8321],511,Mitochondrial dysfunction,177,false
Frizzled,[NCBIGene:8321],511,"Increase, Reactive oxygen species",1115,true
Frizzled,[NCBIGene:8321],511,Activation of inflammation pathway,2009,false
Frizzled,[NCBIGene:8321],511,increased，Vascular endothelial dysfunction,1928,false
Frizzled,[NCBIGene:8321],511,"Increase, Vascular disrupting effects",2161,false
Frizzled,[NCBIGene:8321],511,Angiogenesis dysfunction,2181,false
Frizzled,[NCBIGene:8321],511,"Activation, Dll4-Notch pathway",2164,false
Frizzled,[NCBIGene:8321],511,Activated ANG/Tie2 pathway,2170,false
Frizzled,[NCBIGene:8321],511,Activated BMP/TGF-beta pathway,2171,false
Frizzled,[NCBIGene:8321],511,Activated Wnt/Frizzled pathway,2172,false
Frizzled,[NCBIGene:8321],511,Activated AKT/ERK/PI3K pathway,2173,false
Frizzled,[NCBIGene:8321],511,Inhibition VEGF/VEGFR pathway,2174,false
Frizzled,[NCBIGene:8321],511,Vascular barrier disruption,2178,false
Frizzled,[NCBIGene:8321],511,Impaired Platelet Aggregation,2179,false
Frizzled,[NCBIGene:8321],511,Oxidative Stress,1392,false
Notch,[NCBIGene:4851],511,"KE4 : Uncoupling, eNOS",932,false
Notch,[NCBIGene:4851],511,Mitochondrial dysfunction,177,false
Notch,[NCBIGene:4851],511,"Increase, Reactive oxygen species",1115,true
Notch,[NCBIGene:4851],511,Activation of inflammation pathway,2009,false
Notch,[NCBIGene:4851],511,increased，Vascular endothelial dysfunction,1928,false
Notch,[NCBIGene:4851],511,"Increase, Vascular disrupting effects",2161,false
Notch,[NCBIGene:4851],511,Angiogenesis dysfunction,2181,false
Notch,[NCBIGene:4851],511,"Activation, Dll4-Notch pathway",2164,false
Notch,[NCBIGene:4851],511,Activated ANG/Tie2 pathway,2170,false
Notch,[NCBIGene:4851],511,Activated BMP/TGF-beta pathway,2171,false
Notch,[NCBIGene:4851],511,Activated Wnt/Frizzled pathway,2172,false
Notch,[NCBIGene:4851],511,Activated AKT/ERK/PI3K pathway,2173,false
Notch,[NCBIGene:4851],511,Inhibition VEGF/VEGFR pathway,2174,false
Notch,[NCBIGene:4851],511,Vascular barrier disruption,2178,false
Notch,[NCBIGene:4851],511,Impaired Platelet Aggregation,2179,false
Notch,[NCBIGene:4851],511,Oxidative Stress,1392,false
PI3K,[NCBIGene:5291],511,"KE4 : Uncoupling, eNOS",932,false
PI3K,[NCBIGene:5291],511,Mitochondrial dysfunction,177,false
PI3K,[NCBIGene:5291],511,"Increase, Reactive oxygen species",1115,true
PI3K,[NCBIGene:5291],511,Activation of inflammation pathway,2009,false
PI3K,[NCBIGene:5291],511,increased，Vascular endothelial dysfunction,1928,false
PI3K,[NCBIGene:5291],511,"Increase, Vascular disrupting effects",2161,false
PI3K,[NCBIGene:5291],511,Angiogenesis dysfunction,2181,false
PI3K,[NCBIGene:5291],511,"Activation, Dll4-Notch pathway",2164,false
PI3K,[NCBIGene:5291],511,Activated ANG/Tie2 pathway,2170,false
PI3K,[NCBIGene:5291],511,Activated BMP/TGF-beta pathway,2171,false
PI3K,[NCBIGene:5291],511,Activated Wnt/Frizzled pathway,2172,false
PI3K,[NCBIGene:5291],511,Activated AKT/ERK/PI3K pathway,2173,false
PI3K,[NCBIGene:5291],511,Inhibition VEGF/VEGFR pathway,2174,false
PI3K,[NCBIGene:5291],511,Vascular barrier disruption,2178,false
PI3K,[NCBIGene:5291],511,Impaired Platelet Aggregation,2179,false
PI3K,[NCBIGene:5291],511,Oxidative Stress,1392,false
TGF-1,[NCBIGene:7040],511,"KE4 : Uncoupling, eNOS",932,false
TGF-1,[NCBIGene:7040],511,Mitochondrial dysfunction,177,false
TGF-1,[NCBIGene:7040],511,"Increase, Reactive oxygen species",1115,true
TGF-1,[NCBIGene:7040],511,Activation of inflammation pathway,2009,false
TGF-1,[NCBIGene:7040],511,increased，Vascular endothelial dysfunction,1928,false
TGF-1,[NCBIGene:7040],511,"Increase, Vascular disrupting effects",2161,false
TGF-1,[NCBIGene:7040],511,Angiogenesis dysfunction,2181,false
TGF-1,[NCBIGene:7040],511,"Activation, Dll4-Notch pathway",2164,false
TGF-1,[NCBIGene:7040],511,Activated ANG/Tie2 pathway,2170,false
TGF-1,[NCBIGene:7040],511,Activated BMP/TGF-beta pathway,2171,false
TGF-1,[NCBIGene:7040],511,Activated Wnt/Frizzled pathway,2172,false
TGF-1,[NCBIGene:7040],511,Activated AKT/ERK/PI3K pathway,2173,false
TGF-1,[NCBIGene:7040],511,Inhibition VEGF/VEGFR pathway,2174,false
TGF-1,[NCBIGene:7040],511,Vascular barrier disruption,2178,false
TGF-1,[NCBIGene:7040],511,Impaired Platelet Aggregation,2179,false
TGF-1,[NCBIGene:7040],511,Oxidative Stress,1392,false
Tie2,[NCBIGene:7010],511,"KE4 : Uncoupling, eNOS",932,false
Tie2,[NCBIGene:7010],511,Mitochondrial dysfunction,177,false
Tie2,[NCBIGene:7010],511,"Increase, Reactive oxygen species",1115,true
Tie2,[NCBIGene:7010],511,Activation of inflammation pathway,2009,false
Tie2,[NCBIGene:7010],511,increased，Vascular endothelial dysfunction,1928,false
Tie2,[NCBIGene:7010],511,"Increase, Vascular disrupting effects",2161,false
Tie2,[NCBIGene:7010],511,Angiogenesis dysfunction,2181,false
Tie2,[NCBIGene:7010],511,"Activation, Dll4-Notch pathway",2164,false
Tie2,[NCBIGene:7010],511,Activated ANG/Tie2 pathway,2170,false
Tie2,[NCBIGene:7010],511,Activated BMP/TGF-beta pathway,2171,false
Tie2,[NCBIGene:7010],511,Activated Wnt/Frizzled pathway,2172,false
Tie2,[NCBIGene:7010],511,Activated AKT/ERK/PI3K pathway,2173,false
Tie2,[NCBIGene:7010],511,Inhibition VEGF/VEGFR pathway,2174,false
Tie2,[NCBIGene:7010],511,Vascular barrier disruption,2178,false
Tie2,[NCBIGene:7010],511,Impaired Platelet Aggregation,2179,false
Tie2,[NCBIGene:7010],511,Oxidative Stress,1392,false
VEGF,[NCBIGene:7422],511,"KE4 : Uncoupling, eNOS",932,false
VEGF,[NCBIGene:7422],511,Mitochondrial dysfunction,177,false
VEGF,[NCBIGene:7422],511,"Increase, Reactive oxygen species",1115,true